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 Abstract 
 
      Tendinopathies are a range of diseases characterised by pain and insidious 
degeneration. Although poorly understood, onset is often associated with physical activity. 
Metalloproteinases are regulated differentially in tendinopathy causing disruptions in 
extracellular matrix (ECM) homeostasis. An increase in the anti-inflammatory cytokine 
TGFβ has also been documented.  This project aims to investigate the effect of cyclic 
tensile strain loading and TGFβ stimulation on protease and ECM protein expression by 
human tenocytes and begin to characterise the pathway of mechanotransduction. 
      Human tenocytes were seeded at 1.5x10
6
 cells/ml into collagen gels (rat tail type I, 
1mg/ml) and stretched using a sinusoidal waveform of 0-5% at 1Hz using the Flexcell 
FX4000T™ system. Cultures were treated with or without 1ng/ml TGFβ1 or inhibitors of 
TGFβRI, metalloproteinases, RGD, Mannose-6-phosphate, integrin β1 and a 
thrombospondin as appropriate. qRT-PCR and a cell based luciferase assay were used to 
assess RNA and TGFβ activity respectively.  
      The prolonged application of 5% cyclic mechanical strain in a 3D culture system 
induced an anabolic response in protease and matrix genes. In most genes changes in gene 
expression with loading was mirrored with TGFβ stimulation. We also demonstrated that 
the inhibition of the TGFβRI abrogated the strain induced changes in mRNA. TGFβ 
activity was increased with 48 hours mechanical strain although there was no increase in 
mRNA or total TGFβ. This indicates that TGFβ activation plays an important role in the 
mechanoregulation of gene expression. Inhibition of potential mechanisms of TGFβ 
activation including; serine protease or metalloproteinase activity, integrin or 
thrombospondin interaction with latent TGFβ showed no effect upon TGFβ activation or 
gene regulation with strain. Therefore strain mediated TGFβ activation may occur via a 
novel mechanism. By understanding mechanotransduction, we may be able to determine 
whether dysregulation of this system is involved in the development of tendinopathy. 
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CHAPTER 1: Introduction 
 
Tendinopathies are a range of diseases that are a significant cause of morbidity and 
represent a sizable proportion of referrals to general practitioners (Badley and Tennant 
1993; McCormick, Charlton et al. 1995). Although these individuals do not show risk of 
mortality, they do suffer with a decrease in quality of life, involving pain and decreased 
mobility (Khan, Cook et al. 2000). In addition, long periods of rehabilitation are often 
involved (Clegg, Strassburg et al. 2007). Characteristic symptoms include; chronic pain, 
swelling, localised tenderness, impaired movement, rupture or microinjury (through 
overuse) and insidious degeneration of the tendon (Paavola, Kannus et al. 2002). Vascular 
profusion, impingement, trauma and repetitive unequally distributed strain have been 
implicated in the development of tendinopathy (Riley 2004). Relatively little is understood 
about the underlying mechanisms, though onset is often associated with increased age and 
physical activity (Badley and Tennant 1993; Paavola, Kannus et al. 2002; Fedorczyk 2006; 
Dudhia, Scott et al. 2007).  
Tendons predominantly affected are those exposed to higher levels of mechanical strain 
such as the supraspinatus, Achilles, patella and the lateral and medial epicondyle tendon 
(Woo, Renström et al. 2007). Although prevalent in the general population, athletes are the 
most commonly affected; for example, there is a high incidence of Achilles tendinopathy 
in the running population (Paavola, Kannus et al. 2002; Woo, Renström et al. 2007). 
Mechanical strain is therefore considered to be one of the major contributing factors to the 
onset of the disease. However, due to our inadequate understanding of the disease 
pathology, treatment is restricted to pain relief, exercise, cryotherapy, non-steroidal ant-
inflammatory drugs and surgery (Khan, Cook et al. 2000; Paavola, Kannus et al. 2002). 
However, these treatments are often ineffective (Almekinders and Temple 1998; Khan, 
Cook et al. 2000; Paavola, Kannus et al. 2002), even after corrective surgery only 60-85% 
are able to return to sporting exercise (Woo, Renström et al. 2007). In order to develop 
effective treatments we must first understand the disease mechanistically. 
Chapter1: Introduction 
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1.1. TENDON STRUCTURE  
Tendon is characterized as dense fibrous connective tissue (Riley 2004). Tendon is well 
known for its hierarchal structure (Khan, Cook et al. 1999). Tightly packed  collagen fibrils 
make up fibres, sub fascicles, fascicles and tertiary fibre bundles and are enclosed in the 
endotenon giving tendon its strength and flexibility (Figure 1.1) (Kastelic, Galeski et al. 
1978). Tenocytes form an elaborate interconnecting network of cell processes which run 
longitudinally within the fibre bundles as well as laterally (so that each fibre bundle is 
enclosed in sheet like cell processes). Tenocytes in this arrangement are thought to 
communicate through GAP junctions (McNeilly, Banes et al. 1996). At the periphery of 
the tendon are layers of flattened tenocytes (2-3) that form what is known as the epitenon 
(Kastelic, Galeski et al. 1978). Tenocytes of the epitenon inner layers communicate 
through GAP junctions with the cells of the outer tendon proper (McNeilly, Banes et al. 
1996). Tendon is made up of a complex array of collagens, proteoglycans and 
glycoproteins, some of which are poorly characterised; here we describe tendon 
composition further.   
Chapter1: Introduction 
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Figure 1.1. Tendon Hierarchal structure .  
The tendon is made up of a complex hierarchal structure. Individual collagen 
fibrils group to form collagen fibres, multiple fibres form subfascicles. 
Subfascicles group to form the tertiary fibre bundles. Finally Tertiary fibre 
bundles group to form the tendon. Subfascicles, fascicles and tertiary fibre 
bundles are all surrounded in the endotenon. The entire tendon is enclosed in 
the epitenon. Adapted from (Riley 2005) 
 
Chapter1: Introduction 
16 
 
 
1.1.1. Collagens of tendon 
Twenty eight different types of collagen have been characterised to date (Kadler, Baldock 
et al. 2007). Collagens are generally composed of a right handed triple helix made up of 
homo or heterotrimers of polypeptide chains known as α chains. There are 42 different α 
chains that are combined in triplicate to create different types of collagen (Table 1.1). Each 
α chain within the triple helix is made up of a left-handed helix with an expanse of 18 
amino acids per turn of the helix. Each α chain contains a glycine repeat every three amino 
acids to form Gly-X-Y, where X and Y positions are often occupied by proline and 
hydroxyproline respectively. Specific residues (proline and lysine residues) are modified 
by posttranslational enzymatic hydroxylation. Hydroxyproline content is important for the 
formation of hydrogen bonds within the helix (Gelse, Poschl et al. 2003; Riley 2005; 
Kadler, Baldock et al. 2007).  
Collagen is synthesised as soluble procollagen, flanked with a C-terminal trimeric globular 
propeptide domain and an N-terminal trimeric propeptide domain (Figure 1.2). The C-
terminal globular domain is important in the assembly of the trimeric collagen monomers 
(Gelse, Poschl et al. 2003). Upon secretion the N-terminal and C-terminal pro regions are 
cleaved to produce mature collagen. This is mediated by procollagen metalloproteinases 
such as ADAMTS 2, 3 and 14 which cleave N-terminal procollagen (Colige, Beschin et al. 
1995; Colige, Li et al. 1997; Fernandes, Hirohata et al. 2001; Wang, Lee et al. 2003) and 
BMP-1 which cleaves the C-terminal of procollagen (Li, Sieron et al. 1996). Mature 
collagen spontaneously assembles to form string like aggregates known as fibrils. 
Although this occurs spontaneously, a range of extracellular matrix components are 
involved in the temporal and spatial regulation of collagen fibrillogenesis (Kadler, Hill et 
al. 2008).  Collagens form different structural conformations and they are grouped 
accordingly; fibril forming collagen, meshwork forming collagen, beaded filament 
collagen and fibril-associated collagen with interrupted triple helix (FACIT) (Riley 2005). 
For a more detailed review of basic collagen structure and fibril formation see the 
following articles (Kadler, Holmes et al. 1996; Ottani, Martini et al. 2002; Gelse, Poschl et 
al. 2003; Canty and Kadler 2005; Riley 2005; Kadler, Hill et al. 2008). 
The main constituent  of the tendon hierarchal structure is type I collagen, it forms ~95% 
of tendon mid-substance (Rees, Flannery et al. 2000). Type I collagen is a fibrillar collagen 
Chapter1: Introduction 
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made up of a heterotrimer by two identical α1(I) chains and one α2(I) chain. Triple helices 
align with the longitudinal axis of loading (Screen, Shelton et al. 2005). Type I collagen is 
therefore important in longitudinal strength (Riley, Harrall et al. 1994).  
Type III collagen is made up of a homotrimer of α1(III) chains. Type III collagen is more 
compliant in physiology, forms a meshwork of thinner fibres than type I collagen and 
constitutes approximately 2% of tendon. It is also a fibrillar collagen predominantly 
localized to the surrounding areas of tendon fibres, endotenon and epitenon (Duance, 
Restall et al. 1977; Riley, Harrall et al. 1994).  
Other types of collagen are also present, although less abundantly, such as fibril forming 
collagens type II and type V, network forming collagens such as type IV, type VI 
filamentous collagen, and types XII and XIV which are fibril-associated (Table 1) (Riley, 
Harrall et al. 1994; Riley 2004; Riley 2005). Collagen was first thought to be a static 
protein of little interest, however it is now known that collagen is involved in constant 
turnover, which enables ECM to adapt to the environment (Laurent 1987).  
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Table 1.1. Collagen composition of tendon ECM  
[Adapted from (Gelse, Poschl et al. 2003; Riley 2005)] Abbreviations: FACIT, fibril-associated 
collagen with interrupted triple helix   
Collagen 
                            
Structure/Type Location and function 
   
Type I  
Fibril-forming  
[α1(I)]2,  α2(I) 
Main constituent of tendon  
(~95% of total collagen) 
Type II 
Fibril-forming             
[α1(II)]3 
Restricted to fibrocartilage of the tendon  
forms less-organized meshwork 
Type III  
Fibril-forming             
[α1(III)]3 
Normally restricted to endotenon and 
epitenon 
forms smaller, less-organized fibrils 
Type IV  
Forms meshwork  
[α1(III)]2,  α1-6(III) Basement membrane of blood vessels 
Type V  
Fibril-forming             
α1(V),  α2(V), α3(V) 
Core of type I collagen fibril; forms 
template for fibrillogenesis 
Type VI  
Beaded filaments   
α1(VI),  α2(VI), α3(VI) 
Cell-associated  
found in ‘seams’ between fibrils 
Type IX  
FACIT                      
α1(IX),  α2(IX), α3(IX) 
Mediates cell–matrix interactions with type 
II collagen fibril surface 
Type X  
Forms meshwork     
[α1(X)]3 
Restricted to insertion fibrocartilage  
May be associated with mineralisation 
Type XI  
Fibril-forming           
α1(XI),  α2(XI), α3(XI) 
Core of type II collagen fibril  
forms template for fibrillogenesis 
Type XII 
FACIT                     
[α1(XII)]3 
Mediates cell–matrix interactions with type 
I collagen fibril surface 
Type XIV 
FACIT                     
[α1(XIV)]3 
Mediates cell–matrix interactions with type 
I collagen fibril surface 
Chapter1: Introduction 
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Procollagen α chains 
Nucleation at the C-terminal 
of the propeptides 
Procollagen trimer 
N-terminal C-terminal 
N-proteinase 
cleavage 
C-proteinase 
cleavage 
Collagen 
Cross-linked 
Collagen 
Collagen Fibril assmebley 
Collagen processing 
Figure 1.2. Collagen fibril formation . Procollagen α chains are synthesised in the 
endoplasmic reticulum. The collagen α chains aggregate to form a trimer, this 
interaction begins at the C-terminal propeptide. Procollagen form a rod like triple 
helical domain flanked by N and C-terminal globular propeptides. Collagen propeptides 
are cleaved at the N and C terminal by metalloproteinases to form a mature collagen 
molecule. Mature collagen molecules spontaneously aggregate to form fibrils. 
Crosslinking of collagen by lysyl oxidase stabilises the complex. Adapted from 
(Kadler, Holmes et al. 1996; Gelse, Poschl et al. 2003; Canty and Kadler 2005) 
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1.1.2. Proteoglycans of tendon 
Tendons are composed of 1% proteoglycan (Vogel and Heinegard 1985; Riley 2005), the 
most abundant non-collagenous molecules in tendon (Screen, Shelton et al. 2005). The 
most plentiful of these include small leucine rich proteoglycans (SLRP) such as decorin 
and biglycan and large aggregating proteoglycans such as aggrecan (Rees, Flannery et al. 
2000) (See summary of tendon proteoglycans in Table 1.2). Proteoglycans form bridges 
between collagen fibrils that increase tendon strength and reduce the sliding of fibrils 
(Screen, Shelton et al. 2005). Sulphated Glycosaminoglycans (GAG) such as keratan 
sulphate, dermatan sulphate and chondroitin sulphate, can form part of Proteoglycan 
molecules (Rees, Flannery et al. 2000). Tendons have different total GAG proportions 
according to function, for example the supraspinatus has a high GAG level compared to 
tendons under less strain (Riley, Harrall et al. 1994). Not only do proteoglycans function as 
structural features of tendon but they are also involved in a range of important biological 
processes (Hardingham and Fosang 1992). Proteoglycan and GAG complexes are 
important in tendon resistance to load: for example aggrecan has many GAG regions 
which have a very high negative charge (sulphate and carboxylate groups), this attracts 
counter ions causing the osmotic potential to increase and therefore the tissue retains water. 
Water saturation is resisted by the collagen network, enabling the tendon to maintain a 
turgid structure (Hardingham and Fosang 1992). Areas containing high levels of 
proteoglycan are able to withstand elevated compressive loading, this is evident in tendons 
which undergo high level compressive loading such as the supraspinatus in the rotator cuff 
(Riley 2005).  
Small leucine rich proteoglycans (SLRP) 
SLRPs present in tendon include decorin, biglycan, fibromodulin and lumican, although 
decorin and biglycan are the most abundant. They contain a small core protein (~40kDa) 
consisting of a central domain containing leucine rich repeats involved in collagen binding 
and an N-terminal region capable of binding GAG (Figure 1.3) (Hardingham and Fosang 
1992). Fibromodulin and lumican consist of a core protein bound to GAG side chains; 
fibromodulin contains up to 100 keratan sulphate chains and both fibromodulin and 
lumican bind up to 21 chondroitin sulphate chains (Funderburgh, Caterson et al. 1987; 
Oldberg, Antonsson et al. 1989). Decorin and biglycan contain a similar protein core and 
are able to bind chondroitin sulphate as well as dermatan sulphate, although binding of one 
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dermatan sulphate to decorin and two chondroitin sulphate to biglycan is more common in 
tendon ECM (Hardingham and Fosang 1992).  
Decorin, biglycan, fibromodulin and lumican have the ability to bind fibrillar collagen 
types I and II and are involved in the regulation of collagen fibrillogenesis through the 
interaction of their core protein. These proteoglycans reduce the thickness of collagen 
fibres and delay the process of fibril formation (Danielson, Baribault et al. 1997; 
Chakravarti, Magnuson et al. 1998; Svensson, Aszodi et al. 1999). Biglycan can also bind 
the N-terminal of type VI collagen with high affinity via its core protein and GAG chains. 
Through this interaction, biglycan is involved in the assembly of type VI collagen into a 
hexagonal network, where GAG chains play a key role by separating the collagen 
molecules while the assembly is initiated (Wiberg, Heinegard et al. 2002).  
Decorin, biglycan and fibromodulin are able to bind TGFβ via conserved regions of their 
core protein, however fibromodulin appears to bind with greater affinity to TGFβ1 and 
TGFβ2 isoforms compared to the other proteoglycans, this is due to the inhibition of this 
interaction by GAG chains i.e. chondroitin sulphate. On the other hand, fibromodulin was 
less effective at binding TGFβ3 than decorin and biglycan (Hildebrand, Romaris et al. 
1994). This interaction may lead to the sequestration of TGFβ in the ECM and therefore 
regulate the availability of TGFβ (for more details of TGFβ release and activation see 
section 1.9). Decorin is also able to inhibit the activity of TGFβ, and as TGFβ can induce 
decorin, the inhibition of TGFβ activity by decorin may act as a negative feedback loop 
(Hardingham and Fosang 1992). SLRPs are therefore key regulators in collagen 
fibrillogenesis and the spatial and temporal regulation of TGFβ. 
Large Proteoglycans 
Aggrecan is the most highly characterised of the proteoglycans. It is a large proteoglycan 
with a core protein of approximately 230-250kDa; it is most highly expressed in areas of 
articular cartilage where the need to withstand compressive load is at its highest 
(Hardingham and Fosang 1992). In tendon aggrecan is predominantly expressed in areas 
exposed to high level compressive load. As I have previously mentioned, resistance to 
compressive load involves the interaction of water and aggrecan via its many GAG chains. 
Aggrecan contains a large number of keratan sulphate and chondroitin sulphate chains (see 
Figure 1.3 for aggrecan structure), in fact carbohydrate constitutes 90% of aggrecan 
(Hardingham and Fosang 1992). The GAG binding domain contains 3 distinct sites, one 
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region which binds to keratan sulphate and two regions that bind to chondroitin sulphate 
(often termed CS1 and CS2). As well as the GAG binding domain, aggrecan also contains 
3 globular domains (known as G1, G2 and G3), G1 and G2 are located at the N terminus 
and G3 is located at the C terminus with the GAG binding domain between the G2 and G3 
domains (Riley 2005). The G1 domain containing an immunoglobulin domain may be 
involved in cell recognition. The G2 domain contains a proteoglycan tandem repeat may be 
involved in binding of hyaluronan. The G3 domain may be involved in the intracellular 
processing and trafficking of aggrecan as well as the targeted binding of specific GAG 
chains (Hardingham and Fosang 1992). 
Versican is also a large proteoglycan with a very similar structure to aggrecan, although it 
lacks the G2 domain and carries far less chondroitin sulphate (from 0-23 chains depending 
on the splice variant) and no keratan sulphate (see figure 1.3 for versican structure). 
Versican is expressed as four splice variants generated from one gene. The GAG binding 
domain of versican is divided into sections known as GAGα (exon 7) and GAGβ (exon 8), 
and the four spice variants of versican are created by alternate splicing of these domains 
(Wight 2002). The C terminal G3 domain of both versican and aggrecan contains an 
epidermal growth factor-like domain, a C-type lectin-like domain and a complementary 
regulatory protein-like domain (Hardingham and Fosang 1992). Versican is involved in 
cell adhesion in the pericellular matrix which in turn can modulate cell proliferation, 
migration and phenotype, i.e. increased expression of versican in the pericellular matrix 
can induce a change from fibroblastic to myofibroblastic phenotype (Hattori, Carrino et al. 
2011). 
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Figure 1.3. Proteoglycan Structure in tendon . Decorin, biglycan, fibromodulin and 
lumican are small leucine rich proteoglycans (SLRP) - they have a similar core protein 
structure and bind different glycosaminoglycans (GAG) (keratan sulphate, chondroitin 
sulphate or dermatan sulphate) at either the NH2 terminus or the leucine rich region. Aggrecan 
and versican are large proteoglycans also known as hyalectans. Aggrecan contains G1, G2 and 
G3 domains whereas versican contains only the G1 and G3 domains. Aggrecan binds to 
keratan sulphate at one domain (KS) and chondroitin sulphate at two domains (CS1 and CS2). 
Versican bind only chondroitin sulphate. Versican is expressed as four isoforms, which are 
made up of spice variants of the α and β GAG binding domain. Adapted from (Hardingham 
and Fosang 1992; Riley 2004; Riley 2005). 
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1.1.3. Glycoproteins of tendon 
The main non-collagen glycoproteins present in the tendon include elastin, tenascin-C, 
fibrillin, fibronectin, laminin, link protein, thrombospondin and COMP (See summary of 
tendon glycoproteins in Table 1.2). Elastin is secreted as tropoelastin which is unstable and 
soluble. However once elastin is fully formed into fibres it is characteristically stable and 
insoluble, with many hydrophobic amino acids and a high proportion of glycine and 
proline (Uitto 1979). Elastin fibres are made up of polypeptide chains connected via highly 
stable desmosine and isodesmosine crosslinks which are essential for strength and 
elasticity (Uitto 1979). Elastin is the main component of elastic fibres and although less 
than 2% of the tendon dry weight is made up of elastin, it is has important elastic 
properties including the preservation of the crimp (Kastelic, Galeski et al. 1978; Riley 
2005). Elastin expression is highest at the insertion where the tendon is exposed to the 
highest tensional forces and lowest in areas of fibrocartilage (Ritty, Ditsios et al. 2002).  
Fibrillin is the main constituent of extracellular microfibrils. They are cysteine rich 
glycoproteins consisting of numerous calcium binding epidermal growth factor domains. 
They polymerise extracellularly in a head to tail formation to form parallel bundles which 
are stabilised by calcium and the action of transglutaminase (Ramirez and Pereira 1999). 
Fibrillins are commonly associated with elastic fibres as well as microfibril associated 
glycoproteins 1 and 2 (MAGP1 and MAGP2) (Ritty, Ditsios et al. 2002). Fibrillins form a 
template for tropoelastin in elastic fibrillogenesis (formation of elastin fibres). This is 
mainly achieved by fibrillin-2. Fibrillin-1 is involved in the resistance to tensional force 
(Ramirez and Pereira 1999). Fibrillin also plays a key role in the sequestration of latent 
TGFβ in the ECM (for more details see section 1.9) (Ramirez and Rifkin 2009) and 
interacts with cells via α5β1 and αvβ3 integrins (Bax, Bernard et al. 2003).  
Thrombospondin-1 (TSP1), Fibronectin, COMP and tenascin-C are involved in cell-matrix 
interactions (Riley 2004). TSP1 is a large heterotrimeric and adhesive glycoprotein. Each 
of its three components has a molecular weight of 140kDa and contains three repeating 
subunits (I, II and III) (Wolf, Eddy et al. 1990). TSP1 is able to bind its receptor, CD36, on 
the cell surface (Yehualaeshet, O'Connor et al. 1999) and also other components of the 
ECM such as collagen and laminin (Wolf, Eddy et al. 1990). It is involved in the activation 
of transforming growth factor β, inducing a conformational change in the latent TGFβ 
Chapter1: Introduction 
25 
 
complex upon binding via an LSKL motif (Schultz-Cherry and Murphy-Ullrich 1993). 
This can also occur while TSP1 is bound to its receptor (Yehualaeshet, O'Connor et al. 
1999). TSP1 is also involved in angiogenisis. TSP1 contains two domains which have anti-
angiogenic properties, each can induce anti-angiogenic effects independantly (Tolsma, 
Volpert et al. 1993). 
Fibronectin is made up of either one or two ~250kDa subunits linked by a disulphide bond. 
Different isoforms of fibronectin are generated by alternative splicing of a single gene. 
Fibronectins are implicated in a wide range of processes including cell adhesion, growth 
and differentiation, mainly involving the interaction of cells with the ECM (Pankov and 
Yamada 2002). Fibronectin can bind heparin, collagen and fibrin as well as facilitate 
cellular interactions through integrins. A wide range of integrins, for instance α5β1, can 
bind to fibronectin via an RGD binding motif and a non RGD N-terminal region which 
may facilitate intracellular signalling (Pankov and Yamada 2002). Although fibronectin is 
expressed at relatively low levels in normal tendon it is increased in both chronic and 
ruptured tendinopathies (Ireland, Harrall et al. 2001; Jelinsky, Rodeo et al. 2011).  
Cartilage oligomeric matrix protein (COMP), also known as thrombospondin-5, is a large 
524kDa protein made up of 5 disulphide linked subunits each with EGF-like and calcium 
binding thrombospondin-like domains (Oldberg, Antonsson et al. 1992). Initial studies 
showed that COMP was restricted to cartilage (Hedbom, Antonsson et al. 1992). However 
more recent studies have confirmed that COMP makes up 3% of the tendon dry weight 
(DiCesare, Hauser et al. 1994). It is more abundant in adult tendon compared to foetal 
tendon; it varies according to the site of tendon and is higher in tendons exposed to higher 
tensional force (DiCesare, Hauser et al. 1994; Smith, Zunino et al. 1997). COMP is also 
implicated in collagen fibrillogenesis (Halasz, Kassner et al. 2007). 
Tenascin-C is a large glycoprotein, a smaller (200kDa) and a larger (300kDa) isoform are 
produced through alternative splicing of a single transcript, which are expressed in normal 
and degenerate tendon respectively (Riley, Harrall et al. 1996). Tenascin-C is absent in 
areas of poorly organised matrix but highly expressed in areas of compressive loading 
(Riley, Harrall et al. 1996; Martin, Mehr et al. 2003). Binding of tenascin-C to fibronectin 
prevents cellular interaction with the ECM, the lack of matrix interaction causes the cells 
to become more rounded, i.e. more chondrocyte like. This change in morphology functions 
to protect the cells from excessive compressive loads (Martin, Mehr et al. 2003). Tenascin-
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C may also be involved in the organisation of collagen fibrils in normal tendon (Riley, 
Harrall et al. 1996). 
Other less abundant glycoproteins present in tendon include laminin, link protein and 
fibulin. Laminin is a major component of the basement membrane (Timpl, Rohde et al. 
1979). Link protein is a 45kDa globular protein of which there are 3 isoforms (Link protein 
1-3). Link proteins bind to large proteoglycans such as aggrecan and helps to stabilise their 
interaction with hyaluronan (Neame, Christner et al. 1986). Fibulin is expressed as six 
different genes (Fibulin1-6); Fibulin-1 for example has 4 isoforms termed Fibulin-1 A-D 
which are splice variants of a single gene (Tran, Mattei et al. 1997). Fibulin is reported to 
bind to various matrix components, including elastin (Sasaki, Gohring et al. 1999), and is 
involved in matrix stabilisation (Olin, Morgelin et al. 2001). Fibulin can bind aggrecan as 
well as ADAMTS1; this co-localisation is thought to increase aggrecan proteolysis via 
ADAMTS activity (Lee, Rodriguez-Manzaneque et al. 2005). 
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Proteoglycan 
 Structure/Type    
Type       Location and function 
Decorin  SLRP  
Binds collagen, affects collagen-fibril formation  
Binds growth factors 
Biglycan  SLRP  
Binds collagen, affects collagen-fibril formation 
Binds growth factors 
Fibromodulin  SLRP  
Binds collagen, affects collagen-fibril formation 
Binds growth factors 
Lumican  SLRP  Binds collagen, affects collagen-fibril formation 
Aggrecan  Hyalectan  
Resists compression; most prominent in 
fibrocartilage 
Versican  Hyalectan  Lubricates boundary between adjacent fibrils? 
 
Glycoprotein 
  
Elastin  Branched network 
Forms elastic fibres;  
provides elastic properties of tissue 
Fibrillin  Linear arrays  
Forms elastic fibres;  
provides elastic properties of tissue, binds LTBP 
Tenascin-C  Branched molecule  
Mediates cell–matrix interactions;  
forms ‘seams’ with versican 
COMP  Branched molecule  
Mediates cell–matrix interactions;  
role in fibril formation 
Fibronectin  Modular protein  
Mediates cell–matrix interactions;  
role in tendon healing 
Laminin  Modular protein  Component of basement membranes 
Link protein  Globular protein  Stabilises proteoglycan–hyaluronan interactions 
Thrombospondin  Modular protein  Mediates cell–matrix interactions 
 
Glycosaminoglycans 
 Keratan  
Sulphate Linear polymer 
Resists compression; Binds Fibromodulin and 
Aggrecan in tendon 
 
Dermatan  
Sulphate Linear polymer Resists compression; Binds decorin in tendon 
 
Chondroitin 
sulphate Linear polymer 
Resists compression; Binds biglycan, aggrecan and 
versican in tendon 
 
 
Table 1.2.  Non-collagen composition of tendon ECM 
Adapted from (Riley 2005) Abbreviations: COMP, cartilage oligomeric matrix protein; SLRP, 
small leucine-rich repeat proteoglycan; LTBP, Large TGFβ binding protein. 
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1.2. TENDON CELL POPULATION 
Tendon fibroblasts or tenocytes represent the major cell population within the tendon; they 
are relatively sparsely distributed throughout the tissue, although some areas are more 
populated than others (Clegg, Strassburg et al. 2007). Tenocytes have elongated nuclei and 
are located in longitudinal alignment between the collagen fibres (Clegg, Strassburg et al. 
2007). Cellular protrusions (both sheet like [lateral and longitudinal] and long/thin 
[longitudinal]) are thought to connect adjacent tenocytes though GAP junctions in multiple 
directions throughout the tendon (Senga, Kobayashi et al. 1995; McNeilly, Banes et al. 
1996; Clegg, Strassburg et al. 2007). Tenocytes have also been characterized by their close 
association with local collagen fibrils (McNeilly, Banes et al. 1996). Tenocytes are 
involved in the deposition of matrix components and also the expression of matrix 
degrading proteases involved in the turnover of the ECM. Other cell populations are also 
present but are significantly less abundant; these include; mesenchymal stem cells, 
synovial cells, fibrochondrocytes, endothelial cells, nerve cells and smooth muscle cells 
(Salingcarnboriboon, Yoshitake et al. 2003; Riley 2005). 
1.2.1. Tendon cell markers 
A number of genes have been selected as possible markers of tendon cell phenotype; these 
include: Scleraxis, Tenomodulin, Tenascin-C, COL1A1 and decorin (Salingcarnboriboon, 
Yoshitake et al. 2003; Taylor, Vaughan-Thomas et al. 2009). Scleraxis is a basic helix-
loop-helix transcription factor involved in the regulation of collagen expression (Lejard, 
Brideau et al. 2007; Espira, Lamoureux et al. 2009). Scleraxis has been determined as a 
marker for tendon and ligament progenitor cells during development (Schweitzer, Chyung 
et al. 2001). It was reported that Scleraxis expression was significantly different between 
bone cells and tendon cells, however, it was not significantly different between tendon and 
cartilage (Taylor, Vaughan-Thomas et al. 2009). In addition, a genome wide array study of 
both rat and human adult tissue showed that Scleraxis is not only expressed in tendon but 
also in the muscle midsubstance (Jelinsky, Archambault et al. 2010). This suggests that 
Scleraxis is not a definitive marker of tendon phenotype.  
Tenomodulin is a type II transmembrane glycoprotein expressed in 3 isoforms produced 
from splice variants of a single gene. Tenomodulin is involved in the regulation of cell 
proliferation (Docheva, Hunziker et al. 2005; Qi, Dmochowski et al. 2012) and thought to 
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be a marker of tenocytes in the later stages of tendon formation (Shukunami, Takimoto et 
al. 2006). A genome wide study showed that tenomodulin was consistently expressed in rat 
and human adult tendon, with significantly lower expression in a wide range of other 
tissues (Jelinsky, Archambault et al. 2010). Therefore tenomodulin may be a good 
candidate as a marker of adult tendon phenotype. However, in an equine study 
tenomodulin expression was not significantly different between tendon and bone derived 
cells (Taylor, Vaughan-Thomas et al. 2009). 
Tenascin-C, COL1A1 and decorin are components of the tendon ECM (Hardingham and 
Fosang 1992; Riley, Harrall et al. 1996; Rees, Flannery et al. 2000). In an equine study of 
tendon, cartilage and bone, COL1A2 gene expression was no different in tendon than bone 
cells. COMP and decorin were increased in tendon compared to bone cells, but was not 
significantly different from cartilage. Also tenascin-C was significantly lower in tendon 
than in bone cells; however a decrease in expression is not characteristic of an ideal cell 
marker (Taylor, Vaughan-Thomas et al. 2009). Therefore, not one of these genes alone can 
distinguish between tendon cells from either cartilage or bone derived cells. It has therefore 
been proposed that multiple genes should be used to discriminate between fibroblast cells 
types (Taylor, Vaughan-Thomas et al. 2009). This indicates that there are no definitive 
tendon ‘markers’ that can be used to distinguish between tenocytes and other cell types 
(Riley 2005; Riddle, Taylor et al. 2006).  
A genome wide study of gene expression from a wide range of adult human and rat tissue 
showed that Thrombospondin 4 was more highly expressed in tendon than any other tissue; 
including muscle, cartilage and bone (Jelinsky, Archambault et al. 2010). The function of 
thrombospondin-4 is unknown; however, it is a large glycoprotein capable of binding to 
collagen and COMP (Narouz-Ott, Maurer et al. 2000; Sodersten, Ekman et al. 2006). 
Although it was not possible to differentiate between adult tendon and ligament cells by 
comparing their expression of thrombospondin 4 (Jelinsky, Archambault et al. 2010), this 
indicates that thrombospondin 4 is a potential marker of tendon/ligament phenotype.   
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1.3. VASCULARISATION 
The vascularisation of tendon is relatively low compared to other tissues (Schmidt-
Rohlfing, Graf et al. 1992; Khan, Cook et al. 1999) and this is thought to reduce healing 
capabilities of the tendon once damage has occurred (Ahmed, Lagopoulos et al. 1998). 
Tendon cells are also nourished by the diffusion of synovial fluid in the absence of a more 
vascularised network (Gelberman 1985). Some tendons have regions of further reduced 
vascularity, these include the supraspinatus (Rathbun and Macnab 1970; Determe, 
Rongieres et al. 1996), posterior tibialis (Frey, Shereff et al. 1990) and Achilles (Schmidt-
Rohlfing, Graf et al. 1992). Areas of avascularity are localised to areas of the tendon that 
are exposed to compressive load (Rathbun and Macnab 1970), this suggests that 
differences in mechanical loading are involved in the regulation of vascularity. Poorly 
vascularised tendons appear to be those most commonly affected by tendinopathy and 
areas of tendon rupture also show signs of avascularity (Rathbun and Macnab 1970). 
Conversely, in degenerative tendon areas of increased vascularisation have been reported 
(Rathbun and Macnab 1970). However the increase in vascularity seen in degenerate 
tendinopathy is thought to be a response rather than a cause of the disorder (Fenwick, 
Hazleman et al. 2002). This increase in vascularity can be explained by the following 
scenario; The lack of an oxygen supply to the tendon as a result of avascularity may induce 
hypoxia, hypoxia induces the expression of vascular endothelial growth factor (VEGF) 
which in turn increases vascularisation (Fenwick, Hazleman et al. 2002). Decreased 
vascularity is therefore thought to be a factor in the development of tendinopathy, however 
how this occurs is not fully understood (Rathbun and Macnab 1970; Frey, Shereff et al. 
1990; Determe, Rongieres et al. 1996; Fenwick, Hazleman et al. 2002). 
  
Chapter1: Introduction 
31 
 
 
1.4. TENDON FUNCTION 
Tendon primarily functions as a force transmitter between muscle (myotendinous junction) 
and bone (enthesis) (Rees, Flannery et al. 2000; Screen, Chhaya et al. 2006), in addition to 
joint stabilization, stress absorption and muscle damage restriction (Clegg, Strassburg et al. 
2007). The Achilles tendon is subjected to high levels of strain in comparison to other 
tendons (Wall and Banes 2005) and storage and release of mechanical strain, through 
elastic recoil, plays an important role (Alexander 2002). Tendon hierarchal structure 
enables the tendon to dissipate a certain level of load through fibre alignment and muscle 
rotation as well as straightening of the crimp (Riley 2004; Screen, Lee et al. 2004). This is 
illustrated by the toe region of the stress-strain curve (Figure 1.4) where there is a non-
linear response to an increase in mechanical strain. In addition, the extension of 
tropocollagen molecules facilitated by the rotation of the triple helix (Puxkandl, Zizak et 
al. 2002) as well as collagen molecule sliding contributes to fibril elongation (Purslow, 
Wess et al. 1998). Therefore tenocytes themselves are not exposed to the same mechanical 
strain as the whole tendon fascicle (Screen, Lee et al. 2004). The level of strain transmitted 
to tenocytes in vivo is approximately 6% (Screen, Lee et al. 2004).  
The ‘crimp’ refers to the concertina type morphology of relaxed collagen fibres, the 
possible role of crimp is to absorb a level of tension via the straightening out of fibres 
under longitudinal strain (Kastelic, Galeski et al. 1978). The stress-strain curve illustrates 
the response of the tendon to stress (load per area) through changes in strain (percentage 
elongation) (Figure 1.4). The toe region of the stress-strain curve demonstrates the effect of 
crimp where cellular deformation is limited. With increased stress the collagen fibres are 
straightened. The amount of cellular deformation increases linearly, if the tendon is 
exposed to enough strain, until the tendon fibrils and other higher components of the 
tendon hierarchy rupture. Physiologically relevant strain levels perceived by the cell are 
thought to reach approximately 6% (Lavagnino, Arnoczky et al. 2003; Screen, Lee et al. 
2004). Finite element model studies have shown that the cells ability to contract the ECM 
may be involved in the initiation of crimp during development. Although maintenance of 
the crimp in the adult is more likely due the helical arrangement of microfibrils forming 
kinks in the overall structure (Herchenhan, Kalson et al. 2012).  
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Some tendons can function not only in transferral of stress from muscle to bone but are 
involved in stress transferral over fibrous or bony pulleys such as the flexor tendon pulley, 
these tendons may be exposed to compressive loads. Different tendons are exposed to 
varying stresses and matrix composition is specifically tailored to stresses imposed on the 
tissue. For example tendons exposed to more compressive forces such as pulleys are 
composed of a more fibrocartilagenous substance: increased levels of aggrecan, tenascin-C 
and type II collagen (Perez-Castro and Vogel 1999; Martin, Mehr et al. 2003). Tendons 
whose properties are essential for precision tend to contain higher levels of elastic fibres, 
such as in the flexor tendons of the hand. Tendon composition is also variable between the 
regions of the tendon itself; the mid-substance contains more defined fascicles and the 
enthesis has an increased fibrocartilagenous phenotype (Riley 2004).  
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Figure 1.4. Stress strain curve . Stress, or load, is plotted against 
strain or percentage elongation. In the toe region fibres are exposed to 
very low levels of stress (force per unit area), here fibres are crimped. 
With increasing load, fibres straighten in a linear phase. High 
physiological levels of stress cause microscopic fracture and extreme 
levels of stress cause fibres to rupture.  
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1.5. TENDINOPATHY  
Tendon disorders can be categorized as either acute or chronic.  Acute forms of the disease 
involve an injury caused by either an overloading event or trauma. Subsequent to this event 
inflammation occurs; i.e. inflammatory cells such as mast cells, platelets and macrophages 
infiltrate the damaged area resulting in release of growth factors such as Transforming 
growth factor beta (TGFβ), connective tissue growth factor (CTGF) (Wurgler-Hauri, 
Dourte et al. 2007), basic fibroblast growth factor (bFGF) and platelet derived growth 
factor (PDGF). These factors attract fibroblasts which proliferate and synthesize new 
matrix. This new matrix is less organized and further maturation and reorganization is 
required to regain the strength of the tendon over an extended period (Riley 2004). 
Chronic tendon disorders are thought to arise from prolonged exposure to moderate levels 
of strain and are often termed ‘overuse’ pathologies. These include a complex range of 
diseases whose terminology can be confusing. Chronic disease generally involves pain and 
insidious degeneration, onset of which cannot be associated with one traumatic event. 
Tendinitis and tendinosis are terms used to describe inflammatory involvement and 
degenerative overuse pathologies respectively (Khan, Cook et al. 1999; Khan, Cook et al. 
2000). It is difficult to differentiate between the tendinosis and tendinitis in the absence of 
biopsy, consequently the term tendinopathy is generally used as it does not imply 
knowledge of the inflammatory state (Riley 2004). Chronic tendinopathies are thought to 
be preceded by changes in cellular expression and of the ECM which weaken the tendon 
(Riley 2005); however these changes are not fully understood.   
Many studies examine characteristics of acute, chronic, painful and ruptured tendinopathy 
compared to normal tendon tissue. Differential phenotypes have been observed in each of 
the tendinopathies studied. Tendinopathies can show features of apparent degeneration and 
changes in fibroblastic activity, tenocyte apoptosis  (Lian, Scott et al. 2007), GAG 
accumulation (Kannus and Jozsa 1991; Chard, Cawston et al. 1994; Corps, Robinson et al. 
2006), calcification (Kannus and Jozsa 1991; Chard, Cawston et al. 1994; Riley, Harrall et 
al. 1994), lipid accumulation (Kannus and Jozsa 1991; Riley 2005), mucoid degeneration 
(Kannus and Jozsa 1991), hypoxia (Kannus and Jozsa 1991), increased water content (de 
Mos, van El et al. 2007), increased extracellular matrix turnover and a change in ECM 
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composition (Riley 2005). In the next section I will focus on gene regulation in 
tendinopathy. 
1.5.1. Collagen Expression with Tendinopathy 
The reduction in overall collagen content, decrease in pentosidine cross-links and the 
percentage increase in type III collagen in tendinopathy, suggests that protease degradation 
of collagen and matrix turnover is occurring (Riley, Harrall et al. 1994; Riley, Curry et al. 
2002; Corps, Robinson et al. 2004; de Mos, van El et al. 2007). Other non-type I collagens 
that are also regulated in equine acute tendinopathies include types II, IV, X, XI (Clegg, 
Strassburg et al. 2007). Ireland et al reported that the increase in type III collagen was 
predominant in Achilles tendinopathy. The resulting higher proportion of non-type I 
collagen could explain the reduction in tendon strength, evident where ruptures occur 
(Ireland, Harrall et al. 2001). Riley et al, observed that type III collagen was also increased 
in some non-diseased samples, which may be a result of repeated microinjury. They 
proposed that increased collagen III incorporation may indicate an attempted healing 
response and may predispose tendinopathy (Riley, Harrall et al. 1994).  
1.5.2. GAG and Tendinopathy 
Other changes in ECM composition include increases in Glycosaminoglycans (GAG) such 
as hyaluronan, chondroitin sulphate and dermatan sulphate, which are seen in 
supraspinatus and Achilles tendinopathy (Riley, Harrall et al. 1994; Astrom and Rausing 
1995). However,  analysis of the Achilles ruptured tendon has shown a reduction in GAG 
content (Riley, Curry et al. 2002). This indicates that painful and ruptured tendon diseases 
are distinct in terms of GAG expression.  
1.5.3. Proteoglycan and Glycoprotein regulation with Tendinopathy 
Proteoglycan and glycoprotein mRNA expression is also modified with tendon pathology. 
Both painful and ruptured Achilles tendon mRNA analysis showed decreased expression 
of the proteoglycan versican (Corps, Robinson et al. 2004; Karousou, Ronga et al. 2008), 
another study has shown an increase in expression of versican in Achilles tendinopathy, 
however the study was limited to only four patients (Ireland, Harrall et al. 2001). In painful 
and ruptured tendon increased aggrecan and biglycan mRNA was observed (Ireland, 
Harrall et al. 2001; Corps, Robinson et al. 2006; Clegg, Strassburg et al. 2007; Corps, 
Robinson et al. 2012). In chronic tendinosis or ruptured tendons a decrease in decorin 
mRNA was observed (Alfredson, Lorentzon et al. 2003; Corps, Robinson et al. 2006), 
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however, an increase was reported in ruptured tendon (Karousou, Ronga et al. 2008). Other 
glycoproteins such as fibronectin, and fibrillin were reported to increase in ruptured and 
tendinopathic tendon (Ireland, Harrall et al. 2001; Karousou, Ronga et al. 2008; Jelinsky, 
Rodeo et al. 2011; Corps, Robinson et al. 2012; Legerlotz, Jones et al. 2012). A decrease in 
COMP was observed in a range of tendons affected by tendinopathy (Jelinsky, Rodeo et al. 
2011). Therefore substantial regulation of proteoglycans and glycoproteins is occurring in 
tendinopathic tendon. 
Tenascin C mRNA was increased in both tendinopathic and ruptured (humans and equine) 
tendon (Ireland, Harrall et al. 2001; Taylor, Vaughan-Thomas et al. 2009; Jelinsky, Rodeo 
et al. 2011).  Tenascin is reported to increase with compressive loads, therefore the 
increase in Tenascin C in tendinopathy may be associated with increases in compressive 
force (Riley, Harrall et al. 1996; Martin, Mehr et al. 2003). However, this does not 
necessarily mean that the tendon is responding to compressive loading. In human 
degenerate tendon a 300kd large isoform of tenascin C protein was increased, whereas a 
smaller isoform (200kD) is produced only in normal tendon (Riley, Harrall et al. 1996). 
This 300kD isoform may be involved in the increase of cell proliferation, cell rounding and 
expression of a more fibrocartilagenous phenotype (Riley, Harrall et al. 1996). In addition 
evidence of Tenascin C fragmentation also suggests that metalloproteinase activity is 
increased in degenerate tendinopathy (Riley, Harrall et al. 1996). 
Many of these pathological changes are representative of a more cartilaginous phenotype. 
These changes include the increase in aggrecan, tenascin-C and type II collagen (Perez-
Castro and Vogel 1999; Martin, Mehr et al. 2003). Clegg et al reported a more 
fibrocartilagenous phenotype in acute but not chronic equine superficial digital flexor 
tendon (SDFT) tissue (Clegg, Strassburg et al. 2007). In compressive regions of horse 
SDFT there was a decrease in fibrocartilagenous markers in acute tendon whereas in 
chronic samples the levels were similar to normal tendon. This could be due to changes in 
the loading pattern following injury, changing the compressive force and reducing the 
required stimuli to maintain fibrocartilagenous phenotype in areas normally exposed to 
increased compressive forces (Clegg, Strassburg et al. 2007).  
1.5.4. Inflammatory cytokine regulation with Tendinopathy 
Stimulation of inflammatory cytokines have also been reported in response to tendon 
pathology, these include IL6, IGF and TGFβ. IL6 was increased and IL6R was decreased 
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in both painful and ruptured tendon (6.3 and 180 fold respectively in IL6) (Jelinsky, Rodeo 
et al. 2011; Legerlotz, Jones et al. 2012), however there was no change in either of these 
genes in painful posterior tibialis tendinopathy (Legerlotz, Jones et al. 2012). The 
stimulation of IL6, would suggest that IL6 signalling is stimulated with tendinopathy. 
However due to the simultaneous decrease in IL6R, IL6 signalling may remain unchanged. 
In the ligament, IGF mRNA was increased in response to rupture in a rabbit model (Sciore, 
Boykiw et al. 1998). TGFβ protein is also increased in tendinopathy (Fenwick, Curry et al. 
2001; Fu, Wang et al. 2002). COX2 was increased in both painful and ruptured Achilles 
tendon (2 and 11 fold respectively), however there was no change in painful posterior 
tibialis tendinopathy (Legerlotz, Jones et al. 2012). This does suggest that inflammatory 
pathways may be involved in tendon pathology, although the level of stimulation may be 
variable depending on the region of tendon pathology. There appeared to be less evidence 
of the stimulation of inflammatory mediators in response to posterior tibialis tendinopathy 
(in terms of IL6, COX2 and IL6R). And although in most respects the pathologies are very 
similar, this indicates that those affecting the posterior tibialis are distinct from those 
affecting other tendons such as the Achilles in terms of inflammatory cytokines. 
1.5.5. Tendon ‘marker’ regulation with Tendinopathy  
Although tendon does not have definitive phenotypic markers, some genes that are more 
commonly expressed in tendon can be used as a guide. A murine model of patella tendon 
injury measured an increase in scleraxis after 4-8 weeks, which returned to normal after 12 
weeks (Scott, Sampaio et al. 2010). However, an equine study of acute or chronic tendon; 
showed that Scleraxis was not differentially regulated in either disease (Taylor, Vaughan-
Thomas et al. 2009). This difference in scleraxis expression may be due to a temporal 
change, differential expression according to the pathology or species of origin. 
Immunohistochemistry study of patellar tendinopathy showed the increased expression of 
SOX9 protein and cells displayed a more rounded phenotype. This suggests that there is a 
divergence to a cartilaginous phenotype in some tendinopathic tissues (Rui, Lui et al. 
2011).  
1.5.6. Age and tendinopathy 
Advanced Glycation End product (AGE) cross links accumulate with age, they cause 
reduced elasticity (Sell and Monnier 1989) and ECM turnover (Laurent 1987) by forming 
cross links between collagen fibre. Other age related changes include an overall 
modification of GAG and proteoglycan levels (Riley, Harrall et al. 1994), reduced cell 
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number, cellular elongation and reduced cell contacts (Ippolito, Natali et al. 1980). It has 
been reported that overall collagen content is not significantly modified with age although 
there is an overall increase in ECM density (Riley, Harrall et al. 1994).  Increased type III 
collagen, increased collagen hydroxylysylpyridinoline cross links, lower GAG, smaller 
diameter collagen fibres and lower cellularity were also seen in equine SDFT aging tendon, 
these characteristics seen in aging horses have been suggested to be the early stages of 
tendon degeneration (Birch, Bailey et al. 1999). Age related changes have some 
similarities with the structural changes seen in tendinopathy. Therefore the age of tendon 
may contribute to the development of tendinopathy (Riley, Harrall et al. 1994).  
Relatively little is known about the cause of this group of disorders, although the 
degradation of the ECM plays an important role. This may be a result of altered 
mechanical stress and the differential response in acute and ruptured tendon (Corps, 
Robinson et al. 2006).  
  
Chapter1: Introduction 
39 
 
 
1.6. EXTRACELLULAR MATRIX DEGRADATION IN TENDINOPATHY 
A large array of proteases are expressed in prokaryotic and eukaryotic cells, these are 
divided into several families; including Aspartic, Cysteine, Glutamic, Metallo, Asparagine, 
Serine and Threonine proteases (Rawlings, Barrett et al. 2012). For example, Cathepsin 
proteases are a clan of proteases that form part of the Cysteine family, the majority of 
Cathepsins are lysosomal and are effectiveat a lower pH (Nomura and Katunuma 2005). 
Serine proteases are so called due to their nucleophilic Ser amino acid residue at the active 
site. Serine proteases are secreted as inactive zymogens and include Plasmin and Trypsin 
(Hedstrom 2002). Plasmin is the active form of the zymogen plasminogen, Plasmin is 
present in the blood and can degrade fibrin clots (Rawlings, Barrett et al. 2012). Trypsin is 
the active form of the zymogen trypsinogen, Trypsin hydrolyses proteins, a process known 
as trypsinisation (Rawlings, Barrett et al. 2012). 
Metalloproteinases (Woessner 1991; Nagase and Woessner 1999; Ireland, Harrall et al. 
2001), are proteases with a primary function of controlling the homeostasis of the ECM. 
They can break down components of the ECM so that it can be rebuilt according to current 
strain environment. Expression analysis has shown that a number of these molecules are 
regulated in tendinopathies (Fu, Chan et al. 2002; Alfredson, Lorentzon et al. 2003; Lo, 
Marchuk et al. 2004; Jones, Corps et al. 2006; Clegg, Strassburg et al. 2007). 
Metalloproteinases are subdivided into a number of protein families; Matrix 
metalloproteinase’s (MMPs), a disintegrin and metalloproteinase (ADAM) and a 
disintegrin and metalloproteinase with thrombospondin repeats (ADAMTS). MMPs, 
ADAMs and ADAMTSs are important in the process of extracellular matrix degradation. 
Generally MMP’s mediate the collagen degradation, ADAMs mediate the shedding of 
extracellular portions of transmembrane proteins and ADAMTSs degrade proteoglycans. 
Tissue inhibitors of Metalloproteinases (TIMPs) inhibit the metalloproteinase activity, 
therefore inhibiting the degradation of the ECM. A balance of metalloproteinase activity 
and matrix deposition is essential in the regulation of ECM homeostasis. Metalloproteinase 
expression is modulated by a wide range of  cytokines, growth factors and the cellular 
interaction via cell surface molecules (ICAM, VLA and integrins) and mechanical strain 
(Nagase and Woessner 1999). 
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1.6.1. Matrix Metalloproteinases (MMP) 
MMPs mediate the extracellular degradation of the ECM and they are active at neutral pH. 
They have a catalytic domain known as the metzincin motif with a zinc ion binding 
domain and require calcium for activity (Nagase and Woessner 1999; Bode 2003). In 
humans there are 23 MMPs, one system of categorisation divides them into the subgroups 
known as the stromelysins, gelatinases, collagenases, membrane type MMPs, matrilysins 
and elastin degrading proteases (See Table 1.3), classified according to their activity and 
structure. Collagenases, MMP1, 8 and 13 are involved in the degradation of fibrillar 
collagens. Gelatinases include MMP2 and 9 which degrade gelatin and non-fibrillar 
collagens. Stromelysins degrade type III collagen and proteoglycans (Riley 2005). They 
share a pro-, signal- and catalytic domains and are secreted predominantly as zymogens 
which are largely protease enzyme activated by the disruption of the ‘cysteine switch’ (a 
cysteine residue which ligates the zinc region in order to maintain inactivity) through 
cleavage of the pro-domain (Woessner 1991; Borkakoti 1998; Nagase and Woessner 
1999). There are however exceptions to the rule; MMP23, 11 and all membrane bound 
MMPs are activated intracellularly (Nagase and Woessner 1999).  Some MMPs also share 
a hemopexin-like domain located at the C-terminal, this is thought to be involved in the 
specificity; The hemopexin domain targets the enzyme to collagen, resulting in its cleavage 
(Nagase and Woessner 1999). Changes in MMP expression seen in tendon pathology can 
be associated with increased turnover and deterioration of ECM or matrix repair and 
synthesis (Riley, Curry et al. 2002).  
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Table 1.3.  Matrix Metalloproteinase family of degradative enzymes .  
Adapted from Riley, 2005; Parks and Mecham, 1998; Shiomi, Lemaitre et al ., 
2010. 
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The mechanism of matrix breakdown that MMPs facilitate is fundamental in normal cell 
function. They are important in development, tissue desorption and remodelling, cell 
proliferation, migration, chemotaxis and apoptosis (Nagase and Woessner 1999). 
Dysfunction of these proteins can be involved in disorders such as cancer, rheumatoid 
arthritis, and osteoarthritis (Dudhia, Scott et al. 2007). For this reason broad spectrum 
inhibitors of MMPs have been used in the treatment of diseases such as cancer; MMP 
broad spectrum inhibitors (doxycycline and ilomostat [GM6001]) reduce pericellular 
matrix damage and MMP13 expression in models of tendinopathy (Arnoczky, Lavagnino 
et al. 2007). However these inhibitors have proved relatively ineffective and often induce 
side effects that resemble characteristics of tendinopathies (Drummond, Beckett et al. 
1999; Tierney, Griffin et al. 1999). Although Marimistat was shown to have some 
anticancer effects it also induced tendinitis (musculoskeletal pain and inflammation). 
(Drummond, Beckett et al. 1999). This implicates MMPs as important regulators of the 
tendon ECM, and some activity is required to maintain a healthy tendon (Drummond, 
Beckett et al. 1999). More specific MMP inhibitors have shown to be ineffective in the 
treatment of cancer but do not induce tendinitis, this indicates that specific inhibition of 
MMP targets may have its place in the treatment of cancer and tendinopathy, however, 
more detailed study is required (Drummond, Beckett et al. 1999). 
MMP expression is modified in tendon from pathological tendon compared to healthy 
controls. MMP1 was increased in chronic tendinopathy and ruptured tendon compared to 
normal controls in a range of tendon locations (Fu, Chan et al. 2002; Riley, Curry et al. 
2002; Jones, Corps et al. 2006). Other studies of tendinopathic and ruptured tendon yielded 
very low detection of MMP1 and/or no differential regulation of MMP1 in pathological 
tendon (Ireland, Harrall et al. 2001; Jelinsky, Rodeo et al. 2011). Clegg  et al studied 
tendon injury in a horse model and found that MMP1 was up-regulated in acute 
tendinopathy, but were no different from the control samples in the chronic tendon (Clegg, 
Strassburg et al. 2007). Therefore, it is possible that the induction of MMP1 seen in acute 
disease is a response to matrix damage or inflammation. An increase in active MMP1 
would result in the degradation of fibrillar collagens, including collagen type I (Parks and 
Mecham 1998; Shiomi, Lemaitre et al. 2010). As collagen type I is the major constituent of 
the tendon ECM (Rees, Flannery et al. 2000) this could potentially cause decreased 
strength and overall stability of the tissue. 
Chapter1: Introduction 
43 
 
Although some studies have reported no significant changes in MMP2 with degenerate 
pathology (Jones, Corps et al. 2006), others have shown an induction in MMP2 mRNA and 
protein in tendinopathic or ruptured Achilles, posterior tibialis and supraspinatus tendon 
(Ireland, Harrall et al. 2001; Alfredson, Lorentzon et al. 2003; Karousou, Ronga et al. 
2008; Pasternak, Schepull et al. 2008; Jelinsky, Rodeo et al. 2011; Corps, Robinson et al. 
2012). However, in tendinopathic and ruptured tendon MMP2 expression was decreased at 
the mRNA and protein level in supraspinatus and Achilles tendons respectively (Riley, 
Curry et al. 2002; Lo, Marchuk et al. 2004). Therefore levels of MMP2 expression are 
variable in tendinopathic and ruptured pathologies and each variety of tendon disease does 
not show consistent outcomes in terms of MMP2 expression.  
MMP3 regulation in tendinopathy is more consistent. Studies of human Achilles and 
supraspinatus have recorded a significant down-regulation in mRNA, protein and activity 
levels of MMP3 in tendinopathic or ruptured tendon compared to normal controls (Ireland, 
Harrall et al. 2001; Riley, Curry et al. 2002; Alfredson, Lorentzon et al. 2003; Lo, Marchuk 
et al. 2004; Jones, Corps et al. 2006). In a equine model (SPFT) MMP3 mRNA was also 
down-regulated (50 fold) in acute and chronic tendinopathy (Clegg, Strassburg et al. 2007).  
The substrate range of MMP3 includes proteoglycans (Parks and Mecham 1998; Shiomi, 
Lemaitre et al. 2010), consequently the observed increase of proteoglycan in pathology 
might therefore be explained by the decrease of MMP3. And although MMP1 and MMP3 
show similarities in sequence and promoter regions, they can be regulated through separate 
transcription factors, which could explain their differential regulation in tendon pathologies 
(Buttice, Duterque-Coquillaud et al. 1996; Ireland, Harrall et al. 2001).  
MMP13 mRNA up-regulation has been reported in ruptured rotator cuff tendon (Lo, 
Marchuk et al. 2004) and dysfunctional posterior tibialis tendon (Corps, Robinson et al. 
2012), and also in an equine model of SPFT tendon, in acute and chronic forms of the 
disease (Clegg, Strassburg et al. 2007). However, Jones et al  reported no change in 
MMP13 mRNA in painful or ruptured Achilles pathology (Jones, Corps et al. 2006). In 
addition MMP13 mRNA was undetectable in tendinopathic tissue from a mixture of 
tendon types (Jelinsky, Rodeo et al. 2011). This differential regulation of MMP13 with 
pathology may be related to temporal changes in metalloproteinase expression during the 
course of the disease. 
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Other MMPs have also been observed to be differentially regulated in tendinopathies, 
including MMP9, which is up-regulated at the mRNA level in ruptured Achilles tendon 
(Jones, Corps et al. 2006; Karousou, Ronga et al. 2008). In another Achilles tendon study, 
protein levels of MMP9 were increased, however, this was not reflected at the mRNA 
level, which may be a result of production of MMP9 occurring elsewhere (Karousou, 
Ronga et al. 2008).  MMP19 and MMP25 were increased (mRNA) in ruptured Achilles 
tendon in comparison to normal controls (Jones, Corps et al. 2006; Pasternak, Schepull et 
al. 2008). There is a discrepancy in MMP7 regulation as mRNA was decreased in one 
study (Jones, Corps et al. 2006) and plasma levels increased in another (Pasternak, 
Schepull et al. 2008) in ruptured Achilles. This may be due to the release of MMP7 into 
the blood stream. In painful Achilles tendon lower expression of MMP10 and increased 
MMP23 was detected in comparison to normal tendon at the RNA level (Jones, Corps et 
al. 2006). Therefore multiple MMPs are regulated with ruptured and tendinopathic tendon. 
This disruption in MMP regulation may explain the decreased functionality of the tendon 
in these pathologies. 
1.6.2. Tissue Inhibitors of Metalloproteinases 
In vivo, the main regulatory proteins of the metalloproteinases are the TIMPs, of which 
there are four known examples (TIMP1, TIMP2, TIMP3 and TIMP4). In order to cause 
MMP inhibition, TIMPs bind to the MMP catalytic domain , TIMP occupation of the 
MMP active site results in the inhibition of substrate cleavage (Nagase and Woessner 
1999).  TIMPs are also involved in a number of important regulatory mechanisms 
including the inhibition of cellular invasion and growth (Nagase and Woessner 1999).  
TIMPs inhibit all MMPs (Visse and Nagase 2003), however TIMP1 is unable to inhibit the 
activity of MMP14 (also known as MT1-MMP) (Will, Atkinson et al. 1996). TIMP3 also 
inhibits ADAM and ADAMTS enzymes, such as ADAM12 (Loechel, Fox et al. 2000), and 
the aggrecanases, ADAMTS4 and ADAMTS5 (Kashiwagi, Tortorella et al. 2001). 
Changes in the expression profile of TIMPs are evident in a number of tendon studies. 
TIMP1 has been found to be up-regulated both at the message (Jones, Corps et al. 2006) 
and protein level (Karousou, Ronga et al. 2008) in ruptured Achilles tendon, but not in 
acute or chronic equine tendon (Clegg, Strassburg et al. 2007). Decreased levels of TIMP2 
were seen in ruptured Achilles (Jones, Corps et al. 2006) and rotator cuff tendon (Lo, 
Marchuk et al. 2004). However other studies have also shown TIMP2 is increased in 
ruptured Achilles tendon (Karousou, Ronga et al. 2008; Pasternak, Schepull et al. 2008) 
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and equine data (SPFT) indicated that TIMP2 was unchanged in tendinopathy (Clegg, 
Strassburg et al. 2007). Therefore TIMP2 regulation appears to be much more variable, 
studies of the same tendon pathology (i.e. ruptured Achilles) show variable results. TIMP3 
and TIMP4 regulation in tendon disorders is less variable as evidence suggests that there is 
a decrease in the mRNA expression levels in ruptured (Lo, Marchuk et al. 2004; Jones, 
Corps et al. 2006), painful (Ireland, Harrall et al. 2001; Jones, Corps et al. 2006) and acute 
tendinopathies of the Achilles and rotator cuff (Clegg, Strassburg et al. 2007). This 
decrease in TIMP3 may result in increased aggrecanase activity, as TIMP3 is involved in 
the inhibition of ADAMTS4 and ADAMTS5 (Kashiwagi, Tortorella et al. 2001). 
1.6.3. Disintegrin and Metalloproteinase domain (ADAM) 
ADAMs include both transmembrane and secreted proteins involved in a number of 
important cellular processes including cleavage of the ectodomain of many receptors, 
signalling molecules, growth factors and cytokines (Edwards, Handsley et al. 2008). They 
are thought to be involved in differential protein folding and interaction as well as 
cleavage. ADAMs are made up of metalloproteinase, disintegrin and cysteine rich domains 
and EGF-like repeats, of which the cysteine rich domain is thought to be involved in the 
specific ADAM function. They are activated intracellularly by pro-protein convertases via 
a cysteine switch mechanism similar to the MMPs (Edwards, Handsley et al. 2008). There 
are 25 known ADAMs which include four pseudogenes, not all of which are 
proteolytically active (Table 1.4) (Shiomi, Lemaitre et al. 2010). ADAM12 is a 
catalytically active metalloproteinase involved in myogenesis and is expressed as two 
splice variants; a short form (ADAM12S) and a long, membrane bound form (ADAM12L) 
(Gilpin, Loechel et al. 1998; Loechel, Gilpin et al. 1998). Among other functions, 
ADAM12 has been shown to facilitate TGFβ signalling without the involvement of 
protease activity and is also the regulation of focal adhesion complexes through the 
interaction with integrin β3 (Kveiborg, Albrechtsen et al. 2008). ADAM12 is up-regulated 
in both ruptured and painful Achilles (Jones, Corps et al. 2006). Therefore the increase of 
ADAM12 may result in the dysregulation of TGFβ signalling or cell communication. 
ADAM8 is a sheddase, it is known to cleave L-selectin and may be involved in neutrophil 
function in active sites of inflammation (Gomez-Gaviro, Dominguez-Luis et al. 2007). 
ADAM8 was also increased in ruptured Achilles (Jones, Corps et al. 2006). However the 
role of ADAM8 in tendinopathy remains to be determined. No other studies of pathology 
have studied the regulation of ADAMs.  
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Table 1.4. The ADAM family of Metalloproteinases 
Adapted from Shiomi, Lemaitre et al., 2010. 
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1.6.4. A Disintegrin and Metalloproteinase domain with Thrombospondin motifs 
(ADAMTS) 
There are 19 ADAMTS proteases currently known (Table 1.5); they are synthesized as 
zymogens and activated through the removal of the pro-domain (Wang, Tortorella et al. 
2004). However, ADAMTS7 and ADAMTS13 show catalytic activity when the pro-
domain is still attached (Majerus, Zheng et al. 2003; Somerville, Longpre et al. 2004). 
ADAMTS2, ADAMTS3 and ADAMTS14 are involved in the processing of pro-collagen 
(Colige, Beschin et al. 1995; Colige, Li et al. 1997; Fernandes, Hirohata et al. 2001; Wang, 
Lee et al. 2003). ADAMTS 1, 4, 5 and 15 are reported to possess aggrecanase activity 
(Porter, Clark et al. 2005). ADAMTS4 and ADAMTS5 (also known as aggrecanase 1 and 
2 respectively) are the most well characterised and are also involved in the degradation of 
versican and brevican (Porter, Clark et al. 2005). ADAMTS5 is reported to posses 1000 
fold more aggrecanase activity than ADAMTS4, ADAMTS5 is therefore considered to be 
the major aggrecanase (Gendron, Kashiwagi et al. 2007). ADAMTS7 has no known 
substrate, although it has been established that it does not possess aggrecanase activity 
(Porter, Clark et al. 2005). ADAMTS13 is also known as von Willebrand factor cleavage 
protease and is least like the other ADAMTSs due to its possession of two CUB domains 
(Zheng, Chung et al. 2001; Porter, Clark et al. 2005). ADAMTS13 possesses an RGDS 
domain within the cysteine rich domain that could be involved in integrin binding (Zheng, 
Chung et al. 2001). ADAMTS13 has only one known substrate, which is von Willebrand 
factor (Porter, Clark et al. 2005). 
ADAMTS5 was decreased in acute (Clegg, Strassburg et al. 2007) and painful (Jones, 
Corps et al. 2006) but remained unchanged in equine chronic tendinopathy (Clegg, 
Strassburg et al. 2007). However, an increase in ADAMTS5 is also reported in 
dysfunctional posterior tibialis tendon (Corps, Robinson et al. 2012). Clegg et al showed 
no change in ADAMTS4 in any phenotype in equine tendon pathology (Clegg, Strassburg 
et al. 2007), however human studies demonstrated an increase in ruptured tendon (Jones, 
Corps et al. 2006; Corps, Jones et al. 2008; Jelinsky, Rodeo et al. 2011; Corps, Robinson et 
al. 2012). In addition, Jelinsky et al reported no significant change in ADAMTS genes in 
chronic tendinopathy, however this study groups together many different pathological 
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phenotypes and may not be a good representation of any of these (Jelinsky, Rodeo et al. 
2011). Therefore differences in the pathology and species could explain this variation in 
ADAMTS4 and ADAMTS5 gene expression. The increase in ADAMTS4 in ruptured 
tendinopathy may be associated with increased levels of proteoglycan degradation. Jones et 
al reported that ADAMTS2 and ADAMTS3 are increased in painful tendon (Jones, Corps 
et al. 2006); as ADAMTS2 and ADAMTS3 are involved in pro-collagen processing, pro-
collagen processing may be increased in painful tendon (Colige, Beschin et al. 1995; 
Colige, Li et al. 1997; Fernandes, Hirohata et al. 2001; Wang, Lee et al. 2003). ADAMTS7 
and ADAMTS13 were decreased in ruptured tendon (Jones, Corps et al. 2006); however 
how the regulation of these genes is related to the tendon pathology remains unknown due 
to limited substrate knowledge. 
From these data we can see that a number of metalloproteinases are regulated in tendon 
pathology, however, there is a distinct profile for each classification of tendinopathy such 
as painful and ruptured tendons and also the specific tendon type (Jones, Corps et al. 
2006). A potential mechanism of tendon rupture may be the dysregulation of proteases, 
destabilizing the ECM, predisposing the tendon to rupture (Kannus and Jozsa 1991; Riley, 
Curry et al. 2002; Jones, Corps et al. 2006; Pasternak, Schepull et al. 2008). Further 
understanding of how these metalloproteinases and TIMPs are regulated in these 
pathologies may lead to successful treatment of these disorders. 
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  Table 1.5. ADAMTS Family of Metalloproteases 
Adapted from Porter, Clark et al., 2005; Shiomi, Lemaitre et al., 2010. 
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1.7. MECHANICAL STRAIN 
Moderate mechanical is said to be important in the functioning of normal tissue 
homeostasis (Ingber 1997; Arnoczky, Lavagnino et al. 2008). However, high levels of 
mechanical strain have been implicated as a causative factor of tendinopathies (Dudhia, 
Scott et al. 2007). Compared to the number of similar studies on various other tissue 
fibroblasts; such as cardiac (Brancaccio, Hirsch et al. 2006; Gupta and Grande-Allen 
2006), endothelial (Sasamoto, Nagino et al. 2005) and bone cells (Salter, Wallace et al. 
2000), relatively few studies have focused on the effects of mechanical strain upon tendon 
cells. In non-tendon tissues mechanical strain is reported to increase cellular proliferation 
(Zhang, Li et al. 2003); to modulate ECM molecules including metalloproteinases, 
collagen, glycoproteins, GAGs and growth factors (Gupta and Grande-Allen 2006); to 
accelerate the process of healing as compared to prolonged rest periods (Buckwalter 1996) 
and regulate MMP expression (Meng, Mavromatis et al. 1999). Tendon studies have 
shown that physiological levels of cyclic strain (~5%) induce anabolic regulation of 
collagen related molecules. As a result, strain maintains the ECM and induces modification 
of GAG content and cell proliferation (Screen, Shelton et al. 2005). In summary MMPs are 
important in ECM homeostasis, they are differentially regulated in pathological tendon 
(Ireland, Harrall et al. 2001; Riley, Curry et al. 2002; Lo, Marchuk et al. 2004; Jones, 
Corps et al. 2006; Clegg, Strassburg et al. 2007; Karousou, Ronga et al. 2008; Pasternak, 
Schepull et al. 2008) and mechanical strain can modulate their expression (see below). 
Therefore mechanical strain regulation of MMPs may play a role in the development of 
tendinopathy. 
Existing studies of metalloproteinase expression with mechanical load include multiple 
systems with different types of straining regime. Cyclic loading regimes are used in an 
effort to replicate physiological movement. However, static loading regimes have also 
been studied, which seem much less relevant to physiological movement (For full list of 
references see figures 1.6-1.10). There is a high level of variation in the length of straining 
regime used as well as the measurement of the strain itself (i.e. % strain or MPa); therefore 
it is difficult to compare gene expression between these studies. Some studies also measure 
gene expression some time after the straining has stopped (Tsuzaki, Bynum et al. 2003), 
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therefore consequent changes in gene expression may be more representative of unloaded 
tendon. The majority of studies have used tendon fascicles (Asundi and Rempel 2008), 
however in some cases cells are extracted from tissues and mechanically loaded upon 
stretching devises such as the flexcell
TM
 or the flexible silicone membrane system 
developed by James Wang’s group (Tsuzaki, Bynum et al. 2003; Yang, Im et al. 2005). 
There are obvious limitations to these studies as the cells are not in 3D culture (Taylor, 
Vaughan-Thomas et al. 2009).In vivo studies of partial width laceration in ovine tendon 
may not fully represent stress deprivation and high level strain, as the laceration itself may 
induce changes not related to mechanical loading (Smith, Sakurai et al. 2008). Human in 
vivo studies of metalloproteinase regulation are limited as the measurements are taken 
from dialysate from around the tendon, therefore the metalloproteinase’s measured here 
may not be produced in the tendon at all (Koskinen, Heinemeier et al. 2004). However, 
taken together these studies are beginning to paint a picture of how mechanical loading 
regulates metalloproteinase expression.  
1.7.1. MMP1mRNA regulation with mechanical load 
Static and cyclic strains, as well as fluid flow, have been shown to regulate MMP mRNA 
expression (See tables 1.6-1.11 for summary and references). The regulation of MMP1 
depends on the type and duration of strain. In vitro studies of human and rabbit tendon 
cells (flexor digitorum profundus and Achilles respectively) in monolayer showed that a 
cyclic strain regime of up to 5% (at 1Hz for 2 hours and 18 hours rest or 0.33Hz for 6 
hours) had little effect upon MMP1 expression (Archambault, Tsuzaki et al. 2002; Tsuzaki, 
Bynum et al. 2003). In addition in ex vivo fascicle studies of rabbit flexor tendon, there 
was also no change in MMP1 expression in response to 2-6MPa cyclic strain at 0.45Hz for 
18 hours (Asundi and Rempel 2008). Increased strain levels as a result of in vivo partial 
width laceration in an ovine exercise model showed no change in MMP1 expression after 4 
weeks (Smith, Sakurai et al. 2008).  However, cells from human patellar tendon seeded 
into grooved silicone dishes showed an increase in MMP1 expression in response to 4 or 
8% at 1Hz after 4 hours (Yang, Im et al. 2005). The aforementioned studies where MMP1 
was unchanged in response to mechanical load are of lower frequency or duration, 
therefore the strain response may only occur once a threshold has been reached. However 
this level may never be reached in vivo (see table 1 for a summary of MMP1 changes with 
strain). 
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The induction of MMP1 in response to cyclic strain in the study of human cells seeded 
onto a silicone membrane shows a response unlike any of the rodent studies (Yang, Im et 
al. 2005). Despite the use of human cells in this study, it may not be physiologically 
relevant as tendon cells grown in monolayer behave differently to those in 3D culture 
(Taylor, Vaughan-Thomas et al. 2009), the grooved culture dish used in this study prevents 
transverse cellular interaction. Therefore the responses Yang et al have observed in the 
monolayer culture system are likely to be very different to those observed in vivo. In 
addition the absence of 3D culture means that cells are directly exposed to the loading 
regime imposed upon them; as opposed to cells in 3D culture of tendon fascicles, where 
strain is dissipated by the surrounding matrix. Therefore this experiment may represent the 
response to a higher loading regime. All other studies of MMP1 regulation with strain are 
of non-human derived tissue. Thus existing studies of MMP1 expression in response to 
load may not represent the in vivo situation. Detailed in vivo and in vitro (3D culture) 
study of human tenocytes in response to mechanical load is important to follow up this 
preliminary research. 
Static loading also induces differential modulation of MMP1 compared to unstrained 
controls. Stimulation of ex vivo rabbit tendon fascicles with 6MPa static load induced an 
increase in MMP1 expression after 20 hours. However with a lower magnitude of strain (2 
or 4 MPa) there was no change in MMP1 expression (Asundi and Rempel 2008). Static 
loading therefore appears to have a response threshold similar to cyclic loading, like cyclic 
regimes higher magnitudes of loading induce a catabolic effect.  
During tendon loading, displacement of the ECM can induce the movement of fluid within 
the tissue (Archambault, Elfervig-Wall et al. 2002). Fluid flow induces an increase in 
MMP1 expression after 9 hours at 1dyne/cm
2 
(Archambault, Elfervig-Wall et al. 2002). 
However, physiological levels of fluid flow have not been measured in response to 
mechanical load (Archambault, Elfervig-Wall et al. 2002). Therefore we cannot determine 
whether this level of fluid flow is physiologically relevant. Hence it is not possible to 
directly compare this response to the static or cyclic loading regime. Nevertheless, this 
level of fluid flow induces a catabolic response similar to that of 6MPa static load in a 
rabbit tendon study (Asundi and Rempel 2008). Therefore 1dyne/cm
2
 fluid flow may 
develop in response to approximately 6MPa static load in vivo.  
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Stress deprivation induces an increase in MMP1 expression in an in vivo ovine study 
(Smith, Sakurai et al. 2008). Taken together these data from a range of loading regimes 
suggests that either the lack of or an excess of tension (above a certain threshold) induces 
the up-regulation of MMP1 expression. There is similarity between static and cyclic 
loading in terms of MMP1 regulation, although no direct comparison could be made due to 
differences in loading magnitude and duration. Sensitivity of cells to loading may also 
depend on species. As rabbit studies did show more catabolic response to load in terms of 
MMP1 expression (Archambault, Elfervig-Wall et al. 2002; Asundi and Rempel 2008).  
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Type of mechanical 
stimulation 
Cell or tissue 
origin 
MMP1 regulation Reference 
Cyclic strain 
In vitro -  cells 
seeded onto 
silicone dishes 
Human patellar 
fibroblasts 
MMP1 ↑ with 4 or 8% 
strain at 0.5Hz for 4 
hours 
(Yang, Im et 
al. 2005) 
In vitro – cells 
seeded into 
bioflex culture 
plates 
Human flexor 
digitorum 
profundus 
MMP unchanged with 
3.5% strain at 1Hz (2 
hours followed by 18 
hours rest) 
(Tsuzaki, 
Bynum et al. 
2003) 
Rabbit Achilles 
paratenon (New 
Zealand Male white 
rabbits) 
MMP1 was undetected 
even in control 
cultures (5% 
Elongation at 0.33Hz 
for 6 hours) 
(Archambault, 
Tsuzaki et al. 
2002) 
Ex vivo – flexor 
tendon fascicles 
Rabbit flexor 
tendon 
MMP1 unchanged 
with 2,4 or 6MPa at 
0.45Hz for 18 hours 
(Asundi and 
Rempel 2008) 
In vivo 
exercise 
In vivo partial 
width laceration 
Sheep purebred 
merino wethers, 
infraspinatus tissue 
MMP1 unchanged 
with increased strain 
after 4 weeks 
(Smith, 
Sakurai et al. 
2008) 
Static strain 
Ex vivo – 
Loading of 
flexor tendon 
fascicles 
Rabbit flexor 
tendon 
MMP1 unchanged 
with 2 or 4 MPa 
MMP1 ↑ with 6MPa 
For 20 hours 
(Asundi and 
Rempel 2008) 
Fluid Flow 
In vitro – cells 
seeded onto 
collagen bonded 
glass cover slips 
Rabbit Achilles 
paratenon 
MMP1 ↑ with 9 hours 
fluid flow at 
1dyne/cm
2
 
(Archambault, 
Elfervig-Wall 
et al. 2002) 
Stress 
Deprivation 
In vivo partial 
width laceration 
Sheep purebred 
merino wethers, 
infraspinatus tissue 
MMP1 ↑ with stress 
deprivation after 4 
weeks 
(Smith, 
Sakurai et al. 
2008) 
 
Table 1.6.  MMP1 mRNA regulation with mechanical load 
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1.7.2. MMP2 mRNA regulation with mechanical load 
A human in vivo study showed proMMP2 was decreased in Achilles peritendinous tissue 
dialysate after 1 day and increased after 3 days after 1 hour of intense uphill running 
(Koskinen, Heinemeier et al. 2004). In vivo studies of loading in rodent and ovine tissue 
have shown that after prolonged periods of high-level load, MMP2 mRNA is increased 
(Heinemeier, Olesen et al. 2007; Smith, Sakurai et al. 2008; Sun, Andarawis-Puri et al. 
2010). Therefore prolonged high level loading may induce MMP2 expression; which can 
be associated with matrix reorganisation. Legerlotz et al showed no change in MMP2 
expression after 12 weeks treadmill running inrat Achilles (Legerlotz, Schjerling et al. 
2007). This difference in response could be due to strain magnitude or due to differences in 
species. However it is difficult to compare the level of strain that the cells undergo in 
different models, due to the differential makeup of the tendon. Stress deprivation of rat 
tendon fascicles induced an increase in MMP2 expression in an ex vivo model (Leigh, 
Abreu et al. 2008). This evidence indicates that high level or lack of mechanical load 
increase MMP2, however lower level stress or shorter strain period has no affect upon 
MMP2 mRNA expression. Study of different loading regimes is required to further 
understand MMP2 regulation in human specimens (For a summary of changes with strain 
see table 2). 
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Type of mechanical 
stimulation 
Cell or tissue 
origin 
MMP2 regulation Reference 
In vivo 
exercise 
1 hour of uphill 
treadmill 
running 
Human, healthy 
young males 
proMMP2 ↓ after 1 
day and ↑ after 3 
days (protein) 
(Koskinen, 
Heinemeier et 
al. 2004) 
In vivo partial 
width laceration 
Sheep purebred 
merino wethers, 
infraspinatus tissue 
MMP2 mRNA ↑ 
with increased strain 
after 4 weeks 
(Smith, 
Sakurai et al. 
2008) 
In vivo -  12 
weeks treadmill 
running 
Achilles tendon 
from Sprague 
Dawley Rats 
MMP2 mRNA 
unchanged with 
strain 
(Legerlotz, 
Schjerling et 
al. 2007) 
In vivo - sub 
failure fatigue 
loading 
Rat patellar tendon 
from female 
Sprague Dawley 
rats 
MMP2 mRNA ↑ 1 
and 7 days post 100 
load cycle MMP2 
mRNA ↑ 7 days post 
7200 load cycle but 
not after 1 day 
(Sun, 
Andarawis-
Puri et al. 
2010) 
In vivo - 
electrical muscle 
stimulation 
Female Sprague 
Dawley Rat 
Achilles tendon 
MMP2 mRNA ↑ 
with concentric and 
isometric exercise 
but not eccentric 
after 4 days 
(Heinemeier, 
Olesen et al. 
2007) 
Stress 
Deprivation 
Ex vivo – 
unloading of 
tendon fascicles 
Rat tail tendon 
from Sprague 
Dawley Rats 
MMP2 ↑ with 6 
hours stress 
deprivation 
(Leigh, Abreu 
et al. 2008) 
 
Table 1.7. MMP2 mRNA and protein regulation with mechanical load 
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1.7.3MMP3 mRNA regulation with mechanical load 
In human and rodent in vitro cell culture studies of cyclic strain, MMP3 mRNA was 
increased with 2-6 hours of 3.5-5% strain at 0.33-1Hz followed by 18 hours of rest, 
however this was not reflected at the protein level (Archambault, Tsuzaki et al. 2002; 
Tsuzaki, Bynum et al. 2003). This response may be a result of the 18 hour rest period 
rather than a response to the strain itself. Other studies that have looked at MMP3 
expression directly after loading have shown a decrease in expression. For example a study 
of ex vivo flexor tendon of the rabbit showed MMP3 was decreased in response to 4MPa 
strain at 0.45Hz after 18 hours, and was unchanged with increased magnitude (Asundi and 
Rempel 2008). In rat tail tendon studies MMP3 mRNA was increased after 10 minutes of 
loading but was unchanged after 1 or 24 hours (3% loading upon a static load of 2% at 
1Hz) (Maeda, Shelton et al. 2009; Maeda, Fleischmann et al. 2010). This differential 
response may be due to the underlying static load used in this study (for a summary of 
MMP3 changes with strain see table 3).  
Fatigue loading of rat tail tendon induced an increase in MMP3 expression in response to a 
short loading cycle, whereas a longer strain regime had no effect upon MMP3 expression 
(Sun, Andarawis-Puri et al. 2010). Fluid flow at 1dyne/cm
2
 also increased MMP3 mRNA 
expression (Archambault, Elfervig-Wall et al. 2002). This data suggests that MMP3 
regulation depends of the magnitude and duration of loading. Shorter duration and higher 
magnitude induce a more catabolic response, whereas longer and lower levels of strain 
induce an anabolic response. Stress deprivation induced an increase in MMP3 mRNA after 
8 hours (Leigh, Abreu et al. 2008). Therefore the lack of tension also increases MMP3 
expression. 
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Type of mechanical 
stimulation 
Cell or tissue 
origin 
MMP3 regulation Reference 
Cyclic 
strain 
In vitro – cells 
seeded into 
bioflex culture 
plates 
Human flexor 
digitorum 
profundus 
MMP3 mRNA ↑ with 2 
hours 3.5% strain at 1Hz 
(followed by 18 hours rest) 
(Tsuzaki, 
Bynum et al. 
2003) 
Rabbit Achilles 
paratenon (New 
Zealand Male 
rabbits) 
MMP3 mRNA ↑ with 5% 
Elongation at 0.33Hz for 6 
hours + 18 hours rest 
unchanged with strain at the 
protein level 
(Archambault, 
Tsuzaki et al. 
2002) 
Ex vivo – 
Tendon 
fascicles 
Rabbit flexor 
tendon 
MMP3 mRNA ↓ with 4MPa 
strain at 0.45Hz 
Unchanged at 5MPa  
after 18 hours 
(Asundi and 
Rempel 2008) 
Rat tail tendon 
from male 
Wister rats 
MMP3 mRNA ↑ at 10 
minutes of 3% cyclic strain 
superimposed on a 2% static 
load 
(Maeda, 
Shelton et al. 
2009) 
MMP3 mRNA unchanged at 
either 1 or 24 hours with 3% 
cyclic strain superimposed 
on a 2% static load (4 hour 
incubation in medium before 
strain protocol) at 1Hz 
(Maeda, 
Fleischmann et 
al. 2010) 
In vivo 
exercise 
In vivo - sub 
failure fatigue 
loading 
Rat patellar 
tendon from 
female Sprague 
Dawley rats 
MMP3 mRNA ↑ 1 and 7 
days post 100 load cycle 
MMP3 mRNA unchanged  
post 7200 load cycle  
(Sun, 
Andarawis-
Puri et al. 
2010) 
Fluid flow 
In vitro – cells 
seeded onto 
collagen bonded 
glass coverslips 
Rabbit Achilles 
paratenon 
MMP3 mRNA ↑ with 9 
hours fluid flow at 
1dyne/cm
2
 
(Archambault, 
Elfervig-Wall 
et al. 2002) 
Stress 
Deprivation 
Ex vivo – 
unloading of 
tendon fascicles 
Rat tail tendon 
from Sprague 
Dawley Rats 
MMP3 mRNA ↑ with 8 
hours stress deprivation 
(Leigh, Abreu 
et al. 2008) 
 
Table 1.8. MMP3 regulation with mechanical load 
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1.7.4. MMP9 mRNA regulation with mechanical load 
Studies of in vivo exercise have measured MMP9 expression. Humans showed increased 
levels of proMMP9 in the tendon tissue dialysate, 1 and 3 days after 1 hour of uphill 
treadmill running (Koskinen, Heinemeier et al. 2004). Studies of partial width laceration 
and sub failure fatigue loading showed no change in MMP9 mRNA expression with up to 
4 weeks of mechanical load, however stress deprivation induced an increase in MMP9 
mRNA (Smith, Sakurai et al. 2008; Sun, Andarawis-Puri et al. 2010). In summary, human 
studies suggest that MMP9 induction may occur in response to mechanical load in the 
surrounding tendon area. However in ovine and rodent studies MMP9 is not induced at the 
mRNA level in response to load in tendon cells and lack of tension induces a catabolic 
effect (for a summary of MMP9 changes with strain see table 4). 
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Type of mechanical 
stimulation 
Cell or tissue 
origin 
MMP9 regulation Reference 
In vivo 
exercise 
1 hour of 
uphill 
treadmill 
running 
Human, healthy 
young males 
proMMP9 ↑ after 1 day 
and 3 days (protein) 
(Koskinen, 
Heinemeier et al. 
2004) 
In vivo partial 
width 
laceration 
Sheep purebred 
merino wethers, 
infraspinatus 
tissue 
MMP9 mRNA 
unchanged with 
excessive strain after 4 
weeks 
(Smith, Sakurai et 
al. 2008) 
In vivo - sub 
failure fatigue 
loading 
Rat patellar 
tendon from 
female Sprague 
Dawley rats 
MMP9 mRNA was 
unchanged  with 100 or 
7200 load cycle after 1 
or 7 days 
 
(Sun, Andarawis-
Puri et al. 2010) 
Stress 
Deprivation 
In vivo partial 
width 
laceration 
Sheep purebred 
merino wethers, 
infraspinatus 
tissue 
MMP9 mRNA ↑ with 
stress deprivation after 4 
weeks 
(Smith, Sakurai et 
al. 2008) 
 
Table 1.9. MMP9 regulation with mechanical strain 
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1.7.5. MMP13 mRNA expression with mechanical load 
In vivo and ex vivo rat tail and patellar tendon studies have shown that lower magnitudes 
(<6%) of cyclic strain decrease the level of MMP13 mRNA expression (Arnoczky, 
Lavagnino et al. 2008; Gardner, Arnoczky et al. 2008; Sun, Li et al. 2008; Maeda, Shelton 
et al. 2009; Maeda, Fleischmann et al. 2010). In studies of higher level mechanical loading 
such as repeated cyclic loading of rat patellar tendon until the fascicles reached 1.7% 
elongation (Sun, Li et al. 2008) or partial width laceration in ovine tendon (Smith, Sakurai 
et al. 2008), MMP13 was increased. Intermittent in vitro hydrostatic pressure as well as 
cyclic loading induced a magnitude dependant response. Moderate load (1.5MPa 
hydrostatic pressure or 0.6% elongation) reduced the level of MMP13, however high level 
load (7.5MPa, 1.7% elongation) increased MMP13 mRNA expression (Sun, Li et al. 
2008). This indicates that the strain response of MMP13 mRNA is magnitude sensitive. 
Sub failure fatigue studies showed that low repetition of high level strain induced an 
increase in MMP13 expression, however in response to a longer loading regimen MMP13 
was decreased (Sun, Andarawis-Puri et al. 2010). Therefore low level repetition induces a 
more catabolic response in MMP13 expression than in high level repetition studies. Sun 
and colleagues proposed that prolonged high level loading induced an adaptive response 
rather than a catabolic response (Sun, Andarawis-Puri et al. 2010). This indicates that 
tendon cells may be able to increase tendon strength in response to long term loading by 
reducing the level of ECM degradation, although confirmation that this is actually 
occurring at the protein level is necessary. Stress deprivation of tendon fascicles increased 
MMP13 expression in a number of rat tail tendon studies (Lavagnino, Arnoczky et al. 
2006; Arnoczky, Lavagnino et al. 2007; Arnoczky, Lavagnino et al. 2008; Leigh, Abreu et 
al. 2008). In summary high level and absence of tension induces a catabolic effect whereas 
lower level and/or prolonged strain produces an anabolic response in terms of MMP13 
expression (for summary see table 5). 
  
Chapter1: Introduction 
62 
 
 
Type of mechanical 
stimulation 
Cell or tissue 
origin 
MMP13 regulation Reference 
Cyclic strain 
 
 
In vivo - 
loading of 
tendon 
fascicles 
Rat patellar tendon 
from adult female 
Sprague Dawley rats 
MMP13 mRNA, protein and 
activity  ↓ with loading at 1Hz 
until 0.6% elongation, ↑with 
loading at 1Hz until 1.7% 
elongation 
(Sun, Li et al. 
2008) 
Ex vivo – 
loading of 
tendon 
fascicles 
Rat tail tendon 
MMP13 ↓ with strain (1-6% at 
0.017Hz) 
(Gardner, 
Arnoczky et al. 
2008) 
MMP13 ↓ with 1% strain at 24 
hours 
(Arnoczky, 
Lavagnino et al. 
2008) 
Rat tail tendon from 
male Wister rats 
MMP13 mRNA ↓ at 24 hours of 
3% cyclic strain super-imposed 
on a 2% static load 
(Maeda, 
Shelton et al. 
2009) 
MMP13 mRNA ↓ 1 and 24 
hours with 3% cyclic strain 
superimposed on a 2% static 
load (4 hour incubation in 
mediumbefore strain protocol) 
(Maeda, 
Fleischmann et 
al. 2010) 
Hydrostatic 
pressure 
In vitro – 
intermittent 
hydrostatic 
pressure 
Clonal cells derived 
from rat patellar 
tendon 
MMP13 mRNA, protein and 
activity  ↓ with 1.5MPa at 1Hz 
↑with 7.5 MPa at 1Hz 
(Sun, Li et al. 
2008) 
In vivo 
exercise 
In vivo partial 
width 
laceration 
Sheep purebred 
merino wethers, 
infraspinatus tissue 
MMP13 mRNA ↑ with 
increased strain and strain 
deprivation after 4 weeks 
(Smith, Sakurai 
et al. 2008) 
In vivo - sub 
failure fatigue 
loading 
Rat patellar tendon 
from female Sprague 
Dawley rats 
MMP13 mRNA ↑ 1 and 7 days 
post 100 load cycle MMP13 
mRNA ↓ 7 days post 7200 load 
cycle  
(Sun, 
Andarawis-Puri 
et al. 2010) 
 
Stress 
Deprivation  
Ex vivo –
isolated 
fibrillar 
damage 
Rat tail tendon  
MMP13 mRNA and protein ↑ at 
sites of microdamage 
(Lavagnino, 
Arnoczky et al. 
2006) 
Ex vivo – 
unloading of 
tendon 
fascicles 
MMP13 mRNA, protein and 
activity ↑ with 7 days stress 
deprivation 
(Arnoczky, 
Lavagnino et al. 
2007) 
MMP13 mRNA ↑ with 24 hours 
stress deprivation 
(Arnoczky, 
Lavagnino et al. 
2008) 
MMP13 mRNA ↑ with 8 hours 
stress deprivation 
(Leigh, Abreu 
et al. 2008) 
In vivo partial 
width 
laceration 
Sheep purebred 
merino wethers, 
infraspinatus tissue 
MMP13 mRNA ↑ with stress 
deprivation after 4 weeks 
(Smith, Sakurai 
et al. 2008) 
Table 1.10. MMP13 Regulation with mechanical strain 
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1.7.6. Rat Collagenase 
Sprague Dawley Rats are often used in the study of tendon with respect to mechanical 
load. However rat species do not express MMP1 and MMP13 as they are known in 
humans. They do express what has been termed Rat collagenase, which is most closely 
related in terms of sequence homology to human MMP13 (Mitchell, Magna et al. 1996). 
However, some research groups have published data which describes the regulation of 
MMP1 in Rat tendon in response to mechanical load (Lavagnino, Arnoczky et al. 2003; 
Arnoczky, Tian et al. 2004). However this description is not a true representation as Rat 
collagenase is less homologous to human MMP1 than it is to human MMP13 (Mitchell, 
Magna et al. 1996). Therefore this section describes the regulation of rat collagenase 
separate from the other MMPs. In an in vivo study of rat tendon fascicles 1% strain at 1Hz 
decreased rat collagenase expression after 24 hours (Lavagnino, Arnoczky et al. 2003). 
This study also showed that not only the amplitude but the frequency of strain was also 
important in instigating a response in terms of rat collagenase regulation (Lavagnino, 
Arnoczky et al. 2003). Another study of rat tail tendon showed that rat collagenase was 
decreased with up to 6MPa static load after 24 hours (Arnoczky, Tian et al. 2004). Studies 
of stress deprivation in rat tail tendon, over a period of 24 hours they observed an increase 
in MMP1 mRNA expression (Lavagnino, Arnoczky et al. 2003; Arnoczky, Tian et al. 
2004). Therefore, it is clear that Rat collagenase is decreased in response to moderate 
mechanical strain and increased with stress deprivation (for a summary of rat collagenase 
changes see table 6).  
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Table 1.11. Rat Collagenase mRNA and protein regulation with mechanical 
load 
 
  
Type of mechanical 
stimulation 
Cell or tissue 
origin 
Rat Collagenase 
regulation 
Reference 
Cyclic strain 
Ex vivo – flexor 
tendon fascicles 
Rat tail tendon 
Rat Collagenase ↓ with 
1% strain at 1 Hz for 
24 hours 
(Lavagnino, 
Arnoczky et 
al. 2003) 
Static strain 
Ex vivo – 
Loading of rat 
tail tendon 
Rat tail tendon 
from Sprague 
Dawley rats 
Rat Collagenase ↓ with 
2-6MPa for 24 hours 
(Arnoczky, 
Tian et al. 
2004) 
Stress 
Deprivation 
Ex vivo – Rat 
tendon fascicles 
Rat tail tendon 
Rat Collagenase ↑ with 
24 hours stress 
deprivation 
(Lavagnino, 
Arnoczky et 
al. 2003) 
Rat tail tendon 
from Sprague 
Dawley Rats 
Rat Collagenase ↑ with 
24 hours stress 
deprivation 
(Arnoczky, 
Tian et al. 
2004) 
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1.7.7. Other MMPs regulated with mechanical load 
Previous studies have observed the regulation of MMP14 mRNA in response to 
mechanical loading. After a short period (100 cycles) of straining, MMP14 was increased 
(7 days after the strain period), however, after a longer period (7200 cycles) of strain 
MMP14 was decreased (1 day after the strain period) (Sun, Andarawis-Puri et al. 2010). In 
an ovine study involving partial width laceration of the infraspinatus tendon, MMP14 was 
increased in stress deprived areas but unchanged in areas of increased loading (Smith, 
Sakurai et al. 2008). Therefore MMP14 mRNA is sensitive to mechanical load and 
duration determines the direction of regulation. Maeda et al, also looked at MMP10, 
MMP12, MMP16 and MMP23 using microarray, however they showed no change in any 
of these genes in response to 3% cyclic strain superimposed on a static strain of 2% 
(Maeda, Fleischmann et al. 2010). Therefore not all of the metalloproteinase genes have 
been measured in response to mechanical loading and protein quantification is limited. A 
full investigation of the regulation of metalloproteinase genes is required to further 
understand how matrix turnover is regulated in response to mechanical load. 
1.7.8. ADAMTS and TIMP regulation with mechanical load 
Mechanical stimulation in rat tendon induced an increase in mRNA and protein expression 
of TIMPs 1 and 2 (Heinemeier, Olesen et al. 2007; Legerlotz, Schjerling et al. 2007). The 
increase of TIMP expression is suggestive of a more anabolic phenotype, however 
functions of TIMP2 include the activation of proMMP2 (Wang, Juttermann et al. 2000). 
Therefore the induction of TIMP2 with mechanical load may be inducing activation of 
MMP2, however whether MMP2 is activated and whether it is involved in collagen 
degradation in response to mechanical loading remains to be determined. ADAMTS1 and 
ADAMTS5 mRNA were decreased after 24 hours of 3% cyclic strain superimposed on a 
static 2% load in a study on rat tail tendon fascicles (Maeda, Fleischmann et al. 2010). An 
ovine tendon model reported decreased ADAMTS4 mRNA in overstrained areas of 
infraspinatus tendon (due to partial width laceration) (Smith, Sakurai et al. 2008). 
ADAMTS1, ADAMTS4 and ADAMTS5 all posses some aggrecanase activity, and as they 
are all decreased in response to mechanical loading this suggests that mechanical 
stimulation reduces the breakdown of proteoglycan in the ECM, stabilising the tissue. No 
other studies have reported ADAMTS or TIMP regulation despite their involvement in 
matrix turnover. This area requires further investigation. 
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1.7.9. Matrix protein regulation with mechanical strain 
Mechanical strain has also been shown to increase collagen type I and III protein and 
overall collagen content in vivo, ex vivo and in vitro tendon studies (Yang, Crawford et al. 
2004; Screen, Shelton et al. 2005; Heinemeier, Olesen et al. 2007; Maeda, Shelton et al. 
2009; Szczodry, Zhang et al. 2009). However, a rat study showed that there was no change 
in collagen type III mRNA with mechanical load (Legerlotz, Schjerling et al. 2007). An 
increase in type I collagen with mechanical strain indicates that loading induces growth 
and adaptation of the ECM. Proteoglycan regulation has also been reported in a rat tail 
tendon model. After a cyclic loading regime of 3% overlaying a 2% static strain for 24 
hours decorin, fibronectin and biglycan mRNA was decreased, increased and unchanged 
respectively (Maeda, Shelton et al. 2009; Maeda, Fleischmann et al. 2010). As decorin and 
biglycan are involved in the regulation of collagen fibrillogenesis through the interaction of 
the core protein, which results in the decrease in fibril diameter (Danielson, Baribault et al. 
1997; Chakravarti, Magnuson et al. 1998; Svensson, Aszodi et al. 1999), strain modulation 
of decorin may increase the size of collagen fibrils, increasing tendon strength. An increase 
in fibronectin in response to mechanical strain may alter cellular interaction with the ECM, 
as fibronectin is a major glycoprotein involved in the interaction with integrins (Pankov 
and Yamada 2002).  
1.7.10. Cytokine regulation in response to Mechanical load 
IL6 protein was increased in humans after prolonged running exercise (36km) (Langberg, 
Olesen et al. 2002). In addition a bovine study of fatigue cyclic loading (30% elongation at 
1Hz) reported an increase in IL6 mRNA and decrease in IL6R mRNA (Legerlotz, Jones et 
al. 2011). Immunohistochemical analysis showed that IGF1 protein was markedly 
increased with mechanical loading after twelve weeks of treadmill exercise in a rat model 
(Scott, Cook et al. 2007). However, a rat tendon study of a 3% cyclic strain overlaying a 
2% static strain showed no significant change in IL6 or IGF1 (Maeda, Fleischmann et al. 
2010). The lack of agreement between these studies may stem from the fact that strain has 
variable effects on gene expression. Mechanical loading increased the expression of TGFβ 
at the mRNA and protein level in a number of studies in both rat tendon and human 
patellar fibroblasts (Skutek, van Griensven et al. 2001; Yang, Crawford et al. 2004; 
Heinemeier, Olesen et al. 2007; Maeda, Shelton et al. 2009; Maeda, Fleischmann et al. 
2010), however TGFβ mRNA expression did not change with the application of load in a 
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rat wheel running study (Legerlotz, Schjerling et al. 2007). IL6, IGF1 and TGFβ are 
cytokines that have the potential to induce downstream signalling pathways in response to 
their stimulation. Therefore regulation of these cytokines may be involved in the 
mechanical regulation of downstream effectors.  
Studies of rabbit and human patella fibroblast also showed an increase in COX2 (2 fold) 
with 20h 6MPa static strain (Asundi and Rempel 2008) or after 4 hours of 4% cyclic strain 
at 0.5Hz (Yang, Im et al. 2005) respectively. A rat tendon study of a 3% cyclic strain 
overlaying a 2% static strain showed an significant increase in COX2 after 24 hours 
(Maeda, Fleischmann et al. 2010). COX2 regulation has as yet no clear role in mechanical 
regulation. Rodent tissue studies have also measured IL1β in response to mechanical load; 
a rat in vivo model showed that a 1.7% cyclic load caused an increase in IL1β, however a 
0.6% cyclic load decreased IL1β (Sun, Li et al. 2008), in rabbit flexor tendon tissue 
strained at 4MPa for 20 hours IL1β was decreased 2 fold  (Asundi and Rempel 2008). This 
suggests that above a certain threshold of strain IL1β is increased and below this threshold 
IL1β is decreased. This fits well with the assumption that with high levels of strain there is 
a catabolic response and with low levels of strain there is an anabolic response, as IL1 can 
stimulate MMP activity (Nagase and Woessner 1999).  
1.7.11. Mechanical regulation of ‘markers’ of tendon  
There are no true markers of tendon phenotype; however, genes that are more commonly 
expressed in the tendon rudiment include Scleraxis. Scleraxis has been determined as a 
marker for tendon and ligament progenitor cells during development (Schweitzer, Chyung 
et al. 2001). Multipotent stem cells that have the potential to differentiate into tenocytes, 
stimulation with cyclic and static mechanical load induced the expression of scleraxis 
(Scott, Danielson et al. 2011). Therefore mechanical stimulation may be a key regulator in 
tenocyte homeostasis and may induce tenocytes to show more rudimentary characteristics.  
Taken together this data suggests that moderate straining regimes may therefore maintain 
the ECM, although there appears to be a threshold above which too much strain can induce 
degradative effects upon the surrounding matrix. Whilst magnitude of strain has been 
previously implicated as more of a key regulatory factor (Arnoczky, Tian et al., 2002), in 
2003 Arnoczky’s group published data to suggest that frequency was also important in the 
regulation of rat collagenase (Lavagnino, Arnoczky et al. 2003). Duration of loading may 
also play an important role (Smith, Sakurai et al. 2008). Therefore magnitude, duration and 
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frequency are important in how cells respond to strain. More intensive study in this area is 
required to fully understand how these factors differentially regulate gene expression in 
human tendon.  
1.7.12. Mechanical load and tendinopathy 
Tendons of different anatomical positions have differences in composition and rate of 
turnover, for example positional and energy storing tendons; this is thought to be due to 
their distinct functions and variation in their exposure to mechanical load (Birch 2007). 
Tenocytes respond differently depending on the type of strain, for example tenocytes 
exposed to more compressive strains are morphologically similar to chondrocytes in that 
they are more spherical in nature (Perez-Castro and Vogel 1999). In addition, these tissue 
regions are more fibrocartilagenous with increased expression of type II collagen and 
aggrecan (Perez-Castro and Vogel 1999). Tendons not exposed to high levels of stress, 
such as the biceps brachii tendon, do not undergo such extensive matrix renewal and in 
these tendons only very low expression of MMP1, MMP2 and MMP3 is observed. As this 
type of tendon is less commonly affected by tendinopathy we may conclude that stress may 
be an important factor in tendinopathy development (Riley, Curry et al. 2002).  
Despite this link between tendinopathy and mechanical loading, a level of tension is 
required to maintain healthy tendon as stress deprivation causes increased ECM 
breakdown (Arnoczky, Lavagnino et al. 2008; Egerbacher, Arnoczky et al. 2008). And 
although this association between tendinopathies and increased mechanical strain still 
remains, there is speculation as to whether tendinopathies are the result of an increase or 
absence of mechanical loading (Arnoczky et al, 2002). Mechanical failure (fibril damage) 
of tendon (possibly due to high levels of strain) may result in areas of stress deprivation 
and other areas of increased stress. Therefore tendinopathies may occur as a result of 
abnormally distributed stress rather than simply excessive load (Arnoczky et al, 2002). For 
example, the stress deprivation of rat tail tendon is known to cause the up-regulation of 
catabolic mediators such as rat collagenase / MMP13 which degrade the matrix and as a 
result decrease the strength of the tendon (Lavagnino, Arnoczky et al. 2003; Arnoczky, 
Lavagnino et al. 2008). Stress deprivation has been shown to induce apoptosis in a rat-tail 
tendon model (Egerbacher, Arnoczky et al. 2008). It has been theorized that apoptosis can 
occur due to the loss of cellular homeostatic tension caused by fibril damage in vivo 
(Arnoczky, Lavagnino et al. 2008; Egerbacher, Arnoczky et al. 2008). As physiologically 
relevant levels and types of strain (<6%) (Lavagnino, Arnoczky et al. 2003; Screen, Lee et 
Chapter1: Introduction 
69 
 
al. 2004) show anabolic changes in MMP mRNA expression. Increases in MMP 
expression may be due to a relaxation period after strain (Archambault, Tsuzaki et al. 
2002; Tsuzaki, Bynum et al. 2003; Sun, Andarawis-Puri et al. 2010) or  short term loading 
(Yang, Im et al. 2005; Maeda, Shelton et al. 2009), this may induce a shift in the 
homeostasis which in turn increases MMP expression. It is therefore likely that stress 
deprivation due to localised fibrillar damage plays a key role in the development of 
tendinopathy. 
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1.8. MECHANOSENSATION AND TRANSDUCTION  
Signal transduction as a result of mechanical stimulation is often referred to as 
mechanotransduction. Mechanical strain induces the activation of a network of 
intracellular signalling pathways that are not yet fully understood (Ashida, Takechi et al. 
2003; Riddle, Taylor et al. 2006; Craig, Haimovich et al. 2007). Studies of tendon 
mechanotransduction are limited. However studies covering a wide range of tissues have 
shown that (1) mechanosensation can involve focal adhesions, integrins, ion channels and 
growth factors and (2) mechanotransduction can involve calcium, mitogen activated 
protein kinases (MAPK), Rho/Rho associated protein kinase (ROCK), nuclear factor kappa 
B (NFκB) and stress activated protein kinases (SAPK) such as c-JUN end terminal kinases 
(JNK) (Figure 1.5) (For reviews of mechanotransduction see (Banes, Tsuzaki et al. 1995; 
Lambert, Nusgens et al. 1998; Chiquet 1999; Chiquet, Custaud et al. 2003; Sarasa-Renedo 
and Chiquet 2005; Wall and Banes 2005; Wang 2006; Wang, Tytell et al. 2009)). 
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Figure 1.5. Interaction between integrin, growth factor and calcium mediated 
mechanotransduction. Mechanical load can stimulate the activation of integrins, growth 
factors and ion channels (i.e. stretch activated ion channels). Consequent intracellular 
signalling via Rho/ROCK, NFκB and MAPK regulates gene transcriptional regulation.  
NFκB, Nuclear factor kappa B; IKK, inhibitor of NFκB kinase; MAPK, mitogen activated 
protein kinase; TF, transcription factor; GF, growth factor; PKC, protein kinase C. Adapted 
from (Sarasa-Renedo and Chiquet 2005) 
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1.8.1. Cytoskeletal detection of mechanical strain 
The ‘mechanostat set point’ refers to the level of stress that is required to induce a response 
to mechanical load (Arnoczky, Lavagnino et al. 2008). A deviation from this set point 
results in the modification of the ECM either in an anabolic or catabolic fashion. Changes 
in strain exposure can result in the recalibration of this ‘mechanostat set-point’ (Frost 
1987; Arnoczky, Lavagnino et al. 2008), so that the threshold of strain required to maintain 
the ECM is modified due to changes in the pericellular environment and resulting modified 
cell-matrix interaction. For example, stress deprived tendons had an increased MMP13 
expression compared to freshly extracted controls. Only by up-regulating this strain 
(following the period of stress deprivation) did MMP13 expression match that of the 
loaded controls (Arnoczky, Lavagnino et al. 2008). The idea of resetting of the 
‘mechanostat set-point’ could explain why treatments of eccentric overload are effective. 
Interventions specifically designed to reset the mechanostat set-point might be effective for 
tendinopathy treatment (Arnoczky, Lavagnino et al. 2008). Tensegrity and regulation of 
the ‘mechanostat set point’ is facilitated by a form of mechanotransduction.  
Integrins are transmembrane proteins made up of heterodimers of α and β subunits devoid 
of any intrinsic tyrosine kinase activity (Hynes 1992). There are 14 α subunits and 8 β 
subunits which bind non-covalently. Integrin αβ dimers can exist in an open or closed 
confirmation; this corresponds to their active or inactive nature, respectively (Hynes 1992). 
When active, integrins function can as an interface between the cell and ECM by binding 
to components of the ECM. They are also reported to induce signal transfer (Hynes 1992). 
The cytoplasmic tails of some integrins are linked to the cytoskeleton, the major structural 
components of the cell. This allows the cytoskeleton to form a direct link with the ECM, 
sensitising the cell to changes in mechanical load. Integrins form clusters known as focal 
adhesions; at this site the cytoplasmic domain is connected to a range of adaptor proteins 
including vinculin, tensin, paxillin, α-actinin and talin. Other proteins such as kinases co-
localise with the adaptor proteins; these include focal adhesion kinase (FAK) or integrin 
linked kinase (ILK) (Banes, Tsuzaki et al. 1995; Ingber 1997; Sarasa-Renedo and Chiquet 
2005). The application of mechanical strain to the integrin-ECM ligand complex can 
induce an increase in the formation of focal contacts and integrin activation. As a result of 
load-induced integrin activation, the cytoplasmic tail of the β chain can induce tyrosine 
phosphorylation and consequent activation of FAK. The phosphorylation of adaptor 
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proteins and tyrosine kinases such as Src can trigger the activation of downstream 
signalling pathways including MAPK, NFκB and Rho/Rock signalling (Lambert, Nusgens 
et al. 1998; Sarasa-Renedo and Chiquet 2005). The consequences of these signalling 
cascades often involve the control of gene expression. Therefore the interaction between 
integrins and the cytoskeleton forms a mechanical load sensor.  
Wang and colleagues suggest that mechanical stimulation can be detected by the direct 
linkage of the focal adhesions to the nucleus via cytoskeletal components and associated 
proteins. This association is reported to modulate transcription by chromatin recombination 
and DNA melting via spatial manipulation, or induce nuclear transport by increasing the 
size of nuclear pores through nuclear distortion (Wang, Tytell et al. 2009). However, this 
signalling response has not been confirmed in tendon.  
In vitro tendon studies have shown that strain alters tenocyte ECM conformation which in 
turn alters the shape of the cell and the actin cytoskeleton (Lavagnino, Arnoczky et al. 
2003). Tendon tissue exposed to physiological strain regimes shows cellular and nuclear 
deformation in the direction of the applied force (Arnoczky, Lavagnino et al. 2002). And 
although local strains perceived by the cell are much smaller than those applied to the 
whole tendon in the physiological environment, it is possible that the deformation of the 
cell may invoke a mechanotransduction response (Arnoczky, Lavagnino et al. 2002). Actin 
filament depolarization causes the abrogation of strain induced MMP1 inhibition, 
suggesting that the actin cytoskeleton is involved in MMP1 regulation (Lavagnino, 
Arnoczky et al. 2003; Arnoczky, Tian et al. 2004). Therefore actin filaments may mediate 
mechanosensation in tendon.  
Numerous studies have looked at the response of other cell types to mechanical loading. 
These include epithelial, endothelial, bone and muscle derived cells (Katsumi, Naoe et al. 
2005; Ali, Mungai et al. 2006; Brancaccio, Hirsch et al. 2006). An example of mechanical 
loading in another tissue is the exposure of cardiomyocytes to stress in response to 
hemodynamic overload. Integrin isoform β1D is involved in the detection of mechanical 
load in these cells. Integrin associated proteins including FAK and Src kinases are 
activated and consequently trigger downstream signalling pathways that include AKT, 
RAS and ERK (Brancaccio, Hirsch et al. 2006). In a fibroblastic cell line mechanical load 
induced the activation of αvβ3 integrins via PI3K/Akt signalling. Activation of integrins 
increases their affinity to bind to the extracellular matrix, creating more adhesion sites and 
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activates JNK as a downstream signalling pathway (Katsumi, Naoe et al. 2005). Therefore 
the activation of different signalling pathways in response to strain appears to be cell type 
specific. 
Endothelial cells are exposed to high levels of mechanical stimulation during hypertension 
(Ali, Mungai et al. 2006). Endothelial cell mechanical stimulation induced the release of 
reactive oxygen species (ROS) through the displacement of the cytoskeleton and 
mitochondria (Ali, Mungai et al. 2006). The ROS stimulated the activation of FAK through 
the protein kinase C (PKC) pathway (Ali, Mungai et al. 2006). This demonstrates that 
crosstalk exists between signalling pathways in response to mechanical stimuli. 
Other signalling pathways have been found to be activated in response to mechanical 
loading without apparent cytoskeletal or integrin involvement.  Tenascin-C is expressed in 
tissues that are exposed to high levels of strain (Martin, Mehr et al. 2003), including tendon 
(Riley, Harrall et al. 1996). In response to mechanical load, tenascin-C was induced via the 
Rho/ROCK and not via ROS, IL4 or MAPK signalling pathways in skin fibroblasts 
(Chiquet, Sarasa-Renedo et al. 2004). Mechanical load also stimulates NFκB signalling in 
a magnitude-dependant manner in rabbit articular cartilage (Agarwal, Deschner et al. 
2004). At a high cyclic strain (15-18%), nuclear translocation of NFκB was up-regulated; 
however a low level cyclic strain (4-8%) showed no induction. The stimulation of NFκB in 
combination with NO (nitric oxide) production could be involved in the initiation of pro-
inflammatory events due to excessive loading (Agarwal, Deschner et al. 2004). Therefore 
mechanical strain can regulate a number of mechanotransduction pathways, with 
differential activation of these pathways depending upon cell type and the surrounding 
ECM, as well as the magnitude of mechanical stimulation.  
Studies of mechanical loading in tendon have also highlighted signalling pathways in the 
absence of apparent integrin or cytoskeletal involvement. SAPKs, JNK1 and JNK2 are 
consistently induced in response to mechanical load in human, canine and rabbit patellar 
studies (Arnoczky, Tian et al. 2002; Skutek, van Griensven et al. 2003; Kawabata, Katsura 
et al. 2009). The rabbit tendon studies also showed an increase in phospho-p38 in the 
absence of mechanical load (Kawabata, Katsura et al. 2009). In the same study markers of 
apoptosis were also increased. JNK signalling can be associated with apoptosis (Kawabata, 
Katsura et al. 2009), however not all cyclic loading is associated with increased apoptosis 
(Kawabata, Katsura et al. 2009). In the studies that showed increased apoptosis, a 
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prolonged period of mechanical stimulation induced stress tolerance via heat shock 
protein-mediated suppression of apoptosis (Skutek, van Griensven et al. 2003). In addition, 
the canine studies showed that induction of JNK was facilitated by calcium signalling 
(Arnoczky, Tian et al. 2002). This indicates that calcium signalling may play a role in the 
regulation of downstream signalling pathways in response to tendon loading.  
1.8.2. Stress deprivation 
Not only is increased mechanical stimulation detected via cellular interaction with the 
matrix, an absence of tension can also be detected. Studies have shown that by reducing 
the level of tensional force upon cells in a collagen gel, by gel release, gel contraction and 
MMP expression is stimulated (Langholz, Rockel et al. 1995; Riikonen, Westermarck et al. 
1995; Lambert, Lapiere et al. 1998; Ravanti, Heino et al. 1999). MMPs are of particular 
interest as increased expression can result in the degradation and potential weakening of 
the matrix. Studies of this kind have mainly focused on human skin fibroblasts. They have 
shown that integrins α1β1 and α2β1 are involved in the detection of mechanical stimulus 
with the involvement of the actin cytoskeleton (Langholz, Rockel et al. 1995; Riikonen, 
Westermarck et al. 1995; Lambert, Lapiere et al. 1998; Ravanti, Heino et al. 1999). 
Tyrosine kinase activity, PKC and p38 MAPK signalling was involved in the regulation of 
the majority of MMP genes (including MMP1, MMP3 and MMP13). Although regulation 
of MMP9 did not involve p38 MAPK (Lambert, Colige et al. 2001) and ERK signalling 
had a dampening effect upon MMP13 expression (Ravanti, Heino et al. 1999). MMP2 and 
MMP14 were not regulated by PKC, MEK1/2 or p38 MAPK (Lambert, Colige et al. 2001), 
therefore there regulation must occur through another mechanism. MMP gene expression 
however was not regulated by Rho kinase signalling (Lambert, Colige et al. 2001).  
Stress deprivation in osteoblast like cells increased the expression of α2 integrin and 
MMP3. This regulation was mediated by ROCK and ERK signalling pathways. While 
contraction of the gels was mediated by ROCK and p38 MAPK and was based on the 
integrity of microtubules (Parreno and Hart 2009). Another bone related study showed that 
MMP1 regulation with stress deprivation was mediated via α2β1 integrin, similar to that 
shown in skin fibroblast studies discussed above (Riikonen, Westermarck et al. 1995). 
Retinal pigment epithelial cells contracted under stress deprivation, this response was 
mediated via integrin α2 and α3 as well as FAK-Src intracellular signalling pathways 
(Morales, Mareninov et al. 2007). Therefore the majority of stress deprivation studies have 
shown that integrin α2 is involved in the tension perception and that p38 MAPK is the main 
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signalling molecule involved in the regulation of contraction and MMP expression. 
However, there are differences in signalling responses between contraction and MMP 
expression, as well as in different cell types.  
Tendon studies of stress deprivation showed an increase in contraction and MMP1, and a 
decrease in collagen mRNA expression. Once the contraction was abated the level of 
MMP1 and collagen expression returned to normal levels. This indicates that the cells 
regulate their own tensional homeostasis. Similar results were also seen in response to 
cytochalasin treatment where the cytoskeleton is disrupted. This emphasises that the 
cytoskeleton is a major sensor of cellular tension in tendon cells (Lavagnino and Arnoczky 
2005). A recent ex vivo study of lax rat tail tendon fascicles showed similar results. The 
lack of tension induced an increase in MMP13 expression as well as contraction of the 
tendon fascicle. Contraction was inhibited by cytochalasin D, indicating the involvement 
of the actin network. An increase in α-SMA protein expression occurred in parallel with 
the increase in contraction. Therefore α-SMA may be involved in the contraction, although 
this has not been confirmed. α-SMA is a marker for myofibroblasts, myofibroblasts are 
known for their increased contractility (Hinz, Phan et al. 2007); this further indicates that 
α-SMA may play a role in cell contraction. By pinning these fascicles the induction of 
MMP13 was abated. Indicating that the increase in MMP13 expression is key in the re-
establishment of tensional homeostasis (Gardner, Lavagnino et al. 2012). No other MMPs 
were measured in response to stress deprivation in these tendon studies and the signalling 
pathways that regulate this response were not studied further. However, evidence from 
other cell lineages suggests that integrins, FAK, Src and MAPK may be involved. 
1.8.3. Growth factors 
Growth factors are regulated in response to mechanical strain. For example TGFβ is 
sequestered in the ECM as an inactive complex (Taipale, Saharinen et al. 1996; Nunes, 
Gleizes et al. 1997; Verderio, Gaudry et al. 1999). Upon mechanical stimulation, integrin 
interaction with the inactive complex induces the activation of TGFβ through tensional 
forces (Munger, Huang et al. 1999). In addition, TGFβ is activated in response to 
mechanical loading in a thrombospondin-mediated mechanism in platelet-derived TGFβ 
(Ahamed, Janczak et al. 2009).  
Mechanical load-mediated induction of growth factors also extends to the stimulation of 
IL1β. In bone, mechanical stimulation above a certain threshold induced IL1β through 
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integrin and tyrosine kinase activation (Salter, Wallace et al. 2000). IL1β stimulated the 
depolarisation of calcium activated potassium channels through phospholipase C (PLC), 
inositol (1,4,5)-triphosphate (IP3), PKC and prostaglandins (Salter, Wallace et al. 2000). 
This highlights the complex interaction of kinase signalling with growth factor stimulation. 
These interactions may have their place in tenocyte signalling. 
1.8.4. Gap Junction communication 
Gap junctions are transmembrane channels that connect the cytoplasm of adjacent cells. 
The gap junction is formed from hemichannels located within the cell membrane of 
adjacent cells. Hemichannels are formed from hexameric oligomer transmembrane 
proteins, known as the connexins (Pitts, Kam et al. 1987; Kar, Batra et al. 2012). Gap 
junctions allow small ions to pass freely between cells (Pitts, Kam et al. 1987) as well as 
low molecular mass molecules such as calcium, IP3 and cyclic adenosine monophosphate 
(cAMP) (Figure 2)(Saez, Berthoud et al. 2003). Hemichannels are thought to be involved 
in the passage of Na
+ 
(Sodium), Ca
2+
, glutamate, ATP, PGE2 (prostaglandin E2) and NAD
+ 
in and out of the cell (Kar, Batra et al. 2012). IP3 is involved in the release of calcium from 
intracellular stores; therefore passage of IP3 from one cell can propagate a calcium signal in 
the adjacent cell (Boitano, Dirksen et al. 1992). Rat flexor tendons showed differential 
distribution of connexin molecules on the cell surface (McNeilly, Banes et al. 1996). Cx43 
and Cx32 were localized to areas of the epitenon, closely associated with collagen bundles, 
and generally associated with connections between cell bodies. Cx43 was also associated 
with cell processes (McNeilly, Banes et al. 1996). Cx43 has been reported to increase at 
the mRNA level in response to both fluid induced shear stress (1dyne/cm
2
 for 1 hour and 
18 hours rest) and cyclic loading (3.5% at 1Hz for 8 hours, biaxial in monolayer) in avian 
tendon cells (Elfervig, Lotano et al. 2001; Wall and Banes 2004).  
Egerbacher and colleagues, showed that with stress deprivation there is up-regulation of 
Connexin43 (mRNA and protein) in the pericellular matrix (Egerbacher, Caballero et al. 
2007). These GAP junction components may be up-regulated to compensate for the lack of 
cellular communication (Egerbacher, Caballero et al. 2007). The regulation in GAP 
junction connexins with mechanical load is consistent with their role in 
mechanotransduction. The association of Cx43 with actin is increased with mechanical 
loading in human and avian tenocytes, the actin cytoskeleton is thought to stabilise gap 
junctions and therefore maintain the interaction of cells during periods of high level 
mechanostimulation (Wall, Otey et al. 2007). I have previously mentioned the importance 
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of the cytoskeleton in integrin mediated mechanosensation; here we discuss the association 
of gap junctions with the actin cytoskeleton. Therefore the cytoskeleton clearly plays a key 
role in mechanosensation and transduction.  
TGFβ has been implicated in the control of Cx43 expression via a non SMAD (c-jun/AP-1, 
p38 and PI3K/AKT) mediated pathway in mammary gland epithelial cells (Tacheau, 
Fontaine et al. 2008). In addition, in cardiomyocyte studies, Cx43 is involved in the 
regulation of TGFβ via competitive inhibition of SMAD2/3 binding to microtubules, 
resulting in the accumulation of SMAD2/3 in the nucleus (through SMAD2 
phosphorylation) and therefore induce the activation of target gene transcription (Dai, 
Nakagami et al. 2007). Mechanical strain has also been shown to regulate TGFβ at the 
RNA and protein level (Riser, Cortes et al. 1996) as well as connexin expression (Elfervig, 
Lotano et al. 2001; Wall and Banes 2004). Therefore an intricate mechanical signalling 
network may exist through strain regulation of TGFβ and connexins, as well as the 
interaction between TGFβ and connexins and vice versa. 
1.8.5. Calcium signalling 
Calcium signalling has been reported in response to compression, vibration and fluid flow 
in various tissues (Wall and Banes 2005). However, few studies have shown changes in 
calcium as a result of tensional forces in tendon (Wall and Banes 2005). Human studies of 
cells from flexor digitorum profundus tendon have shown that both fluid flow (1 or 5 
dyne/cm
2
) (Elfervig, Francke et al. 2000; Franke, Banes et al. 2000) and static elongation 
(4-6%) (Elfervig 2001; Wall and Banes 2005) cause an increase in intracellular calcium.  
Avian cell studies of the same tendon showed no effect of 5% cyclic loading (Wall and 
Banes 2004) or up to 20 dynes/cm
2 
(Elfervig, Lotano et al. 2001). A rabbit Achilles tendon 
study showed an induction of calcium transients in response to indentation with a 
micropipette. However, in the same study, fluid flow (up to 25 dyne/cm
2
) did not induce 
significant calcium transients. This suggests that the cells had the potential to induce 
calcium transients but fluid flow was not a sufficient stimulus (Archambault, Elfervig-Wall 
et al. 2002). A canine ligament study showed fluid flow (25dynes/cm
2
) induced significant 
calcium transients (Hung, Allen et al. 1997). Therefore, the effects appear to be species 
specific, as human and canine but not rodent or avian studies showed calcium transients in 
response to mechanical stimulus.  
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Banes and colleagues have shown that a certain level of extracellular calcium is required to 
detect fluid flow (Franke, Banes et al. 2000; Wall and Banes 2005). This indicates that 
extracellular calcium or other molecules such as IP3 may enter the cell via gap junctions or 
other calcium channels; i.e. from an extracellular source rather than from intracellular 
stores. Studies have compared mechanisms of intracellular calcium release in response to 
6% static stretch (equibiaxial) and shear stress (2 minutes at 1 dyne/cm
2
) in human 
tenocytes (Elfervig 2001; Wall and Banes 2005). They showed that stretch activated 
channels were involved in the response to cyclic strain. However in response to shear/fluid 
flow, stretch activated ion channels and voltage dependant L-type calcium channels were 
not involved in the increase in intracellular calcium. Multiple other pathways were 
implicated in the response to shear, these included; partial involvement of cyclooxygenase 
activation; the involvement of G coupled receptors; and cAMP as a signal modifier 
(Elfervig, Francke et al. 2000). The requirement of G protein coupled receptors indicates 
that purinoceptors (just one of the receptor types associated with G proteins) may be 
involved in fluid shear induced calcium transients from intracellular stores. Purinoceptors 
induce release of calcium from intracellular stores through the activation of a signalling 
cascade that involves the activation of a G protein (Discussed below) (Figure 2). Fluid 
flow also induced calcium transients in canine ligaments cells, this was facilitated by 
calcium release from intracellular stores, consistent with tendon studies (Hung, Allen et al. 
1997). Therefore mechanically stimulated signalling mechanisms appear to be specific to 
types of mechanical deformation.  
In conditions of fluid flow anterior cruciate ligament (ACL) cells were responsive to 
extracellular calcium, whereas cells derived from the medial collateral ligament (MCL) 
were not (Hung, Allen et al. 1997). MCL cells were less sensitive to fluid flow, as they 
have a very robust cytoskeleton this could make them less mechanosensitive (Hung, Allen 
et al. 1997). Therefore cells derived from different locations as well as different tissues 
may respond to strain via different mechanisms.   
As we have discussed reports indicate that calcium signalling is activated in response to 
mechanical loading, however, as far as we are aware there is no direct evidence that the 
resulting changes include regulation of metalloproteinase expression in tendon. Although 
collagen synthesis as well as DNA synthesis via mechanical loading is inhibited by 
blockade of calcium signalling via GAP junctions, i.e. the increase in collagen with load 
was inhibited by the addition of octanol (Gap junction blocker) (Banes, Weinhold et al. 
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1999; Sood, Bynum et al. 1999). Therefore regulation of collagen and overall DNA 
synthesis is mediated by GAP junction communication. However, no direct evidence 
implicates calcium signalling in MMP regulation with strain. In fact Archambault and 
colleagues showed that MMP1 and MMP3 were increased in response to 1dyne/cm
2
 fluid 
flow without significant calcium transients in rabbit Achilles tendon (Archambault, 
Elfervig-Wall et al. 2002). However this is a response to fluid flow, a different type of load 
(i.e. tension) or perhaps human derived cells may induce calcium transients. However this 
remains to be determined.  
Evidence of a complex calcium signalling pathway has emerged through studies of cells 
from a wide range of tissues. Increased calcium influx can occur not only via GAP 
junctions but also voltage gated, receptor gated and stretch activated (mechanosensitive) 
channels. Calcium can also be released from intracellular stores; through calcium binding 
to ryanodine sensitive receptors in the endoplasmic reticulum (ER); or through ATP 
binding to purinoceptors (Figure 1.6) (Wall and Banes 2005).  ATP is reported to increase 
as a result of mechanical loading (Graff, Lazarowski et al. 2000; Jones, Wall et al. 2005). It 
is released from stress activated channels (Naruse, Sai et al. 1998; Naruse, Yamada et al. 
1998) as well as connexin hemichannels (Stout, Costantin et al. 2002). ATP, as well as 
ADP and adenosine can act as activators of purinoceptors. Purinoceptors are involved in 
multiple physiological functions including inflammation, peripheral and central neuronal 
transmission and muscle contraction. Purinoceptors are categorised into two main groups, 
those which respond to ATP or its analogs (ADP, AMP or GTP) and those which are 
activated by adenosine these are termed P2 and P1 purinoceptors respectively. P2 
purinoceptors are further categorised into groups P2X and P2Y; P2X are ligand gated ion 
channels which are selectively permeable to cations such as calcium, whereas P2Y are G-
protein coupled receptors (Valera, Hussy et al. 1994; North 2002; Gever, Cockayne et al. 
2006). Activation of P2X purinoceptors (ligand gated ion channels) can cause the influx of 
cations such as calcium (Gever, Cockayne et al. 2006). ATP acts in an autocrine or 
paracrine fashion to activate P2Y purinoceptors which results in G protein activation, 
interaction with phospholipase C, cleavage of phophatidylinositol 4,5-bisphosphate (PIP2) 
to produce IP3 which acts on channels in the ER to release intracellular calcium (Figure 2) 
(Wall and Banes 2005).  
P2Y1 and P2Y2 purinoceptors are responsible for downstream ATP signalling events 
(increase in intracellular calcium) in rodent Achilles tendon (Fox, Jones et al. 2005; Jones, 
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Yang et al. 2005). A study of human cartilage showed that compression induced cellular 
hyperpolarisation and that inhibition of P2Y purinoceptors by Suramin and PPADs 
abrogated this response (Millward-Sadler, Wright et al. 2004). P2Y purinoceptors are also 
reported to be involved in increased calcium mobilisation in response to fluid flow in 
osteoblasts. Further characterisation of this pathway indicated that ATP activated this 
receptor and caused calcium mobilisation via the inositol 1,4,5-trisphosphate pathway 
(You, Jacobs et al. 2002). Although it seems that the majority of mechanically stimulated 
purinoceptors are P2Y forms, stimulation of P2X purinoceptors has also been reported. In 
endothelial cells a fluid flow induced influx of calcium was reported to involve P2X4 
purinoceptors, this was confirmed by the inhibition of P2X4 transcription via antisense 
oligonucleotides (Yamamoto, Korenaga et al. 2000). Mechanical stimulation of smooth 
muscle cells induced calcium transients via adenosine and ATP purinoceptor signalling; 
through P1 and P2 receptors respectively. They also showed that purinoceptor signalling 
stimulates JNK/SAPK, which results in gene transcriptional modification (Hamada, 
Takuwa et al. 1998). Although this connection between purinoceptor signalling and JNK 
has not been shown in tendon, it is possible that it may occur; as JNK activation in 
response to calcium signalling has been shown in tendon studies (Arnoczky, Tian et al. 
2002; Skutek, van Griensven et al. 2003; Kawabata, Katsura et al. 2009).  
Reports of a feedback loop involving a decrease in ATP levels during mechanical loading 
may involve the release of ATPase’s (ATP degrading enzymes) and consequent 
degradation of ATP (Graff, Lazarowski et al. 2000; Yegutkin, Bodin et al. 2000; Tsuzaki, 
Bynum et al. 2005). To complicate matters further ATP can also negatively modulate 
strain induced MMP regulation, where an up-regulation of MMP1 with loading is reversed 
with the addition of ATP, through the dual action of autocrine and paracrine ATP 
signalling (Tsuzaki, Bynum et al. 2003). Prestress can alter the ability of cells to perceive 
mechanical load and can be measured by the contractile ability of cells. ATP inhibits the 
contractile ability of bone cells through MAPK and NFκB signalling and therefore reduces 
the sensitivity of cells to mechanical loading (Qi, Chi et al. 2007; Qi, Chi et al. 2009). 
Therefore ATP mediated mechanotransduction appears complex in nature and may involve 
multiple purinoceptor pathways facilitated by degradation products of ATP. However, this 
complex system is characterised from mostly non-tendon studies and in not fully 
understood in tendon. 
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Figure 1.6. Calcium signalling overview . Calcium can enter the cell through stretch 
activation and calcium ion channels. ATP can be released through hemichannels into the 
extracellular space and can act in a paracrine or autocrine fashion to activate purinoceptor 
signalling. ATP, UTP or adenosine binding of purinoceptors induces the activation of G-
protein. This involves the replacement of GDP with GTP. Activated G-protein induces an 
interaction with phospholipase C (PLC) which cleaves phosphatydlinositol 4,5-
bisphosphate (PIP2) into inositol (1,4,5)-triphosphate (IP3) and 1,2-diacylglycerol (DAG). 
IP3 activates IP3 sensitive calcium channels on the ER and induces the release of calcium 
into the cytoplasm. Calcium stimulates downstream signalling events; such as activation of 
MAPK signalling. DAG induces the activation of protein kinase C (PKC) which is 
involved in multiple downstream processes. GAP junction communication can involve the 
transfer of Calcium and IP3 to adjacent cells. Adapted from (Wall and Banes 2005) 
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1.9. TRANSFORMING GROWTH FACTOR BETA 
Transforming growth factor β (TGFβ) is a cytokine involved in a plethora of cell processes 
including cell proliferation, differentiation, migration, adhesion and apoptosis (Shi and 
Massague 2003). TGFβ is known to stimulate deposition and inhibit the degradation of the 
ECM; through increased collagen (Heinemeier, Olesen et al. 2009) and decreased 
collagenase and stromelysin expression (Zeng, McCue et al. 1996; White, Mitchell et al. 
2000). TGFβ is involved in fibrosis and wound healing and is known to play a role in an 
array of disease phenotypes including cancer, infectious disease and autoimmune disorders 
(Worthington, Klementowicz et al. 2011).  
The TGFβ superfamily of proteins includes TGFβ, inhibins / activins, bone morphogenic 
proteins (BMP) and growth and differentiation factors (GDF). In mammals TGFβ exists in 
3 isoforms; TGFβ1, TGFβ2 and TGFβ3, each is thought to have a distinct function in 
tendon, however this is not fully understood (Fenwick, Curry et al. 2001). Knockout mice 
of each of the three isoforms confirm that each has a distinct function due to the 
differential effects upon development, including defective haematopoiesis and 
vasculogenesis in TGFβ1 null mice (tgfb1-/-) (Dickson, Martin et al. 1995), disruption of 
epithelial-mesenchymal interactions as well as perinatal mortality in TGFβ2 null mice 
(tgfb2
-/-
) (Sanford, Ormsby et al. 1997) and finally cleft palate and delayed pulmonary 
development in TGFβ3 null mice (tgfb3-/-) (Kaartinen, Voncken et al. 1995). TGFβ1, the 
predominant isoform involved in wound healing, was below the level of detection in both 
embryonic and adult tendon studies (Fenwick, Curry et al. 2001; Kuo, Petersen et al. 
2008). TGFβ2 was found to be the predominant isoform expressed in both normal and 
pathological human Achilles tendon (Fenwick, Curry et al. 2001). 
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1.9.1. TGFβ Synthesis and secretion 
Newly synthesised TGFβ protein contains a propeptide known as the latency associated 
peptide (LAP). In the trans-golgi network, post-translational modifications involve 
cleavage of LAP by proprotein convertase furin (Dubois, Blanchette et al. 2001), TGFβ 
and LAP remain non-covalently bound once the complex is released into the extracellular 
space, rendering TGFβ inactive (Gentry and Nash 1990); however the process of inhibition 
is not yet fully understood. TGFβ plus LAP is known as the small latent complex (SLC). 
Latent TGFβ binding proteins (LTBP) form cysteine disulphide linkages with TGFβ 
homodimers via LAP to form the Large Latent Complex (LLC) this occurs before TGFβ is 
released into the extracellular space (Gleizes, Beavis et al. 1996; Saharinen, Taipale et al. 
1996). LTBP is expressed as four variants (LTBP-1, -2, -3 and -4) and is important in the 
secretion, correct folding (Miyazono, Olofsson et al. 1991) and targeting of LLC to the 
extracellular matrix where transglutaminases covalently link LTBP to ECM proteins such 
as fibronectin (Taipale, Saharinen et al. 1996; Nunes, Gleizes et al. 1997; Verderio, Gaudry 
et al. 1999) (Figure 1). Fibrillin microfibrils stabilise the interaction between LTBP and the 
ECM, this interaction is assembled pericellularly and the incorporation of fibrillin into this 
complex involves heparin sulphate (Massam-Wu, Chiu et al. 2010). In the absence of the 
LTBP, the TGFβ SLC is secreted, however this process is a great deal slower (Miyazono, 
Olofsson et al. 1991).  
  
Chapter1: Introduction 
85 
 
 
 
  
RGD 
RGD 
LAP 
TGFβ 
Disulphide  
Bond 
Ca
2+
 binding  
EGF like domain 
 
Cysteine rich domain 
(8-Cys) 
Hybrid domain 
non-Ca
2+
 binding  
EGF like domain 
Hinge region 
(LTBP) 
 
ECM 
SLC 
Transglutaminase  
Linkage  
(Isopeptide bond) 
LLC 
LTBP 
Figure 1.7. TGFβ is deposited in the matrix as a large latent complex (LLC ). 
The LLC is made up of the small latent complex (SLC) and the latent TGFβ binding 
protein (LTBP) adjoined by disulphide bonds.  The SLC consists of TGFβ and its latency 
associated peptide (LAP) connected non-covalently (due to intracellular processing via 
furin), this accumulates as a homodimer. LTBP binds to SLC intracellularly and targets 
the LLC to the ECM. The LTBP is linked to the ECM via its hinge region by isopeptide 
binding which is facilitated by transglutaminases. LTBP-1 is the most characterised 
LTBP; it contains 17 EGF like domains, 3 cysteine rich domains and a hybrid domain. 
The hinge region of LTBP is susceptible to proteolytic cleavage which results in the 
release of a processed form of the LLC (indicated with an arrow). Adapted from (Annes, 
Munger et al. 2003; Wipff and Hinz 2008; Worthington, Klementowicz et al. 2011) 
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1.9.2. Activation of latent TGFβ 
Protease mediated activation 
In the ECM, as part of the LLC, TGFβ is a convenient store of potentially active TGFβ. 
Activation has been reported to occur by a variety of mechanisms that involve proteolytic 
cleavage. Cell surface integrin αvβ8 co-localises with membrane bound protease MT1-
MMP, αvβ8 binds with high affinity to LAP via the RGD motif allowing MT1-MMP to 
proteolytically cleave TGFβ from the complex, rendering TGFβ active and diffusible (Mu, 
Cambier et al. 2002) (Figure 2).   
TGFβ is also thought to be activated by other proteases such as MMP2, MMP3, MMP9, 
MMP13, thrombin and plasmin (Lyons, Keski-Oja et al. 1988; Taipale, Koli et al. 1992; 
Yu and Stamenkovic 2000; D'Angelo, Billings et al. 2001; Maeda, Dean et al. 2002). Many 
of these proteolytic activation mechanisms require cell surface localisation to allow 
interaction between the latent complex and the active protease. CD44 is a cell surface 
receptor involved in cell-cell and cell matrix interactions with a principle role in adhesion. 
CD44 ligands include hyaluronic acid, collagen, fibronectin and laminin (Goodison, 
Urquidi et al. 1999). CD44 acts as a cell surface docking receptor for both MMP2 and 
MMP9 which allows the proteolytic cleavage of LAP resulting in the release and 
consequent activation of TGFβ (Yu and Stamenkovic 2000). αvβ3 has been implicated in 
autocrine TGFβ signalling which may involve the activation of TGFβ (Asano, Ihn et al. 
2005; Wipff, Rifkin et al. 2007), and is reported to co-localise with MMP2 and MMP9. 
This suggests that metalloproteinase activity may be responsible for the activation of TGFβ  
in this case, however, this is as yet unconfirmed (Brooks, Stromblad et al. 1996; Rolli, 
Fransvea et al. 2003) (Figure 3). 
Plasmin also cleaves LAP to release active TGFβ1 (Lyons, Keski-Oja et al. 1988; Sato and 
Rifkin 1989; Lyons, Gentry et al. 1990). Although, once the LLC is sequestered in the 
ECM, direct activation of TGFβ by plasmin is inhibited, as the plasmin sensitive region of 
LAP is masked. However plasmin is able to cleave LTBP so that a processed form of the 
LLC complex is released. This processed form targets Mannose-6-phosphate/Insulin like 
growth factor type II receptor (M6P/IGF-II) at the cell surface (Taipale, Miyazono et al. 
1994; Nunes, Gleizes et al. 1997). Upon localisation M6P/IGF-II can bind to LAP which 
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facilitates the activation of TGFβ through plasmin mediated proteolytic cleavage (Dennis 
and Rifkin 1991; Odekon, Blasi et al. 1994; Nunes, Shapiro et al. 1995) (Figure 4).  
BMP1 and MMP3 have been reported to degrade LTBP, preventing ECM sequestration of 
the TGFβ latent complex and increasing levels of diffusible latent TGFβ. However BMP1 
is not involved in the secondary protease cleavage and consequent activation of TGFβ, this 
requires additional protease activity (Maeda, Dean et al. 2002; Ge and Greenspan 2006). 
MMP3 is also able to cleave LAP and induce the activation of TGFβ once LLC is released 
(Maeda, Dean et al. 2002). Studies of Geleophysic dysplasia, an inherited condition 
resembling a lysosomal storage disorder, have shown that ADAMTSL2 (and perhaps 
ADAMTS10), a gene mutated in the disease, may be involved in the activation of TGFβ  
through the interaction with LTBP-1, however this process of activation is not fully 
elucidated (Le Goff, Morice-Picard et al. 2008). 
Calpain, a calcium dependant cysteine protease and Cathepsin D, lysosomal aspartyl 
protease are also reported to activate latent TGFβ (Lyons, Keski-Oja et al. 1988; Abe, Oda 
et al. 1998). However, Cathepsin activation of TGFβ has only been shown in simple 
experiments in the absence of cells and calpain activation does not occur in response to the 
protease alone; therefore these mechanisms may also not be physiologically relevant 
(Lyons, Keski-Oja et al. 1988; Abe, Oda et al. 1998).  
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Figure 1.8. αvβ8 and MT1-MMP mediated activation of TGFβ.  αvβ8 integrins 
expressed on the cell surface co-localise with membrane bound metalloproteinase MT1-MMP. 
αvβ8 binds to the RGD motif located on LAP. This allows MT1-MMP to cleave active TGFβ 
from the LLC rendering it active and diffusible. Therefore both autocrine and paracrine 
signalling can occur. Adapted from (Wipff and Hinz 2008; Worthington, Klementowicz et al. 
2011) 
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Figure 1.9. Plasmin and M6P/IGF-II mediated activation of TGFβ . Plasmin is 
unable to access the region of LAP in order to cause activation when the LLC is sequestered 
in the ECM. Plasmin cleaves the LTBP from the extracellular matrix via the hinge region, 
this releases a processed form of the LLC complex. LAP is then able to associate with 
M6P/IGF-11 at the cell surface which allows plasmin to cleave LAP and TGFβ becomes 
active and diffusible. Diffusible TGFβ is able to induce both autocrine and paracrine TGFβ 
signalling. Adapted from information gleaned from the following sources (Lyons, Keski-Oja 
et al. 1988; Sato and Rifkin 1989; Lyons, Gentry et al. 1990; Dennis and Rifkin 1991; 
Odekon, Blasi et al. 1994; Taipale, Miyazono et al. 1994; Nunes, Shapiro et al. 1995; Nunes, 
Gleizes et al. 
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Figure 1.10. αvβ3 and MMP mediated activation of TGFβ . αvβ3 integrins expressed 
on the cell surface co-localise with diffusible MMP2 or MMP9. αvβ3 binds to the RGD motif 
located on LAP. This allows MMP2 or MMP9 to cleave active TGFβ from the LLC rendering 
it active and diffusible. Therefore both autocrine and paracrine signalling can occur. Adapted 
from (Wipff and Hinz 2008; Worthington, Klementowicz et al. 2011)                  
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Tensional force mediated activation 
Integrins are also involved in the activation of TGFβ in the absence of proteolytic activity. 
Interaction of integrin αvβ6 with LAP (via an RGD motif) can result in TGFβ activation 
via a conformational change in the latent complex (Figure 5). This mechanism of TGFβ 
activation is not fully understood, yet there is evidence to suggest that it involves tensional 
forces between the cell and ECM, sequestration of the LLC in the ECM via the LTBP, the 
clustering of integrins and linkage to the cytoskeleton via focal adhesion kinase and 
paxillin adaptor proteins (Munger, Huang et al. 1999; Annes, Chen et al. 2004). αvβ6 
expression however is limited to epithelial cells and direct cell to cell contact is required 
for activation to occur (Sheppard 2005). αvβ5 also contains an RGD binding motif and is 
involved in the activation of TGFβ in the absence of protease activity and requires 
substrate tension as well as an intact cytoskeleton (Asano, Ihn et al. 2005; Wipff, Rifkin et 
al. 2007). Inhibition of cell contraction with compounds such as blebbistatin and seeding 
cells on flexible substrates decreases αvβ5 mediated TGFβ activation, demonstrating that 
the contractile ability of cells also regulates TGFβ activation (Wipff, Rifkin et al. 2007). 
This indicates tensional forces play a major role in the activation of TGFβ by αvβ5 and 
αvβ6, with the opposing forces between the ECM, LLC and the cytoskeleton, however 
exactly how this occurs requires clarification (Wipff, Rifkin et al. 2007).  
Other integrins, containing the RGD motif capable of binding to TGFβ LAP are α8β1 and 
αvβ1; however their involvement in TGFβ activation is not well characterised (Munger, 
Harpel et al. 1998; Lu, Munger et al. 2002; Sheppard 2005; Worthington, Klementowicz et 
al. 2011). An unidentified β1 integrin also plays a role in TGFβ activation, however the 
mechanism to which this occurs is not fully understood (Wipff, Rifkin et al. 2007). In 
addition to the positive interaction of integrins and activation of TGFβ, blocking α5 
integrin stimulates TGFβ production, this suggests that α5 integrin may also be involved in 
the inhibition of TGFβ protein synthesis (Matsumoto, Ishimura et al. 2003).  
αvβ6 has been reported to be involved in the activation of both TGFβ1 and TGFβ3, but not 
TGFβ2. The LAP of TGFβ2 lacks an RGD motif and therefore is not able to bind integrins 
as do TGFβ1 or TGFβ3 (Munger, Huang et al. 1999; Annes, Rifkin et al. 2002; Sheppard 
2005). As TGFβ2 is not activated via RGD interaction of integrins it must be regulated by 
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an alternate mechanism, this may not be completely devoid of integrin interaction. 
However there are other mechanisms of TGFβ activation that do not involve integrins.  
TGFβ can also be activated in response to high temperatures (80°C); however this is not 
physiologically relevant. Activation can also occur with mildly acidic pH (4.5), although 
this induces only 20-30% activation and is also unlikely to be physiologically relevant 
(Lyons, Keski-Oja et al. 1988). Reactive oxygen species (ROS) induce the oxidation of 
specific amino acids of latent TGFβ causing a conformational change and subsequent 
activation (Barcellos-Hoff, Derynck et al. 1994; Barcellos-Hoff and Dix 1996). However 
ROS activation of TGFβ appears to be less common than those mechanisms involving 
proteases and integrins.  
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Figure 1.11. αvβ5 and αvβ6 mediated activation of TGFβ via tensional forces . 
αvβ5 or αvβ6 integrins expressed on the cell surface bind to the RGD motif located on LAP. 
As the LLC is sequestered in the matrix and the integrins are linked to the cytoskeleton, 
tensional forces between the cell and the cytoskeleton increase the distance between the 
ECM and the cell surface causing a distortion in the LLC resulting in the exposure of active 
TGFβ. TGFβ can therefore bind to its receptors. TGFβ is not released as a result of this 
interaction and remains attached to the LLC, therefore only autocrine signalling can occur. 
Adapted from (Annes, Munger et al. 2003; Wipff and Hinz 2008; Worthington, 
Klementowicz et al. 2011)    
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Thrombospondin-1 mediated activation 
In the absence of proteolytic activity, certain TGFβ activation mechanisms result in a 
conformational change in TGFβ rendering it active without detachment from the latent 
complex, i.e. non diffusible active TGFβ is produced. We have previously mentioned αvβ5 
and αvβ6 integrins acting in this way, a similar mechanism involves thrombospondin-1 
(TSP-1). TSP-1 can interact with LAP via an LSKL motif resulting in a conformational 
change in the latent complex and TGFβ activation (Schultz-Cherry and Murphy-Ullrich 
1993; Crawford, Stellmach et al. 1998; Ribeiro, Poczatek et al. 1999) (Figure 6). Diffusible 
TSP-1 can bind to a cell surface receptor known as CD36, this can effectively localise 
TSP-1 to the cell surface. TSP-1 can bind to latent TGFβ inducing activation, this can 
occur either through the aforementioned conformational change in the latent TGFβ 
complex or cleavage of LAP by plasmin; only the latter mechanism releases diffusible 
TGFβ (Yehualaeshet, O'Connor et al. 1999). Therefore not only diffusible TSP-1 but also 
membrane bound TSP-1 (via CD36) can regulate TGFβ activation. TGFβ1 and TGFβ2 are 
activated by TSP-1 however it is not clear whether thrombospondin-1 also activates 
TGFβ3 (Crawford, Stellmach et al. 1998). TSP-1 also binds to heparin sulphate 
proteoglycans located at the cell surface (Sun, Mosher et al. 1989), this localisation of 
TSP-1 may also be involved in the activation of TGFβ, however this has not been 
confirmed. 
Thrombospondin (TSP-1) null mice show some similarities in phenotype to tgfb1
-/-
 null 
mice, however this is only a partial overlap which suggests that other mechanisms are 
involved in the activation of TGFβ1 (Crawford, Stellmach et al. 1998). Knockout of 
individual proteases does not induce phenotypic changes comparable with the tgfb1-/- 
phenotype (Annes, Munger et al. 2003). Integrins on the other hand are thought to be the 
predominant mediators of TGFβ1 activation. Studies have shown that mice with an RGD 
to an RGE mutation (tgfb1
RGE/RGE
) display the major features of mice with the tgfb1
-/-
 
mutation including widespread organ inflammation and defects in vasculogenesis, despite 
normal levels of latent TGFβ (Yang, Mu et al. 2007). In addition knockout of αv integrins 
(Itgav
-/-
) induces a similar phenotype to tgfb1
-/-
 (differential vasculogenesis) and tgfb3
-/-
 
(cleft palate) in mice (Dickson, Martin et al. 1995; Kaartinen, Voncken et al. 1995; Bader, 
Rayburn et al. 1998; Worthington, Klementowicz et al. 2011). αvβ6 and αvβ8
 
knockout mice 
(αvβ6
-/-
 and αvβ8
-/-) also show a similar phenotype to tgfβ1-/- and tgfβ3-/- null mice, this 
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indicates that αvβ6 and αvβ8 integrin mediated activation of TGFβ1 and TGFβ3 is 
predominant in vivo (Aluwihare, Mu et al. 2009). 
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Figure 1.12. TSP-1 mediated activation of TGFβ. TSP-1 binds to LAP via an LSKL 
motif which causes a conformational change in LAP. This results in the exposure of active 
TGFβ, which can signal through TGFβ receptors in an autocrine fashion. Further 
processing of TGFβ by plasmin can cause the release of diffusible TGFβ. Diffusible TGFβ 
is able to induce both autocrine and paracrine TGFβ signalling. TSP-1 can also dock with 
its receptor CD36, which causes the complex to be localised to the cell surface. In the 
presence of CD36 the same processing and signalling responses can occur as described 
above. Adapted from information gleaned from the following sources (Schultz-Cherry and 
Murphy-Ullrich 1993; Crawford, Stellmach et al. 1998; Ribeiro, Poczatek et al. 1999; 
Yehualaeshet, O'Connor et al. 1999)  
 
3C456E644E6F74653E3C436974653E3C417574686F723E536368756C747A2D43686572
72793C2F417574686F723E3C596561723E313939333C2F596561723E3C5265634E756D
3E3237323C2F5265634E756D3E3C7265636F72643E3C7265632D6E756D6265723E323
Chapter1: Introduction 
97 
 
 
1.9.3. Disruption of TGFβ regulation 
The LTBP targets the LLC to the ECM and consequently regulates the spatial availability 
of TGFβ. Mutation of LTBP causes a malfunction in the spatial regulation of TGFβ, where 
the lack of a particular LTBP isoform can result in inappropriate coupling of TGFβ with an 
alternate LTBP isoform resulting in modified TGFβ distribution in the ECM (Annes, 
Munger et al. 2003).  Disruption of ECM components can also result in the misregulation 
of TGFβ activation. For example in Marfan syndrome (MFS) the gene encoding fibrillin-1 
is mutated, LTBP is unable to target predefined areas of the ECM (i.e. fibrillin) and the 
LLC cannot be deposited in the matrix. This releases the LLC into the extracellular space 
where it is more vulnerable to processing. Spatially and temporally inappropriate activation 
of TGFβ ensues and as a consequence disproportionate bone growth and changes in 
vascularity occur (Ramirez and Dietz 2007; Ramirez and Rifkin 2009). Chaudhry and 
colleagues have shown that fibrillin fragments can inhibit the interaction of the LLC with 
the ECM and cause inappropriate activation of TGFβ (Chaudhry, Cain et al. 2007). This 
may constitute another level of control of TGFβ activation indicative of the homeostatic 
response involving a shift in complex deposition. TGFβ is therefore regulated on many 
levels, through intracellular post-translational modification, localisation to the ECM and 
through a variety of activation mechanisms. 
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1.9.4. TGFβ Signalling 
Cell surface TGFβ receptors include type I and type II receptors (TGFβRI and TGFβRII) – 
these receptors have serine/threonine kinase activity. A third TGFβ receptor (TGFβRIII) 
can enhance binding of active TGFβ to TGFβRII. In the canonical signalling pathway, 
TGFβ binding to the type II receptor, type I and type II receptors co-localise to form 
heterotetrameric complexes. TGFβRII phosphorylates TGFβRI, leading to phosphorylation 
and subsequent activation of SMAD proteins (R-SMADs, 2 and 3) with the help of SMAD 
anchor for receptor activation (SARA), which co-ordinates R-SMAD docking at TGFβRI. 
Inhibitory SMAD (I-SMAD or SMAD-7) can negatively regulate the phosphorylation of 
R-SMADs. Once Phosphorylated R-SMADs dissociate from TGFβRI and SARA and bind 
to a co-SMAD (SMAD4), this complex translocates to the nucleus and effects 
transcriptional regulation of target genes with the association of co-activators. Co-
repressors and co-stimulators inhibit and stimulate the regulation of target genes 
respectively and represent another level of transcriptional control. SMAD ubiquitination 
regulatory factors (SMURF) are important in the targeted ubiquitination of R-SMADs and 
work in association with I-SMAD to target receptors for ubiquitination, this prevents 
constitutive regulation of TGFβ target genes (for a more detailed review  of TGFβ 
signalling see; (Shi and Massague 2003).  
SMAD signalling is not the only signalling pathway stimulated downstream of TGFβ 
serine/threonine kinase receptors, a complex array of signalling pathways including 
mitogen activated protein kinases (MAPK) (p38, c-Jun N-terminal kinases [JNK] and 
extracellular signal related kinase [ERK]), phosphoinositol 3-kinase (PI3K) / Akt, nuclear 
factor κB (NFκB), Rho/ Rho associated protein kinase (ROCK), Ras and Notch are also 
stimulated by TGFβ (Moustakas and Heldin 2005). Since TGFβ is known to play a major 
role in wound healing and fibrosis, knowledge of its role and regulation in tendon is likely 
to be important in understanding the cause and progression of tendinopathy. 
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Figure 1.13. TGFβ Signalling: An overview . Upon TGFβ ligand binding to the 
type II receptor, type I and type II receptors co-localise to form a heterotetrameric 
complex (TGFβRI and RII are shown here in a single entity instead of duplicate). 
TGFβRIII functions to stabilise this interaction. TGFβRII phosphorylates TGFβRI, 
leading to phosphorylation and subsequent activation of SMAD proteins (R-SMADs, 2 
and 3) with the help of SMAD anchor for receptor activation (SARA), which co-
ordinates R-SMAD docking at TGFβRI. Once Phosphorylated R-SMADs dissociate 
from TGFβRI and SARA and bind to a co-SMAD (SMAD4), this complex 
translocates to the nucleus and effects transcriptional regulation of target genes with 
the association of co-activators and co-repressors. Adapted from (Shi and Massague 
2003) 
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1.9.5. TGFβ and mechanical load 
TGFβ expression as well as TGFβ receptor synthesis and regulation of activity is sensitive 
to mechanical loading in a range of cell types; Latent and active TGFβ1 and latent TGFβ3 
were increased following cyclic stretching in rat mesangial cells (Riser, Cortes et al. 1996); 
mechanical stimulation induced the synthesis and expression of TGFβ receptor I and II in a 
similar model (Riser, Ladson-Wofford et al. 1999). In cell studies of endothelium and 
anterior cruciate ligament mechanical load (fluid shear and tensional forces models 
respectively) induced at least a 50% increase in the level of TGFβ protein expression (Kim, 
Akaike et al. 2002; Baker, Ettenson et al. 2008).  
In human patellar tendon there have been reports of increased levels of TGFβ mRNA and 
protein in response to mechanical loading in monolayer cell culture systems. Cyclic strain 
regimes ranging from 4-8% at 0.5-1Hz showed a 25-64% increase in TGFβ at the protein 
level and 11.5-24.6% increase at the mRNA level, with more robust changes seen with 
higher loading regimes (Skutek, van Griensven et al. 2001; Yang, Crawford et al. 2004). 
However these studies did not confirm the activity of TGFβ or which isoforms were 
regulated. In a murine Achilles tendons cell culture model, TGFβ activity was increased in 
cells exposed to fluid shear stress, however the specific isoform involved was not 
measured (Maeda, Sakabe et al. 2011). In addition a study by Legerlotz and colleagues 
showed no change in the level of TGFβ mRNA in response to mechanical load in an in 
vivo model of rat strength training (Legerlotz, Schjerling et al. 2007). However as the 
levels total and active protein were not measured we cannot rule out effects upon TGFβ 
signalling. Therefore TGFβ is increased in response to strain in a range of tissues and 
different type of strain at the mRNA, protein and activity levels. However, stress 
deprivation of tendon can also induce an increase in TGFβ at the protein level (Uchida, 
Tohyama et al. 2005), whether this is active and capable of signalling remains to be 
elucidated.  
Kjaer et al (Kjaer, Langberg et al. 2009) proposed TGFβ may also play a role in the 
modulation of the adaptive response to strain, as TGFβ regulates collagen (Heinemeier, 
Olesen et al. 2009).  Therefore TGFβ may play a role in the regulation of major 
components of the ECM, which may lead to stabilisation of the matrix in response to load. 
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1.9.6. TGFβ and tendinopathy 
An increase in Transforming Growth Factor β (TGFβ) has been reported in tendinopathy 
(Fenwick, Curry et al. 2001; Fu, Wang et al. 2002); although the activity of these proteins 
was not confirmed, and in the absence of TGFβRI the TGFβ signalling cascade was not 
activated (Fenwick, Curry et al. 2001). This highlights TGFβ signalling as a possible 
candidate in the detection of mechanical stimulation and disruption of this intimate 
relationship could result in tendinopathy. Therefore investigating the role of TGFβ in the 
tendon response to mechanical loading could prove invaluable in the understanding of 
tendinopathy 
 
Aims:  
We hypothesise that moderate / high mechanical loading will induce anabolic changes in 
metalloproteinase and matrix genes and that the regulation of these genes may involve 
TGFβ. We aim to measure gene expression of a broad range of metalloproteinase and 
matrix genes to test whether they are regulated in an anabolic manner. Secondly, to further 
characterise mechanotransduction by the addition of inhibitors of an array of signalling 
pathways; assessment of gene regulation in response to strain with the addition of these 
inhibitors will confirm whether the signalling pathways targeted by these inhibitors are 
involved in mechanoregulation of gene expression. 
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2.1. MATERIALS 
Acetone       Fisher, Leicestershire 
Agar         Fisher, Leicestershire 
Agarose       Sigma Aldrich, Dorset  
All Stars negative control siRNA     Qiagen, Crawley 
Amiloride hydrochloride     Sigma Aldrich, Dorset  
Ampicillin       Sigma Aldrich, Dorset 
Analytical Grade Water     Fisher, Leicestershire 
Apyrase       Sigma Aldrich, Dorset 
Avidin-HRP       BioRad, Hertfordshire 
Biotin rat anti-mouse, human, pig anti-TGF β1 (555053) BD Biosciences, Oxford 
Bovine Serum Albumin     Sigma Aldrich, Dorset 
Brij 35        Fisher, Leicestershire 
Bromophenol blue      Sigma Aldrich, Dorset 
Calcium Chloride      Fisher, Leicestershire 
Calcein AM       Fisher, Leicestershire 
CDP star reagent      Sigma Aldrich, Dorset 
Chloroform       Fisher, Leicestershire 
Cryo-M-Bed embedding compound    Bright, Huntington 
Coomassie Brilliant Blue     Sigma Aldrich, Dorset 
Dharmafect 1       Fisher, Leicestershire 
DMEM       Fisher, Leicestershire 
dNTP mix       Promega, Southampton 
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Doramapimod       Cambridge Bioscience 
Dual luciferase reporter assay kit    Promega, Southampton 
Ethanol       Fisher, Leicestershire 
Ethidium Homodimer      Fisher, Leicestershire 
Fibrinogen from bovine plasma    Sigma Aldrich, Dorset 
GAP27        Severn Biotech Ltd.  
Glycerol       Fisher, Leicestershire 
Glycine       Fisher, Leicestershire 
Glycogen, Molecular biology grade    Sigma Aldrich, Dorset  
GM6001        Millipore, Watford 
GM6001 inactive control      Merck Chemicals Ltd. 
GRGDSP (RDG) peptide inhibitor     Cambridge Bioscience 
GRGESP control peptide      Cambridge Bioscience 
Hirudin       Sigma Aldrich, Dorset  
Human hsa-miR24 (primer set)     Life technologies, Paisley 
Human IL6 siRNA       Qiagen, Crawley 
Human SMAD4 siRNA      Qiagen, Crawley 
Human TGFβ1 siRNA      Qiagen, Crawley 
Human TGFβ2 siRNA      Qiagen, Crawley 
Human TGFβ3 siRNA      Qiagen, Crawley 
Hydrochloric Acid       Fisher, Leicestershire 
IL6 antibody        R&D systems, Abingdon 
Indomethacin        Sigma Aldrich, Dorset  
Isopropanol       Fisher, Leicestershire 
KAPA Probe fast qPCR kit Mastermix   Anachem, Bedfordshire 
LEAF
TM
 purified rat IgG2a κ isotype control antibody  Cambridge Bioscience  
Lipofectamine 2000      Life technologies, Paisley 
LSKL mimetic peptide     Cambridge Bioscience 
MAB13 antibody against integrin β1 (Prof Martin Humphries, Manchester) 
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Mannose-6-Phosphate      Sigma Aldrich, Dorset 
Methanol       Fisher, Leicestershire 
Milk powder       Fisher, Leicestershire 
Na HPO4 (Sodium phosphate)    Fisher, Leicestershire 
NaN2P04       Fisher, Leicestershire 
Nifedipine        Sigma Aldrich, Dorset  
On target plus smartpool human ADAM12 siRNA   Abgene Ltd.  
PD0325901       Cambridge Bioscience 
Pefabloc       Sigma Aldrich, Dorset 
Penicillin / Streptomycin     Fisher, Leicestershire  
Pepstatin        Roche, West Sussex 
Phenol free DMEM      Fisher, Leicestershire 
PI-103        Cambridge Bioscience 
Protease inhibitor cocktail      Sigma Aldrich, Dorset  
Purified rat anti-mouse, human, pig TGFβ1(Capture, 555052) BD Biosciences,Oxford 
PVDF        Millipore, Watford 
QF24 substrate      Enzo life sciences, Exeter 
Random Hexamers      Life technologies, Paisley 
Rat tail type I collagen (2.2mg/ml)     First Link, Birmingham 
Recombinant IL6       R&D systems, Abingdon   
Recombinant TGFβ       R&D systems, Abingdon  
Recombinant MMP2      R&D systems, Abingdon 
RNAsin Ribonuclease inhibitor    Promega, Southhampton 
SB203580         Cambridge Bioscience  
SLLK peptide (unspecific control)    Cambridge Bioscience 
Sodium Chloride      Fisher, Leicestershire 
Sodium dodecyl sulfate     Fisher, Leicestershire 
Sodium Hydroxide      Sigma Aldrich, Dorset 
Sulphuric acid       Fisher, Leicestershire 
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Superscript II Reverse Transcription kit   Life technologies, Paisley 
Tetramethylbenzidine  (TMB)    Sigma Aldrich, Dorset 
TGFβRI inhibitor - SB431542 hydrate    Sigma Aldrich, Dorset  
TGFβ1 antibody (MAB240)     R&D systems, Abingdon 
TGFβ2 antibody (AB-122-NA)    R&D systems, Abingdon 
TGFβ3 antibody (MAB243)     R&D systems, Abingdon 
Thapsigargin        Sigma Aldrich, Dorset  
Thrombin       Sigma Aldrich, Dorset  
Tris        Fisher, Leicestershire 
Trizol        Sigma Aldrich, Dorset 
Trypsin / EDTA (0.25%)     Fisher, Leicestershire  
Tryptone        Fisher, Leicestershire 
Tween 20        Sigma Aldrich, Dorset 
U-0126        Cambridge Bioscience 
U73122 hydrate      Sigma Aldrich, Dorset 
Universal PCR mastermix, No Amperase UNG  Life technologies, Paisley 
Wortmannin       Cambridge Bioscience 
Yeast extract       Fisher, Leicestershire 
α18-glycyrrhetinic acid       Sigma Aldrich, Dorset 
β-mercaptoethanol      Sigma Aldrich, Dorset 
TESPA (3'aminopropyl-triethoxy silane)               Sigma Aldrich, Dorset 
Triton-X100       Sigma Aldrich, Dorset 
Bovine Serum Albumin     Sigma Aldrich, Dorset 
Paraformaldehyde      Fisher, Leicestershire 
Vectashield       Fisher, Leicestershire 
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2.2 CELL CULTURE METHODS 
2.2.1 Cell culture 
Human Achilles tenocytes derived from patients with Achilles tendinopathy were grown 
by explant outgrowth from small pieces of tendon cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) (with sodium pyruvate, phenol red, glutamax
TM
 and low glucose,) 
containing heat inactivated foetal bovine serum and penicillin (10mg/ml) / streptomycin 
(10u/ml) at a ratio of 100:10:1. Medium was replaced every 3 to 4 days until cells reached 
confluence. Cells were passaged using Trypsin / EDTA (0.25%) and divided into cell 
culture flasks at an average ratio of 1:4.  Cells were cultured for up to 9 passages, cells 
later than passage 10 were deemed to have differentiated from the tenocyte phenotype.  
Cells were cryogenically frozen by; trypsinisation, centrifugation at 150 x g for 5 minutes 
and re-suspension in foetal bovine serum (+10% DMSO) before incubation overnight in a 
cell freezing chamber at -80°C. Cells were then transferred to liquid nitrogen for longer 
term storage. 
2.2.2 Tissue Train cell culture protocol 
Tenocytes were grown to ~90% confluence in order to avoid contact inhibition during the 
experimental setup. Cells were trypsinised and re-suspended at either 1x10
6
 or 3x10
6
 
cells/ml (double the final density) in serum free medium (1% penicillin [10mg/ml] / 
streptomycin [10u/ml]). Rat tail type I collagen (2.2mg/ml) was mixed with 10x DMEM at 
a ratio of 9:1 and the pH was adjusted to approximately 7 by the addition of 10M Sodium 
Hydroxide (NaOH), using Phenol red indicator (Orange/red colour indicates a pH of 
approximately 7) to assesss the pH. Neutralised collagen and tenocyte suspension were 
mixed 1:1 (1mg/ml collagen, 0.5x10
6
 and 1.5x10
6
 cells/ml for cell density experiments and 
1.5x10
6
 cells/ml thereafter, final density) and 200µl was pippetted into flexible bottomed 
collagen type I coated Flexcell
TM
 tissue train plates (Dunn Labortechnik, Asbach, 
Germany). During which time the plates were under a continuous vacuum (20% elongation 
of the rubber membrane) over a trough loader (circular posts with a grove to allow the gel 
to rest during polymerisation, see Fig. 2.1) and base plate. The vacuum was controlled by 
the Flexcell
®
 FX-4000™ Tension System consisting of a computer running FX-4000™ 
software, a vacuum controller and a vacuum pump. The computer software regulates the 
vacuum controller which regulates the vacuum pump to pull a vacuum from the base plate. 
Gels (plus tenocytes) were allowed to set for 1 hour at 37
 o
C under a constant vacuum 
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(20% elongation), at which point 3ml serum-free DMEM was added (1% penicillin 
[10mg/ml] / streptomycin [10u/ml]). After a further 72 hours medium was replaced and 
appropriate treatments added (See individual chapters and materials list for details). Tissue 
train plates were transferred onto arctangle loading posts (rectangle posts with arc shaped 
edges to fit into the circular well, see Fig. 2.1) in preparation for mechanical loading 
(Garvin, Qi et al. 2003). A uniaxal strain was applied using the Flexcell FX-4000
TM
 
tension system (non-strain controls included). The uniaxial strain applied was in sinusoidal 
wave form cycling between 0 and 5% elongation at 1 Hz for up to 48 hours. Uniaxial strain 
in sinusoidal wave form was chosen due to the similarity to the physiological movement of 
tendon, i.e. the smooth uniaxial movement during steady excercise such as walking. The 
frequency of 1 Hz was chosen to simulate walking pace. 
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Figure 2.1. Flexcell FX-4000
TM
 tension system tissue train setup. Flexcell
TM
 tissue 
train plates are 6 well plates each with a flexible rubber membrane at its base. At either 
side of each well are fibrous anchors (A). When the tissue train plate is placed upon the 
trough loader and a vacuum is applied (20% elongation) the rubber membrane is pulled 
into the gel trough, the collagen gel (plus tenocytes) can then be seeded into the trough 
(B). 1 hour incubation at 37°C allows the gel to polymerise. The vacuum is released (C) 
and the tissue train plate is transferred to the arctangle loading post, the collagen gel (plus 
tenocytes) remains attached to either side of the well via fibrous anchors. Applying a 
vacuum causes the rubber membrane to deform and stretches the gel uniaxially between 
the fibrous attachments (D). Adapted from (Garvin, Qi et al. 2003). 
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2.2.3 Cell viability testing – Calcein AM and Ethidium Homodimer staining 
To determine the viability of tenocytes after mechanical loading, 3D collagen gels seeded 
with primary Achilles human tenocytes strained for 48 hours using the Flexcell
TM
 tissue 
train cell culture system; 3D collagen gels were stained using Calcein AM, which localises 
to the cytoplasm of viable cells and Ethidium homodimer, which binds to DNA in the 
nucleus of dead cells. In brief; 3D collagen gels were washed in PBS and incubated in 
phenol red - free DMEM containing both Calcein AM and ethidium homodimer (50μg/ml 
and 50μM respectively)) for 45 minutes at 37°C. Gels were transferred to slides and 
coverslips were mounted for viewing on the charge-coupled device (CCD) upright Zeiss 
fluorescence microscope with an attached digital camera and Axiovision 4.7 software 
(Zeiss, Oberkochen, Germany).  Calcein AM emits green fluorescence (500-530 nm) when 
excited with blue light (488 nm) and ethidium homodimer emits a red fluorescence (600-
650 nm) when excited with green light (564nm).  
2.2.4 Cell viability testing – tenocyte extraction by collagenase digestion 
To determine the viability of tenocytes after mechanical loading 3D collagen gels 
seeded with primary human Achilles tenocytes strained for 48 hours using the Flexcell
TM
 
tissue train system; 3D gels were washed in PBS and digested in collagenase from 
Clostridium Histolyticum (10mg/ml) for 5 hours (0.1% Collagenase, 0.4% HEPES in 
DMEM). Cells were centrifuged at 150 x g for 5 minutes, supernatant was removed and 
cells were re-suspended in 200µl of medium. Cells were stained with trypan blue (cells 
stained blue are non-viable) and counted using a haemocytometer. Numbers of live and 
dead cells were quantitated, comparisons were made between cells treated ±strain. 
2.2.5 siRNA knockdown 
Primary Achilles tenocytes were grown to confluence in DMEM containing heat 
inactivated foetal bovine serum (10%) and penicillin / streptomycin 1%. Medium was 
removed and cells were washed in PBS to remove all traces of penicillin / streptomycin. 
Medium was replaced with DMEM containing 10% heat inactivated foetal bovine serum 
without penicillin / streptomycin.  
siRNA (Human IL6, SMAD4, TGFβ1, TGFβ2, TGFβ3 siRNA [Qiagen, Crawley]) and 
Dharmafect 1 (transfection reagent) were equilibrated at room temperature for 5 minutes, 
mixed together and incubated for a further 20 minutes. The resulting transfection medium 
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was incubated with cells for 48 hours before cells were trypsinised and utilised in the tissue 
train cell culture protocol. The final concentrations of siRNA and transfection reagent were 
50nM and 0.2% respectively. And all DMEM used during this protocol contained 10% 
heat inactivated foetal bovine serum in the absence of penicillin / streptomycin.  
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2.3 MOLECULAR ANALYSIS METHODS 
2.3.1 RNA extraction and Reverse Transcription 
Tenocyte-seeded collagen gels were dissolved in Trizol reagent (4x gel volume). RNA was 
isolated as described previously using a tri-spin protocol (Ireland, Harrall et al. 2001). In 
brief, 125ug/ml glycogen was added and incubated at room temperature for 3 minutes 
(glycogen binds to RNA and allows the observation of a clear pellet at the latter stages of 
this protocol). 2/5 sample volume of chloroform was added to the samples which were 
shaken vigorously for 15 seconds then incubated at room temperature for 5 minutes. After 
centrifugation (at 12000 x g for 15 minutes) the upper phase was transferred into a fresh 
1.5ml tube,  an equal volume of isopropanol was added, and samples were incubated at 
room temperature for at least 10 minutes. Samples were centrifuged for 10 minute at 12000 
x g and the supernatant was discarded. Pellets were washed with 1ml ethanol (vortexed 
then centrifuged for 5 minutes at 7500 x g before the ethanol was removed), air dried and 
re-suspended in 50ul of analytical grade water. The RNA concentration of samples was 
estimated using a nanodrop spectrophotometer. The absorbance ratio A260:A280 was 1.76 ± 
0.005 (mean ± S.E.M.) with an average concentration of 43ng/μl ± 0.5 (mean ± S.E.M.). 
This confirms that RNA was of good quality. RNA was diluted to 23-40ng/μl depending 
on the experimental set in preparation for reverse transcription.  
RNA was primed with random hexamers and reverse transcribed with the superscript II kit 
according to manufacturer’s instructions. In brief, RNA was incubated at 70oC for 10 
minutes with 200ng random hexamers. 4µl 5x sample buffer, 10mM DTT, 0.125mM 
dNTP’s (2.5mM), 200units Superscript II and 40units RNase inhibitor were added and 
incubated for 1 hour at 42
o
C and at 70
 o
C  for 10 minutes (all reagents apart from the 
random hexamers are from the superscript II kit).  
2.3.2 Primer Design 
Primers were designed using Primer Express software (Applied Biosystems). Primer 
specificity and dimerisation were estimated using the Primer-BLAST tool (NCBI website - 
http://www.ncbi.nlm.nih.gov). Newly synthesised primers were used to amplify the gene 
of interest using SYBR green RT-PCR and melt curve analysis was performed to 
determine unspecific amplification or primer dimerisation. Agarose gel electrophoresis and 
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oligonucleotide sequencing were used to confirm the correct amplicon size and sequence 
respectively. 
2.3.3 Quantitative Real Time PCR 
The standard qRT-PCR programme was run using selected primer probe sets (see Table 
2.1) and the Applied biosystems 7500 real time PCR system. Each reaction was performed 
in a volume of 25μl including; 11-19ng/well of cDNA (depending on the experimental 
setup), 33% KAPA Probe fast qPCR kit Mastermix (2x), 0.2 nM each of the forward and 
reverse primer and 0.1 nM of probe. The thermal cycles were as follows: 50°C for 2 
minutes, 95°C for 10 minutes followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 
minute. Pooled cDNA products from each experiment were serially diluted to create a 
standard curve. Standard curves were run for each assay to confirm primer probe 
efficiency. As the standard curves were 1:5 serial dilutions the expected slope was -3.8 and 
the Correlation coefficient or R
2
 value expected was 1, only standard curves with similar 
values to this were accepted (slope ±0.5, R2 ±0.1). Relative expression levels in each gene 
of interest were analysed by normalising to endogenous control genes Topoisomerase-1 
(TOP1) or 18s (∆Ct [endogenous control gene Ct-gene of interest Ct]) and linearising these 
data by expressing it as 2
∆Ct
. Alternatively data was expressed as a fold change from the 
control (2
∆∆Ct
 [treatment condition 2
∆Ct
 / Control 2
∆Ct
). Data shown was normalised to 
TOP1, as GeNorm analysis demonstrated TOP1 to be the most stable housekeeping gene 
(normalising to 18s yielded similar results).  
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Gene Sequences Referenc
e 
MMP1 
  
Forward Primer: 5’- AAGATGAAAGGTGGACCAACAATT -3’ 
Reverse Primer: 5’ -CCAAGAGAATGGCCGAGTTC -3’ 
Probe: 5’- FAM-CAGAGAGTACAACTTACATCGTGTTGCGGCTC-
TAMRA -3’ 
(Clark, Young 
et al. 2010) 
MMP3 
 
Forward Primer: 5’- TTCCGCCTGTCTCAAGATGATAT -3’ 
Reverse Primer: 5’- AAAGGACAAAGCAGGATCACAGTT -3’ 
Probe: 5’- FAM-TCAGTCCCTCTATGGACCTCCCCCTGAC-TAMRA -3’ 
 
(Nuttall, 
Pennington et 
al. 2003) 
MMP13 
 
Forward Primer: 5’- AAATTATGGAGGAGATGCCCATT -3’ 
Reverse Primer: 5’- TCCTTGGAGTGGTCAAGACCTAA -3’ 
Probe: 5’- FAM-CTACAACTTGTTTCTTGTTGCTGCGCATGA-TAMRA -3’ 
(Nuttall, 
Pennington et 
al. 2003) 
ADAM12 
 
Forward Primer: 5’-  AGCTATGTCTTAGAACCAATGAAAAGTG –3’ 
Reverse Primer: 5’-  CCCCGGACGCTTTTCAG –3’ 
Probe: 5’- FAM-ACCAACAGATACAAACTCTTCCCAGCGAAGA-TAMRA 
–3’ 
(Jones, Corps 
et al. 2006) 
COL1A1 
 
Forward primer: 5’ –CTGGTCACCATGGTGATCAAG– 3’ 
Reverse primer: 5’ –GCAGGCGGGAGGACTTG– 3’ 
Probe: 5’ – CTGTCGATGGCTGCACGAGTCACAC – TAMRA – 3’ 
(Ireland, 
Harrall et al. 
2001) 
ADAMTS5 
 
Forward primer: 5’-TGTCCTGCCAGCGGATGT-3’ 
Reverse primer: 5’-ACGGAATTACTGTACGGCCTACA-3’ 
Probe: 5’- FAM-TTCTCCAAAGGTGACCGATGGCACTG-TAMRA -3’ 
(Porter, Scott 
et al. 2004) 
TGFβ1 
 
Forward primer: 5’-TGAGGGCTTTCGCCTTAGC-3’ 
Reverse primer: 5’-CGGTAGTGAACCCGTTGATGT-3’ 
Probe: 5’- FAM-CTCCTGTGACAGCAGGGATAACACACTGC-TAMRA-3’ 
Own Design 
TGFβ2 
 
Forward primer: 5’-ACGGATTGAGCTATATCAGATTCTCA-3’ 
Reverse primer: 5’-AACAGCATCAGTTACATCGAAGGA-3’ 
Probe: 5’- FAM-TTTAACATCTCCAACCCAGCGCTACATCG-TAMRA-3’ 
Own Design 
TGFβ3 
 
Forward primer: 5’-TGTCACACCTTTCAGCCCAAT-3’ 
Reverse primer: 5’-CTCCACGGCCATGGTCAT-3’ 
Probe: 5’- FAM-ATTGTCCACGCCTTTGAATTTGATTTCCAT-TAMRA-3’ 
Own Design 
TOP1 Perfect probe reference gene assay from Primer design 
Primer design 
kit 
18s 
 
Forward primer: 5’-GCCGCTAGAGGTGAAATTCTTG-3’ 
Reverse primer: 5’-CATTCTTGGCAAATGCTTTCG-3’ 
Probe: 5’-ACCGGCGCAAGACGGACCAG-3’ 
(Corps, 
Robinson et 
al. 2006) 
  
Table 2.1. Quantitative Real Time PCR primer probe sets. Primer and probe sets 
are listed for the genes analysed using qRT-PCR. Our own design primer probe sets 
were designed using the Primer Express software (Applied Biosystems). The 
fluorophore used was FAM and the quencher used was TAMRA. 
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2.3.4 Taqman Low Density Array (TLDA) analysis 
The TLDA (Applied Biosystems) was designed to assess all 23 MMP genes as well as 18 
of the 19 currently identified ADAMTS genes (our study excludes ADAMTS20 due to the 
lack of space on the TLDA plate), all 4 TIMP genes, 10 selected Proteoglycan (known to 
be expressed in tendon) and 4 collagen genes (known to be expressed in tendon), as well as 
the endogenous control gene 18s (See Table 2.2 & Table 2.3). 50ng (Metalloproteinase and 
TIMP family analysis TLDA) or 243ng (Time course of selected genes TLDA) 
(concentration dependant on available cDNA) cDNA and universal PCR mastermix (50µl) 
were loaded into the fill reservoirs (100µl/reservoir) and the plate was run according to 
manufacturer’s instructions, using the Applied biosystems 7900HT Real-Time PCR 
System and Applied biosystems Sequence Detection Systems (SDS 2.3 and RQ manager 
1.2) software. The thermal cycles were as follows: 50°C for 2 minutes, 94.5°C for 10 
minutes followed by 40 cycles of 97°C for 30 seconds and 59.7°C for 1 minute. Details of 
the primer, probe sets chosen are listed in Tables 2 (metalloproteinase and TIMP family 
analysis TLDA) and 3 (Time course of selected genes TLDA). Undetected samples were 
given an arbitrary Ct value of 40. Where the average Ct for a particular gene was ≥37 the 
level was deemed too low for detection Relative expression levels in each gene of interest 
were analysed by normalizing to endogenous control gene 18s (∆Ct [endogenous control 
gene Ct-gene of interest Ct]) and expressing these data as 2
∆∆Ct
 (fold change with strain 
and / or TGFβ). 
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Table 2.2. Taqman Low Density Array primer sets: Metalloproteinase and TIMP family 
analysis TLDA. Primer and probe sets are listed for the genes analysed using qRT-PCR. 
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Table 2.3. Taqman Low Density Array primer sets: Time course analysis of selected 
genes TLDA. Primer and probe sets are listed for the genes analysed using qRT-PCR. 
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2.4 PROTEIN ANALYSIS METHODS 
2.4.1 TGFβ activity analysis  
TGFβ can be detected using a cell based luciferase assay. Activation of SMAD proteins is 
a key step in the TGFβ signalling cascade. Cells transfected with a plasmid containing a 
construct that specifically binds to phosphorylated SMAD proteins and a luciferase 
reporter was used to detect TGFβ signalling. The construct binds to activated SMAD 
proteins, which induces the production of luciferase. Cell lysis releases the luciferase from 
confinement within the cell. In order to measure the level of luciferase produced, Luciferin 
was added. Luciferase cleaves Luciferin and a proportional increase in fluorescence was 
measured. In this way conditioned medium was assessed for active TGFβ. Medium was 
heat activated before incubation with the transfected cells to calculate total TGFβ. A 
transfection control plasmid was also used (Renilla), which produced luciferase upon 
entering the cell. The TGFβ luciferase assay was conducted essentially as described by 
(Jonk, Itoh et al. 1998). However the protocol used is described in detail below. 
Confirmation of the specificity of this assay is shown in section 3.3 of the optimisation 
chapter. In brief, we have shown that the Pan TGFβ antibody and the TGFβRI inhibitor 
abrogate the detection of the SMAD activation in strain or non-strain conditioned media 
from multiple experiments. This indicates that the assay is specifically detecting TGFβ and 
not BMPs. 
Preparation of competent DH5α cells 
E. Coli DH5α cells were spread on agar plates supplemented with 100µg/µl ampicillin and 
incubated overnight at 37°C. A single colony was inoculated into 5ml of LB broth (1% w/v 
Tryptone, 2% w/v Yeast Extract and 0.5% w/v Sodium Chloride) and incubated overnight 
at 37°C whilst shaking. Cells were grown to optimum density (OD600 = 0.6) and chilled on 
ice for 10 minutes (25ml tubes). Cells were centrifuged at 1000 x g for 10 minutes at 4°C 
and supernatant was removed. The cell pellet was re-suspended in 5ml 0.1M CaCl and 
incubated on ice for 10 minutes. The suspension was centrifuged at 1000 x g for 10 
minutes at 4°C and supernatant was removed. The pellet was re-suspended in 1ml ice cold 
0.1M CaCl and glycerol (400μl / ml) and stored frozen at -80°C.  
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Transformation of DH5α competent cells 
CAGA or Renilla plasmid was added to 50µl suspension of competent DH5α cells at a 
ratio of 1:50; cells were incubated for 15 minutes on ice, 42°C for 32 seconds and 2 
minutes on ice. DH5 cells were spread onto agar plates (1% w/v Tryptone, 2% w/v Yeast 
Extract, 0.5% w/v Sodium Chloride and 1.6% w/v Agar) and incubated overnight at 37°C. 
Individual colonies were picked and transferred to 5ml vials of LB broth (1% w/v 
Tryptone, 2% w/v Yeast Extract and 0.5% w/v Sodium Chloride) along with Ampicillin 
100µg/ml and incubated overnight on a shaking device at 37°C. 
Plasmid extraction (Qiagen mini preps) 
Plasmids were extracted using a Qiagen mini prep kit following manufacturer’s 
instructions. In brief, bacterial cells were spun at 13000rpm for 5 minutes, supernatant 
removed and the pellet was re-suspended in 250µl P1 buffer. 250µl P2 buffer was added 
and mixed thoroughly. 350µl N3 buffer was added, mixed by inversion and centrifuged at 
13000rpm for 10 minutes. The supernatant was transferred into QIAspin columns, 
centrifuged for 1 minute after which the flow through was discarded. 750µl of PE buffer 
was added to the column and centrifuged at 13000rpm for 1 minute, supernatant was 
discarded and the plasmid was eluted with 30µl of analytical grade water by centrifugation 
for 1 minute at 13000rpm. All buffers described above are from the Qiagen mini prep kit. 
SW1353 transfection 
Chondrosarcoma cell line SW1353 cells were plated at 4 x 10
4
 cells/ml (500µl/well in a 24 
well plate) and incubated overnight at 37°C. Cells were transfected with 500ng 
Lipofectamine 2000, 200ng of CAGA plasmid and 50ng Renilla plasmid overnight (Jonk, 
Itoh et al. 1998). SW1353 cells were serum starved overnight (DMEM alone). SW1353 
cells were chosen as they are a fast growing cell line that are easily transfected. 
Luciferase assay 
SW1353 cells transfected with CAGA and Renilla constructs were incubated for 6 hours 
with 500µl conditioned medium from 48 hour strained/non-strained cultures. Duplicate 
samples of conditioned medium were heated for 5 minutes at 80°C to activate TGFβ before 
incubation with SW1353 cells. Unconditioned medium ±1ng/ml recombinant TGFβ1 were 
used as negative and positive controls. The Promega Dual Luciferase™ Reporter Assay 
was used to measure luciferase activity according to manufacturer’s instructions. In brief, 
SW1353 cells were washed in PBS, treated with 50µl of lysis buffer, scraped and 
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incubated for 15 minutes at room temperature. 10µl was transferred to a 96 well plate and 
50µl of luciferase assay reagent II was added. Luminescence was measured using a Perkin 
Elmer spectrophotometer (Luminescence 700 setting on the Envision plate reader, 560nm), 
50µl of stop and go solution was added and the plate was measured for a second time to 
measure renilla activity (Luminescence 700 setting on the envision plate reader, 560nm). 
CAGA luciferase units were normalised to renilla luciferase units to account for 
transfection efficiency (CAGA Luciferase units/Renilla luciferase units). These values 
were normalised to the non-conditioned medium and expressed as a percentage of the total 
TGFβ in non-strained controls. 
2.4.2 Western Blotting  
TCA precipitation 
In order to concentrate medium samples for the detection of metalloproteinase expression 
using western blotting, Trichloroacetic acid (TCA) precipitation was used. Culture medium 
was mixed with 10% TCA at a ratio of 2:1 and incubated on ice for 1 hour. The samples 
were centrifuged for 15 minutes at 13000 x g at 4°C. The supernatant was removed and the 
pellet was washed with 70% ethanol. The supernatant was removed and the pellet was air 
dried before resuspension in final sample buffer (2% w/v SDS, 2mM β-mercaptoethanol, 
4% v/v glycerol, 40mM Tris-HCl (pH 6.8), 0.01% w/v Bromophenol blue). The pH was 
adjusted using 10M NaOH as required. 
SDS-PAGE  
 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was conducted 
essentially as described by (Shapiro, Vinuela et al. 1967). In brief, 10% v/v Acrylamide, 
365mM Tris-HCl (pH 8.8), 0.1% w/v SDS, 0.05% w/v Ammonium persulphate (APS) and 
0.04% w/v Tetramethylethylenediamine (TEMED) were combined to create a running gel. 
This was allowed to polymerise before a stacking gel (4% v/v Acrylamide, 365mM Tris-
HCl (pH 8.8), 0.1% w/v SDS, 0.1% w/v APS and 0.04% w/v TEMED) was added and in 
turn allowed to polymerise with the addition of the comb to created loading wells. The 
SDS-PAGE apparatus was assembled and running buffer was loaded into the tank (25mM 
Tris-HCl, 200mM Glycine and 0.1% w/v SDS). 
Western Blotting  
Western blotting was conducted essentially as described by (Towbin, Staehelin et al. 
1979). In brief, conditioned medium and standards were mixed with 5x sample buffer 
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(10% w/v SDS, 10mM β-mercaptoethanol, 20% v/v glycerol, 0.2M Tris-HCl (pH 6.8), 
0.05% w/v Bromophenol blue) at a ratio of 4:1 and incubated at 100
 o
C for 5 minutes. 
Samples were run on an SDS-PAGE gel at 200v for 45 minutes (See protocol above for 
SDS-PAGE setup). Proteins were transferred onto PVDF (Polyvinylidene Fluoride 
membrane) using the semi-dry blot technique in the presence of transfer buffer (0.29% w/v 
Glycine, 0.58% w/v Tris, 0.037% w/v SDS and 20% w/v Methanol) at 10v for 30 minutes. 
PVDF membranes were incubated in blocking solution (5% milk powder, Tris Buffered 
Saline solution [TBS- 150mM NaCl, 100mM Tris, pH 7.5]) for at least 1 hour, rinsed in 
wash buffer (TBS, 0.1% w/v Tween 20 and 1% w/v milk powder) and incubated in the 
primary antibody (diluted into antibody buffer; TBS, 0.1% v/v Tween 20 and 2.5% w/v 
milk, for details of primary antibodies used see table 2.4) for 1 hour. The PVDF’s were 
rinsed and incubated (3 x 5 minutes) in wash buffer and incubated in secondary antibody 
(1:4000 dilution, for details of secondary antibodies see table 2.4) for 30 minutes. The 
PVDF was rinsed and incubated (3 x 5 minutes) in wash buffer and rinsed and then 
incubated for 40 minutes in CDP star buffer (0.1M Tris HCl and 0.1M NaCl at pH 9.5). 
CDP star reagent (chemilluminescent substrate) (diluted in CDP star buffer 1:4000) was 
added to the protein saturated side of the PVDF. The PVDF was then incubated with 
chemilluminescent film which was developed using the Odyssey Xograph (LI-COR 
Biosciences UK Ltd, Cambridge). 
  
Chapter 2: Materials and Methods 
121 
 
 
 
Protein of interest Primary Antibody Secondary Antibody 
MMP1 
Rabbit polyclonal                    
TCS Cellworks (1:400 dilution) 
Goat polyclonal anti-Rabbit IgG, Alkaline Phosphatase, 
Abcam ab6722-1, (1:1000 dilution) 
MMP2 
Mouse monoclonal                  
TCS Cellworks (1:400 dilution) 
Rabbit polyclonal to anti-Mouse IgG, Alkaline 
Phosphatase. Abcam ab6729-1, (1:1000 dilution) 
MMP13 
Mouse monoclonal                 
TCS Cellworks (1:4000 dilution) 
Rabbit polyclonal to anti-Mouse IgG, Alkaline 
Phosphatase. Abcam ab6729-1 (1:1000 dilution) 
MMP23 Rabbit polyclonal                     
TCS Cellworks (1:250 dilution) 
Goat R&D systems anti-Rabbit IgG, Alkaline 
Phosphatase, Abcam ab6722-1, (1:1000 dilution) 
ADAM12 
Goat polyclonal                  
Abcam ab28747-100 
Rabbit polyclonal to anti-Goat IgG, Alkaline 
Phosphatase. Abcam ab6742-1, (1:10000 dilution) 
All isoforms of 
TGFβ 
Pan Specific polyclonal antibody 
NB-100-NA Rabbit IgG (2μl/ml) 
Goat polyclonal anti-Rabbit IgG, Alkaline phosphatise, 
Abcam ab6722-1, (1:1000 dilution) 
TGFβ1 
R&D systems MAB240 Mouse 
Monoclonal IgG (2μl/ml) 
Rabbit polyclonal anti-mouse IgG,  Alkaline 
Phosphatase, Abcam ab67291, (1:1000 dilution) 
TGFβ2 
R&D systems AB-122-NA Goat 
IgG (2μl/ml) 
Rabbit anti-Goat IgG, Alkaline Phosphatase.           
Sigma A4062. (1:10000 dilution) 
TGFβ3 
R&D systems MAB243 Mouse 
IgG (2μl/ml) 
Rabbit polyclonal anti-mouse IgG,  Alkaline 
Phosphatase, Abcam ab67291, (1:1000 dilution) 
             
  
Table 2.4: Western blot antibodies Suppliers: R&D systems (Abingdon), Abcam 
(Cambridge), Sigma Aldrich (Dorset), TCS Cellworks (Buckingham) 
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2.4.3 TGFβ ELISA  
Freeze drying  
In order to concentrate medium samples for the detection of TGFβ expression using 
ELISA, the freeze drying protocol was used. 500μl of conditioned medium was aliquoted 
into a vented micro-centrifuge tube (a small hole was made in the lid with a syringe 
needle), frozen to at -80°C overnight before it was placed in the desiccation chamber of the 
freeze drying apparatus (Edwards, Crawley, West Sussex). A vacuum was set to remove 
moisture from the samples in the desiccation chamber for a period of 8 hours. After 8 
hours the samples were dry. The protein pellets were resuspended in 100μl of analytical 
grade water. 
Enzyme Linked Immunosorbent Assay (ELISA) 
Conditioned medium was freeze dried and re-suspended in analytical grade water (5x 
concentration). Medsorp microplates (Fisher, Leicestershire) were incubated overnight at 
4°C with anti-TGFβ1 capture antibody (Purified rat anti-mouse, human, pig, 4µg/ml) in 
binding solution (0.1M Na HPO4, Adjust to pH9 with 0.1M NaH2P04). TGFβ1 antibody 
coated plates were blocked (10% w/v BSA, 0.1% w/v tween in PBS) for 1 hour and rinsed 
with wash buffer (0.1% v/v Tween 20 in phosphate buffered saline [PBS]). Samples and 
standards were incubated on the plate overnight at 4°C and the plate was rinsed in wash 
buffer. Biotinylated anti-TGFβ detection antibody (2μg/ml) diluted in blocking buffer was 
incubated on the plate for 1 hour at room temperature. The plate was washed in wash 
buffer and incubated in Avidin-HRP (Chemilluminescent substrate) diluted 1:1000 in 
blocking buffer plus Tween 20 (10% BSA, 0.1% tween in PBS). The plate was washed and 
incubated in TMB (Tetramethylbenzidine) for 30 minutes before the reaction was stopped 
by adding 1M Sulphuric acid (colour change to yellow). The absorbance was read on a 
Perkin Elmer spectrophotometer at 450nm (and corrected to the background of 550nm or 
630nm). Data was either presented as relative value or percentage of total TGFβ in control 
samples. Recombinant TGFβ1 (R&D systems, Abingdon) was used to create a standard 
curve (0.1, 0.2, 0.5, 1 and 5ng/ml). An estimate of the levels of TGFβ in the medium was 
calculated using the standard curve (exponential trend line). 
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2.4.4 Gelatin Zymography 
Gelatin Zymography was conducted essentially as described in (Clark, Young et al. 2010). 
In brief 10% resolving SDS-PAGE gel containing gelatin was prepared and incubated for 1 
hour at room temperature (1% w/v gelatin, 0.6M TRIS, 10% v/v Acrylamide, 0.1% w/v 
Sodium Dodecyl Sulphate [SDS], 0.1% w/v ammonium persulphate [APS] and 0.04% v/v 
TEMED). A 5% stacking gel (0.12M TRIS, 5% v/v Acrylamide, 0.1% w/v SDS, 0.1% w/v 
APS and 0.04% v/v TEMED) was loaded above the resolving gel and allowed to set for 30 
minutes at room temperature. Conditioned medium and loading buffer (200mM Tris pH 
6.8, 4% w/v SDS, 0.1% w/v Bromophenol blue and 40% w/v Glycerol) was loaded onto 
the SDS-PAGE gel (containing gelatin) as well as a positive control (10ng MMP2 and 
MMP9) and run at 150V for 90 minutes.  Gelatin gels were incubated twice for 15 minutes 
in rinse buffer (5% Triton-X100) to remove SDS and incubated overnight in incubation 
buffer (50mM Tris pH 7.5 and 5mM CaCl2)(+ ~2ml rinse buffer remaining) at 37
ο
C, 
rinsed with water and stained in Coomassie Brilliant Blue (30% v/v Isopropanol, 10% v/v 
Acetic acid and 2.5mg/ml Coomassie Brilliant Blue R) overnight. Gels were rinsed in 
water, incubated in destain (10% v/v isopropanol and 10% v/v acetic acid) for 1 hour and 
rinsed in water before imaging using the Licor Odyssey imaging system. Quantification of 
each band was achieved using image J software. As the standard (10ng of recombinant 
MMP2) appeared over exposed relative quantification was calculated by normalising these 
data to the 48 hour proMMP2 band.  
 
2.4.5 QF24 assay; Metalloproteinase activity assay 
QF24 is a quenched-fluorescence substrate that can be cleaved by MMPs [Mca-ProLeu-
Gly-Leu-Dpa-Ala-Arg-NH2 (Uria and Lopez-Otin 2000)]. Cleavage of QF24 increases the 
level of fluorescence emitted by the substrate. Therefore an increase in MMP activity 
correlates with an increase in fluorescence. Conditioned medium from SW1353 cells 
stimulated with IL1 was collected as this medium contains a high level of active MMPs; 
this was used as a positive control.  5µl of bovine nasal cartilage conditioned medium was 
aliquoted into each well of a white 96 well plate, to selected wells 1.6µM EDTA was 
added as a negative control. 5µl of conditioned medium from samples treated ±GM6001 or 
inactive control for 24 and 48 hours was added to selected wells to test the ability of the 
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GM6001 to inhibit MMP activity in the bovine nasal cartilage conditioned medium. To all 
wells FAB buffer (50mM Tris-HCl, pH7.5, 150mM NaCl, 10mM CaCl2 and 0.05% Brij 
35) (each well was made up to 200µl final volume) and 1µM QF24 fluorescent substrate 
was added. The fluorescence was measured using a Perkin Elmer spectrophotometer to 
measure the level of MMP activity (excitation wavelength of 328 nm, emission wavelength 
of 393 nm). 
2.4.6 Immunostaining of tenocyte seeded collagen gels 
Cell seeded collagen gels were harvested after 48 hours of strain. Gels were immersed in 
Cryo-M-Bed embedding compound, frozen for 1 hour at -20°C followed and overnight at -
80°C. 15μm cryosections were cut using a cryostat (Jencons, Bedfordshire) at -30°C. 
Sections were mounted onto 3-triethoxysilylpropylamine (TESPA) coated slides (see 
protocol below) and incubated at -20C overnight. Sections were fixed in 4% 
paraformaldehyde for 1 hour, washed in PBS and incubated for 30 minutes in 0.5% Triton-
X100. Sections were washed in PBS, blocked overnight (in 1% w/v BSA in PBS) at 4°C, 
washed in PBS, incubated overnight in primary antibody (for details of primary antibodies 
used see table 2.5) (in PBS), washed in PBS and blocked overnight at 4°C. Sections were 
washed in PBS, incubated in appropriate secondary antibody (see table 2.5 for details of 
secondary antibodies used) for 2 hours, washed in PBS and blocked for a further 2 hours in 
(0.1% w/v BSA in PBS). Blocking solution was removed using a PBS wash and 
Vectasheild (Fisher, Leicestershire) fluorescence marker imaging fluid containing 4',6-
diamidino-2-phenylindole (DAPI) was added to the sections before a cover slip was 
mounted. DAPI is a fluorescent stain that is absorbed by the nucleus of the cell, this/ 
allowed us ascertain whether the proteins detected by the antibody were localised to the 
nuclei. Sections were imaged using a charge-coupled device (CCD) upright Zeiss 
fluorescence microscope with an attached digital camera and Axiovision 4.7 software 
(Zeiss, Oberkochen, Germany).   
TESPA coating of microscope slides 
Glass slides were immersed in acetone for 30 seconds then in acetone plus 5% v/v 3-
triethoxysilylpropylamine (TESPA) for 1 minute. Slides were then immersed in acetone 
twice before a final rinse in distilled water. Slides were dried at 37°C before use. 
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2.4.7 Statistical analysis 
Data was presented as a mean ± standard error (or where n=1 data are shown as the mean ± 
standard deviation). Data was tested for normal distribution using the Shapiro-Wilk 
normality test. The Wilcoxon signed rank test and the Students T test (2 tailed, assuming 
unequal variance) (the paired T test is used where appropriate) were used to analyse qRT-
PCR data and TGFβ luciferase data using SASW Statistics 18 and Microsoft Excel as 
appropriate. p<0.05 was chosen as the cut off for statistical significance. 
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Protein Target Primary Antibody Secondary Antibody 
TGFβ1 
Anti-TGFβ1, Rabbit Polyclonal,  
Santa Cruz Biotechnology sc-146 (1:200 dilution) 
Goat polyclonal antibody to 
Rabbit IgG (Cy3 labelled)  
Abcam, ab6939 
(1:40 dilution) 
TGFβRI 
Anit-TGFβRI, Rabbit polyclonal,  
Santa Cruz Biotechnology sc-398 (1:200 dilution) 
SMAD2 
Anti-SMAD2, Rabbit monoclonal IgG  
Cell Signalling 3122. (1:400 dilution) 
Phospho-SMAD2 
Anti-phospho-SMAD2 (Ser465/467), Rabbit monoclonal IgG  
Cell signalling 3108, , (1:500 dilution) 
      
Table 2.5: Immunostaining antibodies Suppliers: Cell signalling (Hertfordshire), Santa 
Cruz Biotechnology (Insight Biotechnology Ltd, Middlesex), Abcam (Cambridge) 
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3.1. CELL VIABILITY TESTING 
In order to validate our experiments we needed to confirm that the cells were viable in the 
3D collagen gels in the presence or absence of mechanical load. To test the viability of 
cells following a loading regime of 0-5% cyclic strain at 1Hz for a period of 48 hours we 
used two methods of viability testing: Calcein AM (Live cells) and ethidium homodimer 
(dead cells) staining and collagenase extraction of cells, followed by quantification of dead 
cells using trypan blue staining. 
3.1.1. Methods 
 Calcein AM and Ethidium Homodimer staining 
Tenocyte-seeded 3D gels were stained using Calcein AM, which localises to the cytoplasm 
of viable cells and Ethidium homodimer, which binds to DNA in the nucleus of dead cells. 
In brief, 3D collagen gels were washed in PBS and incubated in phenol-free DMEM 
containing both Calcein AM and ethidium homodimer (1/20 dilution) for 45 minutes at 
37°C. Gels were transferred to slides and cover slips were mounted for viewing on the 
charge-coupled device (CCD) upright Zeiss fluorescence microscope with an attached 
digital camera and Axiovision 4.7 software (Zeiss, Oberkochen, Germany).  Calcein AM 
fluoresces green (500-530) when excited with blue light (488 nm) and ethidium 
homodimer emits a red fluorescence (600-650) when excited with green light (564nm).  
Tenocyte extraction by collagenase digestion 
Tenocyte seeded 3D gels were washed in PBS and digested in collagenase for 5 hours 
(0.1% Collagenase, 0.4% HEPES in DMEM). Cells were centrifuged at 150 x g for 5 
minutes, supernatant was removed and DMEM was added; this process was repeated three 
times to remove collagenase. Cells were pelleted and re-suspended in a known volume of 
DMEM. Cells were stained with trypan blue (cells stained blue are non-viable) and 
Chapter 3: Optimisation 
128 
 
counted using a haemocytometer. Live and dead cells were quantified, and comparisons 
were made between cells treated ±strain. 
3.1.2. Results and Discussion  
Calcein AM and Ethidium Homodimer staining 
Cell seeded collagen gels exposed to 1 hour at -20°C were used as positive controls for 
ethidium homodimer staining as this caused 100% cell death. Figure 1 B and D show 
positive controls where cells are clearly stained with ethidium homodimer at their nucleus, 
confirming that the dead cell staining was successful. In addition in these positive controls 
no calcium AM staining was evident indicating that the live cell staining is specific. In 
non-strained and strained samples there was high levels of calcium AM staining indicating 
that a high percentage of cells were viable, in addition there was little ethidium homodimer 
staining indicating low levels of cell death. There appeared to be less cell death in strained 
cultures compared to non-strained controls; however we were unable to quantitate this due 
to the compact nature of cells.  It was clear that in strained cultures the cells were more 
tightly packed, making it more difficult for us to quantitate these results. As a result we 
chose to use an additional means to measure cell viability that enabled us to measure 
viability in a more quantitative manner. Calcein AM staining of the cytoplasm of live cells 
also indicates that in strained cultures the cells are aligned to the direction of loading, 
whereas in non-strained cultures this is much less obvious. This indicates that cells are able 
to adapt in morphology in response to mechanical load. 
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Figure 3.1. Calcein  AM and Etidium Homodimer cell viability testing. Primary human 
Achilles tenocytes were seeded into type I rat tail collagen (final concentration of 1.5x10
6 
cells/ml and 1mg/ml collagen) and cyclically strained (5% at 1Hz) for 48 hours. Cells were 
stained using Calcein  AM (live cells – green) and Ethidium Homodimer (dead cells – red).  
Non-strained (A and B), strained (C and D) and positive controls for Ethidium homodimer 
staining (B and D) are shown (frozen for 1 hour at -20°C). These images are representative 
of a large number of images taken at different positions of the 3D culture (n=1). 
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Tenocyte extraction by collagenase digestion 
Live and dead cells were counted and data expressed as a percentage of the total cell 
number. The average of three experiments is shown. The number of dead cells was 3% and 
4% in non-strained and strained cultures respectively (see figure 3.2); however the number 
of dead cells was not significantly different between strained and non-strained cultures (T 
test [2 way, unequal variance]).  
There was a high percentage of viable cells and a low level of dead cells in the collagenase 
digestion and trypan blue staining experiment, consistent with the ethidium homodimer 
and Calcein AM staining. However, cell numbers were lower than expected when cells 
were counted following collagenase digestion (~50% of the cells seeded into the gel). This 
is most likely due to the loss of cells during the centrifugation stages to wash collagenase 
from the cells. However due to the consistency of low cell death with the Calcein AM and 
ethidium homodimer staining we can conclude that the level of cell viability is high. 
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Figure 3.2. Collagenase digestion and trypan blue staining: cell viability testing. 
Primary human Achilles tenocytes were seeded into type I rat tail collagen (final 
concentration of 1.5x10
6 
cells/ml and 1mg/ml collagen) and cyclically strained (5% 
at 1Hz) for 48 hours. Cells were digested in bacterial collagenase and stained with 
trypan blue (only dead cells take up the trypan blue stain). Both live and dead cells 
were counted and expressed as a percentage of the total number of cells (n=3). 
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3.2. TGFβ CONCENTRATION TITRATION 
TGFβ expression is increased in tendinopathy (Fenwick, Curry et al. 2001; Fu, Wang et al. 
2002); therefore we were interested in treating tendon cells with TGFβ to observe the 
effects of TGFβ in conjunction with mechanical loading. We have shown COL1A1 is 
stimulated in response to TGFβ; this gene was chosen as a measure of the cells response to 
TGFβ. Our aim was to determine the optimum concentration of TGFβ required to stimulate 
a response in COL1A1 expression.  
3.2.1. Method 
Primary human Achilles tenocytes were trypsinised and re-suspended at 3x10
6
 cells/ml 
(double the final density) in serum free medium (1% penicillin [10mg/ml] / streptomycin 
[10u/ml]). Rat tail type I collagen (2.2mg/ml) was mixed with 10x DMEM at a ratio of 9:1 
and the pH was adjusted to approximately 7 by the addition of 10M Sodium Hydroxide 
(NaOH), using DMEM colour (Orange/red colour indicates a pH of approximately 7) to 
assesss the Ph. Neutralised collagen and tenocyte suspension were mixed 1:1 (1mg/ml 
collagen, 1.5x10
6
 cells/ml final density) and 200µl was pipetted into each well of a 48 well 
plate. Gels (plus tenocytes) were allowed to set for 1 hour at 37
 oC, at which point 500μl 
serum free DMEM was added (1% penicillin [10mg/ml] / streptomycin [10u/ml]). A range 
of concentrations of TGFβ (0, 0.1, 0.5, 1, 2, 5, 8 and 10ng/ml) was added to the tenocyte 
seeded collagen gels. Gels (plus tenocytes) were harvested after 48 hours; medium was 
removed and gels were dissolved in 4 x the gel volume of trizol. RNA was isolated using 
the tri-spin protocol, reverse transcribed and standard qRT-PCR was used to analyse TOP1 
(endogenous control) and COL1A1.  The COL1A1 data was normalised to TOP1 and 
expressed as 2
∆Ct
. The Students t-test (two tailed, paired) was used to assess statistical 
significance, p<0.05 was chosen as the cut off for significance. 
3.2.2. Results and Discussion 
COL1A1 expression was increased with TGFβ (Figure 3). At 0.1, 0.5, 5 and 8ng/ml there 
was a trend to increase in COL1A1 expression with TGFβ treatment, however this was not 
significant. With 1, 2 and 10ng/ml TGFβ there was a significant increase in COL1A1 
expression. Therefore 1ng/ml was chosen as the most effective and economical 
concentration of TGFβ. 
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Figure 3.3. COL1A1 expression in response to TGFβ treatment. Primary 
human Achilles tenocytes were seeded into type I rat tail collagen (final 
concentration of 1.5x10
6 
cells/ml and 1mg/ml collagen) and treated with a range 
of TGFβ concentrations (0, 0.1, 0.5, 1, 2, 5, 8 and 10ng/ml). COL1A1 mRNA 
was measured using qRT-PCR. Data was normalised to TOP1 and expressed as 
2
∆Ct
. The students t test (two tailed, paired) was used to assess statistical 
significance, p<0.05 was chosen as the cut off for significance (n=3). 
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3.3. TGFβ LUCIFERASE ASSAY SPECIFICITY CONFIRMATION 
We used a cell based luciferase assay to measure active TGFβ (See chapter 5). However 
because this assay was a measure of SMAD activity we needed to confirm that TGFβ 
signalling and more specifically TGFβ activity is responsible for the stimulation of SMAD 
activity. In order to test this we incubated strain and non-strained conditioned medium with 
either the TGFβRI inhibitor or a Pan-TGFβ inhibitory antibody in the cell based assay. In 
addition we used unconditioned medium ±TGFβ (5ng/ml) in combination with either the 
TGFβRI inhibitor or a Pan-TGFβ inhibitory antibody in the cell based assay. This would 
allow us to test the TGFβ inhibitory ability of these inhibitors as well as to confirm that the 
soluble mediator of downstream SMAD activation was TGFβ. 
In order to test which isoform was activated in response to mechanical load (See chapter 5, 
section 5.3.6), functionally inhibiting antibodies targeting TGFβ isoforms 1, 2 and 3 were 
added to the luciferase assay with strain and non-strain conditioned medium. TGFβ 
antibodies were also added in combination, i.e. TGFβ1 plus TGFβ3, to determine whether 
a combination of isoforms was responsible.  
3.3.3. Methods 
Conditioned medium was collected from tenocyte seeded collagen gels strained for 48 
hours at 5% cyclic strain at 1Hz. SWI353 cells transfected with CAGA and Renilla 
constructs were incubated with strain conditioned medium with the addition of TGFβRI 
(SB431542, 10µM), TGFβ1 (MAB240, 1-2.5μg/ml), TGFβ2 (AB-122-NA, 1-2.5μg/ml), 
TGFβ3 (MAB243, 1-2.5μg/ml) or Pan-TGFβ inhibitory antibody (2.5μg/ml) for 6 hours 
(TGFβ isoforms were also added in combination). In addition unconditioned medium 
±TGFβ (5ng/ml) was incubated with TGFβRI (SB431542, 10µM) or Pan-TGFβ inhibitory 
antibody (2.5μg/ml) with the transfected SW1353 cells for 6 hours. Medium was removed 
and cells were washed in PBS before cells were lysed for 15 minutes. Cell lysate was 
transferred into a 96 well plate (10μl) to which 50μl of luciferin was added (Dual luciferase 
reporter assay). The absorbance was read on a spectrometer (CAGA), stop and glo solution 
(from the dual luciferase reporter assay kit) was added and the plate was read again 
(Renilla) (Dual luciferase reporter assay). CAGA absorbance units (measure of SMAD 
activation) were normalised to the Renilla absorbance units (transfection control). These 
values where then normalised to negative control samples. For more details on the TGFβ 
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luciferase assay see methods section. The t test was used to assesss statistical significance 
(assuming unequal variance and two tailed distribution), p<0.05 was chosen for the cut off 
for significance. 
3.3.4. Results and Discussion 
TGFβ significantly stimulated SMAD activation compared to samples incubated with non-
conditioned medium only (Figure 3.4). Both the TGFβRI inhibitor and the Pan specific 
TGFβ inhibitory antibody significantly abrogated SMAD activation. Strain conditioned 
medium showed a significantly high level of SMAD activation compared to non-strained 
controls. With the addition of the TGFβRI inhibitor the strain induced activation of SMAD 
was completely abrogated. This suggests that the SMAD is activated via TGFβRI by a 
soluble factor present in the conditioned medium of strained Achilles tenocytes. With the 
addition of the Pan specific TGFβ inhibitory antibody there was a significant reduction in 
the strain conditioned medium stimulated response. As the Pan specific TGFβ antibody is 
thought to inhibit the activity of all TGFβ isoforms, this indicates that TGFβ is the soluble 
factor present in strain conditioned medium that stimulates SMAD activation. Antibodies 
more specific to the isoforms of TGFβ could therefore isolate the predominant isoform or 
isoforms activated in response to mechanical load. However, none of the antibodies we 
tried successfully abrogated the strain induced SMAD activation, despite the use of these 
antibodies in combination (data not shown). This is likely due to the ineffective nature of 
the antibodies tested.  
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Figure 3.4. TGFβ luciferase assay specificity test. The TGFβ luciferase assay gives 
a reading of relative luciferase units that is a measure of SMAD activity. In order to 
confirm that TGFβ signalling and more specifically TGFβ activity is responsible for 
the stimulation of SMAD activity, inhibitors of TGFβ activity and TGFβ signalling 
were used. Non-conditioned media ± TGFβ, strain and non-strain conditioned media 
was incubated with TGFβRI inhibitor (A) and a Pan specific TGFβ inhibitory 
antibody (B) to confirm the measure of SMAD activation was stimulated via TGFβ. 
Statistical analysis was performed using the t test (assuming unequal variance and 
two tailed distribution) and the statistical cut off was chosen as p<0.05 (n=3, 
conditioned media from one cell isolate only). 
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3.4. GM6001 ACTIVITY TEST 
As GM6001 had no effect upon the strain mediated activation of TGFβ or 
metalloproteinase gene expression (presented section 6.3.1.), we needed to confirm that 
GM6001 added to cultures was persistently active after 8, 24 and 48 hours of culture with 
primary Achilles tenocytes. A fluorescent MMP substrate called QF24 was used to assesss 
the inhibitory activity of GM6001 in the presence of conditioned medium with high levels 
of active MMPs.  
3.4.1. Method 
Conditioned medium from cultures of the bovine nasal cartilage treated with IL1 for 14 
days contains a high level of active MMPs.  5µl of bovine nasal cartilage conditioned 
medium was aliquoted into each well of a white 96 well plate, to selected wells EDTA 
(1.6µM final concentration) was added as a negative control (inhibitor of MMP activity). 
5µl of strain or non-strained conditioned medium from samples treated ±GM6001 or 
inactive control (similar peptide structure to GM6001 that does not inhibit 
metalloproteinase activity) for 24 and 48 hours was added to selected wells to test the 
ability of the GM6001 to inhibit MMP activity in the bovine nasal cartilage conditioned 
medium (positive control). To all wells FAB buffer (50mM Tris-HCl, pH7.5, 150mM 
NaCl, 10mM CaCl2 and 0.05% Brij 35) (each well was made up to 200µl final volume) 
and  QF24 (1µM final concentration) fluorescent substrate was added. The absorbance was 
measured using a perk and Elmer spectrophotometer to gauge the level of MMP activity 
(excitation wavelength of 328 nm, emission wavelength of 393 nm). 
3.4.2. Results and Discussion 
Conditioned medium from bovine nasal cartilage (positive control) caused an increase in 
the level of absorbance units which peaked at approximately 1000000 units after 61 
readings (Figure 5); this indicates that the high level of MMP activity caused the 
degradation of the QF24 substrate. Where a combination of positive control medium and 
EDTA was assessed, there was a reduction in the level of absorbance units after 61 
readings (200000units) compared to positive control medium alone. EDTA prevents MMP 
activity therefore degradation of QF24 is completely abrogated. A combination of 
GM6001 (250μM) and positive control medium also caused a decrease in the level of 
MMP activity, compared to the positive control. However, this reduction was not as 
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marked as samples incubated with EDTA. A combination of positive control medium and 
conditioned medium (±strain) with the addition of GM6001 showed a decrease in relative 
absorbance units after reading 61 compared to positive control. There was no clear 
difference ±strain or between different time points. This indicates that the GM6001 added 
to these samples at the start of culture was still active after 48 hours of culture. There was 
little difference between positive control cultures and a combination of strain conditioned 
medium with inactive GM6001 and positive control medium in terms of relative 
absorbance units, this indicates that inactive GM6001 has no effect upon MMP activity, as 
expected.  
Failure to use an equal amount of GM6001 in the negative control as added to the cultures 
means that cannot confirm that GM6001 retained its full activity during its 48 hour culture 
period (0.1μM in the QF24 assay from conditioned medium samples, 250μM was used in 
the QF24 assay as a negative control). However we can still see that GM6001 retained 
some activity in the conditioned medium. And as the positive control medium contained 
far more MMP activity that in the tenocyte culture medium (MMP activity from the 
tenocyte conditioned medium was undetectable, data not shown), we can assume that this 
was sufficient to inhibit any metalloproteinase activity after 48 hours of culture. 
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Figure 3.5. A fluorescent MMP substrate (QF24) as a measure the inhibitory 
activity of GM6001. Conditioned media was collected from tenocyte seeded type I rat 
tail collagen gels strained at 5% at 1Hz for 8, 24 and 48 hours, ±GM6001 / Control 
peptide. Conditioned media from cartilage explants cultured for 14 days was used as a 
positive control due to the high level of MMP activity. Positive control conditioned 
media was used in all conditions in the presence or absence of tenocyte conditioned 
media. EDTA, GM6001 and inactive GM6001 were added as additional controls in the 
absence of strain conditioned media. Samples with red markers are those containing 
GM6001 or EDTA control. Those in black contain ± control inactive GM6001 (n=1). 
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3.5. TGFβ LUCIFERASE ASSAY REAGENT INTERFERENCE TEST 
As the TGFβ luciferase is a cell based system, there is a risk that cell treatments may affect 
the relative measure of TGFβ activity. To test whether treatments (see chapter 7) affected 
this measure we examined their effects upon TGFβ stimulation of the cell based luciferase 
assay. 
3.5.1 Methods 
Apyrase (10U/ml), M6P (10μM), SB203580 (5µM), Doramapimod (0.1µM), PD0325901 
(0.1µM), U-0126 (20µM), Wortmannin (0.1µM) and PI-103 (0.5µM), were added (along 
with TGFβ and non-conditioned DMEM) to the CAGA and Renilla transfected SW1353 
cells and incubated for 6 hours. Medium was removed and cells were washed in PBS 
before cells were lysed for 15 minutes. Cell lysate was transferred into a 96 well plate 
(10μl) to which 50μl of luciferin was added (Dual luciferase reporter assay). The 
absorbance was read on a spectrometer (CAGA), stop and glo solution was added and the 
plate was read again (Renilla) (Dual luciferase reporter assay). CAGA absorbance units 
(measure of SMAD activation) were normalised to the Renilla absorbance units 
(transfection control). These values where then normalised to negative control samples. 
For more details on the TGFβ luciferase assay see methods section. 
3.5.2. Results and Discussion 
TGFβ treatment induced a significant increase in the level of active TGFβ detected using 
the TGFβ luciferase assay compared to control. In TGFβ treated cultures M6P, 
Doramapimod, PD0325901, U-0126 and Wortmannin significantly increased the level of 
active TGFβ detected in the luciferase assay compared to controls (without TGFβ 
treatment). However, Apyrase, SB203580 and PI-103 did not show a significant level of 
active TGFβ in TGFβ treated cultures according to the luciferase assay. In TGFβ treated 
cultures Apyrase, M6P, U0126 and PI-103 treatment showed significantly less detection of 
active TGFβ compared to TGFβ treated controls. Therefore, Apyrase, M6P, U0126 and PI-
103 significantly affected the detection of TGFβ using the cell based luciferase assay, this 
means that conditioned medium from cells initially treated with these inhibitors may not 
give an accurate reading in terms of TGFβ when analysed using the luciferase assay. Here 
we show the effect of fresh inhibitor directly on the luciferase assay, as the treatments are 
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incubated at 37°C for a period of up to 48 hours before the luciferase assay, in the full 
experiment their ability to interfere with the luciferase assay may have decreased. 
Therefore these results may show an exaggerated level of inhibition of the luciferase assay. 
In order to confirm this, we could test treatments incubated at 37°C for 48 hours. 
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Figure 3.6. TGFβ luciferase assay reagent interference test. Apyrase (10U/ml), 
M6P (10μM), SB203580 (5µM), Doramapimod (0.1µM), PD0325901 (0.1µM), U-
0126 (20µM), Wortmannin (0.1µM) and PI-103 (0.5µM), were added (along with 
TGFβ and non-conditioned) to the CAGA and Renilla transfected SW1353 cells. The 
dual luciferase reporter assay was used to assesss the level of active TGFβ. CAGA 
luciferase units were normalised to renilla luciferase units (transfection control) 
before being normalised to negative controls. Statistical analysis was performed using 
the t test (assuming unequal variance and two tailed distribution) and the statistical cut 
off was chosen as p<0.05 (n=3, conditioned media from one cell isolate only). * 
indicates that there is a significant difference between TGFβ treatment and controls, # 
indicates a significant difference between the treatment plus TGFβ and controls plus 
TGFβ. 
 
  
 
 
 
CHAPTER 4: Mechanical load regulation of 
metalloproteinase and matrix gene expression  
 
 
4.1. INTRODUCTION 
Mechanical loading across the tendon tissue has been implicated in the development of 
tendinopathy; however the mechanism is not fully understood. Differential regulation of 
matrix proteins and metalloproteinase enzymes has been associated with tendinopathy 
(Ireland, Harrall et al. 2001; Fu, Chan et al. 2002; Riley, Curry et al. 2002; Alfredson, 
Lorentzon et al. 2003; Lo, Marchuk et al. 2004; Jones, Corps et al. 2006; Clegg, Strassburg 
et al. 2007; Jelinsky, Rodeo et al. 2011; Corps, Robinson et al. 2012) and also with 
mechanical loading (Archambault, Tsuzaki et al. 2002; Archambault, Elfervig-Wall et al. 
2002; Tsuzaki, Bynum et al. 2003; Koskinen, Heinemeier et al. 2004; Yang, Crawford et 
al. 2004; Screen, Shelton et al. 2005; Yang, Im et al. 2005; Heinemeier, Olesen et al. 2007; 
Legerlotz, Schjerling et al. 2007; Arnoczky, Lavagnino et al. 2008; Asundi and Rempel 
2008; Gardner, Arnoczky et al. 2008; Smith, Sakurai et al. 2008; Sun, Li et al. 2008; 
Maeda, Shelton et al. 2009; Szczodry, Zhang et al. 2009; Maeda, Fleischmann et al. 2010; 
Sun, Andarawis-Puri et al. 2010). Therefore we are interested in studying the effects of 
mechanical loading upon metalloproteinase expression. By further understanding this 
pathway of mechanical regulation we may begin to understand the role of mechanical load 
in tendinopathy.  
The majority of studies of the regulation of metalloproteinase and matrix genes in response 
to mechanical load in tendon mainly concern rodent tissue or cells, with a shortage of 
human studies (Archambault, Tsuzaki et al. 2002; Archambault, Elfervig-Wall et al. 2002; 
Lavagnino, Arnoczky et al. 2003; Arnoczky, Tian et al. 2004; Heinemeier, Olesen et al. 
2007; Legerlotz, Schjerling et al. 2007; Arnoczky, Lavagnino et al. 2008; Asundi and 
Chapter 4:Mechanical load regulation 
144 
 
Rempel 2008; Gardner, Arnoczky et al. 2008; Leigh, Abreu et al. 2008; Sun, Li et al. 2008; 
Maeda, Shelton et al. 2009; Maeda, Fleischmann et al. 2010; Sun, Andarawis-Puri et al. 
2010). In addition, the majority of these studies have looked at only a very limited array of 
metalloproteinase and matrix genes, mainly focussing on MMP1, MMP2, MMP3, MMP13 
and COL1A1 (Archambault, Tsuzaki et al. 2002; Archambault, Elfervig-Wall et al. 2002; 
Tsuzaki, Bynum et al. 2003; Koskinen, Heinemeier et al. 2004; Yang, Crawford et al. 
2004; Screen, Shelton et al. 2005; Yang, Im et al. 2005; Heinemeier, Olesen et al. 2007; 
Legerlotz, Schjerling et al. 2007; Arnoczky, Lavagnino et al. 2008; Asundi and Rempel 
2008; Gardner, Arnoczky et al. 2008; Smith, Sakurai et al. 2008; Sun, Li et al. 2008; 
Maeda, Shelton et al. 2009; Szczodry, Zhang et al. 2009; Maeda, Fleischmann et al. 2010; 
Sun, Andarawis-Puri et al. 2010). The aims of this study include the confirmation of 
existing evidence that shows MMP1, MMP13 and COL1A1 regulation with mechanical 
load and to look at a wider range of metalloproteinase, matrix genes, cytokines and 
transcription factors. We chose these genes on the basis of their involvement in matrix 
turnover and their regulation in tendinopathy. We hypothesise that there will be a response 
to loading in a wide range of metalloproteinase, TIMPs and matrix genes. 
Tenocytes themselves are not exposed to the same mechanical strain as the whole tendon 
fascicle due to: fibre alignment, muscle rotation, straightening of the crimp and fibril 
elongation (Purslow, Wess et al. 1998; Puxkandl, Zizak et al. 2002; Riley 2004; Screen, 
Lee et al. 2004). The level of strain transmitted to tenocytes ex vivo in tendon fascicles is 
<2% (Screen, Lee et al. 2004). Screen et al reported that rat tendon fascicles were 
elongated to between 6-13% in rat tail tendon fascicles cause irreversible damage (Screen, 
Lee et al. 2004). Therefore this is equivalent to 0.12-0.26% elongation of the cells in the 
fascicle. One issue about some of the existing studies of tendon mechanical loading is that 
the strain used is larger than the predicted level of physiologically relevant strain; in vitro 
cell studies using strain levels as high as 8% strain which is much greater than in tissue 
studies where irreversible damage has been observed (Lavagnino, Arnoczky et al. 2003; 
Screen, Lee et al. 2004). For example Wang et al seeded cells directly on a silicone 
membrane before exposing them to 4 and 8% elongation (Yang, Im et al. 2005), as the 
cells are in direct contact with the silicone membrane they are exposed to this load in its 
entirety.  
Here we are interested in investigating moderately high levels of physiologically relevant 
strain; therefore we have chosen 5% strain. Although it is difficult to determine the actual 
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load that human tenocytes undergo within the tendon matrix due to lack of human studies 
in this area, this is our best educated guess, taking into account data from rat tendon studies 
described above. One of the aims of this study is to determine the effects of moderately 
high mechanical load upon tenocytes and to measure these effects by mRNA analysis of 
metalloproteinase and matrix genes.  
Previous studies have shown that cell-cell contact may play an important role in the cells 
ability to perceive mechanical load (Wall and Banes 2005). As we have discussed in the 
introduction, GAP junctions and integrins form links between cells and between cells and 
their environment. Evidence in the literature supports the role of these molecules in the 
perception of load  (Arnoczky, Lavagnino et al. 2008). Here we aimed to compare two cell 
densities, a lower and a higher cell density; the latter would show increased cellular 
proximity and therefore increased cellular interaction, with the opposite effect in low cell 
density cultures. We hypothesise that a decreased level of cellular interaction will result in 
a reduced response to mechanical loading and vice versa. 
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4.2. METHODS 
Analysis of gene expression with mechanical load: Tenocytes derived from 
tendinopathic, normal or ruptured tendon were seeded in type I collagen into Flexcell™ 
tissue train plates and loaded at 1Hz at 5% strain for a range of time points; 2, 4, 8, 24 and 
48 hours at either 0.5 x 10
6
 or 1.5 x 10
6
 cells/ml. Gels were dissolved in Trizol and RNA 
was extracted using the tri-spin method essentially as described elsewhere (Ireland, Harrall 
et al. 2001). RNA was quantitated, reverse transcribed and analysed via qRT-PCR 
(Taqman) for a range of metalloproteinase and matrix genes (see table 2.1 in methods 
section). Data was normalised to the housekeeping gene TOP1 and expressed as the 2
∆∆Ct
.  
Statistical analysis was performed using the Wilcoxon signed rank test after a normality 
test (Shapiro Wilk W) confirmed the distribution was not normal. For full details see 
methods section 2.2 and 2.3. 
Taqman low density array (TLDA) analysis: Due to the more robust response in 
cultures seeded at the higher cell density tenocytes were seeded at 1.5 x 10
6 
cells/ml in type 
I rat tail collagen (1mg/ml) were plated into Flexcell™ tissue train plates and uniaxially 
strained at 5% at 1Hz for up to 48 hours (Metalloproteinase and TIMP family analysis 
focused on 24 and 48 hours, whereas Time course analysis of selected genes looked at a 
time course of  2, 4, 8, 24 and 48 hours). Gels were harvested in Trizol and RNA extracted 
using the tri-spin method essentially as described elsewhere (Ireland, Harrall et al. 2001). 
RNA was quantitated, reverse transcribed and analysed using TLDA qRT-PCR. 
Metalloproteinase and TIMP family analysis focused 19 ADAMTS genes, all 23 MMP 
genes and all 4 TIMP genes.  Genes were selected for analysis on the time course TLDA 
on the basis of robust response in the metalloproteinase and TIMP family TLDA (see table 
2.2 and 2.3 in methods section for a full list of the genes analysed).  
Data was normalised to 18s and expressed as the 2
∆∆Ct
. Statistical analysis was performed 
using the Student’s t test (two tailed distribution, paired t test), as there were only 3 repeats 
we were unable to confirm whether these data were normally distributed and non-
parametric tests are not suitable for n=3. For full details see methods section 2.3.4. For the 
TLDA analysis TOP1 was not available for analysis. However, when using standard qRT-
PCR, there was very little difference in data normalised to TOP1 and 18s. 
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Gelatin Zymography – MMP2 detection: Conditioned medium was collected and loaded 
onto gelatin-containing SDS-PAGE gels essentially as described by Clarke et al (Clark, 
Young et al. 2010). Gels were incubated overnight at 37°C in order to allow MMP activity 
to degrade the gelatin and stained using Coomassie Brilliant Blue R. Gels were imaged 
using the Licor Odyssey imaging system. Relative Quantification was calculated using 
Image J software. Due to the overexposure of recombinant MMP2 samples data was 
expressed as a percentage of proMMP2 (unprocessed / inactive) at 48 hours non-strain. 
Statistical analysis was performed using the Student’s t test (2 way, paired t test) as we 
determined these data were normally distributed using the Shapiro Wilk normality test.  
For full details see methods section 2.4.4. 
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4.3. RESULTS 
 
4.3.1. Cell-density dependant changes 
There were significant decreases in the mRNA  levels in MMP1 (3.2 fold), MMP2 (1.5 
fold), MMP3 (1.38 fold), MMP13 (2.3 fold) and Fibulin-1 (2.3 fold) in response to 48 
hours cyclical mechanical load in collagen gels seeded with 1.5 x 10
6
 cells/ml (4.1). At the 
lower cell density only MMP13 (1.4 fold) showed significant changes, in which case the 
response was less marked than in cultures seeded at the higher cell density.  
There were significant increases in ADAM12 (2.1 fold), COL1A1 (1.8 fold) and Elastin 
(3.8 fold) in response to mechanical load at 24 hours in cells seeded at the higher cell 
density (See figure 4.1). At 48 hours Elastin (12.4 fold) also showed a significant response 
to load in cells cultures seeded at the higher cell density. No significant changes were seen 
at the lower cell density. 
Generally responses were less variable at the higher cell density compared to those seeded 
at the low cell density. Some early responses were evident in cultures seeded at the lower 
cell density that were not present in cultures seeded at the high cell density. MMP2 (1.6 
fold) was increased with load at 2 hours and MMP13 was increased with load at both 2 and 
4 hours (1.9 fold and 2.2 fold). For a summary table showing statistical p values see table 
4.1. 
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Figure 4.1. Cell-density dependant changes in metalloproteinase and matrix gene 
expression over a time course. Cells were seeded in type I collagen at either 0.5 or 1.5 x 
10
6
 cells/ml into Flexcell™ tissue train plates and subjected to 0-48 hours of strain at 5% at 
1Hz.  mRNA of a number of key metalloproteinase and matrix genes was measured using 
standard qRT-PCR. Data was normalised to TOP1 and presented as a mean (n≥6, ± SE) 
fold change with strain (2
∆∆Ct
). The Wilcoxon signed rank test was used to test statistical 
significance (p<0.05). Significant changes in expression is denoted by * for samples 
seeded at 0.5 x 10
6
 cells/ml or # for samples seeded at 1.5 x 10
6
 cells/ml.  
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Table 4.1. Fold change (A) and Statistical significance (B) values for 
the cell density dependant comparison. Cells were seeded in type I 
collagen at either 0.5 or 1.5 x 10
6
 cells/ml into Flexcell tissue train plates 
and subjected to 0-48 hours of strain at 5% at 1Hz. mRNA of a selection 
of metalloproteinase and matrix genes were measured using standard 
qRT-PCR. The Wilcoxon signed rank test was used to test statistical 
significance, the chosen cut off for significance was p=0.05. Values 
highlighted in grey were below p=0.05 and therefore significant. P 
values printed in white font and highlighted in darker grey were <0.01 
and therefore significant. (n≥6). 
 
B A Fold change Statistical significance 
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4.3.2. Metalloproteinase family and TIMP family analysis 
The expression of 18 ADAMTS genes, all 23 MMP genes and all 4 TIMP genes were 
analysed in samples treated with or without strain at 24 and 48 hours. Of the 18 ADAMTS 
genes and 23 MMP genes ADAMTS8, ADAMTS15, ADAMTS18, ADMATS19, MMP12, 
MMP20, MMP21, MMP25, MMP26 and MMP28 were not detected (Average Ct>37). 
Genes with low expression (Ct between 35 and 37) included ADAMTS9, ADAMTS16 and 
ADAMTS17, MMP1, MMP3, MMP7, MMP8, MMP10, MMP15, MMP24 and MMP28.  
The following genes showed a significant increase after 24 hours mechanical strain: 
ADAMTS2 (2.5 fold), ADAMTS4 (3.2 fold), ADAMTS6 (3.6 fold), ADAMTS14 (3 fold), 
ADAMTS16 (25.6 fold), MMP10 (53.5 fold), MMP24 (5.2 fold) and TIMP3 (4.6 fold) 
(Fig. 1.2). At 48 hours the following genes were increased; ADAMTS2 (2 fold), 
ADAMTS4 (7.1 fold), ADAMTS10 (2.6 fold), ADAMTS16 (24.1 fold), MMP24 (35.2 
fold) and TIMP3 (5.3 fold). At 48 hours there was a decrease with strain in MMP3 (33.3 
fold), MMP10 (4 fold), MMP11 (1.6 fold) and MMP17 (2 fold) (For statistical or fold 
changes see table 4.2). 
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Figure 4.2. Metalloproteinase and TIMP family expression in response to 
mechanical load: TLDA analysis at 24 and 48 hours. Cells were seeded in type I 
collagen at 1.5 x 10
6
 cells/ml into Flexcell tissue train plates and subjected to 24 and 48 
hours of strain at 5% at 1Hz. mRNA analysis of ADAMTS (A), MMP (B) and TIMP 
(C) genes was measured using TLDA qRT-PCR. The grey bars represent 24 hour and 
black bars represent 48 hour time points.  Data was normalised to 18s and presented as 
a mean (n=3, ± SE) fold change with strain (2∆∆Ct). Significance is denoted by * 
according to the paired t test (2 way) (p<0.05). 
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Table 4.2.  Fold change and statistical significance values for Metalloproteinase and 
TIMP family analysis. Cells were seeded in type I collagen at 1.5 x 10
6
 cells/ml into 
Flexcell tissue train plates and subjected to 24 and 48 hours of strain at 5% at 1Hz. mRNA 
analysis of a selection of metalloproteinase and TIMP genes were measured using TLDA 
qRT-PCR (n=3). Genes highlighted in grey have an average Ct of >35. Values highlighted 
in red indicate that there is a significant change and p<0.05. 
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4.3.3. Time course analysis of selected genes 
Time course analysis included time points 2, 4, 8, 24 and 48 hours and a select number of 
metalloproteinase genes selected on the basis of responses seen at 24 and 48 hours in the 
previous TLDA as well as a range of matrix genes, cytokines and tendon markers,. Of 
these genes MMP8, ADAMTS16, COL2A1, Tenomodulin, IL1β, IL4, IL17, TNF and 
metabotropic glutamate receptor (GRM) 5 and GRM6 were not sufficiently detected. 
MMP3 had low expression across the range of conditions (Ct>35). 
There were no significant changes in collagen expression. Of the proteoglycans 
investigated, Aggrecan was decreased with loading at 4 hours (1.4 fold) (Fig 4.4). Decorin 
was decreased with strain at 2 hours (1.3 fold). Lumican was decreased significantly with 
strain at 48 hours (1.4 fold). Versican showed a similar pattern of regulation to decorin and 
was decreased with strain at 8 hours (1.2 fold, p=0.004), but this decrease was not 
maintained. Thrombospondin-1 was increased with strain at 24 hours (p=0.045).  
ADAMTS genes selected for TLDA analysis were ADAMTS4, ADAMTS5, ADAMTS6 
and ADAMTS10 as they showed some of the most robust changes seen in the 
metalloproteinase and TIMP TLDA in terms of ADAMTS genes. ADAMTS10 was the 
only ADAMTS to be significantly increased with strain (2.8 fold) at 24 hours (Fig 4.5).  
MMP1, MMP2, MMP3, MMP8, MMP10 and MMP13 were selected for analysis of the 
time course experiments due to interesting responses at 24 and 48 hours in the 
metalloproteinase and TIMP TLDA. MMP2 was significantly decreased with mechanical 
load (1.3 fold) at 48 hours (Fig 4.5). MMP10 was not significantly regulated by strain at 48 
hours; however there was a significant increase at 2 hours of strain (1.16 fold). 
Of the four TIMPs; TIMP1, TIMP2 and TIMP3 were chosen for analysis. TIMP4 was 
omitted on the grounds that we were unable to consistently measure TIMP4 response to 
strain using standard qRT-PCR. TIMP1 and TIMP2 were not significantly regulated with 
mechanical load (Fig 4.5). TIMP3 was significantly increased with strain (5.9 fold) at 48 
hours. 
Cytokines and cytokine receptors often associated with tendinopathy were selected, these 
included IL6, IL6R, IGF, COX2, TGFβ and CTGF. IL6R was significantly decreased at 2 
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(1.28 fold) and 48 (4.2 fold) hours with strain. IGF1 was significantly increased with strain 
(2.3 fold) at 24 hours. There was no significant change in CTGF, COX2 or TGFβ.  
Despite the lack of true ‘markers’ of tendon phenotype, genes indicative of tendon cell 
phenotype were selected to identify whether cells had deviated from the tendon phenotype, 
these were tenomodulin, scleraxis and SOX9. However we were unable to detect 
tenomodulin in any of our samples.  There were no significant changes in Scleraxis or 
SOX9. Fold changes and statistical p values for all genes in the metalloproteinase and 
TIMP family TLDA are shown in tables 4.3 and 4.4. 
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Figure 4.3. Regulation of Collagen expression with mechanical loading: TLDA time 
course 0-48 hours. TLDA analysis of cells seeded at 1.5 x 10
6
 cells/ml in type I rat tail 
collagen at 1 mg/ml after 5% cyclic strain over a time course of 0-48 hours. COL1A1 
(A), COL3A1 (B), COL12A1 (C) and COL14A1 (D) were analysed using TLDA. Data 
was normalised to 18s and presented as a mean (n=3, ± SE) fold change with strain 
(2
∆∆Ct
). Statistical analysis was performed using the Student’s t-test (2 way, paired). 
Significance is denoted as * (p=0.05).  
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Figure 4.4.  Regulation of Matrix gene expression with mechanical loading: Time 
course TLDA 0-48 hours. TLDA analysis of cells seeded at 1.5 x 10
6
 cells/ml in type 
I rat tail collagen at 1 mg/ml after 5% cyclic strain over a time course of 0-48 hours. 
Aggrecan (A), Biglycan (B), Lumican (C), Versican (D), Decorin (E), Fibrillin-1 (F), 
COMP (G), Fibronectin (H), Link protein (I), Tenascin-C (J) and Thrombospondin-1 
(K) were measured using TLDA. Data was normalised to 18s and presented as a mean 
(n=3, ± SE) fold change with strain (2∆∆Ct). Statistical analysis was performed using the 
Student’s t-test (2 way, paired). Significance is denoted as * (p=0.05). 
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Figure 4.5. Regulation of metalloproteinases with mechanical loading: Time course 
TLDA 0-48 hours. TLDA analysis of cells seeded at 1.5 x 10
6
 cells/ml in type I rat tail 
collagen at 1 mg/ml after 5% cyclic strain over a time course of 0-48 hours. ADAMTS4 
(A), ADAMTS5 (B), ADAMTS6 (C), ADAMTS10 (D), MMP1 (E), MMP2 (F), MMP3 
(G), MMP10 (H) MMP13 (I), TIMP1 (J), TIMP2 (K) and TIMP3 (L) were analysed 
using TLDA. Data was normalised to 18s and presented as a mean (n=3, ± SE) fold 
change with strain (2
∆∆Ct
). Statistical analysis was performed using the Student’s t-test (2 
way, paired). Significance is denoted as * (p=0.05). 
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Figure 4.6. Regulation of cytokine expression with mechanical loading: Time course 
TLDA 0-48 hours. TLDA analysis of cells seeded at 1.5 x 10
6
 cells/ml in type I rat tail 
collagen at 1 mg/ml after 5% cyclic strain over a time course of 0-48 hours. IL6 (A), IL6R 
(B), IGF1 (C), COX2 (D), CTGF (E), TGFβ1 (F) were analysed using TLDA. Data was 
normalised to 18s and presented as a mean (n=3, ± SE) fold change with strain (2∆∆Ct). 
Statistical analysis was performed using the Student’s t-test (2 way, paired). Significance 
is denoted as * (p=0.05). 
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Figure 4.7. Regulation of cell lineage ‘markers’ with mechanical loading: Time 
course TLDA 0-48 hours. TLDA analysis of cells seeded at 1.5 x 10
6
 cells/ml in type I 
rat tail collagen at 1 mg/ml after 5% cyclic strain over a time course of 0-48 hours. 
Scleraxis and SOX9 were measured using TLDA. Data was normalised to 18s and 
presented as a mean (n=3, ± SE) fold change with strain (2∆∆Ct). Statistical analysis was 
performed using the Student’s t-test (2 way, paired). Significance is denoted as * 
(p=0.05). 
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  Table 4.3.  Fold change values for Time course for selected gene analysis. Cells 
were seeded in type I collagen at 1.5 x 10
6
 cells/ml into Flexcell tissue train plates 
and subjected to 0-48 hours of strain at 5% at 1Hz. mRNA analysis of a selection of 
metalloproteinase and matrix genes were measured using TLDA qRT-PCR (n=3). 
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Table 4.4.  Statistical significance values for Time course of selected genes 
TLDA. Cells were seeded in type I collagen at 1.5 x 10
6
 cells/ml into Flexcell tissue 
train plates and subjected to 0- 48 hours of strain at 5% at 1Hz. mRNA analysis of a 
selection of metalloproteinase and matrix genes were measured using TLDA qRT-
PCR (n=3). Genes highlighted in grey have an average Ct of >35. Values 
highlighted in red indicate that there is a significant change and p<0.05. 
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4.3.4. Comparison of normal and pathological tenocytes 
All metalloproteinase and matrix gene responses we have mentioned above are those 
observed in cells collected from patients with Achilles tendinopathy, however, we are also 
interested in whether the same responses were seen in cells derived from patients with 
ruptured tendon or normal tendon phenotype. Single cell isolates derived from each of 
these cell lineages were compared in terms of MMP1 and MMP13 expression (Fig 4.8). 
MMP1 (14.3, 2.2 and 6.5 fold) and MMP13 (6.3, 3, 2 fold) were decreased with 
mechanical loading in all cell lineages (normal, tendinopathy and ruptured respectively) 
despite the differences in disease phenotype.(Figure 4.8).  
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  Figure 4.8. MMP1 (A) and MMP13 (B) regulation with mechanical loading in cells 
derived from normal, tendinopathic and ruptured tendon. Cells were seeded in type 
I collagen at 1.5 x 10
6
 cells/ml into Flexcell tissue train plates and subjected to 0-48 
hours of strain at 5% at 1Hz.  mRNA of MMP1 and MMP13 was measured using 
standard qRT-PCR. Data was normalised to TOP1 and presented as a fold change with 
strain (2
∆∆Ct
) (n=1). 
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4.3.5. MMP2 protein expression 
Unprocessed (72kDa) and processed (68kDa) forms of MMP2 were detectable at all time 
points (Figure 4.9). These correspond to inactive (proMMP2, 72kDa) and active forms of 
MMP2 (MMP2, 68kDa) respectively, however this assay does not confirm MMP2 activity 
of the sample outside the assay. MMP2 is increased in both processed and unprocessed 
forms during the time course; this may be due to accumulation of MMP2 in the medium 
during the time course as the medium was not replaced during this period. There is no 
difference between the level of either processed or unprocessed MMP2 between strain and 
non-strain cultures at 2, 4, 24 or 48 hours, however at 8 hours of strain there was an 
increase in the level of processed MMP2 compared to non-strained controls (1.54 fold, 
p=0.0219). We were unable to sufficiently detect either unprocessed or processed MMP9 
protein using gelatin zymography (data not shown). 
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Figure 4.9. Gelatin zymogram of MMP2 protein expression in strain conditioned 
media. Cells were seeded in type I collagen at 1.5 x 10
6
 cells/ml into Flexcell tissue 
train plates and subjected to 0-48 hours of strain at 5% at 1Hz.  Conditioned media was 
analysed using gelatin zymography. Zymograms were imaged and bands were 
quantitated using image j software. Data was expressed as a percentage of 2 hour non-
strained unprocessed MMP2 levels, the mean (± SE) of 6 separate experiments (A). 
Zymograms from 6 different cell isolates are shown (B). The 68kDa band corresponds 
to the unprocessed form of MMP2, The 72kDa band corresponds to the processed form 
of MMP2. Statistical analysis was performed using the t test (2 way, paired t test). 
Significance is denoted as * (n=6) (p=0.05). 
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4.4. DISCUSSION 
We have shown that mRNA expression of MMP1, MMP2, MMP3, MMP13 and fibulin-1 
are significantly decreased after 48 hours and ADAM12 and matrix genes COL1A1 and 
Elastin are significantly increased in response to 24 hours of 0-5% cyclic loading at 1Hz in 
tendinopathy derived tenocytes. Our results show that gene responses were more robust in 
cells seeded at the higher cell density therefore cell interactions may be involved in the 
mechanoregulation of these genes. However, more detailed study is required to confirm 
this. Using TLDA analysis of a wide range of metalloproteinase, TIMPs, cytokines, cell 
lineage markers and collagens, we can see that there is an overall increase in ADAMTS, 
tendon cell lineage markers and collagen expression, and a decrease in MMP expression at 
24 and 48 hours. There was therefore a general anabolic response to mechanical load. Our 
data indicates that not only do tendinopathy derived cells respond to mechanical loading 
but cells derived from normal and ruptured tendon also show a similar pattern of 
regulation, with normal tendon derived cells showing a more marked pattern of response in 
preliminary experiments. It is possible that cells derived from ruptured and tendinopathic 
tissues are less responsive to mechanical load. However, due to time constraints and 
relative paucity of normal tendon we were only able to repeat this experiment in one cell 
isolate. To confirm this more cell isolate repeats are required. 
Data from the TLDA experiments could not be combined with standard qRT-PCR analysis 
because the target amplicons of primers and probe sets were different on the TLDA 
compared to these used for standard qRT-PCR. The consistency in the majority of gene 
changes between standard qRT-PCR analysis and TLDA analysis with different primer and 
probe sets increases confidence in gene changes  
Some genes were analysed both by TLDA and the standard qRT-PCR analysis.  The 
majority of gene changes were consistent between TLDA and standard qRT-PCR analysis, 
however a number of changes were significant in the standard qRT-PCR analysis and not 
in TLDA analysis, for example there were significant changes in MMP1, MMP3 and 
MMP13 with mechanical load using standard qRT-PCR, however despite a trend to 
decrease these genes were not significantly regulated with mechanical load in the TLDA. 
The lack of statistical significance in the TLDA experiments compared to standard qRT-
PCR could be explained by the fact that TLDA experiments were not sufficiently powered: 
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they were only repeated 3 times compared to an n≤6 in standard qRT-PCR experiments. 
Also TLDA analysis utilises a lower level of RNA and would therefore yield more variable 
results in genes of low expression. MMP10 however was shown to increase with strain at 
24 hours the preliminary metalloproteinase and matrix gene TLDA, whereas there was no 
change in MMP10 at 24 hours in the time course TLDA. This may be due to variation in 
response according to the cell isolates studied.  
In the current study genes were chosen for analysis on the basis that they are reportedly 
modified by mechanical load or tendinopathy in some shape or form. However a number 
of genes we chose for analysis were not detected. The glutamate receptors, metabotropic 
glutamate receptor (GRM) 5 and GRM6 were measured as previous studies have shown an 
increase in glutamate in patellar tendinopathy and its association with pain (Alfredson, 
Thorsen et al. 1999; Alfredson, Forsgren et al. 2001), however neither GRM5 nor GRM6 
were sufficiently detected. This indicates that glutamate receptors are not expressed in 
passaged tenocytes, however because we did not include a positive control we cannot 
confirm this. IL4 and IL17 were also not detected. We chose to measure IL17 as it was 
decreased at the mRNA level in diseased tendon in a human study focusing on patients 
with chronic tendinopathy (Jelinsky, Rodeo et al. 2011). IL4 is implicated in the strain 
mediated regulation of MMP3 and ADAMTS4 mRNA (but not aggrecan or collagen) in 
invertebral disc annulus fibrosus cells (Gilbert, Hoyland et al. 2011). Therefore we 
measured IL4 mRNA to assess the cytokines role in tenocyte mechanotransduction. Both 
IL4 and IL17 are inflammatory cytokines, therefore we wanted to measure their response 
to mechanical loading as it remains uncertain what role inflammation plays in the 
development of tendinopathy. Due to the fact that neither IL4 nor IL17 were detectable in 
our study, it is therefore likely that cultured tenocytes do not express either of these 
proteins and that IL4 is not involved in tenocyte mechanotransduction (at least in vitro). 
TNF is an inflammatory cytokine involved in the regulation of cellular apoptosis. 
Apoptosis is reported to increase in athletes with patellar tendinopathy (Lian, Scott et al. 
2007).  TNF has been shown to increase in rotator cuff disease (Voloshin, Gelinas et al. 
2005) and also increase with stress deprivation in the patellar tendon (Uchida, Tohyama et 
al. 2005) and in rat tail tendon studies (Egerbacher, Arnoczky et al. 2008). Therefore we 
chose to measure TNF mRNA. However in our TLDA, TNF gene expression was 
undetectable. This indicates that TNF is not expressed in cultured tenocytes. 
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We are the first to study the effect of mechanical regulation on an array of protease genes 
in human tenocytes. We have chosen 5% uniaxial strain as we believe cells undergo 
similar levels of strain in vivo. Although it is extremely difficult to determine what levels 
of strain are physiologically relevant, our data shows that 5% mechanical strain has a 
potential anabolic effect on the collagenous matrix, as three collagenases (MMP1, MMP8 
and MMP13) are decreased at the mRNA level with mechanical strain, accompanied by an 
increase in COL1A1 expression. Comparing this data to other studies indicates that in the 
current study strain levels are more physiologically relevant than others using higher strain 
levels have shown a more catabolic response; i.e. an increase in MMP13 (Asundi and 
Rempel 2008; Sun, Li et al. 2008).  
The responses to strain are more robust in cultures seeded at a high cell density. This may 
be due to increases in the number of cells resulting in increased cellular proximity and 
therefore increased the level of cell-cell signalling. These data suggest that an increase in 
cell-cell communication may play a role in mechanoregulation of metalloproteinase and 
matrix protein gene expression. However to determine which molecules are involved more 
specific inhibitory experiments are required, i.e. inhibition of specific integrins and 
connexins. An early response seen in cultures at the lower cell density only, could be 
representative of a mechanism of load perception that has less requirement for cell to cell 
contact. This early response involved an increase in MMP2 and MMP13 as well as a trend 
to increase in ADAM12 and Elastin. This increase in MMP expression indicates that lack 
of cell contact may result in a modification in the response to mechanical loading; 
therefore areas of very low or high cellularity may be affected by strain differently. 
Differences in cellularity are evident in diseased tendon (Khan, Cook et al. 1999), therefore 
changes in cellular communication may play a key role in tendinopathy. 
We have described an overall anabolic response in metalloproteinase and matrix gene 
expression which indicates that there is a reduction of matrix turnover. Potential anti-
cancer drugs were trailed in the 1990’s that targeted metalloproteinase activity, these 
included doxycycline and illomastat (GM6001) (Drummond, Beckett et al. 1999; Tierney, 
Griffin et al. 1999). It became clear that these anti-cancer drugs induced side effects that 
resembled tendinopathies; therefore a certain level of metalloproteinase activity is required 
for normal tendon homeostasis. This suggests that the reduction in matrix turnover in 
response to strain may not be a positive response. In theory, the reduction in turnover in 
response to high levels of strain may induce a weakening of the tendon and potential 
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tendinopathic phenotype after prolonged exposure. However, despite the decrease in 
metalloproteinase mRNA, metalloproteinases are still expressed in strained tenocytes in 
the current study; therefore turnover can still occur. However, it still remains to be seen 
whether the level of turnover is sufficient to maintain a healthy balance.  
We have also measured the levels of proMMP2 and MMP2 protein expression in response 
to mechanical load; we showed a 1.5 fold increase in active MMP2 after 8 hours of strain 
compared to non-strained controls. Both proMMP2 and MMP2 were increased over the 
time course peaking at 48 hours and at 48 hours there was no difference between strained 
and non-strained cultures in terms of MMP2. This indicates that despite the reduction in 
MMP2 mRNA expression we still see increased levels of gelatinase activity and therefore 
matrix turnover may be maintained. The mechanism of strain induced activation of MMP2 
at 8 hours is unknown, however MMP24 which is stimulated at 24 and 48 hours with strain 
in the current study, may be involved as it plays a role in the activation of proMMP2 
(Visse and Nagase 2003). To confirm this mRNA and protein analysis of MMP24 would 
be required at a time point that precedes the activation in MMP2 in response to load. A 
limitation of this study is the lack of protein data. We were unable to measure the protein 
expression of other MMPs due to the low levels of detection in both strained and non-
strained samples without cytokine stimulation (using western blotting techniques). 
Measurement of collagen degradation (using the Hydroxyproline assay or running protein 
extracts on a SDS-PAGE gel to assess collagen breakdown), metalloproteinase protein 
(using specific ELISAs)  and activity of metalloproteinases (specific fluorescent substrates) 
would be the next step in understanding the level of turnover that is occurring in response 
to load.  
There have been a number of studies that have looked at the effects of mechanical strain on 
MMPs, mainly in rodent tendon in vivo, ex vivo or in vitro cell studies. Obvious 
limitations of these studies include the differences in species as rodents do not express 
MMP1; instead they only express MMP13, which is the nearest homologue. In some 
studies 2D models lack the cell-matrix contact that is so obviously important in the 3D 
matrix seen in vivo. Moderate levels of strain are considered to be <6% (Lavagnino, 
Arnoczky et al. 2003; Screen, Lee et al. 2004), Studies focusing on a similar regime are 
reported to have an anabolic effect upon the tendon, consistent with the current study. For 
example in rabbit flexor tendon studies MMP3 was decreased with ≤4MPa (Asundi and 
Rempel 2008) and rat tail tendon studies ex vivo and in vitro have revealed a decrease in 
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MMP13 following 1% cyclic strain (Arnoczky, Lavagnino et al. 2008) or 3% cyclic strain 
superimposed on a static strain of 2% (Maeda, Fleischmann et al. 2010). Similarly static or 
cyclic loading at loads of up to 2.6MPa (Arnoczky, Tian et al. 2004) or 6% cyclic load (up 
to 1Hz) (Lavagnino, Arnoczky et al. 2003) have been reported to down-regulate MMP13 
(MMP1 homologue) mRNA in rat tail tendon fascicles after 24 hours. Sun and colleagues 
have cyclically loaded (1Hz) rat patella tendons in vivo and cells in vitro, and in both 
instances observed a decrease in MMP13 (mRNA and protein) with load; cells at <5MPa 
or tendon until 0.6% elongation (Sun, Li et al. 2008). However, a number of rodent tendon 
in vivo and in vitro studies have shown no significant change in MMP3 or MMP13 mRNA 
upon moderate loading (Archambault, Tsuzaki et al. 2002; Asundi and Rempel 2008; 
Asundi and Rempel 2008; Maeda, Fleischmann et al. 2010), this may be due to a lower 
frequency in strain (<0.5Hz) or the reduced loading time. This is consistent with our data 
as MMP1, MMP3 and MMP13 are not significantly regulated by strain until 48 hours.  
At higher strain levels (more than 1.7% tendon elongation or 4-7.5MPa in the rat) in both 
in vivo and in vitro tendon MMP13 mRNA was significantly increased (Asundi and 
Rempel 2008; Sun, Li et al. 2008). Koskinen and colleagues have shown a decrease in 
proMMP2 protein immediately after exercise and an increase after 3 days in human 
runners peritendinous tissue dialysate (Koskinen, Heinemeier et al. 2004). In addition a rat 
in vivo study showed an increase in MMP2 mRNA with different strain regimes via sciatic 
nerve stimulation (Heinemeier, Olesen et al. 2007). This data is not entirely in agreement 
with our studies in terms of MMP2 and MMP13 mRNA regulation with strain, although 
we do show an increase in active MMP2 protein after 8 hours of strain.  Again these 
differences could be due to the higher stress regimes; this indicates that high levels of 
strain have a more catabolic effect.  
Interestingly Maeda et al showed an initial increase in MMP3 and MMP13 mRNA (after 
10 minutes)  followed by a progressive decrease until 24 hours in a 3% cyclic strain regime 
superimposed on a static strain of 2% in rat tendon fascicles (Maeda, Shelton et al. 2009). 
Our data shows a trend to increase in MMP3 at 4 hours which progressively decreases until 
48 hours (however this was not the case with MMP13). Maeda and colleagues showed a 
decrease in MMP9 and MMP14 after 24 hours of mechanical load (Maeda, Fleischmann et 
al. 2010), the current study showed a small decrease in MMP9 but no change in MMP14 
after 24 hours strain. These differences could be due to the difference in species (rat 
tendon) and the different strain regime (3% strain superimposed on a 2% static strain). 
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Strain regulation of other MMPs in tendon is not well published. In our TLDA screen 
regulation of MMP10 and MMP24 with mechanical strain was highlighted, which has not 
previously been reported in tendon.  
An ovine tendon model reported decreased ADAMTS4 mRNA in overstrained areas of 
infraspinatus tendon (due to partial width laceration) (Smith, Sakurai et al. 2008). We 
report that ADAMTS4 mRNA is increased with strain. The difference in regulation may 
well be due to the less damaging loading applied in this study. ADAMTS1 and ADAMTS5 
were reported to decrease after 24 hours of 3% cyclic strain superimposed on a static 2% 
load in a study on rat tail tendon fascicles (Maeda, Fleischmann et al. 2010). Our array data 
shows agreement in terms of ADAMTS1 expression; however ADAMTS5 shows the 
opposite effect. This may be due to the underlying static loads or may relate to the 
difference in species.  
TIMPs 1 and 2 have been shown to increase with mechanical strain in rat tendon at the 
protein and mRNA level, with TIMP1 mRNA regulation reaching a 6 fold increase 
(Heinemeier, Olesen et al. 2007; Legerlotz, Schjerling et al. 2007). We have not observed 
changes in either TIMP1 or TIMP2, but showed an increase in TIMP3 with strain in the 
current study, again this could be due to differences in the loading regime. TIMP3 is 
reported to inhibit the activity of ADAM12 (Loechel, Fox et al. 2000), therefore the 
induction of TIMP3 may be enough to abrogate the activity of ADAM12 despite the fact 
that ADAM12 is also induced with mechanical loading. TIMP3 has also been reported to 
cause inhibition of MMP1, MMP2, MMP3, ADAMTS4 and ADAMTS5 at the protein 
level (Kashiwagi, Tortorella et al. 2001; Visse and Nagase 2003). This indicates that strain 
has a potential protective effect on not only collagen but also proteoglycan due the 
inhibitory effects of TIMP3 upon ADAMTS4 and ADAMTS5 (Kashiwagi, Tortorella et al. 
2001), at the protein level. As ADAMTS4 and ADAMTS5 are the primary aggrecan 
degrading enzymes (Gendron, Kashiwagi et al. 2007), this may involve a reduction in the 
level of aggrecan degradation. ADAMTS1 and ADAMTS15 also possess aggrecanase 
activity (Porter, Clark et al. 2005), and as ADAMTS15 mRNA was undetected in our cells 
and ADAMTS1 mRNA was decreased in response to loading we can assume that 
mechanical loading may reduce the level of aggrecan degradation, indicative of adaption to 
compressive loading. ADAMTS2 and ADAMTS14 are involved in collagen processing 
(Colige, Beschin et al. 1995; Colige, Li et al. 1997; Fernandes, Hirohata et al. 2001; Wang, 
Lee et al. 2003), as COL1A1, ADAMTS2 and ADAMTS14 are increased at the mRNA 
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level in response to load this indicates that collagen production and processing may occur 
in response to load. However to confirm this more detailed protein analysis is required. 
Mechanical strain has also been shown to increase collagen type I and III protein and 
overall collagen content in vivo, ex vivo and in vitro tendon studies (mainly in the rat) 
(Yang, Crawford et al. 2004; Screen, Shelton et al. 2005; Heinemeier, Olesen et al. 2007; 
Maeda, Shelton et al. 2009; Szczodry, Zhang et al. 2009), the current study shows 
regulation of collagen type I but little regulation in terms of collagen III, another rat study 
showed agreement with our data as they showed that there was no change in collagen type 
III with mechanical load (Legerlotz, Schjerling et al. 2007). Proteoglycan regulation has 
also been reported in a rat tail tendon model. After a cyclic loading regime of 3% 
overlaying a 2% static strain for 24 hours decorin, fibronectin and biglycan mRNA was 
decreased, increased and unchanged respectively (Maeda, Shelton et al. 2009; Maeda, 
Fleischmann et al. 2010). We have shown a similar pattern of regulation (although not 
significant) in decorin and fibronectin. However we showed a small trend to increase in 
biglycan at 48 hours, although this regulation is not significant, it is opposite to changes 
reported by Maeda. Again this is likely to be due to differences in species and loading 
regime.  
Decorin is the most abundant proteoglycan in tendon (Vogel and Heinegard 1985), 
however with load mRNA expression is decreased. In addition aggrecan, which is 
expressed throughout the tendon (Samiric, Ilic et al. 2004), although most predominantly 
in compressed regions of tendon (Vogel and Koob 1989), shows a trend to increase at the 
mRNA level. This potentially indicates compressive forces are present as well as tensional 
forces although aggrecan is also stimulated by growth factors TGFβ (Robbins, Evanko et 
al. 1997). Despite the increase in COL1A1 mRNA expression, decorin and COL3A1 
mRNA are decreased and unchanged respectively in response to mechanical load. Decorin 
and COL1A1 protein products are involved in type I collagen deposition (Thieszen and 
Rosenquist 1995; Hakkinen, Strassburger et al. 2000). This indicates that collagen 
deposition may not occur efficiently despite the increase in collagen type I mRNA 
expression, to confirm this levels of decorin and collagen should be quantitated at the 
protein level. 
Relatively few studies have looked at cytokine regulation in response to mechanical strain. 
Rat tendon study of a 3% cyclic strain overlaying a 2% static strain showed an significant 
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increase in COX2 after 24 hours, they also looked at IL6 and IGF1 however these genes 
were not significantly regulated (Maeda, Fleischmann et al. 2010). IL6 protein was 
increased in humans after prolonged running exercise (36km) (Langberg, Olesen et al. 
2002). In addition a bovine study of fatigue cyclic loading (30% elongation at 1Hz) 
reported an increase in IL6 mRNA and decrease in IL6R mRNA (IL6R response in 
GAPDH normalised data only)(Legerlotz, Jones et al. 2011), no other published studies 
have looked at IL6R expression in response to mechanical loading. Studies of rabbit and 
human patella fibroblast also showed an increase in COX2 (2 fold) with 20h 6MPa static 
strain (Asundi and Rempel 2008) or after 4 hours of 4% cyclic strain at 0.5Hz (Yang, Im et 
al. 2005) respectively. Immunohistochemical analysis showed that IGF1 protein was 
markedly increased with mechanical loading after twelve weeks of treadmill exercise in a 
rat model (Scott, Cook et al. 2007). The current study shows a trend to increase in COX2 
and IL6 and a significant increase in IGF1 after 24 hours of cyclic loading analogous to 
many of the changes described above.  Lack of gene responses (IL6 and IGF1) in some 
studies could be due to differences in species or load regime.  
TGFβ mRNA and protein expression is increased in response to mechanical loading in a 
number of studies in both rat tendon and human patellar fibroblasts (Skutek, van Griensven 
et al. 2001; Yang, Crawford et al. 2004; Heinemeier, Olesen et al. 2007; Maeda, Shelton et 
al. 2009; Maeda, Fleischmann et al. 2010), however in a rat wheel running study they did 
not show any change in expression (Legerlotz, Schjerling et al. 2007). In the current study 
we do not show a significant increase in TGFβ mRNA, however there is a very small trend 
to increase after 24 hours cyclic strain. We have shown an increase in CTGF of 36.27 fold 
after 24 hours of cyclic loading, although this was not significant. A number of rat studies 
have looked at the effects of mechanical loading on the expression of CTGF; however 
none of these studies have shown any significant change (Heinemeier, Olesen et al. 2007; 
Legerlotz, Schjerling et al. 2007; Maeda, Fleischmann et al. 2010). This difference in 
response may be due to differences in species and differences in load regime. In fibroblasts 
CTGF is thought to act as a downstream mediator of TGFβ (Grotendorst 1997); therefore 
TGFβ may induce the increase in CTGF seen in response to mechanical load. However, 
this has not been confirmed in the current study. 
Rodent tissue studies have also measured IL1β in response to mechanical load, a rat in vivo 
model showed that a 1.7% cyclic load caused an increase in IL1β, however a 0.6% cyclic 
load decreased IL1β (Sun, Li et al. 2008), in rabbit flexor tendon tissue strained at 4MPa 
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for 20 hours IL1 β was decreased 2 fold  (Asundi and Rempel 2008). IL1 stimulates MMP 
expression (Nagase and Woessner 1999) and as MMP expression is decreased in response 
to load we can only assume that IL1 is not increased and may be decreased in response to 
load. As we were unable to detect IL1β using the TLDA we cannot confirm that IL1β was 
regulated with 5% cyclic strain, however we cannot confirm that IL1β is not expressed in 
our cultures. This may have been due to defective primers and probe, further standard 
qRT-PCR with validated primers and probes is required. 
Few studies have measured the regulation of genes indicative of tendon phenotype in 
response to mechanical load. Scleraxis was increased with both cyclic and static loading 
regimes in multipotent stem cells (Scott, Danielson et al. 2011), this indicates that with 
mechanical load stem cells may become more tendon like. We have also shown a trend to 
increase in scleraxis expression in response to mechanical loading. Although we do not 
have true markers of tendon phenotype, this indicates that mechanical load may maintain 
the tendon phenotype. Tenascin C, another ‘marker’ of tendon, was increased in response 
to a compressive loading (Martin, Mehr et al. 2003), here we observe a trend to increase in 
tenascin C expression after 24 hours of cyclic loading. This indicates that cells may 
undergo compressive loading as well as tensile strain, as tenascin-C is thought to be up-
regulated with compressive load (Martin, Mehr et al. 2003). 
No other published studies have looked into the mechanical regulation of the ADAMs, 
TIMPs 3 and 4 and such a large array of ADAMTS and matrix proteins at either the 
mRNA or protein level in human tendon. Our data suggests that generally there is a 
decrease in MMPs (MMP1, -2, -3, -8, -10, -11, -13 and -17) and an increase in collagen at 
the mRNA level. We have also shown an increase in TIMP3 mRNA which is known to 
inhibit MMP2 activity (Kashiwagi, Tortorella et al. 2001). An increase in MMP2 after 8 
hours in the current study is therefore likely to be inhibited by TIMP3. Although to 
confirm this TIMP3 protein quantification and activity (achievable by reverse 
zymography) measurement is required. This supports earlier reports that moderate cyclic 
strain is largely anabolic, i.e. maintaining the collagen components of the ECM. 
Arnoczky’s group has shown that mechanical strain is important in tendon ECM 
homeostasis in that MMPs are increased with the absence of tension (Lavagnino, Arnoczky 
et al. 2003; Arnoczky, Tian et al. 2004; Arnoczky, Lavagnino et al. 2008; Gardner, 
Arnoczky et al. 2008), data from Smith et al also support this (Smith, Sakurai et al. 2008). 
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In addition Arnoczky’s group have proposed that as stress deprivation caused by isolated 
tendon fibre damage due to fatigue loading, may be the key factor in causing tendinopathy 
as opposed to the overall increased mechanical load of the tendon. They argue that load 
induced tendon catabolism requires a level of strain that does not occur in the tendon in 
vivo (Arnoczky, Lavagnino et al. 2007). In the current study we have shown little evidence 
of load inducing catabolic effects, hence our data support Arnoczky’s ideas. Therefore it is 
important for us to fully elucidate the process of mechanotransduction to truly understand 
the underlying factors contributing to tendinopathy development.  
Comparing the responses of metalloproteinase and matrix genes to strain and changes in 
human tendinopathy may shed light on the relationship between mechanical loading and 
tendinopathy development. MMP3 and MMP2 expression shows a significant decrease in 
ruptured and dysfunctional tendon at the mRNA and protein level (Ireland, Harrall et al. 
2001; Riley, Curry et al. 2002; Alfredson, Lorentzon et al. 2003; Lo, Marchuk et al. 2004; 
Jones, Corps et al. 2006). This correlates with the decreases we have observed in MMP2 
and MMP3 regulation with mechanical strain in this study. However, in chronic 
tendinopathy and dysfunctional posterior tibialis tendon MMP2 was increased, which 
differs to our response seen with strain (Alfredson, Lorentzon et al. 2003; Jelinsky, Rodeo 
et al. 2011; Corps, Robinson et al. 2012). MMP8 expression was unchanged in 
tendinopathy (Jones, Corps et al. 2006) whereas we showed a trend to decrease with strain. 
In addition MMP1 (tendinosis or ruptured tendon), MMP13 (acute tendinopathy, 
dysfunctional or ruptured tendon) and MMP10 (painful tendinopathy) have been reported 
to increase, increase and decrease respectively (Fu, Chan et al. 2002; Riley, Curry et al. 
2002; Lo, Marchuk et al. 2004; Jones, Corps et al. 2006; Clegg, Strassburg et al. 2007; 
Corps, Robinson et al. 2012). These changes are opposite to that seen in our study, as we 
see a decrease in MMP1 and MMP13. In another study MMP1 and MMP13 mRNA were 
undetectable in tendinopathic tissue (Jelinsky, Rodeo et al. 2011). These similarities and 
discrepancies in terms of RNA responses in tendinopathic phenotype and strain regulation 
may indicate that tendon disease may be a result of a complex set of causative factors as 
well as increased loading.  
 ADAMTS4 and ADAM12 have been reported to increase in ruptured tendon (Jones, 
Corps et al. 2006; Corps, Jones et al. 2008; Jelinsky, Rodeo et al. 2011; Corps, Robinson et 
al. 2012), An increase in ADAMTS5 is also reported in dysfunctional posterior tibialis 
tendon (Corps, Robinson et al. 2012), which draws a parallel with our strain data. 
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However, Jelinsky et al reported no significant change in ADAMTS genes in chronic 
tendinopathy (Jelinsky, Rodeo et al. 2011). Another study reported ADAMTS2, 
ADAMTS3 and ADAMTS5 were increased, increased and decreased respectively in 
painful tendon (Jones, Corps et al. 2006). ADAMTS4, ADAMTS7 and ADAMTS13 were 
increased, decreased and decreased respectively in ruptured tendon (Jones, Corps et al. 
2006). We observed similar responses with strain in ADAMTS2 and ADAMTS4 but 
opposite effects in ADAMTS3, ADAMTS5, ADAMTS7 and ADAMTS13. We have 
shown an increase in ADAMTS10, ADAMTS14 and ADAMTS16, these were not 
regulated in either ruptured or painful tendon (Jones, Corps et al. 2006). We have shown an 
overall increase in ADAMTS mRNA expression with strain, however several ADAMTS 
genes were decreased in tendinopathy, again this indicates that the disease phenotype 
involves a complex set of causative factors, mechanical loading being one of them. TIMP3 
expression at the mRNA level is lowered in both painful and ruptured tendon (Ireland, 
Harrall et al. 2001; Jones, Corps et al. 2006; Clegg, Strassburg et al. 2007). Here we show 
that TIMP3 is increased with strain, indicating a more anabolic phenotype compared to the 
disease state. 
Both painful and ruptured Achilles tendon mRNA expression analysis showed decreased 
expression of the proteoglycan versican (Corps, Robinson et al. 2004; Karousou, Ronga et 
al. 2008), another study has shown an increase in expression of versican in Achilles 
tendinopathy (Ireland, Harrall et al. 2001). In painful and ruptured tendon increased 
aggrecan and biglycan mRNA is seen (Ireland, Harrall et al. 2001; Corps, Robinson et al. 
2006; Clegg, Strassburg et al. 2007; Corps, Robinson et al. 2012). In chronic tendinosis or 
ruptured tendons a decrease (Alfredson, Lorentzon et al. 2003; Corps, Robinson et al. 
2006) and an increase in ruptured tendon (Karousou, Ronga et al. 2008) have been reported 
in decorin mRNA. In the present study versican showed the opposite response to that seen 
in painful and ruptured Achilles tendon.  However similar results were seen with loading 
compared to tendinopathy in aggrecan and biglycan, although changes were less marked 
and close to the cut off for significance. Collagen type I, type II and other glycoproteins 
such as fibronectin, and fibrillin were reported to increase in ruptured tendon and 
tendinopathies (Ireland, Harrall et al. 2001; Karousou, Ronga et al. 2008; Jelinsky, Rodeo 
et al. 2011; Corps, Robinson et al. 2012; Legerlotz, Jones et al. 2012), this is similar to the 
strain response. COMP was reported to decrease in tendinopathy (Jelinsky, Rodeo et al. 
2011), whereas with strain we have shown an increase trend. No change was seen in 
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thrombospondin 1 mRNA expression in tendinopathy or ruptured tendon (Ireland, Harrall 
et al. 2001), whereas we have shown an increase in response to mechanical load, however 
this change is close to the cut off for significance.  
IL6 was increased in both painful and ruptured Achilles tendon (6.3 and 180 fold 
respectively), however there was no change in painful posterior tibialis tendinopathy 
(Legerlotz, Jones et al. 2012). IL6R mRNA was decreased in ruptured as well as painful 
Achilles tendinopathy (Jelinsky, Rodeo et al. 2011; Legerlotz, Jones et al. 2012), however 
there was no significant change in painful posterior tibialis tendinopathy (Legerlotz, Jones 
et al. 2012). We have shown a trend to increase in IL6 and a significant decrease in IL6R 
in response to mechanical load, which is similar to the disease phenotype. An increase in 
IL6 mRNA with strain would suggest that IL6 signalling may be increased with 
mechanical load, however due to the fact that IL6R mRNA is decreased with strain this 
may not be the case. To confirm this measurement of proteins involved in canonical IL6 
signalling is required (JAK/STAT). IL6 may however have some other function in 
response to strain other than canonical IL6 signalling.  
COX2 is an inflammatory enzyme involved in the processing of prostaglandins. COX2 
was increased in both painful and ruptured Achilles tendon (2 and 11 fold respectively), 
however there was no change in painful posterior tibialis tendinopathy (Legerlotz, Jones et 
al. 2012). We see a trend to increase in COX2 in response to mechanical loading, similar to 
the levels seen in painful tendinopathy, indicating that inflammatory mediators may be 
involved in the strain response. IGF is a growth factor involved in the stimulation of 
collagen expression (Gillery, Leperre et al. 1992). In the ligament one study has shown up 
to a 5 fold increase in IGF1 mRNA in response to rupture in a rabbit model (Sciore, 
Boykiw et al. 1998). This draws parallel with the 2 fold increase in IGF1 mRNA following 
24 hours cyclic mechanical loading. As previously described in the introduction, TGFβ 
protein is increased in tendinopathy (Fenwick, Curry et al. 2001; Fu, Wang et al. 2002). 
However, we have shown little regulation of TGFβ mRNA in response to strain, further 
characterisation to confirm whether protein levels are effected by load are required. 
Studies of tendinopathy have looked at the expression of ‘tendon markers’ to determine 
whether tenocytes have deviated from the tendon phenotype. Tenascin C mRNA was 
increased 2-4 fold in both tendinopathy and ruptured tendon (Ireland, Harrall et al. 2001; 
Jelinsky, Rodeo et al. 2011). An increase of more than 10 fold was seen in Tenascin C 
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mRNA in acute tendinopathy compared to adult controls in horse tendon (Taylor, 
Vaughan-Thomas et al. 2009), and a study of human tendon degeneration showed an 
increase in the levels of 300kd tenascin C protein, a large isoform of tenascin C generated 
by alternate splicing (Riley, Harrall et al. 1996). These changes coordinate with the 
changes in mRNA measured in the current study. Scleraxis was not differentially regulated 
in either acute or chronic tendon disease according to a study by Taylor and colleagues of 
equine tendon (Taylor, Vaughan-Thomas et al. 2009). A murine model of patella tendon 
injury measured an increase in scleraxis after 4-8 weeks, which returned to normal after 12 
weeks (Scott, Sampaio et al. 2010). Therefore a temporal change in scleraxis may be 
involved in tendinopathy. This mirrors the increase seen in response to mechanical load in 
our study. An immunohistochemistry study showed the increased expression of SOX9 
protein in patellar tendinopathy, with a more rounded cell phenotype suggesting a 
divergence to a cartilaginous phenotype (Rui, Lui et al. 2011). We have not observed any 
significant changes in SOX9 expression in response to loading. Therefore phenotypic 
divergence of tenocytes may have some involvement in the development of tendinopathy, 
perhaps in the absence of ‘normal’ loading. We have shown an increase in the ‘tendon 
markers’ in response to mechanical load, this indicates that tenocytes exposed to load may 
become more tendon like. However this is difficult to confirm due to the absence of 
definitive tendon markers. 
Taking into account change in metalloproteinases, matrix genes, cytokines and tendon 
‘markers’ in response to mechanical load and tendinopathy, we can see that there are a 
number of similarities between the two conditions, this is consistent with mechanical load 
playing role in tendinopathy. However, a more complex relationship seems to be involved 
in the disease phenotype, for example different magnitudes and frequencies of strain may 
induce differential regulation of key regulators of tendon stability. Differences between 
strain regulated and tendinopathic changes highlight the complex mechanisms of 
tendinopathy development and the limitations of using strain induced tendinopathy models. 
The homogeneous nature of tendinopathies is emphasized by the different gene expression 
patterns in tendinopathies. For example different tendon positions can influence the 
response to mechanical load, Legerlotz et al showed differential responses to mechanical 
load in Achilles compared to posterior tibialis tendon in a range of IL6 related genes 
(Legerlotz, Jones et al. 2012). Subsets of the disease or disease affecting tendon of 
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particular locations may involve different causative factors, however mechanical load 
seems to be the common denominator.  
 
4.5. CONCLUSIONS  
1. There is a general anabolic response to 5% mechanical loading at 1Hz in tenocytes 
derived from tendinopathic tendon. 
2. The response to mechanical load is cell density dependant 
3. Our investigation covers a larger range of genes than previously described in terms 
of mechanical regulation in human tenocytes.  We have shown that MMP1, MMP2, 
MMP3, MMP13, ADAMTS2, ADAMTS4, ADAMTS10, Decorin, IL6, Lumican 
and Fibulin are decreased, and ADAM12, TIMP3, IGF1, Thrombospondin 1, 
COL1A1 and Elastin are increased in response to mechanical strain. 
4. Similar patterns of regulation are seen in cells derived from normal and ruptured 
tendon.
  
 
 
 
CHAPTER 5:  TGFβ and mechanical strain regulation of 
metalloproteinase and matrix genes 
 
5.1. INTRODUCTION 
As we have discussed in the introduction MMPs, matrix genes, transcription factors and 
cytokines are differentially regulated in tendinopathic tendon compared to normal tendon. 
As mechanical load is thought to play a key role in the development of tendinopathy, 
loading changes may be the cause of this differential regulation. Further characterisation of 
these changes may highlight key players in mechanotransduction. TGFβ is one such 
candidate, with an up regulation of protein expression in tendinopathy (Fenwick, Curry et 
al. 2001; Fu, Wang et al. 2002) and an up regulation of protein and mRNA with 
mechanical strain in tenocytes (Skutek, van Griensven et al. 2001; Yang, Crawford et al. 
2004) and other cell types (Riser, Cortes et al. 1996; Riser, Ladson-Wofford et al. 1999). 
However, studies have not looked at the activation status of TGFβ as well as the mRNA 
and total protein level in response to load. 
The aims of this chapter are to elucidate the effects of TGFβ in the regulation of matrix 
metalloproteinase expression and to assesss whether TGFβ plays a role in 
mechanoregulation of metalloproteinase and matrix genes. To do this we compared the 
effects of TGFβ to the strain induced response in the FlexcellTM 3D culture system. In 
addition we used a TGFβRI inhibitor (SB431542) which specifically inhibits the 
downstream phosphorylation of SMAD (Callahan, Burgess et al. 2002) to assesss whether 
TGFβ signalling is involved in the strain mediated regulation of metalloproteinase and 
matrix genes. We also measured levels of total and active TGFβ in the medium, using a 
cell based luciferase assay. We hypothesise that TGFβ regulates metalloproteinase and 
matrix genes in a similar (anabolic) way to mechanical loading and that TGFβ signalling is 
involved in the strain mediated regulation of metalloproteinase and matrix genes. 
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5.2. Methods 
Analysis of gene expression with mechanical load: Tenocytes derived from 
tendinopathic, normal or ruptured tendon were seeded in type I collagen into Flexcell™ 
tissue train plates and loaded at 1Hz at 5% strain for a range of time points; 2, 4, 8, 24 and 
48 hours at 1.5 x 10
6
 cells/ml with or without TGFβ (1ng/ml). Gels were dissolved in 
Trizol and RNA was extracted using the tri-spin method essentially as described elsewhere 
(Ireland, Harrall et al. 2001). RNA was quantitated, reverse transcribed and analysed via 
qRT-PCR (Taqman) for a range of metalloproteinase and matrix genes (see table 2.1 in 
methods section). Data was normalised to the housekeeping gene TOP1 and expressed as 
the 2
∆∆Ct
.  Statistical analysis was performed using the Wilcoxon signed rank test after a 
normality test (Shapiro Wilk W) confirmed the distribution was not normal. For full details 
see methods section 2.2 and 2.3. 
Taqman low density array (TLDA) analysis: Due to the more robust response in 
cultures seeded at the higher cell density tenocytes were seeded at 1.5 x 10
6 
cells/ml in type 
I rat tail collagen (1mg/ml) were plated into tissue train Flexcell™ plates and uniaxially 
strained at 5% at 1Hz for up to 48 hours with or without TGFβ (1ng/ml) 
(Metalloproteinase and TIMP family analysis focused on 24 and 48 hours, whereas Time 
course analysis of selected genes looked at a time course of  2, 4, 8, 24 and 48 hours). Gels 
were harvested in Trizol and RNA extracted using the tri-spin method essentially as 
described elsewhere (Ireland, Harrall et al. 2001). RNA was quantitated, reverse 
transcribed and analysed using TLDA qRT-PCR. Metalloproteinase and TIMP family 
analysis focused 19 ADAMTS genes, all 23 MMP genes and all 4 TIMP genes.  Genes 
were selected for analysis on the time course TLDA on the basis of robust response in the 
metalloproteinase and TIMP family TLDA (see table 2.2 and 2.3 in methods section for a 
full list of the genes analysed). 
Data was normalised to 18s and expressed as the 2
∆∆Ct
. Statistical analysis was performed 
using the Student’s t test (two tailed distribution, paired t test), as there were only 3 repeats 
we were unable to confirm whether these data were normally distributed and non-
parametric tests are not suitable for n=3. For full details see methods section 2.3.4. 
TGFβRI inhibition: Tenocytes seeded (1.5 x 10
6 
cells/ml) in type I collagen gels 
(1mg/ml) were plated into Flexcell
TM
 tissue train plates and uniaxially strained to 5% at 
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1Hz for 48 hours with or without TGFβRI inhibitor (SB431542, 10µM). Gels were 
harvested in Trizol and RNA extracted using the tri-spin method. RNA was quantitated, 
reverse transcribed and analysed using qRT-PCR for a selection of metalloproteinase and 
matrix genes. Data was normalised to TOP1 and expressed as the 2
∆∆Ct
. Statistical analysis 
was performed using the Wilcoxon signed rank test. For full details of protocols see 
methods section 2.3. 
TGFβ activity measurement: TGFβ was measured using a cell based system targeting 
SMAD proteins involved in TGFβ signalling. Tenocytes seeded (1.5 x 106 cells/ml) in type 
I collagen gels (1mg/ml) were strained to 5% at 1Hz for 48 hours using the Flexcell
TM
 
vacuum powered system. Medium from 48 hour strained and non-strained gels was 
transferred onto SW1353 cells transfected with a SMAD specific construct linked to a 
luciferase reporter. Total TGFβ was measured by heat activating the TGFβ in the medium 
before incubation with the transfected SW1353 cells. Luciferin was added to samples and 
fluorescence measured on the luminometer. For details of this protocol see methods section 
2.4.1. 
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5.3. RESULTS 
5.3.1. Metalloproteinase and TIMP family analysis  
The Metalloproteinase and TIMP family analysis TLDA covered 18 ADAMTS genes, all 
23 MMP genes and all 4 TIMP genes analysing samples treated with or without strain or 
TGFβ at 24 and 48 hours. Of the 19 ADAMTS genes and 23 MMP genes the following 
were not sufficiently detected; ADAMTS8, ADAMTS15, ADAMTS18, ADMATS19, 
MMP12, MMP20, MMP21, MMP25, MMP26 and MMP28 (Average Ct>37). Genes with 
low expression (Ct between 35 and 37) included ADAMTS9, ADAMTS16 and 
ADAMTS17, MMP1, MMP3, MMP7, MMP8, MMP10, MMP15, MMP24 and MMP28.  
MMP regulation with strain and TGFβ  
At 24 hours the following genes were decreased with TGFβ; MMP2 (1.3 fold), MMP8 (7.1 
fold), MMP11 (2.1 fold) and MMP19 (1.9 fold). At 24 hours MMP15 (2.7 fold) and 
MMP24 (12.5 fold) were increased with TGFβ (figure 5.1) (Statistical p values are shown 
in Table 5.2). MMP10 (53.5 fold) and MMP24 (5.2 fold) were increased with strain and 
MMP16 (2.1 fold) and MMP24 (30 fold) were increased with a combined strain and TGFβ 
treatment at 24 hours. At 48 hours MMP1 (11.1 fold), MMP10 (50 fold) and MMP13 (3.7 
fold) were decreased with TGFβ. MMP24 was increased with strain (35.2 fold), TGFβ 
(21.7 fold) and a combination of the two (55.4 fold) and MMP3 (33.3 fold), MMP10 (4 
fold) and MMP17 (2 fold) were decreased with strain at 48 hours. Also at 48 hours MMP1 
and MMP17 were decreased with a combination of strain and TGFβ (10 fold and 1.6 fold 
respectively). TGFβ and strain responses were similar in pattern although each gene was 
not always significantly different (from controls) in both conditions. 
ADAMTS regulation with strain and TGFβ 
At 24 hours ADAMTS2 (2.1-2.9 fold), ADAMTS4 (3.2-9.9 fold), ADAMTS6 (3.6-5.8 
fold), ADAMTS14 (2.7-4.9 fold) and ADAMTS16 (26-199 fold) were increased with 
strain, TGFβ and a combination of the two (Figure 5.2). ADAMTS10 was increased with 
TGFβ (2.4 fold). At 48 hours ADAMTS2 (1.7-2 fold), ADAMTS4 (7.1-10.2 fold) and 
ADAMTS16 (24.1-86 fold) were regulated with strain, TGFβ and a combination of the 
two. ADAMTS6 was significantly increased with strain (3.1 fold) and a combination of 
strain and TGFβ (2.4 fold). At 48 hours ADAMTS10 was increased with strain (2.6 fold) 
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and a combination of TGFβ and strain (2.7 fold). ADAMTS1 was decreased with a 
combination of strain and TGFβ (4.2 fold). ADAMTS12 (1.2-2.8 fold) and ADAMTS13 
(1.7-2.9 fold) were decreased with TGFβ at 48 hours. The majority of ADAMTS responses 
were similar between strain and TGFβ. 
TIMP regulation with strain and TGFβ  
At 24 hours TIMP2 was decreased with TGFβ (1.3 fold), however there was little 
regulation with strain (figure 5.3). At 24 and 48 hours TIMP3 was similarly regulated with 
TGFβ (6.4 fold, 2.6 fold) and strain (4.6 fold, 5.3 fold) and a combination of the two (9 
fold, 2.9 fold). At 48 hours TIMP1 and TIMP2 were decreased with a combination of 
TGFβ and strain (1.4 fold). TIMP4 was increased with TGFβ (1.5 fold), however there was 
no change with strain. There was poor regulation of TIMPs 1, 2 and 4 with strain alone. 
The majority of MMPS, ADAMTSs and TIMPs were similarly regulated with strain and 
TGFβ. However ADAMTS5, ADAMTS7, MMP7, MMP15, MMP16 and TIMP4 are 
regulated by strain differently to TGFβ at either 24 or 48 hours (See fold changes outlined 
in bold, Table 5.1). ADAMTS5 and ADAMTS7 were decreased with TGFβ (1.4 and 1.5 
fold respectively) and increased with strain (5.7 and 1.3 fold respectively) at 24 hours. At 
either 24 or 48 hours MMP15 and TIMP4 were increased with TGF (2.7 and 1.4 fold 
respectively) and with strain MMP15 remained unaffected (1 fold) and TIMP4 was 
decreased with strain (2.2 fold). MMP7 and MMP16 were decreased (1.4 and 1.4 fold 
respectively) with TGFβ and increased with strain (1.4 and 1.4 fold respectively) at 48 
hours. TIMP4 was increased with TGFβ (1.5 fold) but was unaffected by mechanical 
loading at 48 hours. 
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Figure 5.1.  Metalloproteinase family expression in response to mechanical load 
and TGFβ: TLDA analysis at 24 and 48 hours. Taqman Low density array 
analysis of cells seeded at 1.5 x 10
6
 cells/ml in type I rat tail collagen at 1 mg/ml 
after 5% cyclic strain over 24 and 48 hours. Data was normalised to 18s and 
presented as a mean (± SE, n=3) fold change with strain (2
∆∆Ct
). Significance is 
denoted by * according to the paired t test (p<0.05). 
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Figure 5.2.  Regulation of ADAMTS family genes with mechanical loading and 
TGFβ: 24 and 48 hours. Taqman Low density array analysis of cells seeded at 1.5 x 
10
6
 cells/ml in type I rat tail collagen at 1 mg/ml after 5% cyclic strain over 24 and 48 
hours. Data was normalised to 18s and presented as a mean (± SE, n=3) fold change 
with strain (2
∆∆Ct
). Significance is denoted by * according to the paired t test (p<0.05). 
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Figure 5.3.  Regulation of TIMP family genes with mechanical loading and 
TGFβ: 24 and 48 hours. Taqman Low density array analysis of cells seeded at 
1.5 x 10
6
 cells/ml in type I rat tail collagen at 1 mg/ml after 5% cyclic strain over 
24 and 48 hours. Data was normalised to 18s and presented as a mean (± SE, 
n=3) fold change with strain (2
∆∆Ct
). Significance is denoted by * according to 
the paired t test (p<0.05). 
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Table 5.1. Fold changes in Metalloproteinase and TIMP family analysis with 
mechanical loading and TGFβ: 24 and 48 hours. Taqman Low density array analysis 
of cells seeded at 1.5 x 10
6
 cells/ml in type I rat tail collagen at 1 mg/ml after 5% cyclic 
strain over 24 and 48 hours. Data was normalised to 18s and presented as a mean (± SE, 
n=3) fold change with strain (2
∆∆Ct
). Mean Ct values are shown in the right hand column; 
Ct values of more than 35 are highlighted in light grey. Genes that showed a differential 
response to strain and TGFβ are highlighted with a black border.  
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Table 5.2. Statistical analysis with Metalloproteinase and TIMP family analysis with 
mechanical loading and TGFβ: 24 and 48 hours. Taqman Low density array analysis of 
cells seeded at 1.5 x 10
6
 cells/ml in type I rat tail collagen at 1 mg/ml after 5% cyclic strain 
over 24 and 48 hours. 18s normalised data was statistically analysed using the students t-test 
(2-tailed, paired t-test) (n=3). Statistical p values are shown, those below the significance cut 
of point (p<0.05) are highlighted in red. Mean Ct values are shown in the right hand column; 
Ct values of more than 35 are highlighted in light grey. 
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5.3.2. Time course analysis of selected genes TLDA 
The time course analysis of selected genes TLDA included time points 2, 4, 8, 24 and 48 
hours and included a selected number of metalloproteinase genes as well as a range of 
matrix genes, cytokines and tendon markers. Of these genes MMP8, ADAMTS16, 
COL2A1, Tenomodulin, IL1β, IL4, IL17, TNF and metabotropic glutamate receptor 
(GRM) 5 and GRM6 were not sufficiently detected. MMP3 was the only gene that had low 
expression across the range of conditions (Ct>35) 
ADAMTS RNA analysis 
ADAMTS10 was the only ADAMTS to be significantly increased with strain (2.8 fold) 
and TGFβ (3.5 fold) at 24 hours. At 8 and 24 hours ADAMTS6 was increased with TGFβ 
(3.6 fold and 5.3 fold) and a combination of strain and TGFβ (4.1 fold, 7.3 fold). 
ADAMTS5 significantly increased with a combination of strain and TGFβ (3.1 fold) at 8 
hours. Patterns of regulation with strain and TGFβ at 48 hours were very similar except for 
ADAMTS5, where the increase in response to TGFβ occurred at 4 hours was not 
maintained until 48 hours. At 48 hours ADAMTS10 was increased with TGFβ (2.6 fold). 
Generally ADAMTS genes showed an early response with TGFβ and a later response to 
strain although these changes reached similar levels at their peak. 
MMP RNA analysis 
MMP1, MMP2, MMP3, MMP8, MMP10 and MMP13 were selected for analysis of the 
time course experiments. MMP2 was significantly decreased with both mechanical load 
(1.3 fold) and TGFβ (1.6 fold), with a combination of strain and TGFβ there was a trend to 
decrease. The other MMPs showed a trend to increase with TGFβ and strain at 48 hours, 
however this was not significant. MMP10 on the other hand was not clearly regulated by 
TGFβ, but was increased with strain at 2 hours (1.2 fold).  
TIMP RNA analysis 
TIMP4 was omitted from TLDA analysis as standard qRT-PCR failed to produce 
consistent results. TIMP1 and TIMP2 were not significantly regulated with mechanical 
load, however TIMP2 was decreased with TGFβ (1.4 fold). TIMP3 on the other hand was 
increased with both strain (5.9 fold at 48 hours) and TGFβ (2.6 and 6.5 fold at 4 and 8 
hours respectively) although the response to TGFβ is much earlier than the response to 
strain. 
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Collagen RNA analysis 
COL1A1 was increased with TGFβ at 48 hours (2.25 fold). COL3A1 was not regulated 
with mechanical loading; however it was increased with TGFβ at 24 hours (1.9 fold). 
COL12A1 was not significantly regulated by either mechanical loading or TGFβ. 
COL14A1 was decreased with TGFβ at 24 hours (2 fold). The combined effect of strain 
and TGFβ was similar to that of TGFβ alone in COL1A1, COL3A1 and COL14A1. 
Matrix protein RNA analysis 
Aggrecan was decreased with loading at 4 hours (1.4 fold); however this was not 
maintained later in the time course. Biglycan was significantly increased at 48 hours with 
TGFβ (1.74 fold). Decorin was decreased with strain at 2 hours (1.3 fold). A combination 
of TGFβ and strain induced a significant decrease in decorin at 48 hours (2.6 fold) similar. 
Lumican was decreased significantly with both strain (1.4 fold) and TGFβ (1.6 fold) at 48 
hours. Versican was decreased with strain at 8 hours (1.2 fold). Versican was increased 
with TGFβ at 48 hours (1.3 fold). Fibrillin-1 was increased with a combination of strain 
and TGFβ at 24 hours (1.9 fold), and although not significant responses to strain or TGFβ. 
COMP was significantly increased at 48 hours with TGFβ and combined conditions (3.9 
and 5.1 fold respectively). Fibronectin-1 was increased at 24 hours with both TGFβ (2.8 
fold) and combined strain and TGFβ (2.3 fold). Thrombospondin-1 was significantly 
increased with strain at 24 hours (8.6 fold), the combination of TGFβ and strain induced an 
increase at 8 hours (6 fold). With respect to the response to TGFβ appears to be an earlier 
response compared to that with strain. 
Tendon ‘marker’ RNA analysis 
Although there are no true ‘markers’ of tendon, ‘markers’ of cell phenotype were chosen to 
identify whether cells differentiated from the tendon phenotype, these were tenascin C, 
scleraxis and SOX9.  Tenascin C was increased with TGFβ at 4 hours (1.4 fold). Scleraxis 
was increased with TGFβ at 8 and 48 hours (5.6 and 4.8 fold respectively); in combined 
conditions Scleraxis was increased at 8 and 24 hours (7.8 and 13.5 fold. SOX9 was not 
clearly regulated by strain or TGFβ. 
Cytokine RNA analysis 
COX2 was not significantly regulated with either strain or TGFβ. IL6 was increased with 
TGFβ at 8 hours (21.2 fold). IL6R was decreased at 48 hours with strain (4.2 fold), TGFβ 
(9 fold) and combined conditions (6.8 fold). Therefore strain and TGFβ showed a similar 
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response although the TGFβ response occurred earlier than the strain induced response. 
IGF1 was increased with strain (2.3 fold, 24 hours), TGFβ (13.6 fold, 24 hours) and 
combined conditions (7.9 fold, 8 hours), although the response to TGFβ was far more 
marked and earlier than the response to strain. CTGF was increased with TGFβ at 24 hours 
(10.3 fold) and with the combined condition at both 4 (48.7 fold) and 8 hours (118.5 fold). 
TGFβ was not regulated significantly with strain, however at 4 (1.4 fold), 8 (1.8 fold) and 
24 hours (2 fold) there was an increase with TGFβ and at 8 hours with combined treatment 
(2.2 fold). 
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  Figure 5.4. Regulation of metalloproteinases and TIMPs with mechanical loading: 
0-48 hours. Taqman Low density array analysis of cells seeded at 1.5 x 10
6
 cells/ml in 
type I rat tail collagen at 1 mg/ml after 5% cyclic strain over a time course of 0-48 hours. 
Data was normalised to 18s and presented as a mean (± SE, n=3) fold change with strain 
(2
∆∆Ct
). Significance is denoted by * for strain, # for TGFβ and @ for strain plus TGFβ 
according to the paired t test (p<0.05).  
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Table 5.3. Statistical analysis of metalloproteinases and TIMP regulation with 
mechanical loading and TGFβ: 0-48 hour time course TLDA. Taqman Low density 
array analysis of cells seeded at 1.5 x 10
6
 cells/ml in type I rat tail collagen at 1 mg/ml 
after 5% cyclic strain over a time course of 0-48 hours. 18s Data normalised was 
statistically analysed using the students t-test (2-tailed, paired t-test) (n=3). Statistical p 
values are shown, those below the significance cut of point (p<0.05) are highlighted in 
red. Mean Ct values are shown in the right hand column; Ct values of more than 35 are 
highlighted in light grey. Where no values appear some of the samples were 
undetectable 
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Figure 5.5.  Regulation of Collagen expression with mechanical loading. Taqman Low 
density array analysis of cells seeded at 1.5 x 10
6
 cells/ml in type I rat tail collagen at 1 
mg/ml after 5% cyclic strain over a time course of 0-48 hours. Data was normalised to 18s 
and presented as a mean (± SE, n=3) fold change with strain (2∆∆Ct). Significance is 
denoted by * for strain, # for TGFβ and @ for strain plus TGFβ according to the paired t 
test (p<0.05). 
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Table 5.4. Statistical analysis of collagen expression with mechanical loading and 
TGFβ: 0-48 hour time course TLDA. Taqman Low density array analysis of cells 
seeded at 1.5 x 10
6
 cells/ml in type I rat tail collagen at 1 mg/ml after 5% cyclic strain 
over a time course of 0-48 hours. 18s normalised data was statistically analysed using the 
t-test (2-tailed, paired t-test) (n=3). Statistical p values are shown, those below the 
significance cut of point (p<0.05) are highlighted in red. Mean Ct values are shown in the 
right hand column. 
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Figure 5.6.  Regulation of Matrix gene expression with mechanical loading. Taqman 
Low density array analysis of cells seeded at 1.5 x 10
6
 cells/ml in type I rat tail collagen at 
1 mg/ml after 5% cyclic strain over a time course of 0-48 hours. Data was normalised to 
18s and presented as a mean (± SE, n=3) fold change with strain and/or TGFβ (2∆∆Ct). 
Significance is denoted by * for strain, # for TGFβ and @ for strain plus TGFβ according 
to the students paired t test (p<0.05). 
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Table 5.5. Statistical analysis of matrix gene regulation with mechanical loading and 
TGFβ: 0-48 hour time course TLDA. Taqman Low density array analysis of cells 
seeded at 1.5 x 10
6
 cells/ml in type I rat tail collagen at 1 mg/ml after 5% cyclic strain 
over a time course of 0-48 hours. 18s Data normalised was statistically analysed using the 
t-test (2-tailed, paired t-test) (n=3). Statistical p values are shown, those below the 
significance cut of point (p<0.05) are highlighted in red. Mean Ct values are shown in the 
right hand column; Ct values of more than 35 are highlighted in light grey. Where no 
values appear some of the samples were undetectable. 
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Figure 5.7.  Regulation of cell lineage ‘markers’ with mechanical loading. 
Taqman Low density array analysis of cells seeded at 1.5 x 10
6
 cells/ml in type I rat 
tail collagen at 1 mg/ml after 5% cyclic strain over a time course of 0-48 hours. Data 
was normalised to 18s and presented as a mean (± SE, n=3) fold change with strain 
and/or TGFβ (2∆∆Ct). Significance is denoted by * for strain, # for TGFβ and @ for 
strain plus TGFβ according to the paired t test (p<0.05). 
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Table 5.6. Statistical analysis of cell lineage ‘markers’ regulation with mechanical 
loading and TGFβ: 0-48 hour time courseTLDA. Taqman Low density array analysis of 
cells seeded at 1.5 x 10
6
 cells/ml in type I rat tail collagen at 1 mg/ml after 5% cyclic strain 
over a time course of 0-48 hours. 18s Data normalised was statistically analysed using the 
t-test (2-tailed, paired t-test) (n=3). Statistical p values are shown, those below the 
significance cut of point (p>0.05) are highlighted in red. Mean Ct values are shown in the 
right hand column, Ct values of more than 35 are highlighted in light grey, and those 
highlighted in darker grey were undetectable in the majority of samples.  Where no 
values appear some of the samples were undetectable 
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Figure 5.8.  Regulation of cytokine expression with mechanical loading. Taqman Low 
density array analysis of cells seeded at 1.5 x 10
6
 cells/ml in type I rat tail collagen at 1 
mg/ml after 5% cyclic strain over a time course of 0-48 hours. Data was normalised to 
18s and presented as a mean (± SE, n=3) fold change with strain and/or TGFβ (2∆∆Ct). 
Significance is denoted by * for strain, # for TGFβ and @ for strain plus TGFβ according 
to the paired t test (p<0.05).  
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Table 5.7.  Statistical analysis cytokine regulation with mechanical load and TGFβ: 0-
48 hour time course TLDA. Taqman Low density array analysis of cells seeded at 1.5 x 
10
6
 cells/ml in type I rat tail collagen at 1 mg/ml after 5% cyclic strain over a period of 0-
48 hours. 18s normalised data was statistically analysed using the students t-test (2-tailed, 
paired t-test) (n=3). Statistical p values are shown, those below the significance cut of point 
(p>0.05) are highlighted in red. Mean Ct values are shown in the right hand column; Ct 
values of more than 35 are highlighted in light grey. 
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5.3.3. Strain and TGFβ regulation of selected Metalloproteinase and matrix genes 
A number of genes were selected for further qRT-PCR analysis. MMPs were chosen 
because of our particular interest in the regulation of matrix turnover with mechanical load 
and the anabolic effects seen in our preliminary TLDA. ADAM12 was chosen because of 
its response in tendinopathy and its regulation with mechanical load seen earlier. 
ADAMTS5 was chosen due to the differential effects of TGFβ and strain upon its 
expression in the preliminary analysis. COL1A1 and Elastin were chosen as they are the 
most abundant components of the tendon ECM. Fibulin-1 was chosen due to existing 
interests in the laboratory and its interaction with elastin. 
MMP1 (48 hours), MMP2 (24 and 48 hours), MMP3 (4 hours) and fibulin-1 (48 hours) 
were significantly decreased with mechanical load, TGFβ and a combination of the two. 
Elastin was increased significantly with all three conditions at 8, 24 and 48 hours. MMP13 
was significantly decreased with both strain and TGFβ at 24 and 48 hours. MMP3 is 
significantly decreased with TGFβ at 2 and 4 hours and decreased with strain after 48 
hours. However at 24 hours TGFβ induces an increase in MMP3, which is not seen in 
response to strain. TGFβ treatment causes an increase in ADAM12 expression at 8, 24 and 
48 hours, however the response to strain is only significant after 24 hours.  MMP1 (4, 8 
and 24 hours), MMP3 (2 and 4 hours) and fibulin-1(2, 4, 8 and 24 hours) responded to 
TGFβ at much earlier time points than they responded to mechanical load. COL1A1 was 
increased with TGFβ at 4, 8, 24 and 48 hours however there was only a significant 
response to strain at 24 hours. ADAMTS5 was different to the other genes, it was 
increased at 24 hours with strain or a combination of TGFβ and strain, however there were 
no significant changes with TGFβ alone. 
Generally the combination of TGFβ and strain did not cause an additive effect accept for in 
Fibulin-1 where there was more of a decrease with a combination of the TGFβ and strain. 
Elastin on the other hand showed less of a response compared to TGFβ treatment at the 
earlier time points. Generally TGFβ responses were more marked compared to those 
responses to mechanical loading, especially in MMP1 and MMP13 at 48 hours, and in 
Elastin at around 8 hours. 
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Figure 5.9. Strain and TGFβ modulation of selected Metalloproteinases and 
matrix genes. Standard quantitative Real Time PCR analysis of cells seeded at 1.5x10
6
 
cells/ml in type I rat tail collagen at 1 mg/ml after 5% cyclic strain over a time course of 
0-48 hours. Data was normalised to TOP1 and presented as a mean (± SE, n=3) fold 
change with strain and/or TGFβ (2∆∆Ct).  Significant values are indicated as * (changes 
with strain), # (changes with TGFβ) or @ (changes with strain plus TGFβ) according to 
the Wilcoxon signed rank test (p<0.05)  
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Table 5.8. Statistical analysis of Strain and TGFβ modulation of selected 
Metalloproteinases and matrix genes. Taqman Low density array analysis of cells 
seeded at 1.5 x 10
6
 cells/ml in type I rat tail collagen at 1 mg/ml after 5% cyclic strain 
over a period of 0-48 hours. TOP1 normalised data was statistically analysed using 
Wilcoxon signed rank test. Statistical p values are shown, those below the significance 
cut of point (p<0.05) are highlighted in red (n≥6). 
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5.3.4. TGFβRI abrogated strain induced gene regulation 
In order to determine whether TGFβ signalling was involved in the mechanical regulation 
of the genes selected in figure 5.9, an inhibitor of TGFβRI was added to tenocyte seeded 
gels before 48 hours of mechanical strain. The TGFβRI inhibitor is an ATP binding site 
kinase inhibitor which has been shown to inhibit immobilised SMAD phosphorylation, 
therefore it effectively inhibits the phosphorylation of SMAD by TGFβRI (IC50 94nM). 
Previous studies have used this inhibitor at 10μM and have shown no effect upon cell 
viability (Callahan, Burgess et al. 2002; Inman, Nicolas et al. 2002). We have not tested for 
cell viability, however no observable changes were seen in cell morphology and levels of 
RNA were consistent upon extraction from cultures. This inhibitor is specific for ALK4, 
ALK5 and ALK7. Previous publications have shown that the inhibitor does not affect other 
ALK receptors including those involved in BMP signalling (ALK1, ALK2, ALK3 or 
ALK6) (Callahan, Burgess et al. 2002; Inman, Nicolas et al. 2002). 
 MMP1, MMP3 and fibulin-1 were decreased with mechanical loading as we have seen 
earlier, however the addition of the TGFβRI inhibitor caused a significant increase in the 
expression of these genes and therefore caused an abrogation of the strain induced 
response. ADAM12, Elastin and COL1A1 were increased with mechanical loading and 
TGFβ as we have previously been reported, however with the addition of the TGFβRI 
inhibitor the expression of these genes was decreased. Again this means that there was an 
abrogation of the strain induced response. ADAMTS5, which was differentially regulated 
with mechanical loading in the previous experiment, did not show a decrease in the strain 
response with the addition of the TGFβRI inhibitor. In fact the TGFβRI inhibitor increased 
the strain induced effects. Even in the non-strained control cultures the addition of the 
inhibitor causes the mRNA level to change in the opposite direction to the strain response.  
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Figure 5.10. The effect of a TGFβRI inhibitor on strain regulated gene expression. 
Quantitative Real Time PCR analysis of cells seeded at 1.5x10
6
 cells/ml in type I rat tail 
collagen at 1mg/ml (+/- TGFβRI inhibitor, 10μM) after 5% cyclic strain at 48 hours. Data was 
normalised to TOP1 and presented as a mean (n=5) fold change with strain and/or TGFβ 
(2
∆∆Ct
). TOP1 normalised data was statistically analysed using Wilcoxon signed rank test. 
Values marked with * were significantly different from the same condition without TGFβRI 
inhibitor (p<0.05).  
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Table 5.9. Statistical analysis of the effect of the TGFβRI inhibitor. Quantitative 
Real Time PCR analysis of cells seeded at 1.5x10
6
 cells/ml in type I rat tail collagen at 
1mg/ml (+/- TGFβRI inhibitor, 10μM) after 5% cyclic strain at 48 hours. TOP1 
normalised data was statistically analysed using Wilcoxon signed rank test. Statistical p 
values are shown, those below the significance cut of point (p<0.05) are highlighted in 
red (n=5). 
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5.3.5. TGFβ isoform and receptor regulation with mechanical load 
There was no significant increase in TGFβ isoforms expression with strain at any of the 
time points that were analysed (see figure 5.11). TGFβ1 was decreased with mechanical 
load after 8 hours of loading (1.3 fold); TGFβ2 was also decreased with load after 24 hours 
(2.7 fold). TGFβ3 was decreased with strain after 8 and 24 hours (1.6 and 1.7 fold 
respectively). TGFβ1 and TGFβ2 were increased with TGFβ treatment after 2 hours (1.5 
and 1.5 fold respectively), and TGFβ3 was decreased with TGFβ treatment after 4 and 8 
hours (1.7 and 2.8 fold respectively). The combination of TGFβ and strain caused an 
additive effect with respect to TGFβ2 and TGFβ3 at 8 hours. On the other hand TGFβRI 
was increased with strain at 24 hours (2.1 fold). However, TGFβRI responded to TGFβ 
treatment at 2, 4 and 8 hours (1.6, 1.5 and 1.8 fold increase) much earlier than the response 
to strain. TGFβRI responded to a combination of TGFβ and strain in a similar manner to 
the response to TGFβ alone.  
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Figure 5.11. Regulation of TGFβ isoform and TGFβRI mRNA expression with 
strain and TGFβ. Quantitative Real Time PCR analysis of TGFβ isoforms in cells 
seeded at 1.5x10
6
 cells/ml in type I rat tail collagen at 1mg/ml after 5% cyclic strain 
over a time course of 0-48 hours. Data was normalised to TOP1 and presented as a 
mean (n=6, ± SE) fold change with strain and/or TGFβ (2∆∆Ct).  Significant values are 
indicated as * (strain: non-strain), # (control: TGFβ) or @ (control: Strain plus TGFβ) 
according to the Wilcoxon signed rank test (p<0.05). 
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Table 5.10. Statistical analysis of TGFβ isoform and TGFβRI regulation 
with strain and TGFβ. Quantitative Real Time PCR analysis of TGFβ 
isoforms in cells seeded at 1.5x10
6
 cells/ml in type I rat tail collagen at 1mg/ml 
after 5% cyclic strain over a time course of 0-48 hours. Data normalised to 
TOP1 and expressed as a ratio of strain: non-strain, control: TGFβ and control: 
Strain plus TGFβ (n>6). The Wilcoxon signed rank test was used to test 
statistical significance (p<0.05). P values are shown above; significant values 
are highlighted in red. 
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5.3.6. Active TGFβ is increased with mechanical loading 
Preliminary experiments over a time course of 2, 4, 8, 12, 24 and 48 hours show that active 
TGFβ in increased after 24 and 48 hours (Figure 5.12). At 48 hours TGFβ was similar 
between strained and non-strained cultures in terms of total TGFβ. However the level of 
active TGFβ was significantly increased in strained cultures compared to non-strain (~40 
fold increase, p=0.028). This indicates that strain induces TGFβ activation.  
A Pan TGFβ inhibitory antibody as well as the TGFβRI inhibitor inhibits the detection of 
SMAD activity in strain conditioned media from 3 cell isolates (See section 3.3 of the 
optimisation chapter). This indicates that the assay is specific to TGFβ and not BMP 
signalling. We have not added BMP to the assay to determine whether it detects BMP 
signalling. However, doing so would confirm the specificity of the assay further. 
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Figure 5.12. TGFβ Activation is increased with mechanical strain.  A cell based 
luciferase assay measuring levels of SMAD activatory soluble factor (see luciferase 
assay in methods section for details). Data is normalised to transfection controls and 
then negative controls before expression as a percentage of Total TGFβ (non-strain). In 
preliminary experiments TGFβ was measured over a time course period of 2, 4, 8, 12, 
24 and 48 hours (A) (n=1). TGFβ was measured (total TGFβ from heat activated 
conditioned media cultures, active from untreated conditioned media) at 48 hours (B) 
(mean, n=5). Significant values are indicated as * according to the Wilcoxon signed 
rank test (p<0.05). 
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5.4. DISCUSSION 
In this chapter we have shown that mechanical strain regulates multiple protease and 
matrix genes at the mRNA level and that changes in mRNA level are analogous to those 
induced by TGFβ stimulation. Furthermore, the inhibition of the TGFβ signalling pathway 
abrogated the strain-induced changes in mRNA level, demonstrating signalling via 
TGFβRI which mediates downstream phosphorylation of SMAD (Callahan, Burgess et al. 
2002). This indicates that signalling is mediated via the canonical TGFβ signalling 
pathway which involves SMAD translocation to the nucleus and consequent transcriptional 
regulation. In further support of this we have shown that SMAD activation was similar in 
strained and non-strained samples in heat activated conditioned medium (total TGFβ) but 
significantly increased in strain conditioned medium (non heat activated, active TGFβ) 
compared to controls, suggesting that total TGFβ in strained and non-strained samples was 
similar, and that activation rather than synthesis of TGFβ is important in the mechanical 
regulation we have observed. We therefore hypothesise that application of 5% strain at 
1Hz in our model induces TGFβ activation, subsequent signalling and regulation of genes 
in response to mechanical load. 
We have observed that the vast majority of changes reported in response to strain have 
shown a similar pattern of response to TGFβ. Some of the gene changes in response to 
TGFβ have previously been reported in other cell types. For example TGFβ is reported to 
regulate ADAM12 (Le Pabic, Bonnier et al. 2003), ADAMTS1 (Cross, Chandrasekharan 
et al. 2005), ADAMTS4 (Yamanishi, Boyle et al. 2002; Corps, Jones et al. 2008), 
ADAMTS16 (Surridge, Rodgers et al. 2009), TIMP3 (Su, DiBattista et al. 1998), TIMP4 
(Hyc, Osiecka-Iwan et al. 2011), Thrombospondin (Nakagawa, Li et al. 2004), aggrecan 
(Watanabe, de Caestecker et al. 2001), tenascin-C (Pearson, Pearson et al. 1988), collagen 
and fibronectin (Ignotz and Massague 1986). These responses are analogous to those seen 
in our model with TGFβ and strain, further supporting our conclusion that TGFβ plays a 
key role in the strain regulation of most metalloproteinase genes. ADAMTS5 has been 
shown to either be unresponsive (Yamanishi, Boyle et al. 2002) or to decrease (Cross, 
Chandrasekharan et al. 2005) in response to TGFβ. This corresponds with the current study 
in that induction of ADAMTS5 by strain is not related to TGFβ signalling directly. Recent 
research has also reported that ADAMTS5 can also positively regulate TGFβ signalling 
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through degradation of aggrecan, allowing TGFβ to access receptor molecules (Velasco, Li 
et al. 2011). The increase of ADAMTS5 in our system in response to strain may therefore 
increase TGFβ signalling, if this is reflected in ADAMTS5 expression at the protein level. 
Although MMP13 shows similar response to strain and TGFβ, regulation does not appear 
to be mediated via the TGFβRI pathway either. This indicates that regulation of MMP13 
by TGFβ is via another TGFβ signalling pathway. 
As previously described in the introduction, TGFβ protein is increased in tendinopathy 
(Fenwick, Curry et al. 2001; Fu, Wang et al. 2002). Pathway analysis following global 
gene expression profiling of chronic tendinopathic tendon tissue also showed an increase in 
genes related to TGFβ signalling (Jelinsky, Rodeo et al. 2011). In the previous chapter we 
have compared gene regulation in tendinopathy and response to mechanical load. We 
showed that there were many similarities. However expression also suggested that the 
mechanotransduction mechanism has been disrupted in some way in tendinopathy as there 
were also some differences in the response to mechanical load and those seen in 
tendinopathy. This indicates that TGFβ signalling response to load may be disrupted in 
some way. Abnormal loading regimes may result in differential response of TGFβ and 
contribute to tendinopathy development.  
The majority of gene changes in response to strain and TGFβ appear to be very similar in 
most cases. However in some instances there is an additive effect when both strain and 
TGFβ are applied. ADAMTS5 is increased significantly with strain after 24 hours (2.2 
fold), in response to TGFβ there was a trend to increase, however with a combination of 
strain and TGFβ treatment ADAMTS5 was increased further than strain alone (2.8 fold, 24 
hours). Fibulin-1 was decreased with strain at 48 hours (2.3 fold) with TGFβ (3 fold) and 
was decreased further with a combination of the two conditions (4.9 fold). At 8 hours 
TGFβ2 was decreased 1.3 fold with TGFβ, remained unchanged with strain but was 
decreased further (2.8 fold) with a combination of TGFβ and strain. This indicates that 
either; strain and TGFβ responses in these cases rely on different mechanisms, i.e. the 
response is not TGFβ signal mediated, or the accumulation of strain activated TGFβ and 
the addition of active TGFβ may induce a more robust response. We have shown that 
fibulin-1 regulation with mechanical strain is reliant on the TGFβRI signalling, this 
suggests that in this case the latter explanation is more likely. Fibulin-1 therefore seems to 
be more sensitive to accumulation of TGFβ, different from many of the other genes that are 
responsive to strain via TGFβRI signalling. However, ADAMTS5 stimulation with strain 
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is not mediated via TGFβRI signalling therefore the former could be true. We have not 
confirmed whether the regulation of TGFβ2 is mediated via TGFβRI signalling therefore 
we cannot speculate as to why this occurs. This indicates that for these different genes 
there may be different modes of regulation. Mechanotransduction and the resulting 
modification of metalloproteinase and matrix genes is therefore complex. To complicate 
things further we have noted that Elastin showed a decreased response when strain and 
TGFβ were combined; Elastin was increased 3.8 fold with strain, 27.5 fold with TGFβ and 
11.2 fold with strain and TGFβ in combination. We have shown that Elastin was regulated 
via TGFβRI however we were unable to fully characterise this response. In speculation, 
this may result from a negative feedback mechanism triggered when the levels of TGFβ 
reach a threshold; more research is required to test this hypothesis. 
Even in the non-strained control cultures the addition of TGFβRI inhibitor caused mRNA 
levels to change in the opposite direction to the strain response, indicating a basal level of 
TGFβ signalling in non-strained cultures. This may be due to the tensional forces present 
across the tenocyte seeded collagen gel in the absence of cyclic loading. Even though the 
statistical values are close to the cut off for significance it is clear by the consistency of 
response between genes that TGFβRI is involved in their mechanotransduction.We have 
shown that TGFβ isoforms are not significantly increased with mechanical loading. 
However TGFβRI is increased with strain. The response of TGFβRI to strain paired with 
the increased in active TGFβ would result in an increased level of TGFβ signalling and 
therefore sensitising the TGFβ signalling pathway to the increase in active TGFβ. However 
to confirm this we would need to also measure TGFβRI at the protein level, perhaps by 
immunolocalisation studies. It would also be interesting to look at other TGFβ receptors 
such as TGFβRII and TGFβRIII which are also involved in the regulation of TGFβ 
signalling, however TGFβRI is the primary receptor involved in the canonical TGFβ 
signalling pathway. 
Our results have shown that in many cases the response to TGFβ tends to occur earlier than 
the response to mechanical loading: for example all the ADAMTSs, TIMP3, Fibronectin, 
thrombospondin-1, Tenascin C, Scleraxis, IL6, IGF1, CTGF, Elastin and TGFβRI all 
respond to TGFβ much quicker than they respond to strain alone. As the majority of these 
genes are being regulated by TGFβ signalling in response to mechanical load this is 
reflected in the temporal delay of gene regulation. We have shown that TGFβ is activated 
between 12 and 24 hours, at which point we see regulation of strain responsive genes. With 
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TGFβ the response is seen as early as 2 hours. Genes that show a later response to TGFβ, 
such as COL1A1, may be regulated by TGFβ indirectly because of the delay in response to 
TGFβ treatment. This could be mediated by CTGF, as CTGF has been shown to act as a 
downstream mediator of collagen synthesis (Duncan, Frazier et al. 1999). Pathway analysis 
is required to confirm this mechanism. 
COX2 and IL6 are regulated as early as 2 hours with mechanical strain. This suggests that 
they are responsive to mechanical loading by a mechanism that does not involve the 
activation of TGFβ at such as early time point. We have shown that IL6 response to 
mechanical loading at 24 and 48 hours involves TGFβRI signalling as inhibition of 
TGFβRI phosphorylation of SMAD proteins abrogates this strain induced response (data 
not shown). However we have not tested the expression of COX2 with the use of this same 
inhibitor, therefore we cannot confirm the involvement of TGFβ in the regulation of COX2 
after 24 hours. However it seems likely that the early response of these genes to load does 
not involve TGFβ activation as activation only occurs after 12 hours. COX2 or IL6 may be 
involved in the activation of TGFβ via some other signalling pathway.  
Taken together our data suggest that activation of TGFβ and subsequent TGFβ signalling is 
part of the mechanotransduction response of tenocytes to moderately high levels of strain. 
TGFβ up-regulation at both the protein and mRNA level with mechanical strain has been 
previously reported in tenocytes (Skutek, van Griensven et al. 2001; Yang, Crawford et al. 
2004) and other cell types (Riser, Cortes et al. 1996; Riser, Ladson-Wofford et al. 1999; 
Kim, Akaike et al. 2002; Baker, Ettenson et al. 2008). TGFβ has also been implicated as a 
regulatory step in the mechanical regulation of collagen (Yang, Crawford et al. 2004; 
Heinemeier, Olesen et al. 2007), although these studies have not specifically shown that 
activation of TGFβ is involved. Maeda and colleagues (Maeda, Sakabe et al. 2011) have 
reported TGFβ activation as a key regulator in scleraxis (a transcription factor expressed in 
tendon). However, we are the first to implicate TGFβ activation as a key regulator in the 
mechanoregulation of metalloproteinases and other matrix genes. As ADAMTS5 is not 
regulated via the same TGFβ signalling pathway, this suggests there is an alternative 
mechanotransduction pathway. This pathway may involve crosstalk with or may precede 
TGFβ activation. The next goal is to elucidate the mechanism by which mechanical strain 
induces latent TGFβ activation. As doing so could help us to fully understand how we 
could treat and ultimately prevent tendon disease.  
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5.5. CONCLUSIONS  
1. The majority of matrix gene and metalloproteinase respond to strain in are very 
similar manner to TGFβ. 
2. The majority of strain regulated changes of metalloproteinase and matrix genes 
is facilitated via TGFβRI. 
3. TGFβ isoforms are not significantly increased with mechanical load at the 
mRNA level. However, TGFβRI mRNA is significantly increased with 
mechanical load. 
4. TGFβ activation and not total TGFβ is increased in response to mechanical 
load. 
5. Two exceptions; ADAMTS5 and MMP13 may be regulated via another 
mechanotransduction mechanism. 
 
  
 
 
 
CHAPTER 6: How is TGFβ activated in response to 
mechanical loading? 
 
 
6.1. INTRODUCTION 
We have shown in the previous chapter that TGFβ activation occurs in response to 
mechanical loading in primary Achilles tenocytes, and that activation of TGFβ leads to the 
regulation of metalloproteinases, TIMPs and matrix genes. TGFβ is regulated on a number 
of levels including intracellular processing and the activation of a latent complex; several 
mechanisms of TGFβ activation have been defined in non tendon tissues. There are three 
main channels of activation which include protease cleavage, activation through integrin 
mediated tensional forces and the interaction of thrombospondin with LAP, generating 
either diffusible or non-diffusible TGFβ. 
Newly synthesised TGFβ protein contains a pro-peptide known as the latency associated 
peptide (LAP). In the trans-golgi network, post-translational modifications involve 
cleavage of LAP by the proprotein convertase furin (Dubois, Blanchette et al. 2001). TGFβ 
and LAP remain non-covalently bound rendering TGFβ inactive (Gentry and Nash 1990). 
However the process of inhibition is not yet fully understood. Latent TGFβ binding 
proteins (LTBP) form cysteine disulphide linkages with TGFβ homodimers via LAP, to 
form the Large Latent Complex (LLC) (Gleizes, Beavis et al. 1996; Saharinen, Taipale et 
al. 1996). LTBP is important in the secretion (Miyazono, Olofsson et al. 1991) and 
targeting of LLC to the extracellular matrix where transglutaminases covalently link the 
LTBP to ECM proteins such as fibronectin (Taipale, Saharinen et al. 1996; Nunes, Gleizes 
et al. 1997; Verderio, Gaudry et al. 1999).  
In the ECM, the LLC is a convenient store of potentially active TGFβ. Protease mediated 
activation of TGFβ can involve the activity of various proteases such as MT1-MMP, 
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MMP2, MMP3, MMP13, plasmin and thrombin (Lyons, Keski-Oja et al. 1988; Taipale, 
Koli et al. 1992; Yu and Stamenkovic 2000; D'Angelo, Billings et al. 2001; Maeda, Dean 
et al. 2002; Mu, Cambier et al. 2002). They can activate TGFβ by cleaving LAP from the 
latent TGFβ complex thereby releasing active TGFβ into the extracellular space. Surface 
localisation of proteases can involve M6P/IGF-II, CD44 or integrin interaction via RGD 
motifs. This releases active TGFβ pericellularly (Dennis and Rifkin 1991; Yu and 
Stamenkovic 2000; Mu, Cambier et al. 2002; Asano, Ihn et al. 2005). Integrins are also 
involved in the activation of TGFβ in the absence of protease activity. This involves 
tensional forces between the LLC sequestered in the ECM and the cellular cytoskeleton 
through the interaction of integrins with LAP (Munger, Huang et al. 1999; Wipff, Rifkin et 
al. 2007). This mechanism does not involve release of diffusible TGFβ but involves a 
conformational change and activation of TGFβ. Thrombospondin can also activate TGFβ. 
This occurs through the interaction of the LSKL motif with LAP and results in a 
conformational change and consequent activation of TGFβ without the release from the 
LAP (Schultz-Cherry and Murphy-Ullrich 1993; Crawford, Stellmach et al. 1998; Ribeiro, 
Poczatek et al. 1999). TGFβ is therefore regulated on many levels, through intracellular 
post-translational modification, localisation to the ECM and through a variety of activation 
mechanisms (For more details of TGFβ activation mechanisms see introduction). 
The aim of this experiment is to target known mechanisms of TGFβ activation to 
determine whether they are involved in the activation of TGFβ in response to mechanical 
loading. To do this a range of protease inhibitors to inhibit protease cleavage of TGFβ, an 
RGD inhibitory peptide preventing integrin binding to TGFβ, an inhibitory antibody 
against integrin β1, an LSKL peptide to prevent interaction of thrombospondin with LAP 
and a M6P peptide to inhibit M6P/IGF-II interaction with LAP were applied (see table 6.1 
for a list of inhibitors and their functions). 
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6.2. METHODS 
Inhibition of mechanisms of TGFβ activation: Tenocytes seeded (1.5 x 10
6 
cells/ml) in 
type I collagen (1mg/ml) were plated into tissue train Flexcell
TM
 plates and uniaxially 
strained at 5% at 1Hz for 48 hours with or without GM6001 and its inactive control, 
Pefabloc, Protease inhibitor cocktail, Pepstatin, Hirudin, RDG peptide inhibitor and control 
peptide, MAB13 antibody against integrin β1, LSKL mimetic peptides and an unspecific 
control (SLLK) and Mannose-6-Phosphate peptide inhibitor (for details of concentrations 
and functions see table 6.1). We were unable to complete dose response experiments for all 
these inhibitors due to constraints of time and funding, concentrations used were chosen on 
the basis of those used in previous experiments (see references in table 6.1). Medium was 
collected for analysis in the TGFβ Luciferase assay and gels were dissolved in Trizol for 
further RNA analysis. For further details of the Flexcell
TM
 setup see methods section 2.2.2. 
RNA analysis: RNA was extracted using the tri-spin method. RNA was quantitated, 
reverse transcribed and analysed using qRT-PCR for a selection of metalloproteinase and 
matrix genes. Data was normalised to TOP1 and expressed as the 2
∆Ct 
(mean ± SE or SD) 
Statistical analysis was performed using either the students t-test (two way, paired) or the 
Wilcoxon signed rank test depending on the number of repeats and normal distribution. For 
full details of protocols see methods section 2.3. 
TGFβ Luciferase assay: TGFβ was measured using a cell based system targeting SMAD 
proteins involved in TGFβ signalling. Medium from 48 hour strained gels was transferred 
onto SW1353 cells transfected with a SMAD specific construct linked to a luciferase 
reporter. Total TGFβ was measured by heat activating the TGFβ in the medium before 
incubation with the SW1353 cells. Luciferin was added to samples and fluorescence 
measured on the luminometer. For details of this protocol see general methods section 
2.4.1.  
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Inhibitor Concentration Function 
GM6001 10µM 
Broad spectrum inhibitor of metalloproteinase 
activity  
(Li, Chen et al., 2008) 
 
Pefabloc 0.5mM 
An inhibitor of Serine proteases 
(Nunes, et al. 1995) 
Protease inhibitor cocktail 1/500 dilution 
contains 4-(2-aminoethyl) benzenesulfonyl 
fluoride (AEBSF), pepstatinA, E-64, bestatin, 
leupeptin, and aprotinin. PIC inhibits a variety of 
proteases with broad specificity; more 
specifically the inhibition of serine, cysteine, 
aspartic proteases and aminopeptidases. 
Pepstatin 1µM An Aspartate protease inhibitor 
Hirudin 2U/ml 
An inhibitor of Thombin 
(Lockwood, toti et al., 2005; Norwitz, 
Snegovskikh et al., 2007) 
GRGDSP and control 
peptide GRGESP 
13µM 
RDG peptide inhibitor (Peptide sequence 
expressed by some integrins, that can bind LAP) 
(Munger et al., 1998; Choi, Kim et al., 2010) 
 
MAB13 20µg/ml 
antibody against integrin β1 
Given to us by Martin Humpheries 
LSKL mimetic peptides 
and 
SLLK unspecific control 
13µM 
LSKL is a peptide sequence within 
Thrombospondin that binds to LAP. 
(Kondou et al., 2003; Meek et al., 2003) 
Mannose-6-Phosphate 10µM 
A peptide that inhibits the interaction between 
M6P/IGF-II and LAP 
(Nunes et al., 1995) 
 
Table 6.1. Summary of Inhibitors and their functions.  References listed in the right 
hand column are those used to determine concentration for in the current study 
(Choi, Kim et al. 2010) (Nunes, Shapiro et al. 1995; Munger, Harpel et al. 1998; Kondou, 
Mushiake et al. 2003; Meek, Cooney et al. 2003; Lockwood, Toti et al. 2005; Norwitz, 
Snegovskikh et al. 2007; Li, Chen et al. 2008). Where no reference is listed the 
concentration suggested by the supplier was used. 
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6.3. RESULTS 
6.3.1. Protease inhibition studies 
There was no significant difference in the response to mechanical load in the level of 
active or total TGFβ in the presence of GM6001 compared to non-treated controls (Figure 
6.1 A). RNA analysis revealed no significant difference in MMP1, MMP13, ADAMTS5 or 
Elastin response to mechanical loading in the presence of GM6001 (Figure 6.1 B). We 
have confirmed that GM6001 was active even after 48 hours in culture (see optimisation 
section 3.4). 
The response of active TGFβ to mechanical load was not significantly changed with the 
addition of pefabloc compared to non-treated controls (Figure 6.2 A). There was no 
significant change in Total or active TGFβ. MMP1 mRNA was decreased in both strain 
and non-strain conditions in response to pefabloc treatment (Figure 6.2 B).  
Neither active nor total TGFβ regulation with strain was clearly affected by the addition of 
protease inhibitor cocktail (PIC) (Figure 6.3 A). MMP1 and MMP13 mRNA regulation 
with mechanical load was unaffected by the addition of PIC (Figure 6.3 B). However in 
ADAMTS5 there was a reduction in the response to strain with the addition of PIC. Elastin 
failed to show a clear response to mechanical load in this particular cell isolate. 
Pepstatin did not substantially alter the regulation of active or total TGFβ with strain (Fig 
6.4 A). There was a trend to decrease in the level of active TGFβ in the presence of 
pepstatin. MMP1, MMP13, ADAMTS5 and Elastin actually showed an increase in the 
response to mechanical loading compared to non-treated controls (Figure 6.4 B). 
Responses to mechanical loading were not substantially altered with the addition of 
hirudin; however there was a trend to increase in active and total TGFβ with the addition of 
hirudin in both strained and non-strained cultures (Figure 6.5 A). A similar response to 
mechanical loading was seen in cultures with or without hirudin in MMP1, MMP13 and 
ADAMTS5 (Figure 6.5 B). However Hirudin did cause a decrease in the strain response in 
Elastin. 
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Figure 6.1. GM6001 has no effect upon strain regulated TGFβ activation or strain 
regulated gene expression. (A) A cell based luciferase assay measuring levels of SMAD 
activatory soluble factor (see methods for details). GM6001 and its inactive control were added 
before the straining protocol (10µM). Data is normalised to transfection controls and negative 
controls before expression as a percentage of Total TGFβ (non-strain) (mean, n=3). (B) 
Quantitative Real Time PCR analysis of MMP1, MMP13, ADAMTS5 and Elastin in cells 
seeded at 1.5x10
6
 cells/ml in type I rat tail collagen at 1mg/ml after 5% cyclic strain after 48 
hours. Data normalised to TOP1 and expressed as the mean fold change with strain (n=3). 
Significant values are indicated as * (p<0.05) and ns = not significant; according to the t-test (2 
way, paired). 
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Figure 6.2. Pefabloc has a small effect upon strain regulated TGFβ activation. (A) A cell 
based luciferase assay measuring levels of SMAD activatory soluble factor (see methods for 
details). Pefabloc was added before the straining protocol (0.5mM). Data is normalised to 
transfection controls and negative controls before expression as a percentage of Total TGFβ 
(non-strain) (mean, n=3). (B) Quantitative Real Time PCR analysis of MMP1, MMP13, 
ADAMTS5 and Elastin in cells seeded at 1.5x10
6
 cells/ml in type I rat tail collagen at 1mg/ml 
after 5% cyclic strain after 48 hours. Data normalised to TOP1 and expressed as 2
∆Ct
, to 
highlight the differential regulation in both strain and non-strained samples (mean, n=3). 
Significant values are indicated as * (p<0.05) and ns = not significant; according to the t-test (2 
way, paired).  
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Figure 6.3. Protease inhibitor cocktail has no effect upon strain regulated TGFβ 
activation. (A) A cell based luciferase assay measuring levels of SMAD activatory soluble 
factor (see methods for details). Protease inhibitor cocktail was added before the straining 
protocol (1/500 dilution). Data is normalised to transfection controls and negative controls 
before expression as a percentage of Total TGFβ (non-strain) (mean ±SD, n=1). (B) 
Quantitative Real Time PCR analysis of MMP1, MMP13, ADAMTS5 and Elastin in cells 
seeded at 1.5x10
6
 cells/ml in type I rat tail collagen at 1mg/ml after 5% cyclic strain after 48 
hours. Data normalised to TOP1 and expressed as 2
∆Ct
, to highlight the differential regulation 
in both strain and non-strained samples (mean ±SD, n=1). 
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Figure 6.4. Pepstatin has no effect upon strain regulated TGFβ activation. (A) A cell 
based luciferase assay measuring levels of SMAD activatory soluble factor (see methods 
for details).  Pepstatin was added before the straining protocol (1µM). Data is normalised 
to transfection controls and negative controls before expression as a percentage of Total 
TGFβ (non-strain) (mean ±SD, n=1). (B) Quantitative Real Time PCR analysis of 
MMP1, MMP13, ADAMTS5 and Elastin in cells seeded at 1.5x10
6
 cells/ml in type I rat 
tail collagen at 1mg/ml after 5% cyclic strain after 48 hours. Data normalised to TOP1 
and expressed as 2
∆Ct
, to highlight the differential regulation in both strain and non-
strained samples (mean ±SD, n=1). 
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Figure 6.5. Hirudin has no effect upon strain regulated TGFβ activation. (A) A cell 
based luciferase assay measuring levels of SMAD activatory soluble factor (see methods 
for details). Hirudin was added before the straining protocol (2U/ml). Data is normalised to 
transfection controls and negative controls before expression as a percentage of Total 
TGFβ (non-strain) (mean ±SD, n=1). (B) Quantitative Real Time PCR analysis of MMP1, 
MMP13, ADAMTS5 and Elastin in cells seeded at 1.5x10
6
 cells/ml in type I rat tail 
collagen at 1mg/ml after 5% cyclic strain after 48 hours. Data normalised to TOP1 and 
expressed as a ratio of strain: non-strain (mean ±SD, n=1). 
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6.3.2. Inhibition of LAP-thrombospondin interaction  
LSKL is an inhibitory peptide of the interaction between thrombospondin and LAP; SLLK 
is a control peptide similar in structure to LSKL but without the ability to inhibit LAP 
interaction. Mechanical loading induced an increase in the level of active TGFβ in control, 
SLLK and LSKL treated cultures. There was no significant change in strain induced active 
or total TGFβ with the addition of LSKL (Figure 6.6 A). MMP1 mRNA regulation did not 
show such a marked change with strain compared to previous experiments. MMP1, 
MMP13, ADAMTS5 and Elastin mRNA regulation with mechanical strain was not 
significantly different when LSKL was added (Figure 6.6 B). 
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Figure 6.6. LSKL mimetic peptide has no effect upon strain regulated TGFβ activation. 
(A) A cell based luciferase assay measuring levels of SMAD activatory soluble factor (see 
methods for details). LSKL mimetic peptides and an unspecific control (SLLK) were added 
before the straining protocol (13µM). Data is normalised to transfection controls and negative 
controls before expression as a percentage of Total TGFβ (non-strain) (n=3). (B) Quantitative 
Real Time PCR analysis of MMP1, MMP13, ADAMTS5 and Elastin in cells seeded at 
1.5x10
6
 cells/ml in type I rat tail collagen at 1mg/ml after 5% cyclic strain after 48 hours. 
Data normalised to TOP1 and expressed as the mean fold change with strain (n=3). 
Significant values are indicated as * according to the t-test (2 way, paired) (p<0.05). 
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6.3.3. Integrin inhibition 
Control and MAB13 (integrin β1 antibody) treated cultures showed a significant increase 
in active TGFβ in response to mechanical loading. However those treated with control IgG 
did not show a significant change (Figure 6.7 A). Total TGFβ was not significantly 
different between control and MAB13 treated cultures. MMP1 mRNA did not show the 
usual decrease in response to strain (Figure 6.7 B). Control IgG treatment showed a similar 
response to controls with mechanical loading. Treatment with MAB13 showed a 
significant increase in Elastin in response to mechanical loading.  
There was no significant difference between control cultures and those treated with 
GRGDSP in terms of active TGFβ (Figure 6.8 A). Statistical analysis was only possible 
between strain and non-strain samples in control cultures and also between control and 
GRGDSP in strained cultures as the first repeat of this experiment did not include all 
conditions; restricting the statistical analysis to those conditions where three repeats were 
available. Again with the mRNA analysis we were restricted with statistical testing to those 
experiments that were of three repeats or more, however we were able to confirm that 
MMP1 and MMP13 regulation with strain were not significantly different in GRGDSP 
cultures compared to controls (Figure 6.8 B). ADAMTS5 and Elastin has similar patterns 
of regulation with strain in control, GRGESP and GRGDSP treated cultures, although this 
was restricted to n=2. 
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Figure 6.7. MAB13 β1 integrin antibody has no effect upon strain regulated TGFβ activation. 
(A) A cell based luciferase assay measuring levels of SMAD activatory soluble factor (see methods 
for details). MAB13 was added 30 minutes before the straining protocol (20µg/ml). Data is normalised 
to transfection controls and negative controls before expression as a percentage of Total TGFβ (non-
strain) (mean, n=3). (B) Quantitative Real Time PCR analysis of MMP1, MMP13, ADAMTS5 and 
Elastin in cells seeded at 1.5x10
6
 cells/ml in type I rat tail collagen at 1mg/ml after 5% cyclic strain 
after 48 hours. Data normalised to TOP1 and expressed as the mean fold change with strain (n=4). 
Significant values are indicated as * according to the t-test (2 way, paired) (p<0.05). 
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Figure 6.8. RGD peptide inhibition has no effect upon strain regulated TGFβ 
activation. (A) A cell based luciferase assay measuring levels of SMAD activatory soluble 
factor (see methods for details). GRGDSP and GRGESP were added before the straining 
protocol (7µM). Data is normalised to transfection controls and negative controls before 
expression as a percentage of Total TGFβ (non-strain) (mean, n=3). (B) Quantitative Real 
Time PCR analysis of MMP1, MMP13, ADAMTS5 and Elastin in cells seeded at 1.5x10
6
 
cells/ml in type I rat tail collagen at 1mg/ml after 5% cyclic strain after 48 hours. Data 
normalised to TOP1 and expressed as the mean  fold change with strain (n=3). Significant 
values are indicated as *, according to the t-test (2 way, paired) (p<0.05). 
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6.3.4. Inhibition of TGFβ - M6P/IGF-II interactions 
Although we were only able to repeat the luciferase assay to measure active and total 
TGFβ twice, we can see that the addition of M6P does not sufficiently affect the level of 
active TGFβ (Figure 6.9 A). There was no significant difference between control and M6P 
treatments in the presence of strain in MMP1, MMP13 or ADAMTS5 (Figure 6.9 B). 
However M6P significantly decreased Elastin mRNA expression compared to untreated 
controls in strained cultures, although this change was small (1.1 fold). 
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Figure 6.9. Mannose-6-Phosphate has no effect upon strain regulated TGFβ activation. 
(A) A cell based luciferase assay measuring levels of SMAD activatory soluble factor (see 
methods for details). Mannose-6-Phosphate was added to cultures before the straining 
protocol (10µM). Data is normalised to transfection controls and negative controls before 
expression as a percentage of Total TGFβ (non-strain) (n=2, n=1 is shown this is 
representative of both repeats, mean ±SD). (B) Quantitative Real Time PCR analysis of 
MMP1, MMP13, ADAMTS5 and Elastin in cells seeded at 1.5x10
6
 cells/ml in type I rat tail 
collagen at 1mg/ml after 5% cyclic strain after 48 hours. Data normalised to TOP1 and 
expressed as the mean fold change with strain (n=3). Significant values are indicated as *, 
according to the t-test (2 way, paired) (p<0.05). 
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6.4. DISCUSSION 
In this chapter we have shown that metallo, serine, cysteine, aspartic proteases and 
aminopeptidases are probably not involved in the activation of TGFβ  in response to 
mechanical loading (through the use of GM6001, pefabloc, protease inhibitor cocktail, 
pepstatin and hirudin), despite the evidence to show that protease can play an important 
role in the activation of TGFβ in other systems (Lyons, Keski-Oja et al. 1988; Taipale, 
Koli et al. 1992; Yu and Stamenkovic 2000; D'Angelo, Billings et al. 2001; Maeda, Dean 
et al. 2002; Mu, Cambier et al. 2002). TSP1 has also been reported to be one of the key 
regulators of TGFβ activation in other systems (Schultz-Cherry and Murphy-Ullrich 1993; 
Crawford, Stellmach et al. 1998; Ribeiro, Poczatek et al. 1999). In addition there is 
evidence to suggest that shear force is able to stimulate the activation of TGFβ in blood 
platelets (Ahamed, Burg et al. 2008), and that activation of TGFβ is partially facilitated by 
TSP1 (Ahamed, Janczak et al. 2009). However, here we show that the interaction between 
thrombospondin and LAP via the LSKL motif is not involved in the activation of TGFβ in 
response to mechanical load; this could be due to differences in force (shear and tensional 
force) or cell type (blood platelets and tenocytes). M6P/IGF-II interaction with LAP has 
also been shown to regulate TGFβ activation in other tissues (Dennis and Rifkin 1991). 
Here we show that TGFβ activation does not involve the interaction of TGFβ and 
M6P/IGF-II via M6P. 
Integrins have been reported as major regulators in the activation of TGFβ mainly via the 
RGD motif expressed by a subset of integrins (Yang, Mu et al. 2007; Aluwihare, Mu et al. 
2009). We have shown that RGD interactions may be obsolete in the regulation of TGFβ 
activation in response to mechanical load in tendon cells. In addition β1 integrin may not 
play a role in this process of activation. We therefore propose that TGFβ activation in 
response to mechanical loading in tenocytes is mediated by an unknown mechanism. 
As we have described in the introduction, TGFβ is targeted to the ECM in a large latent 
complex made up of the inactive TGFβ and the LLC. LTBP targets the LLC to the ECM 
where transglutaminase can bind the complex to components of the matrix such as 
fibronectin. The ECM is thought to act as a store of potentially active TGFβ. Therefore we 
should not be able to measure total TGFβ in the medium as usually this store of inactive 
TGFβ is sequestered in the ECM. In our system we have shown that both active and 
inactive TGFβ are detected in the medium. This suggests that, perhaps due to the lack of a 
more complex ECM (i.e. our cells are seeded into type I rat tail collagen), 
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transglutaminases are unable to sequester TGFβ LLC into the matrix and therefore TGFβ is 
detectable in the medium. It is likely that other ECM components such as fibronectin are 
laid down into the ECM as the cells are allowed to settle into the matrix for 72 hours 
before the loading regime is started. However an inability to attach to the matrix may be 
due to the lack of specific components such as mature fibronectin. Therefore the 
mechanism of activation in this simplified system may involve the activation of TGFβ as it 
is roams freely in the medium, which may rule out mechanisms of activation that involve 
tensional forces between the cells and the ECM. To further characterise the process of 
TGFβ activation we need to determine whether LTBP associates with TGFβ and whether 
the complex is sequestered in the ECM at any point. To do this we could use western 
blotting, ELISA or immune-localisation using specific LTBP binding antibodies.  
Another possibility is that TGFβ is sequestered in the ECM but proteases cleave the LLC 
so that a processed form of the LLC becomes diffusible and open to further activation. 
However because none of our protease inhibitors had any effect upon levels of active or 
total TGFβ, this does not appear to be the case. However, this cleavage may be mediated 
by a protease that is not abrogated by the inhibitors we have tested. For example, as we 
have discussed in the introduction BMP1 can produce a diffusible processed LLC (Ge and 
Greenspan 2006), though BMP1 has metalloprotease activity it is unclear whether BMP1 is 
inhibited by any of the protease inhibitors we have used. Therefore specific inhibition of 
BMP1 could determine whether it is involved in LLC release from the ECM. In addition 
we would need to confirm the activation mechanism that follows this release, as there is no 
evidence that BMP1 can also achieve this. 
MMP1, MMP13, Elastin and ADAMTS5 were chosen for RNA analysis in these inhibitor 
experiments to determine whether the inhibition of TGFβ activation mechanisms had any 
effect upon the regulation of these genes with mechanical strain. MMP1 and Elastin were 
chosen due to their robust responses and differential effects in response to mechanical 
loading. MMP13 and ADAMST5 were chosen because their regulation was independent of 
TGFβRI signalling; consequently if the inhibitors of TGFβ activation could inhibit 
MMP13 or ADAMTS5 regulation with strain we would be able to determine that another 
TGFβ pathway independent of TGFβRI was involved in their regulation. RNA analysis 
showed little difference in MMP1, MMP13, elastin and ADAMTS5 regulation with strain 
with the addition of the majority of these inhibitors. However, in cultures treated with 
pefabloc, MMP1 showed a trend to decrease in non-strained controls (not significant) and 
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an increase in strained cultures (highly significant, p=0.00678). This suggests that rather 
than inhibiting the strain induced response there was a more systemic effect. Similar results 
were seen in ADAMTS5 and elastin although these changes were not significant. Pepstatin 
induced an amplification of the strain induced decrease in MMP1 expression. Although not 
significant, Hirudin reduced the level of elastin and ADAMTS5 in response to mechanical 
strain and similar effects were seen with the protease inhibitor cocktail. This suggests that 
inhibition of thrombin may have some other effect upon ADAMTS5 and elastin that does 
not affect the mechanical regulation of MMP1 or MMP13. However because these 
experiments only looked at one cell isolate this cannot be confirmed at this stage. 
The response of elastin to mechanical loading was not as marked in these inhibitor 
experiments as previously reported. This may be due to the cell isolates used in these 
particular experiments. In addition these experiments were run for 48 hours without 
stopping the loading regime. Previous studies focused on a time course which meant 
stopping the strain multiple times during the regime in order to harvest different time 
points. The lack of pause in this regime may have resulted in elastin reaching its peak of 
stimulation at an earlier time point. This has been previously noted in experiments looking 
at only 24 and 48 hours, where they have only been paused once during the regime. The 
regulation at 24 hours was similar to that seen after 48 hours in time course experiments, 
with levels beginning to return to control levels after 48 hours (Data not shown). M6P 
significantly decreased the level of elastin stimulated in response to mechanical loading. 
However this was only a very small change, with a statistical value very close to the cut off 
for significance (p=0.0442). Therefore M6P is unlikely to have a regulatory role in the 
absence of any affect in TGFβ activation. 
Although we have looked at a wide range of TGFβ inhibition mechanisms, the study does 
have some limitations; many of our experiments were repeated less than three times due to 
time constraints, therefore they were not repeated enough times allow statistical testing. In 
addition, we were unable to confirm the effectiveness of all the inhibitors we used. 
However, we were able to confirm that GM6001 was capable of inhibiting MMP activity 
even after 48 hours of culture with tenocytes using a fluorescent substrate (see section 3.4). 
In addition, although we did not see the effect of these inhibitors upon the activation of 
TGFβ, some of the genes we measured showed a modified trend with inhibitor treatment, 
despite these changes not shedding light on strain mediated changes in gene expression. 
For example PIC reduced strain regulation of ADAMTS5, pepstatin induced an increase in 
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the strain response in MMP1, MMP13, elastin and ADAMTS5, and finally hirudin showed 
a decrease in the strain response in elastin. In addition the integrin β1 inhibitory antibody 
(MAB13) abrogated gel contraction seen in response to mechanical load (data not shown). 
This indicates that these inhibitors were effective at inhibiting there specific targets but did 
not affect TGFβ activation. However, neither the RGD nor LSKL peptide inhibitors 
showed any significant changes in terms of TGFβ activity or gene expression. Due to time 
constraints we were unable to confirm the inhibitory ability of these peptides. 
Confirmation of the activity of each of these inhibitors is required. 
We have shown that known mechanisms of TGFβ activation are probably not responsible 
for the activation of TGFβ in response to mechanical load; therefore this could represent a 
novel mechanism of activation. However, to characterise this mechanism, further research 
is needed. The literature reports that other signalling pathways, such as calcium and 
MAPK signalling (Wall and Banes 2005), are important in mechanotransduction. Perhaps 
targeting these pathways may determine how TGFβ is activated or to characterise the 
signalling mechanism proceeding TGFβ activation. Integrins are important communicators 
with the ECM, other integrin motifs such as the collagen binding motif GFOGER (Xu, 
Gurusiddappa et al. 2000; Zhang, Kapyla et al. 2003) could be involved in the regulation of 
TGFβ activation. Due to time constraints we were unable to test this hypothesis. However, 
inhibition of integrin binding of collagen via the GFOGER motif may reveal a novel 
mechanism of TGFβ activation. 
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6.5. CONCLUSIONS 
1. None of the known mechanisms of TGFβ activation are responsible for TGFβ 
activation in response to mechanical strain in our system. 
2. A novel mechanism of activation could be responsible for strain activation of 
TGFβ in the current study. 
 
  
 
 
 
CHAPTER 7:  Further characterisation of the 
mechanotransduction mechanism in human tenocytes 
 
 
7.1. INTRODUCTION 
ATP, as well as ADP and adenosine can act as activators of purinoceptors. Purinoceptors 
are involved in multiple physiological functions including inflammation, peripheral and 
central neuronal transmission and muscle contraction. Purinoceptors are categorised into 
two main groups, those which respond to ATP or its analogs (ADP, AMP and GTP) and 
those which are activated by adenosine these are termed P2 and P1 purinoceptors 
respectively. P2 purinoceptors are further categorised into groups P2X and P2Y; P2X are 
ligand gated ion channels which are selectively permeable to cations such as calcium, 
whereas P2Y are G-protein coupled receptors (Valera, Hussy et al. 1994; North 2002; 
Gever, Cockayne et al. 2006). A number purinoceptor signalling pathways have been 
implicated in the process of mechanotransduction. For example, ATP is released from the 
cell in response to mechanical loading (Graff, Lazarowski et al. 2000; Jones, Wall et al. 
2005); it can signal via P2 purinoreceptors. Activation of P2X purinoceptors (ligand gated 
ion channels) can cause the influx of cations such as calcium (Gever, Cockayne et al. 
2006).  P2Y activation via ATP can act in either an autocrine or paracrine fashion. Upon 
ATP binding to G coupled purinoreceptors (P2Y), G proteins are activated via GTP 
binding, this results in the activation of phospholipase C which cleaves 
phosphotidylinositol 4,5- bisphosphate (PIP2) into Inositol-3-phosphate (IP3) and 1,2 
dicylglycerol (GAG). Inositol 1,4,5-triphosphate (IP3) translocates into the cytoplasm and 
can act upon calcium sensitive ion channels located on the endoplasmic reticulum (ER), 
this results in the release of calcium from intracellular stores. Calcium, IP3 and ATP can 
enter the cell or be released to signal to other cells through GAP junction hemi-channels or 
calcium channels (Naruse, Sai et al. 1998; Naruse, Yamada et al. 1998; Stout, Costantin et 
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al. 2002; Wall and Banes 2005). Calcium transients have been reported in some studies and 
not others, therefore the role of calcium in tendon mechanotransduction is not fully 
understood (Hung, Allen et al. 1997; Elfervig, Francke et al. 2000; Franke, Banes et al. 
2000; Elfervig 2001; Elfervig, Lotano et al. 2001; Archambault, Elfervig-Wall et al. 2002; 
Wall and Banes 2004; Wall and Banes 2005).  
P2Y1 and P2Y2 purinoceptors are responsible for downstream ATP signalling events 
(increase in intracellular calcium) in rodent Achilles tendon (Fox, Jones et al. 2005; Jones, 
Yang et al. 2005). Studies of various other organs have also shown that P2X and P2Y 
purinoceptors are involved in the response to mechanical load; these include response to 
compressive force upon human cartilage (P2Y) (Millward-Sadler, Wright et al. 2004), fluid 
flow in osteoblasts (P2Y) (You, Jacobs et al. 2002), fluid flow endothelial cells (P2X4) 
(Yamamoto, Korenaga et al. 2000) and mechanical stimulation of smooth muscle cells (P1 
and P2 receptors) (Hamada, Takuwa et al. 1998).  
By blocking calcium channels, phospholipase C and intracellular storage of calcium we 
hoped to confirm whether calcium signalling is involved in the response to mechanical 
load. The following inhibitors were selected: α18-Glycerrhitinic acid and GAP27 are gap 
junction inhibitors, α18-glycerrhitinic acid is a general gap junction blocker and Gap27 is a 
selective gap junction blocker specific to Cx43 (a mimetic peptide derived from the Gap27 
domain of connexin 43). Thapsigargin is a non-competitive inhibitor of calcium ATPase 
and results in the increase of cytosolic calcium and depletion of intracellular calcium 
stores. U73122, Nifedipine and Amiloride are an inhibitor of phospholipase C, an L-type 
calcium channel blocker and a t-type calcium channel blocker respectively. Apyrase 
contains 2 isoenzymes; ATPase and ADPase they are involved in the degradation of ATP 
and ADP (ATP → ADp + Pi → AMP + 2Pi).  
The MAPK network is involved in multiple cell processes. Components of MAPK 
signalling are reported to be involved in TGFβ signalling (Moustakas and Heldin 2005) 
and mechanotransduction in terms of stress deprivation (Kawabata, Katsura et al. 2009). 
For instance p38 MAPK is stimulated in response to stress deprivation and p38, MKK1 
and PI3K are involved in TGFβ signalling crosstalk (Moustakas and Heldin 2005; 
Kawabata, Katsura et al. 2009). By inhibiting a range of these kinases we can determine 
whether they are involved in the mechanotransduction and consequent regulation of 
metalloproteinase and matrix regulation with mechanical strain or determine whether 
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signalling via MAPK pre or proceeds the activation of TGFβ. Two inhibitors for each of 
the following pathways were chosen: p38 MAPK (SB203580, Doramapimod), MKK1 
pathway (PD0325901, U0126) and PI3K (Wortmannin, PI-103). Each of these inhibitors 
acts in a different manner to its partner inhibitor, therefore when both inhibitors effectively 
inhibit either TGFβ activation or gene regulation we can confirm which pathway is 
involved. 
Previous studies have looked at the functional interaction of TGFβ and IL6. In intestinal 
epithelial cells TGFβ has been shown to abrogate the phosphorylation of STAT1 and 
STAT3 in response to IL6 stimulation. This suggests that TGFβ is able to modify the IL6 
signalling pathway (Walia, Wang et al. 2003). A study of airway smooth muscle cells has 
shown that TGFβ can induce IL6 release (Michaeloudes, Sukkar et al. 2011). Therefore 
TGFβ has the potential to either positively or negatively regulate IL6 protein synthesis as 
well as its signalling. 
IL6 may also play a role in the regulation of TGFβ signalling. For example, IL6 positively 
regulates TGFβ induction of CTGF in studies of cardiac allograft rejection (Booth, 
Csencsits-Smith et al. 2010). In response to IL6 treatment in epithelial cells, TGFβ 
signalling was increased due to the reduced localisation of IL6 receptor with Calveolin-1 
lipid rafts, this increased the level of TGFβ receptor localisation to early endosome 
antigen-1 (EEA-1) non lipid raft pathways, which meant an increase in trafficking of TGFβ 
receptors and increased TGFβ signalling (Zhang, Topley et al. 2005). However, IL6 was 
also shown to inhibit TGFβ stimulated apoptosis via PI3K/Akt and STAT3 in the liver 
(Chen, Chang et al. 1999). This indicates that there is a complex relationship between 
TGFβ and IL6; they are able to regulate each other’s expression and signalling in both a 
positive and negative manner. Therefore there is a possibility that IL6 may be involved in 
the regulation of strain induced TGFβ signalling in some way. In addition, IL6 was 
increased and IL6R was decreased in both painful and ruptured tendon (Jelinsky, Rodeo et 
al. 2011; Legerlotz, Jones et al. 2012). This indicates that IL6 may also play a role in 
tendinopathy. 
According to our TLDA analysis, IL6 mRNA showed a trend to increase after 2 hours in 
response to mechanical loading. Standard Taqman analysis showed IL6 was significantly 
regulated with strain compared to non-strained controls after 24 hours (data not shown). 
We have confirmed that at 24 hours IL6 stimulation is mediated via TGFβ signalling, as 
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TGFβRI inhibitor abrogated the strain induced increase in IL6 (data not shown). However 
this cannot be the case for the early stimulation because TGFβ activation does not occur 
until after 8 hours (see chapter 5), therefore these proteins may be involved in the 
activation of TGFβ. By using a functionally inhibiting antibody of IL6 as well as siRNA 
we aimed to characterise the role of IL6 in mechanotransduction.  
In our TLDA experiments (see chapter 4) COX2 mRNA was increased in response to 2 
hours mechanical loading, as this precedes TGFβ activation COX2 may be involved in the 
activation of TGFβ in response to mechanical loading. COX2 was also increased in both 
painful and ruptured tendon (Legerlotz, Jones et al. 2012), therefore COX2 may also play a 
role in tendinopathy. We chose to use an inhibitor known as Indomethacin, a non steroidal 
anti-inflammatory drug known to inhibit both COX1 and COX2, to determine whether 
COX2 was involved in mechanotransduction. 
ADAM12 is reported to facilitate TGFβ signalling via the association of ADAM12 with 
TGFβRII, resulting in the accumulation of ADAM12/TGFβRII in the early endosome, the 
suppression of TGFβRII association with SMAD7 (inhibitory SMAD) and the initiation of 
SMAD signalling; which occurs in the absence of protease activity (Atfi, Dumont et al. 
2007). ADAM12 is also able to bind to β1 and β3 integrins via a non-RGD and RGD-like 
motif respectively. ADAM12 ligation of integrin β3 in human breast carcinoma cells, can 
induce a RhoA signalling cascade followed by an increase in focal adhesion complexes 
(Kveiborg, Albrechtsen et al. 2008). As we have discussed in chapter 1, integrins have 
been reported as key sensors in the detection of mechanical load. The increase in 
ADAM12 in the response to mechanical load (see chapter 4) may induce the formation of 
focal adhesions and therefore increase the cells sensitivity to mechanical load or increase 
TGFβ signalling, which we have shown to be involved in mechanotransduction. Although 
as this evidence comes from experiments performed on human breast carcinoma and 
kidney cell lines, it may not be applicable to tenocytes. However there is a possibility that 
ADAM12 may play a role in the mechanotransduction pathway in tendon via integrin or 
TGFβ interaction. To determine whether ADAM12 is involved in TGFβ activation in 
response to mechanical loading we used siRNA to knockdown ADAM12 mRNA. 
We have shown that TGFβ is activated in response to mechanical load. However the 
luciferase assay we use to determine TGFβ activation (See chapter 5) does not discriminate 
between the different isoforms of TGFβ. In order to determine which isoforms are 
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activated in response to mechanical strain we used siRNA to knockdown each isoform, by 
measuring the activation of TGFβ using the luciferase assay we could therefore determine 
the isoforms involved and by using qRT-PCR we can determine the differential effects of 
each TGFβ isoform upon strain induced gene expression. 
SMAD4 is the co-SMAD involved in both TGFβ and BMP signalling (Shi and Massague 
2003). We have shown that some genes such as MMP13 and ADAMTS5 are regulated 
with mechanical load but not via TGFβRI (see chapter 5). Therefore we chose to use 
siRNA to inhibit SMAD4 to determine whether SMAD4 signalling is involved in the 
regulation of these genes.  
In summary, in this chapter we aimed to determine whether any of the above mechanisms 
are involved in either the activation of TGFβ or the regulation of metalloproteinase and 
matrix genes or both. Active and Total TGFβ were measured to confirm whether the 
inhibitors are abrogating the activation of TGFβ and a range of metalloproteinase and 
matrix genes were measured by qRT-PCR to confirm whether regulation occurs 
downstream of TGFβ activation. 
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7.2 METHODS 
Inhibitor experiments: Tenocytes were seeded (1.5 x 10
6 
cells/ml) in type I collagen 
(1mg/ml), plated into tissue train Flexcell
TM
 plates and uniaxially strained at 5% at 1Hz for 
48 hours with or without the following: Indomethacin, SB203580, Doramapimod, 
PD0325901, U-0126, Wortmannin and PI-103, GAP27, 18α-glycyrrhetinic acid, 
Thapsigargin, U73122, Nifedipine, Amiloride, Apyrase, recombinant IL6 (0.8ng/ml), IL6 
antibody and LEAF
TM
 purified rat IgG2 control antibody (for a summary of inhibitor 
functions and concentrations see table 7.1.) as appropriate (treatments were added just 
before the strain protocol was started). Medium was collected for analysis in the TGFβ 
Luciferase assay and gels were dissolved in Trizol for further RNA analysis. For full 
details of this protocol see methods section 2.2. 
siRNA knockdown experiments: Tenocytes were incubated with transfection medium 
(TGFβ1, TGFβ2, TGFβ3, SMAD4, IL6 and ADAM12 siRNA plus Dharmafect 1 
transfection reagent at 50nM and 0.2% respectively) for 48 hours. Cells were seeded (1.5 x 
10
6 
cells/ml) in type I collagen (1mg/ml), plated into tissue train Flexcell
TM
 plates and 
uniaxially strained at 5% at 1Hz for 48 hours. Medium was collected for analysis in the 
TGFβ Luciferase assay and gels were dissolved in Trizol for further RNA analysis. For full 
details of this protocol see methods section 2.2.5. 
RNA analysis: RNA was extracted using the tri-spin method essentially as described by 
(Ireland, Harrall et al. 2001). RNA was quantitated, reverse transcribed and analysed using 
qRT-PCR for a selection of metalloproteinase and matrix genes. Data was normalised to 
TOP1 and expressed as the 2
∆Ct
 or 2
∆∆Ct
. The Students T-test (two-way, paired) was used to 
assess statistical significance. In some experiments we were unable to perform statistical 
analysis on experiments where n<3. For full details of this protocol see methods section 
2.3. 
TGFβ Luciferase assay: The TGFβ luciferase assay was conducted essentially as 
described by Jonk (Jonk, Itoh et al. 1998). In brief, TGFβ was measured using a cell based 
system to measure SMAD activity, a key step in canonical TGFβ signalling. Medium from 
48 hour strained gels was transferred onto SW1353 cells transfected with a SMAD specific 
construct linked to a luciferase reporter. Total TGFβ was measured by heat activating the 
TGFβ in the medium before incubation with the SW1353 cells. Luciferin was added to 
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samples and fluorescence measured on the illuminometer. For details of this protocol see 
methods section 2.4.1. 
  
Chapter 7: Further Characterisation of Mechanotransduction 
249 
 
 
Inhibitor Concentration Function 
 
Indomethacin 
 
25µM 
 
Inhibitor of COX1 and COX2 
(Wang, Jia et al., 2003) 
SB203580 5µM 
Inhibitor of p38 MAPK 
(Bain, Plater etal., 2007) 
Doramapimod 0.1µM 
Inhibitor of p38 MAPK 
(Bain, Plater etal., 2007) 
PD0325901 0.1µM 
Inhibitor of MKK1 
(Bain, Plater etal., 2007) 
U-0126 20µM 
Inhibitor of MKK1 
(Bain, Plater etal., 2007) 
Wortmannin 0.1µM 
Inhibitor of PI3K 
(Bain, Plater etal., 2007) 
PI-103 0.5µM 
Inhibitor of PI3K 
(Bain, Plater etal., 2007) 
GAP27 50µM 
Specific inhibitor of Cx43 Gap junctions 
(Wright, Van Steensel et al., 2009) 
18α-glycyrrhetinic acid 100µM 
Broad spectrum Gap junction inhibitor 
(Kamijo, Haraguchi et al., 2006) 
Thapsigargin 10µM 
Non-competitive inhibitor of calcium ATPase 
(Law, Pachter et al., 1990) 
U73122 10µM 
Inhibitor of phospholipase C 
(Suh, Kim et al., 2000) 
Nifedipine 10µM 
An L-type Calcium channel blocker 
(Hattori, Matsunaga et al., 2006) 
 
Amiloride 10µM 
A T-Type calcium channel blocker 
(Rusch, Kros et al., 1994) 
Apyrase 10U/ml 
Contains ATPase and ADPase which catalyse the 
degradation of ATP and ATP respectively 
(Cao, young et al., 2007) 
IL6 antibody 0.4µg/ml 
Functionally inhibiting antibody against IL6 
(Antibody requirement calculated according to level 
of IL6 measured in the media) 
LEAF
TM
 purified rat 
IgG2 control antibody 
 
0.4µg/ml Control antibody for functional studies 
 
Table 7.1 Summary of Inhibitors and their functions. References listed in the right hand 
column are those used to determine concentration for in the current study (Law, Pachter et 
al. 1990; Rusch, Kros et al. 1994; Suh, Kim et al. 2000; Wang, Jia et al. 2003; Hattori, 
Matsunaga et al. 2006; Kamijo, Haraguchi et al. 2006; Bain, Plater et al. 2007; Cao, Young 
et al. 2007; Wright, van Steensel et al. 2009). 
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7.3. RESULTS 
 
7.3.1. Inhibition of Calcium signalling 
Active TGFβ was increased and total TGFβ remained unchanged in response to 
mechanical loading as we have reported in previous experiments (Figure 7.1 A). α18-
glycerritinic acid induced a trend to decrease in the level of active TGFβ in strained and 
non-strained cultures, with no effect upon total TGFβ. Whereas gap27 has no effect upon 
active TGFβ in terms of either active or total TGFβ. Thapsigargin induced a trend to 
decrease in the level of active TGFβ with mechanical loading but also decreased total 
levels of TGFβ in both strained and non-strained cultures. U73122, Nifedipine and 
Amiloride did not have substantial effects upon the levels of active or total TGFβ released 
in response to mechanical loading.  
ADAM12 mRNA is increased with mechanical loading as in previous experiments (Figure 
7.1 B). Thapsigargin induced a trend to decrease in the levels of ADAM12 in both strained 
and unstrained cultures. U73122 and α18-glycerritinic acid induced a trend to increase in 
ADAM12 expression in non-strained cultures and decrease in strained cultures. Gap27, 
nifedipine and amiloride did not have an effect upon the regulation of ADAM12 with 
mechanical load.  
In this experiment Elastin was increased (~1.5 fold) with mechanical load, substantially 
less than reported previously (Figure 7.1 C). U73122 and Thapsigargin reduced the overall 
level of Elastin expression with no effect upon the strain response (fold change with 
strain). α18-glycerrhitinic acid induced a trend to decrease in the strain induced regulation 
of Elastin. Gap27 and nifedipine had little effect upon the strain regulation of elastin, 
however amiloride increased the strain induced response by decreasing Elastin expression 
in non-strained cultures only. 
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Figure 7.1. Inhibition of Calcium signalling in mechanically strained tenocytes. (A) 
A cell based luciferase assay measuring levels of SMAD activatory soluble factor (see 
methods for details). GAP27 (50µM), 18α-glycyrrhetinic acid (100µM), Thapsigargin 
(10µM), U73122 (10µM), Nifedipine (10µM), Amiloride (10µM) were added to cells 
seeded at 1.5x10
6
 cells/ml in type I rat tail collagen at 1mg/ml before they were 
cyclically strained at 5% at 1Hz for 48 hours. Data was normalised to transfection 
controls and negative controls before expression as a percentage of Total TGFβ (non-
strain) (n=2, n=1 is shown and is representative of both sets of data, ± SD). (B and C) 
Quantitative Real Time PCR analysis of ADAM12 and Elastin in cells seeded at 1.5x10
6
 
cells/ml in type I rat tail collagen at 1mg/ml after 5% cyclic strain (1Hz) after 48 hours. 
Data normalised to TOP1 and expressed as the 2
∆Ct
 (n=2, n=1 is shown and is 
representative of both sets of data, ± SD). 
 
Chapter 7: Further Characterisation of Mechanotransduction 
252 
 
7.3.2. ATP/ADP degradation  
Apyrase decreases the level of active TGFβ increased with mechanical load, however the 
total level of TGFβ was also decreased in both strained and non-strained samples (Figure 
7.2 A). In order to test whether Apyrase effects the measurement of TGFβ using the 
luciferase assay SW1353 cells were incubated with 1ng/ml TGFβ and Apyrase (Figure 7.2 
B). The results showed that Apyrase inhibited the detection of TGFβ in the medium. We 
also measured a range of metalloproteinases and cytokines using qRT-PCR including 
TGFβ1, TGFβ2, TGFβ3, IL1, IL6, MMP1, ADAM12 and Elastin (Figure 7.2 C). Overall, 
Apyrase affected basal levels of gene expression but had no clear affects upon strain 
regulation of the genes tested
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Figure 7.2. Apyrase regulates basal levels of cytokines, protease and matrix genes but 
has no clear effect upon their strain regulation. (A,B) A cell based luciferase assay 
measuring levels of SMAD activatory soluble factor (see methods for details). Apyrase was 
added before the straining protocol (10U/ml). Data is normalised to transfection controls and 
negative controls before expression as a percentage of Total TGFβ (non-strain) (n=3). (B) 
TGFβ ±Apyrase were added to the luciferase assay to test whether Apyrase effects the 
detection of TGFβ. (C) Quantitative Real Time PCR analysis of MMP1, MMP13, ADAMTS5 
and Elastin in cells seeded at 1.5x10
6
 cells/ml in type I rat tail collagen at 1mg/ml after 5% 
cyclic strain after 48 hours. Data normalised to TOP1 and expressed as the 2
∆Ct
 (n=3).  
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7.3.3. Inhibition of Kinases  
The responses of two cell isolates are shown in figure 7.3 A and B, active TGFβ was 
increased with strain as we have previously reported. SB203580, Doramapimod, 
PD0325901, Wortmannin and PI-103 had little effect upon the strain induced up-regulation 
of active TGFβ in either cell isolate. U0126 induced a trend to decrease in the level of 
active TGFβ measured in strained cultures. However there was a high standard deviation in 
these experiments and high variability between cell isolates.  
MMP1 mRNA was decreased with mechanical loading in control cultures (Figure 7.3 C). 
The p38 MAPK inhibitors SB203580 and Doramapimod did not modify MMP1 regulation 
with strain. MKK1 pathway inhibitors were inconsistent in their response. PI3K inhibitors 
PI-103 increased MMP1 mRNA in both strained and non-strained conditions (p=0.03), 
however despite the addition of PI-103 there was still a decrease in the level of MMP1 in 
strained compared to non-strained cultures. 
MMP13 and ADAMTS5 were decreased and increased respectively in response to strain as 
in previous experiments (Figure 7.3 D and E).  However the addition of MAPK inhibitors 
did not significantly regulate strain induced MMP13 or ADAMTS5 expression. 
Elastin was increased with mechanical strain as we have shown previously. SB203580, 
Doramapimod, Wortmannin and PD0325901 had little effect upon the strain regulation of 
Elastin (Figure 7.3 F). U0126 increased the level of Elastin in non-strained cultures 
compared to untreated controls but had no effect upon strained samples (p=0.04) and PI-
103 decreased the level of Elastin in strained cultures compared to untreated controls 
(p=0.005). However the strain response (as a fold change) was not substantially affected 
with the addition of U0126 or PI-103. 
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Figure 7.3. Inhibition of kinases in mechanically strained tenocytes. (A) A cell based 
luciferase assay measuring levels of SMAD activatory soluble factor (see methods for 
details). SB203580 (5µM), Doramapimod (0.1µM), PD0325901 (0.1µM), U-0126 (20µM), 
Wortmannin (0.1µM) and PI-103 (0.5µM) were added to cells seeded at 1.5x10
6
 cells/ml in 
type I rat tail collagen at 1mg/ml before they were cyclically strained at 5% at 1Hz for 48 
hours. Data was normalised to transfection controls and negative controls before expression 
as a percentage of Total TGFβ (non-strain) (n=2, data of n=1 is shown and is representative of 
both repeats, ± SD). (B-E) Quantitative Real Time PCR analysis of MMP1 (B), MMP13 (C), 
ADAMTS5 (D) and Elastin (E) in cells seeded at 1.5x10
6
 cells/ml in type I rat tail collagen at 
1mg/ml after 5% cyclic strain after 48 hours. Data normalised to TOP1 and expressed as the 
2
∆Ct
 ± SD. Students T-test (two way, paired) was used to test statistical significance. 
Significance is denoted by * (compared to paired [either non-strain or strain] control) (n=3). 
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7.3.4. COX inhibition  
Active TGFβ was increased with 48 hours of strain as we have reported previously (Figure 
7.4 A). Indomethacin had no effect upon the strain regulation of TGFβ, with no change in 
active or total TGFβ in strained or non-strained cultures. MMP1 and MMP13 were 
decreased with mechanical strain and COL1A1, ADAMTS5 and Elastin were increased in 
response to loading, however these levels were not as marked as in previous experiments. 
The addition of Indomethacin had no effect on the expression of these genes in response to 
strain (Figure 7.4 B).   
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Figure 7.4. Cyclooxygenase inhibition has no effect upon the level of TGFβ activation 
stimulated by strain. (A) A cell based luciferase assay measuring levels of SMAD 
activatory soluble factor (see methods for details). Indomethacin (25µM) was added to 
cultures before the straining protocol. Data was normalised to transfection controls and 
negative controls before expression as a percentage of Total TGFβ (non-strain) (n=2, n=1 
is shown and is representative of the two repeats, ± SD). (B) Quantitative Real Time PCR 
analysis of MMP1, MMP13, ADAMTS5, COL1A1 and Elastin in cells seeded at 1.5x10
6
 
cells/ml in type I rat tail collagen at 1mg/ml after 5% cyclic strain after 48 hours. Data was 
normalised to TOP1 and expressed as the 2
∆Ct
 ± SD (n=1 is shown and is representative of 
the two repeats). 
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7.3.5. IL6 functionally inhibiting antibody inhibits TGFβ activation 
Active TGFβ was increased in response to mechanical loading as previously reported. IL6 
alone had no effect upon activity of TGFβ; however, the IL6 antibody decreased the level 
of active TGFβ in strained cultures by approximately ~50% (Figure 7.5 A). The addition of 
recombinant IL6 in combination with IL6 neutralising antibody did not affect the level of 
active TGFβ compared to non-treated controls. Detection of total TGFβ was higher in 
controls than in cultures treated with recombinant IL6 or IL6 neutralising antibody. 
MMP1 mRNA was decreased with mechanical loading as previously reported (Figure 7.5 
B). Recombinant IL6 had little effect upon MMP1 expression; however IL6 neutralising 
antibody inhibited the decrease in MMP1 in response to strain. MMP13 mRNA was 
decreased with strain (Figure 7.5 D); recombinant IL6 had little effect upon strain 
regulation of MMP13 mRNA; however a combination of recombinant IL6 and IL6 
antibody increased the level of MMP13 in strained cultures. IL6 antibody alone had little 
effect upon strain regulation of MMP13. ADAMTS5, Elastin and COL1A1 were increased 
with mechanical loading as in previous experiments (Figure 7.5 B, C and E). Addition of 
recombinant IL6 and IL6 neutralising antibody had no effect upon the expression of 
ADAMTS5, Elastin or COL1A1.  
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Figure 7.5. IL6 inhibitory antibody reduces the level of TGFβ activation stimulated by 
strain. (A) A cell based luciferase assay measuring levels of SMAD activatory soluble factor 
(see methods for details). 0.8ng/ml recombinant IL6 and 0.4µg/ml IL6 antibody were added to 
cells seeded at 1.5x10
6
 cells/ml in type I rat tail collagen at 1mg/ml before they were cyclically 
strained at 5% at 1Hz for 48 hours. Data was normalised to transfection controls and negative 
controls before expression as a percentage of Total TGFβ (non-strain) (n=2, n=1 is shown and 
is representative of the two repeats, ± SD). (B-F) Quantitative Real Time PCR analysis of 
MMP1 (B), MMP13 (D), ADAMTS5 (C), COL1A1 (E) and Elastin (F) in cells seeded at 
1.5x10
6
 cells/ml in type I rat tail collagen at 1mg/ml after 5% cyclic strain after 48 hours. Data 
was normalised to TOP1 and expressed as the 2
∆Ct
 ± SD (n=2, n=1 is shown and is 
representative of the two repeats). 
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7.3.6. siRNA Knockdown  
TGFβ isoforms 
All TGFβ siRNA produced 99% knockdown of their respective isoforms (Figure 7.6 A). 
TGFβ1 and TGFβ3 siRNA reduced the level of TGFβ activation by 71 and 39% 
respectively (Figure 7.6 B). TGFβ2 siRNA had little effect upon the level of TGFβ 
activation in response to mechanical strain. TGFβ1 siRNA induced a trend to increase, 
decrease and decrease in MMP1, ADAMTS5 and TGFβ2 expression (respectively) in 
strained cultures compared to the scrambled control (Figure 7.7). TGFβ2 siRNA induced a 
trend to decrease in MMP13 and ADAMTS5 expression in strained cultures compared to 
scrambled controls. TGFβ3 siRNA induced a trend to decrease in MMP1 and MMP13 
expression in strained cultures compared to scrambled controls. TGFβ siRNA had no clear 
effects upon Elastin regulation (Data not shown). 
ADAM12 
ADAM12 siRNA successfully knocked down the expression of ADAM12 by 99% (Figure 
7.6 A). However ADAM12 siRNA had no effect upon TGFβ activation or the regulation of 
MMP1, MMP13, Elastin, ADAMTS5, SMAD4, TGFβ1, TGFβ2 or TGFβ3 mRNA 
expression (Figure 7.7) (Elastin, TGFβ1, TGFβ2, TGFβ3 and SMAD mRNA data not 
shown). 
IL6 
We were unable to determine whether IL6 was knocked down was successful, as IL6 was 
undetectable in all samples. However, previous knockdown was more than 99% successful. 
IL6 knockdown induced a trend to increase in MMP1 and MMP13 expression in strained 
samples compared to scrambled controls (~2fold) (figure 7.7 A and B). IL6 knockdown 
had no effect upon ADAM12, ADAMTS5, Elastin, SMAD4, TGFβ1, TGFβ2 or TGFβ3 
mRNA expression. (Elastin, TGFβ1, TGFβ2, TGFβ3 and SMAD mRNA: data not shown). 
SMAD4 
SMAD4 mRNA was successfully knocked down with siRNA (99%) (Figure 7.6 A). 
SMAD4 knockdown induced a trend to increase in MMP13 expression (figure 7.7 B) and a 
trend to decrease in ADAM12 expression (data not shown) in response to strain compared 
to the scrambled siRNA control. SMAD4 siRNA had little effect upon MMP1, Elastin 
(data not shown) and ADAMTS5 regulation with mechanical strain (Figure 7.6 A and C).  
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Figure 7.6. Knockdown of TGFβ1 and TGFβ3 RNA reduces the activation of 
TGFβ with strain. Percentage knockdown of TGFβ isoforms 1, 2 and 3, SMAD4 
and ADAM12 are shown (A). A cell based luciferase assay measuring levels of 
SMAD activatory soluble factor (see methods for details). Cells were treated with 
transfection media for 48 hours before they were seeded at 1.5x10
6
 cells/ml in type I 
rat tail collagen at 1mg/ml. Tenocyte seeded gels were cyclically strained at 5% at 
1Hz for 48 hours. Data was normalised to transfection controls and negative controls 
before expression as a percentage of total TGFβ (non-strain) (n=1, ± SD) (B).  
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Figure 7.7. siRNA knockdown and regulation of gene expression in response to 
strain. Cells were treated with transfection media for 48 hours before they were seeded at 
1.5x10
6
 cells/ml in type I rat tail collagen at 1mg/ml. Tenocyte seeded gels were 
cyclically strained at 5% at 1Hz for 48 hours. Quantitative RT-PCR was used to measure 
MMP1 (A), MMP13 (B) and ADAMTS5 (C) RNA. Data is normalised to TOP1 and 
expressed as 2
∆Ct
 ± SD (n=1).  
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7.4. DISCUSSION 
In this chapter I present preliminary evidence to indicate that TGFβ1 and TGFβ3 are the 
major isoforms of TGFβ activated with mechanical strain (approximately 70% and 30% 
respectively). This correlates well with the mRNA data, which showed high levels of 
expression of TGFβ1 and TGFβ3 compared to TGFβ2 (TGFβ1, TGFβ2 and TGFβ3 had an 
average Ct of 22.5, 33.3 and 25.6 respectively). We have evidence to show that MMP1, 
MMP13 and ADAMTS5 are regulated via separate pathways, and that each involves TGFβ 
signalling in some way (discussed further below). In an effort to further characterise 
preceding events in the activation of TGFβ, we have shown that calcium signalling via 
GAP junctions, phospholipase conversion of PIP2 to PI3 kinase, as well as the transport of 
calcium via L and T type calcium channels are probably not involved in the activation of 
TGFβ with strain or proceeding gene regulation. MAP kinase signalling pathways 
previously thought to be involved in TGFβ signalling crosstalk (P38 MAPK, MKK1 and 
PI3K kinase signalling pathways) are also not involved in the strain induced activation of 
TGFβ or consequent gene regulation. And despite the increase in COX2 mRNA expression 
preceding TGFβ activation, prostaglandin is not involved in the activation of TGFβ or gene 
regulation in response to mechanical load. An IL6 functionally inhibiting antibody did 
reduce the activation of TGFβ by ~50%, and although the activation was not completely 
abrogated, this indicates that IL6 may play a role in the activation of TGFβ in response to 
mechanical load. In apparent contradiction, IL6 knockdown showed no effect on activation 
of TGFβ, but did show an effect on MMP1. This was similar to the effect seen in MMP1 
with the IL6 inhibitory antibody. This suggests that IL6 does have some effect upon the 
regulation of MMP1 in response to mechanical load. However to confirm this more repeats 
and further pathway analysis is required. 
We were unable to determine the direct effect of Thapsigargin, 18α-glycyrrhetinic acid or 
Apyrase upon TGFβ activity, due to their inhibitory effects upon this assay. Apyrase 
addition to the cell based luciferase assay confirmed this, however due to time constraints 
we were unable to repeat this for all inhibitors. It has previously been reported that 
Thapsigargin interferes with the TGFβ luciferase assay and therefore yields an inaccurate 
measure of TGFβ (Wicks, Lui et al. 2000). It is interesting that 18α-glycyrrhetinic acid, 
Thapsigargin and Apyrase, which are all inhibitors of calcium signalling, affected the 
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efficiency of the TGFβ luciferase assay to detect TGFβ. This indicates that at least in 
SW1353 chondrosarcoma cell line calcium signalling may be involved in the regulation of 
the TGFβ signalling pathway. Wicks et al, have reported that increased cytoplasmic 
calcium can regulate SMAD function through the activity of Cam Kinases (Wicks, Lui et 
al. 2000). This shows that calcium signalling can regulate TGFβ signalling. However in the 
current tendon study this is less clear.  
In terms of mRNA regulation in response to the addition of the range of calcium inhibitors 
we see little change in the strain response of ADAM12 and Elastin expression in response 
to Gap27, amiloride or nifedipine. The addition of Thapsigargin decreased ADAM12 and 
Elastin in both strained and non-strained cultures. This indicates that increased cytosolic 
calcium has a dampening effect upon Elastin and ADAM12 gene expression which may be 
a reflection of cell viability. Therefore cell viability testing in the presence of thapsigargin 
must be completed in order to validate these experiments. Even though α18-glycerrhitinic 
acid decreased strain induced response in TGFβ, Elastin and ADAM12, the effect may be 
non-specific to connexins as it is not seen with Gap27. Although it is possible that another 
connexin is involved. U73122 increased ADAM12 expression in non-strained cultures, 
decreased ADAM12 expression in strained cultures and decreased overall expression of 
Elastin, in the absence of any differential regulation of TGFβ. This may be due to non-
specific effects of U73122, rather than its primary function of inhibiting Phospholipase C. 
Other functions of U73122 include activation of ion channels, release of calcium from 
intracellular stores and induction of IP3 mediated calcium release (Mogami, Lloyd Mills et 
al. 1997). The lack of a clear abrogation of strain induced effects indicates that another 
pathway may be affecting ADAM12 and Elastin expression independent of TGFβ 
signalling or the strain response.  
Overall this range of calcium inhibitors does not show any involvement of calcium 
signalling in the regulation of either TGFβ or gene regulation of ADAM12 or Elastin in 
response to mechanical strain. The literature reports varied strain responses in different 
species in terms of calcium transients. For example studies on cells from human flexor 
digitorum profundus tendon have shown that both fluid flow (Elfervig, Francke et al. 2000; 
Franke, Banes et al. 2000) and static elongation (4-6%) (Elfervig 2001; Wall and Banes 
2005) induce an increase in calcium. A canine ligament study showed fluid flow 
(25dynes/cm
2
) also induced significant calcium transients (Hung, Allen et al. 1997). 
However in avian and rodent tendon cell studies there was no effect of 5% cyclic loading 
Chapter 7: Further Characterisation of Mechanotransduction 
265 
 
(Wall and Banes 2004) or fluid flow
 
(Elfervig, Lotano et al. 2001; Archambault, Elfervig-
Wall et al. 2002). Therefore, the effects appear to be variable, as studies of human and 
canine but not avian and rodent species produced calcium transients in response to 
mechanical load. Although we have not confirmed whether calcium signalling is 
stimulated in response to mechanical strain in the current study, it does not seem to have an 
effect upon TGFβ activation and gene regulation in response to strain. Further study may 
involve the measurement of calcium transients in response to mechanical load in our 
system. Additional study in this area could help us to understand what stimuli is required to 
induce calcium signalling in response to mechanical strain and which types of cells are 
able to respond to mechanical strain in this way. In addition if our cells are capable of 
producing a calcium signal in response to mechanical strain, what changes occur as a result 
of this? The literature shows that collagen synthesis as well as DNA synthesis is stimulated 
in response to mechanical loading through calcium signalling via GAP junctions (Banes, 
Weinhold et al. 1999; Sood, Bynum et al. 1999). However, no direct evidence implicates 
calcium signalling in the regulation of metalloproteinases with strain. Therefore to confirm 
that collagen is regulated via calcium signalling, measurement of collagen mRNA in 
response to strain must be completed. It may be that calcium signalling specifically 
regulates collagen, is not involved in MMP regulation and that other genes are regulated 
via a different pathway. 
We were unable to measure TGFβ using the luciferase assay in cultures where Apyrase 
was added to the culture medium. However, we could use another means of TGFβ 
measurement (i.e. ELISA) to confirm whether Apyrase regulates TGFβ activity or protein 
levels in future experiments. Apyrase caused differential expression of key 
metalloproteinase and matrix genes as well as cytokines associated with tendon disease 
(Figure 7.2); however these changes did not result in the abrogation of strain induced 
regulation of these genes. MMP1, ADAM12, Elastin, IL1 and IL6 showed a trend to 
increase, TGFβ1 and TGFβ3 were not substantially regulated and TGFβ2 showed a trend 
to decrease in response to Apyrase. All of these genes showed a similar pattern of 
regulation in response to strain with or without Apyrase (i.e. the fold change with strain 
remained the same), except for IL6 which showed a trend to decrease in response to strain. 
However we cannot say that Apyrase abrogated the strain response due to the large 
stimulation of IL6 with Apyrase, in addition the changes induced by apyrase were not 
statistically significant. IL1 is a known stimulator of IL6 expression (Sironi, Breviario et 
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al. 1989), therefore the increase in IL1 in response to Apyrase treatment may be 
responsible for the induction of the IL6 response. This could be tested by the use of an IL1 
receptor antagonist. In rodent Achilles tendon studies P2Y1 and P2Y2 purinoceptors were 
shown to be responsible for downstream ATP signalling events (increase in intracellular 
calcium) (Fox, Jones et al. 2005; Jones, Yang et al. 2005). Therefore the use of more 
specific inhibitors of purinoreceptor signalling may be used to confirm these results. For 
example; Suramin, a P2 purinoreceptor inhibitor and CGS-21680, a P1 and adenosine 
purinoreceptor agonist could be used to isolate specific purinoreceptors. 
Inhibition of p38 MAPK signalling was achieved with the addition of SB203580 and 
Doramapimod. There was no substantial decrease in the level of TGFβ activated in 
response to mechanical loading. In addition there was no clear difference in the strain 
induced regulation of MMP1, MMP13, ADAMTS5 or Elastin. ADAMTS5 was increased 
in response to both of these inhibitors, although this did not affect the level of expression 
with strain. This suggests that p38 MAPK signalling does not play a role in the activation 
of TGFβ or regulation of gene expression in response to mechanical load. However, since 
activity of the kinase inhibitors was not confirmed, we cannot rule out some role for these 
pathways. To confirm this we could use western blotting of the phosphorylated and non-
phosphorylated forms of p38 from protein extracts of cells. 
Inhibition of MMK1 pathway signalling was achieved using the PD0325901 and U0126 
inhibitors. There was no substantial decrease in the level of TGFβ activated in response to 
mechanical load in response to PD0325901; however there was a decrease in active TGFβ 
when U0126 was added. Differential effects of these two inhibitors suggest that the U0126 
inhibitor is showing non-specific affects. U0126 increased the expression of MMP1 and 
decreased the expression of MMP13 in both strained and non-strained cultures. In addition, 
the strain induced increase in ADAMTS5 was abrogated in response to U0126. As this 
effect was only observed in response to U0126 and not PD0325901, this must be an 
unspecific effect unrelated to MKK1. This suggests that MKK1 is not involved in the 
mechanical activation of TGFβ or the regulation of MMP1, MMP13, ADAMTS5 or 
Elastin. As these inhibitors did produce changes in gene regulation, it appears that they do 
have some effect, although confirmation that the MKK1 pathway is specifically abrogated 
would further substantiate this negative data. 
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In order to inhibit PI3K signalling Wortmannin and PI-103 inhibitors were chosen. There 
was little affect upon the strain mediated TGFβ activation, in addition the response of 
MMP1, MMP13, ADAMTS5 and Elastin in response to mechanical loading remained 
unchanged. This suggested that PI3K is not involved in the activation of TGFβ in response 
to mechanical loading. In order to confirm these negative results, the efficacy of these 
inhibitors must be substantiated. This could be achieved by western blotting of protein 
extracts for PI3K. 
The inconsistency between pairs of inhibitors chosen for the inhibition of p38, MKK1 and 
PI3K, as well as the lack of abrogation of strain induced changes indicates a high 
probability that these pathways are not involved in the strain response. Published data 
indicates that p38 is increased in response stress deprivation in rabbit tendon (Lambert, 
Colige et al. 2001; Kawabata, Katsura et al. 2009). As we have shown that p38 may not be 
involved in the strain regulation of selected genes, this indicates that different pathways are 
activated in response to mechanical load and stress deprivation.  
Indomethacin is an NSAID that inhibits both COX1 and COX2. Previously we showed that 
COX2 was increased in trend after 2 hours in the presence of mechanical loading. 
Therefore we wanted to test whether the inhibition of COX2 would decrease the level of 
TGFβ activation in response to mechanical loading, we could then confirm whether COX2 
preceded and regulates TGFβ activation in response to mechanical load. We were also 
interested in COX2 as it is increased in tendinopathy (Legerlotz, Jones et al. 2012). 
However we have shown that neither the activation of TGFβ in response to mechanical 
load nor the regulation of metalloproteinase and matrix genes in response to load is 
abrogated by the inhibition of COX. Therefore COX2 is not involved in the regulation of 
TGFβ and matrix genes in response to mechanical load. However, in order to confirm that 
COX2 activity is abrogated by indomethacin in these experiments we could measure PGE2 
by western blotting or ELISA; As COX2 regulates the production of prostaglandins. 
We have shown that IL6 functionally inhibiting antibody reduces the activation of TGFβ 
by ~50%. We have also shown that the decrease in MMP1 seen in response to mechanical 
loading is abrogated with the addition of this same antibody. However none of the other 
genes that were analysed show the same response. As MMP13 and ADAMTS5 are not 
regulated via canonical TGFβ signalling we would not expect these genes to be regulated 
by IL6 siRNA. Elastin and COL1A1 are regulated via TGFβR1 (see chapter 4), but the 
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strain induced regulation of these genes was not inhibited by IL6 siRNA. This may be due 
to the sensitivity of these genes to TGFβ stimulation, i.e. the threshold of TGFβ signalling 
required to stimulate changes in gene regulation may be lower. Despite the effect of the 
IL6 antibody in reducing the level of active TGFβ this does not account for all TGFβ 
activation stimulated in response to mechanical loading. Therefore another mechanism 
may be involved. However IL6 inhibitory antibody experiments were only repeated on two 
cell isolates, therefore more repeats are required to confirm this. In addition siRNA 
knockdown of IL6 did not show the same decrease in TGFβ activation seen with the 
functionally inhibiting antibody. However as this experiment was limited to a single repeat, 
more replicates are also necessary to determine whether IL6 is involved in the activation of 
TGFβ. Interestingly IL6 siRNA reduced the strain induced response in MMP1 and 
MMP13, which was similar to that seen in the inhibitory antibody experiments in terms of 
MMP1. Both of these experiments show that ADAMTS5 and Elastin are not affected by 
IL6 knockdown. Therefore due to the consistency of results from two different 
mechanisms of IL6 inhibition, IL6 may be involved in MMP1 regulation. However, more 
replicates of each of these experiments are needed to validate this data. In addition, 
confirmation that the IL6 siRNA is effectively abrogating IL6 expression is required as in 
the current study we were unable to verify knockdown had occurred. However, it follows 
that if IL6 blockade does regulate TGFβ in SW1353 cells then it is possible that the same 
crosstalk between IL6 and TGFβ signalling will occur in tenocytes. 
The IL6 inhibitory antibody may be inhibiting the luciferase assay, in order to take this 
work any further this must be confirmed by adding IL6 inhibitory antibody to TGFβ 
treated cells in the luciferase assay. If this shows that IL6 inhibitory antibody is inhibiting 
the assay this would indicate that IL6 is not involved in the activation of TGFβ. However 
because IL6 inhibitory antibody reduces the MMP1 response to mechanical strain in both 
IL6 inhibitory antibody and siRNA studies that IL6 is regulating the mechanical strain 
response downstream of TGFβ activation. This may be a result of IL6 controlling 
localisation of TGFβRI to the early endosome resulting in increased TGFβ signalling or 
some other means of crosstalk (Zhang, Topley et al. 2005). Chen et al reported that IL6 can 
regulate TGFβ stimulated apoptosis via PI3K/Akt and STAT (Chen, Chang et al. 1999). 
However PI3K is not likely to be involved in the IL6 regulation of TGFβ signalling as we 
have reported that PI3K is not involved in the mechanoregulation of MMP1.  
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IL6 is a cytokine with potential pro and anti inflammatory activity and is regulated by the 
NFκB signalling pathway. IL6 signalling involves the IL6R which is made up of two 
subunits, the IL6R subunit which specifically binds to IL6 and a signal-transducing 
element also known as gp130. Upon binding of IL6 to the IL6R, gp130 homodimerize, 
resulting in the activation of associated kinases Janus and tyrosine kinases (JAK), JAK1, 
JAK2 and TYK2 resulting in the phosphorylation of the cytoplasmic tail of gp130. Signal 
transducers and activators of transcription (STATs), STAT1 and STAT3 can dock at 
phosphotyrosine residues on gp130. Upon docking STATs become phosphorylated, 
dimerize and translocate to the nucleus. At the nucleus they regulate the transcription of 
target genes (Heinrich, Behrmann et al. 1998; Maggio, Guralnik et al. 2006). Another 
pathway instigated by the binding of IL6 to the IL6R is the RAS/Raf pathway, activation 
of which causes the phosphorylation of MAPK and consequent processing of nuclear 
factor IL6 (NF-IL6). NF-IL6 can also translocate to the nucleus and regulate the 
transcription of target genes (Maggio, Guralnik et al. 2006). Among other targets of NF-
IL6 is the promoter sequence of IL6 and TNF (Akira, Isshiki et al. 1990). IL6 has been 
shown to suppress the expression of TNF as well as IL1 in mononuclear cells (Schindler, 
Mancilla et al. 1990), this fits well with our data as we have shown an increase in IL6 
mRNA, however we have not been able to detect IL1 or TNF with qRT-PCR. Therefore 
constitutively expressed or strain stimulated expression of IL6 could be regulating IL1 and 
TNF, to confirm this further analysis of IL1, IL6 and TNF at the protein level as well as 
IL6 pathway analysis is required.  
Soluble IL6R (sIL6R) can also induce IL6 signalling; IL6 bound IL6R molecules bind to 
gp130 on the cell surface resulting in activation of gp130 and consequent signalling, this 
has been termed ‘trans signalling’ (Narazaki, Yasukawa et al. 1993; Maggio, Guralnik et 
al. 2006). Soluble gp130 however can antagonise IL6 signalling by binding to IL6-sIL6R 
complexes preventing the signalling through membrane bound gp130 (Jostock, Mullberg et 
al. 2001; Maggio, Guralnik et al. 2006). As we have preliminary data that shows IL6 
inhibition may reduce the level of TGFβ activation and gene regulation in response to 
mechanical load, to validate this we could use an IL6 receptor fusion protein consisting of 
IL6R and gp130, which would prevent IL6 signalling (Metz, Wiesinger et al. 2007). The 
next step would be to characterize the mechanism by which this is controlled. This could 
be achieved by targeting the IL6 pathway in multiple ways. For example, inhibiting NFκB 
signalling by specifically inhibiting IKKβ [PS1145 and BMS 345541 (Bain, Plater et al. 
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2007)] would tell us whether the strain regulated increase in IL6 is mediated via the NFκB 
pathway. Inhibition of the IL6R using inhibitory antibodies [Tocilizumab (Maggio, 
Guralnik et al. 2006)], soluble gp130 (Nowell, Richards et al. 2003), or the JAK/STAT and 
JAK/MAPK pathways by specifically targeting JAK2 [Tyrphostin, also known as AG-490 
(Wang, Kirken et al. 1999; Maggio, Guralnik et al. 2006)] we could determine whether IL6 
signalling and consequent activation of TGFβ involves the IL6R and JAK/STAT or 
JAK/MAPK signalling. 
siRNA knockdown of all three TGFβ isoforms as well as SMAD4 has shed some light on a 
complex set of signalling mechanisms. The strain regulation of MMP1 appears to be 
decreased via the activation of TGFβ1 and despite the involvement of TGFβRI (reported in 
chapter 4) the canonical TGFβ signalling pathways is not involved, i.e. SMAD4 
knockdown does not abrogate this response. MMP13 on the other hand appears to be 
regulated by means other than TGFβ, as knockdown of TGFβ isoforms does not abrogate 
the strain induced reduction in MMP13 with strain. Previously we have shown that 
MMP13 is not regulated via TGFβRI (reported in chapter 5); however SMAD4 appears to 
be involved in MMP13 regulation with strain as knockdown of SMAD4 abrogates this 
response. This indicates that some other receptor is involved, perhaps a BMP receptor that 
also induces SMAD4 translocation to the nucleus. In chapter 4 we showed that ADAMTS5 
is stimulated by strain but this does not involve TGFβRI. In the current chapter we have 
shown that TGFβ1 and TGFβ2 may be involved in the regulation of ADAMTS5, however 
SMAD4 and TGFβ3 are not. Therefore TGFβ receptors and SMAD proteins are not 
involved in the regulation of ADAMTS5 in response to mechanical strain. A limitation of 
the siRNA knockdown studies includes the absence of a scrambled non-strain control; 
therefore non-strained treated samples cannot be properly compared to a control. To 
confirm that these different pathways of regulation exist, these experiments must be 
repeated with the inclusion of all possible control conditions. 
siRNA data also indicates that TGFβ3 induces expression of MMP1 and MMP13, as 
knockdown of TGFβ3 decreases overall expression of both MMP1 and MMP13. This 
highlights the differential effects of the different TGFβ isoforms. In addition, as TGFβ1 
appears to be responsible for the decrease in MMP1 expression in response to mechanical 
strain and it appears to be the isoform that forms the majority of active TGFβ, TGFβ1 may 
be the isoform that is responsible for the majority of gene mechanoregulation. This is 
supported by studies that have characterised the regulation of collagen through TGFβ1 in 
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response to mechanical strain (Yang, Crawford et al. 2004; Heinemeier, Olesen et al. 
2007). However, further study is required to determine the exact role of active TGFβ1 and 
TGFβ2 isoforms in the regulation of gene expression with mechanical strain. 
This chapter describes a set of preliminary data that may lead on to a further understanding 
of strain mediated modulation of gene expression. Time constraints prevented the 
completion of three repeats in all these experiments; ideally, to confirm these results at 
least three repeats would be required. In addition, cell viability assays would be important 
to confirm that these inhibitors are not inducing apoptosis or necrosis. This could be 
achieved by collagenase digestion of the gels followed by trypan blue staining and 
counting of viable and non-viable cells. Confirmation that the inhibitors effectively 
suppress their targets, the use of more specific inhibitors and the use of multiple inhibitors 
of the same target that work via different mechanisms would also substantiate the existing 
data. An increase in the number of genes analysed could lead to a further understanding of 
a greater breadth of genes that may be regulated by the aforementioned signalling 
pathways. Further characterisation of the involvement of calcium and IL6 signalling in the 
regulation of mechanotransduction may be of particular importance. Future studies may 
also include the inhibition of other pathways such as Rho/Rock and Wnt signalling as these 
pathways have also been reported in TGFβ signalling crosstalk (Moustakas and Heldin 
2005). Rho signalling has already been implicated in the regulation of Tenascin C in 
response to mechanical loading (Chiquet, Sarasa-Renedo et al. 2004). Therefore 
confirmation of the involvement of Rho signalling in Tenascin C regulation would be an 
interesting start point and to determine whether Rho signalling is involved in the regulation 
of other genes in response to mechanical loading. Interestingly Chiquet and colleagues 
reported that Tenascin C is regulated by both TGFβ and strain in a similar way via 
different signalling mechanisms; p38 MAPK is involved in the TGFβ mediated regulation, 
whereas strain regulation of Tenascin C is mediated via Rho signalling (Chiquet, Sarasa-
Renedo et al. 2004). This indicates that Tenascin C and perhaps other genes are not 
regulated through TGFβ activation and signalling in response to strain. Taken together this 
data suggests that gene expression in response to mechanical strain involves a complex 
network of signalling pathways that require further characterisation.  
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7.5. CONCLUSIONS 
1. TGFβ1 and TGFβ3 are the major isoforms activated by mechanical load 
2. Neither the strain regulation of TGFβ or gene expression was affected by p38, 
MKK1, PI3K, COX2, Gap junction, PLC or L and T Ca
2+
 channel inhibition. 
3. IL6 inhibition using an antibody reduced strain activation of TGFβ by ~50%.  
4. IL6 siRNA did not inhibit the activation of TGFβ; therefore a further mechanism is 
probably involved in strain mediated activation of TGFβ.  
5. Strain regulation of MMP1 was abrogated by the addition of IL6 functionally 
inhibiting antibody and siRNA knockdown, other genes we measured remained 
unaffected. This suggests a role for IL6 in MMP1 regulation. 
6. MMP1, MMP13 and ADAMTS5 may be regulated by distinct signalling pathways. 
  
 
 
 
CHAPTER 8:  Overall Conclusions  
 
Published work has focused on a limited number of genes in response to mechanical load 
in tendon. In chapter 3 we aimed to document mechanical regulation of a wider range of 
matrix related genes. Using TLDA analysis we showed that mechanical strain regulates of 
a wide range of metalloproteinase, TIMPs, cytokines, cell lineage markers and collagens in 
response to 2-48 hours of 0-5% cyclic loading at 1Hz in tendinopathy derived tenocytes. 
We showed that the majority of collagens, metalloproteinase and TIMP genes are regulated 
in an anabolic manner. In addition ADAMTSs, tendon cell lineage ‘markers’ were 
increased, and MMPs were decreased after 24 and 48 hours. We showed strain regulation 
of novel genes which included ADAMTS2, ADAMTS5, ADAMTS10, ADAMTS16 and 
TIMP3. Gene responses were more robust in cells seeded at the higher cell density, 
indicating that cell to cell interactions play a role in gene mechanoregulation. These 
observations led us to focus on gap junctions with respect to calcium signalling (chapter 7) 
and to integrins in terms of TGFβ activation (chapter 5). We found that not only do 
tendinopathy derived cells respond to mechanical loading but cells derived from normal 
and ruptured tendon also show a similar pattern of regulation. 
TGFβ is increased in tendinopathy (Fenwick, Curry et al. 2001; Fu, Wang et al. 2002). 
This inspired our interest in comparing the regulation of genes to strain and TGFβ 
treatment. In chapter 4 we showed that the mechanical strain regulation of protease and 
matrix genes at the mRNA level is analogous to those induced by TGFβ stimulation. 
Furthermore, the inhibition of the TGFβ signalling pathway, using a specific inhibitor of 
TGFβRI, abrogated the strain-induced changes in mRNA level. This suggested that 
mechanoregulation of gene expression is mediated via the canonical TGFβ signalling 
pathway which involves SMAD translocation to the nucleus and consequent transcriptional 
regulation. Measurement of TGFβ protein expression using a cell based luciferase assay 
showed that total TGFβ in strained and non-strained samples was similar. However, active 
TGFβ was significantly increased in strained compared to non-strained controls. TGFβ was 
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not significantly increased at the mRNA level in response to mechanical load. Therefore 
application of 5% strain at 1Hz in our model induces TGFβ activation, subsequent 
signalling and regulation of genes in response to mechanical load. In chapter 6 we used 
siRNA to inhibit all three of the TGFβ isoforms. We showed that TGFβ1 and TGFβ3 are 
the major isoforms of TGFβ activated with mechanical strain (approximately 70% and 
30% respectively). Although this experiment was only n=1 this data was supported by 
qRT-PCR where Ct values were of a similar ratio; TGFβ1, TGFβ2 and TGFβ3 had an 
average Ct of 22.5, 33.3 and 25.6 respectively. Although we have shown that TGFβ1 and 
TGFβ3 activation occurs in response to mechanical strain, we have not confirmed that both 
of these isoforms are involved in the regulation of genes seen in response to mechanical 
strain. Although, siRNA knockdown of TGFβ1 indicates that the anabolic regulation of 
MMP1 with mechanical strain is induced by TGFβ1, the strain regulation of other genes 
may be regulated by TGFβ3. Analysis of a broader range of genes in TGFβ1 and TGFβ3 
knockdown experiments would indicate whether this was the case.  
TGFβ up-regulation at both the protein and mRNA level with mechanical strain has been 
previously reported in tenocytes (Skutek, van Griensven et al. 2001; Yang, Crawford et al. 
2004) and other cell types (Riser, Cortes et al. 1996; Riser, Ladson-Wofford et al. 1999; 
Kim, Akaike et al. 2002; Baker, Ettenson et al. 2008). TGFβ1 has also been implicated as a 
regulatory step in the mechanical regulation of collagen (Yang, Crawford et al. 2004; 
Heinemeier, Olesen et al. 2007), although these studies have not specifically shown that 
activation of TGFβ is involved. Maeda and colleagues (Maeda, Sakabe et al. 2011) have 
reported TGFβ activation as a key regulator in scleraxis. However, we are the first to 
implicate TGFβ activation as a key regulator in the mechanoregulation of 
metalloproteinases and other matrix genes.  
TGFβ activation mechanisms are well characterised in the literature. In chapter 4 we 
showed that TGFβ activation and not changes in mRNA or protein was responsible for the 
strain regulated gene expression. We aimed to characterise the method of activation 
occurring in response to mechanical strain in our system.  In chapter 5 we have shown that 
metallo, serine, cysteine, aspartic proteases and aminopeptidases are not involved in the 
activation of TGFβ  in response to mechanical loading, despite the evidence to show that 
protease can play an important role in the activation of TGFβ in other systems (Lyons, 
Keski-Oja et al. 1988; Taipale, Koli et al. 1992; Yu and Stamenkovic 2000; D'Angelo, 
Billings et al. 2001; Maeda, Dean et al. 2002; Mu, Cambier et al. 2002). TSP1 has also 
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been reported to be one of the key regulators of TGFβ activation in other systems (Schultz-
Cherry and Murphy-Ullrich 1993; Crawford, Stellmach et al. 1998; Ribeiro, Poczatek et al. 
1999). In addition there is evidence to suggest that shear force is able to stimulate the 
activation of TGFβ in blood platelets (Ahamed, Burg et al. 2008), and that activation of 
TGFβ can be partially facilitated by TSP-1 (Ahamed, Janczak et al. 2009). However, we 
showed that the interaction between thrombospondin and LAP via the LSKL motif is not 
involved in the activation of TGFβ in response to mechanical load; this could be due to 
differences in force (shear and tensional force) or cell type (blood platelets and tenocytes). 
M6P/IGF-II interaction with LAP has also been shown to regulate TGFβ activation in 
other tissues (Dennis and Rifkin 1991), here we show that TGFβ activation does not 
involve the interaction of TGFβ and M6P/IGF-II via M6P. Therefore none of the major 
mechanisms of TGFβ activation were responsible for the activation of TGFβ in response to 
strain. A novel and as yet undetermined method of TGFβ activation may be responsible. 
As we were unable to pinpoint the mechanism of TGFβ activation induced in response to 
mechanical loading we widened our studies to encompass a wider range of signalling 
mediators that may be involved in the mechanical regulation of gene expression we 
showed in chapter 4. In a range of preliminary experiments we showed that calcium 
signalling via GAP junctions, phospholipase conversion of PIP2 to PI3 kinase, as well as 
the transport of calcium via L and T type calcium channels are not involved in the 
activation of TGFβ with strain or proceeding gene regulation. MAP kinase signalling 
pathways previously thought to be involved in TGFβ signalling crosstalk (P38 MAPK, 
MKK1 and PI3K kinase signalling pathways) are also not involved in the strain induced 
activation of TGFβ or consequent gene regulation. And despite the increase in COX2 
mRNA expression preceding TGFβ activation COX2 is not involved in the activation of 
TGFβ or gene regulation in response to mechanical load. IL6 mRNA was also induced at 
an early time point (2 hours) in response to strain, preceding the activation of TGFβ. 
Therefore in order to test the hypothesis that IL6 is involved in the activation of TGFβ, we 
used an IL6 functionally inhibiting antibody against IL6. IL6 abrogation using the 
inhibitory antibody reduced the activation of TGFβ by ~50%. In contrast, IL6 siRNA 
knockdown did not show the same abrogation of TGFβ activation. The functionally 
inhibitory antibody and the IL6 siRNA, however, decreased the MMP1 response to strain. 
This suggests that IL6 does have some effect upon the regulation of MMP1 in response to 
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mechanical load. This also showed that different genes are regulated by different means as 
the other genes analysed did not respond to IL6 inhibition in the same manner.  
siRNA knockdown of TGFβ3 indicates that TGFβ3 induces expression of MMP1 and 
MMP13, as knockdown of TGFβ3 decreases overall expression of both MMP1 and 
MMP13. This highlights the differential effects of the different TGFβ isoforms. As TGFβ3 
increases overall MMP1 and MMP13 expression, it appears that TGFβ1 is the primary 
TGFβ involved in the regulation of genes in response to mechanical strain. With reference 
to the anabolic or catabolic affects produced in response to TGFβ1 and TGFβ3 
(respectively), differential expression of different isoforms of TGFβ as well as receptor 
expression could be involved in the development of pathology in tendon (Fenwick, Curry 
et al. 2001). 
siRNA knockdown of the different TGFβ isoforms as well as SMAD4 allowed us to 
further characterise mechanotransduction pathways. The strain regulation of MMP1 
appears to be decreased via the activation of TGFβ1 and despite the involvement of 
TGFβRI (reported in chapter 4) the canonical TGFβ signalling pathways is not involved, 
i.e. SMAD4 knockdown does not abrogate this response. MMP13 on the other hand 
appears to be regulated by means other than TGFβ, as knockdown of TGFβ isoforms does 
not abrogate the strain induced reduction in MMP13 with strain. SMAD4 appears to be 
involved in MMP13 regulation with strain as knockdown of SMAD4 abrogates this 
response, although we have also shown that MMP13 is not regulated via TGFβRI (reported 
in chapter 4). This indicates that some other receptor is involved, perhaps a BMP receptor 
that also induces SMAD4 translocation to the nucleus.  In chapter 5 we showed that 
ADAMTS5 is stimulated by strain but this does not involve TGFβRI. In chapter 7 we 
showed that TGFβ1 and TGFβ2 may be involved in the regulation of ADAMTS5, however 
SMAD4 and TGFβ3 are not.  This suggests that ADAMTS5 is regulated by TGFβ but not 
as a result of canonical TGFβ signalling.  
We therefore have evidence to show that MMP1, MMP13 and ADAMTS5 are regulated 
via separate pathways, and that each involves TGFβ signalling in some way. However to 
confirm these different pathways of regulation exist these experiments must be repeated 
and extended. By understanding this complex set of regulatory mechanisms we may be 
able to determine whether dysregulation of this system is involved in the development of 
tendinopathy. 
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FUTURE WORK 
 
 Repetition of incomplete studies  
 Verification of inhibitor efficacy in the studies described in this thesis 
IL6 characterisation 
 To test whether IL6 antibody is inhibiting the TGFβ luciferase assay 
 Validation of the role of IL6 in MMP1 regulation with strain 
 Further characterisation of IL6 signalling and how this relates to the strain response 
Further characterisation of strain regulated gene expression 
 To characterise the different signalling pathways that regulate MMP1, MMP13 and 
ADAMTS5 in response to mechanical strain 
 To determine whether other genes are regulated by the same mechanisms 
 To inhibit Rho/Rock and Wnt signalling 
TGFβ activation 
 Measurement of LTBP and identification of whether LTBP targets the LLC 
complex to the ECM 
 Identification of whether inactive TGFβ measured in the luciferase assay, is 
associated with a proportion of the LLC 
 Identification of TGFβ activation mechanisms (i.e. inhibition of other proteases 
such as BMP1) 
Mechanical stress 
 To determine how much strain that the cell seeded collagen gels undergo in the 
Flexcell
TM
 system, during 48 hours of loading 
 To determine the level of strain that tenocytes are exposed to 
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Abbreviations 
 
α-SMA  Alpha Smooth Muscle Actin 
 
18S   18s Ribosomal Ribonucleic Acid 
a1-PI   Alpha 1-Proteinase Inhibitor 
a2-M   Alpha 2-Macroglobulin 
ACAN   Aggrecan 
ACL    Anterior Cruciate Ligament 
ACTA1   Alpha Smooth Muscle Actin 
ACTA2   α Smooth Muscle Actin  
ADAM  A Disintegrin And Metalloproteinase 
ADAMTS  A Disintegrin And Metalloproteinase with Thrombospondin motifs 
AEBSF   4-(2-aminoethyl) benzenesulfonyl fluoride 
APP   Amyloid Precursor Protein 
APS    Ammonium persulphate 
ATP   Adenosine Triphosphate 
bFGF    Basic Fibroblast Growth Factor  
BGN    Biglycan 
BMP    Bone Morphogenic Proteins  
BSA   Bovine Serum Albumin 
CA   Cysteine Array 
Ca
2+
   Calcium 
CaCl   Calcium Chloride 
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cAMP    Cyclic Adenosine Monophosphate 
CCD    Charge-Coupled Device 
cAMP   Cyclic adenosine monophosphate 
cMMP   Chicken MMP;  
COL1A1   Collagen, type I, alpha 1 
COL2A1   Collagen, type II, alpha 1 
COL3A1   Collagen, type III, alpha 1 
COL12A1   Collagen, type XII, alpha 1 
COL14A1   Collagen, type XIV, alpha 1 
COMP   Complex Oligomeric Matrix Protein 
COX2   Cyclooxygenase 2 
CS   Chondroitin sulphate  
CTGF    Connective Tissue Growth Factor 
Cx    Connexins 
DAG    1,2-diacylglycerol 
DAPI    4',6-diamidino-2-phenylindole 
DCN    Decorin 
DMEM   Dulbecco’s modified Eagle’s medium 
DMSO   Dimethyl sulfoxide 
DNA   Deoxyribonucleic Acid 
dNTP’s  Deoxyribonucleotide triphosphate  
DTT   Dithiothreitol 
ECM   Extracellular Matrix 
EDTA   Ethylenediaminetetraacetic acid 
EEA-1   Early Endosome Antigen-1 
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ER    Endoplasmic reticulum 
ERK   extracellular-signal-regulated kinases  
FACIT   Beaded Filament Collagen and Fibril-Associated Collagen with 
Interrupted Triple Helix 
FAK    Focal Adhesion Kinase 
Fas-L   Fas Ligand 
FBN   Fibronectin 
FGF   Fibroblast Growth Factor 
Fn   Fibronectin 
GAG    Glycosaminoglycans 
GAPDH   Glyceraldehyde 3-phosphate dehydrogenase 
GDF    Growth and Differentiation Factors 
GF    Growth Factor;  
GPI   Glycosylphosphatidylinositol 
GRM   Metabotropic glutamate receptor 
GTP   Guanadine Tri-Phosphate 
HAPLN1   Link Protein 
HB-EGF  Heparin-Binding Epidermal Growth Factor  
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HGNC   HUGO Gene Nomenclature Committee 
ICAM   Intercellular Adhesion Molecule 
IGF   Insulin-like Growth Factor 
IGFBP   Insulin-Like Growth Factor Binding Protein 
IKK   Inhibitor of Kappa B Kinase   
IL   Interleukin 
IL1B    Interleukin 1B 
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IL4    Interleukin 4 
IL6    Interleukin 6 
IL6R    Interleukin 6 Receptor 
IL17A   Interleukin 17A 
IL6R   Interleukin-6 Receptor 
IP3   Inositol (1,4,5)-Triphosphate 
I-SMAD  Inhibitory SMAD 
JNK    c-JUN end terminal Kinases 
Kit-L   kit Ligand 
KL-1   Kit-Ligand-1 
KS   keratin sulphate at one domain 
LAP    Latency Associated Peptide 
LLC    Large Latent Complex 
Ln   Laminin 
LTBP   Large TGFβ Binding Protein 
LUM    Lumican 
M6P   Mannose-6-Phosphate 
M6P/IGF-II  Mannose 6-Phosphate/Insulin-Like Growth Factor-II Receptor  
MAGP1   Microfibril Associated Glycoproteins  
MAPK   Mitogen Activated Protein Kinase 
MBP   Myelin Basic Protein 
MCL    Medial Collateral ligament 
MCP-3  Monocyte Chemotactic Protein-3 
METH-1  Methamphetamine-1 (Human ortholog of ADAMTS-1) 
METH-2  Methamphetamine-2 
Chapter 8: Overall Conclusions 
282 
 
MFS    Marfan syndrome 
MKK1   Mitogen Activated protein Kinase Kinase 1 
MMP   Matrix Metalloproteinase 
MT1-MMP  Membrane-Type Matrix Metalloproteinase 
NA   Not Applicable  
Na
+  
 Sodium 
NAD
+   
Nicotinamide Adenine Dinucleotide  
NaOH    Sodium Hydroxide 
ND   No Data 
NF-IL6  Nuclear Factor Interleukin 6 
NFκB    Nuclear Factor Kappa B  
NO    Nitric Oxide 
NS    Not Significant 
NSAID  Non-steroidal Anti-inflammatory Drug 
OD    Optimum Density 
PBS   Phosphate Buffered Saline 
PDGF    Platelet Derived Growth Factor 
PG   Proteoglycan 
PGE2   Prosteglandin E2  
PI3   Phosphatidylinositol 3 
PIP2   Phophatidylinositol 4,5-bisphosphate 
PKC    Protein Kinase C 
PLC    Phospholipase C  
Pro   Proteinase type 
pro-IL-1  Pro-Interleukin 1 
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ProMMP  Latent Matrix Metalloproteinase 
proTGF-b  Pro Transforming Growth Factor beta 
proTNF-a  Pro Tumor Necrosis Factor-alpha 
PTGS2   Cyclooxygenase 2 
PUMP   Putative Metalloproteinase 
PVDF    Polyvinylidene Flouride membrane 
qRT-PCR   Quantitative Real Time Polymerase Chain Reaction 
RANKL  Receptor Activator of Nuclear Factor Kappa B Ligand 
RASI-1  Rheumatoid Arthritis Synovium Inflamed 1 
RNA   Ribonucleic Acid 
ROCK   Rho/ Rho associated protein kinase 
ROS   Reactive Oxygen Species 
R-SMAD  Receptor Regulated SMAD 
SAPK    Stress Activated Protein Kinase 
SARA   SMAD anchor for receptor activation 
SCX    Scleraxis 
SD   Standard Deviation 
SDFT    Superficial Digital Flexor Tendon 
SDS   Sodium Dodecyl Sylphate 
SDS-PAGE   Polyacrylamide Gel Electrophoresis 
SE    Standard error 
siRNA   Small Interfering Ribonucleic Acid 
SLC    Small Latent Complex 
SLRP    Small leucine rich proteoglycans 
SOX9 SRY(sex determining region Y) -type HMG (High mobility group 
box) 
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STAT3  Signal Transducers and Activators of Transcription 
TBS    Tris Buffered Saline Solution 
TCA    Trichloroacetic Acid 
TEMED   Tetramethylethylenediamine 
TESPA   3-triethoxysilylpropylamine 
 TF   Transcription Factor;  
TGFB1   Transforming Growth Factor β1 
TGFβ   Transforming growth factor beta 
TGFβRI  Transforming Growth factor beta receptor I 
TGFβRII  Transforming Growth factor beta receptor I 
THBS1 / TSP1 Thrombospondin -1 
TIMP   Tissue Inhibitor of Metalloproteinase 
TLDA   Taqman Low density array 
TNC    Tenascin C 
TNF   Tumour Necrosis Factor  
TNMD   Tenomodulin 
TOP1    Topoisomerase 1 
TRANCE  TNF-related activation induced cytokine. 
TSP1   Thrombospondin-1 
uPA   Urokinase Plasminogen Activator 
VCAN   Versican 
VLA   Very Late Antigen 
vWF    Von Willebrand Factor 
vWFCP   Von Willebrand Factor-Cleaving Protease 
xMMP   Xenopus Matrix Metalloproteinase
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